data_2l4t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.825 0.821 . . . . 1.4299999999999999 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.988 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.8500000000000001 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 2.27 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.3100000000000001 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 4.3499999999999996 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.427 HG21 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 1.4299999999999999 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.758 HG23 ' HA ' ' A' ' 66' ' ' ALA . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 1.6100000000000001 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 4.3099999999999996 114.192 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.971 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.869 -0.789 . . . . 0.87 108.869 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.6699999999999999 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 1.54 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.84999999999999998 112.316 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.45 109.708 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.443 -0.871 0 CA-C-O 120.696 0.053 . . . . 1.3 113.114 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.626 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 1.3600000000000001 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.8900000000000001 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.768 HG23 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 1.3700000000000001 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.45 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.531 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.6000000000000001 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.971 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 1.3799999999999999 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 2.1299999999999999 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.2799999999999998 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.76 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 1.0900000000000001 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 1.48 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 1.1200000000000001 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.48999999999999999 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 2.2200000000000002 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.3599999999999999 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 1.24 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.59999999999999998 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.453 ' HB2' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.3500000000000001 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.6800000000000002 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 1.3200000000000001 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 1.1299999999999999 111.206 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.973 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.2599999999999998 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG23 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 1.45 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.8999999999999999 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1000000000000001 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 3.5099999999999998 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.96 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.6100000000000001 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.973 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.8400000000000001 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.75 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.838 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 2.1499999999999999 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.686 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.48 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.484 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 59.8 t-80 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 3.1000000000000001 110.912 -174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.594 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.8100000000000001 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.838 ' HB2' HG12 ' A' ' 88' ' ' VAL . 4.9 mm100 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.9700000000000002 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 1.4299999999999999 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.535 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 4.5199999999999996 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.9300000000000002 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.628 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 4.3899999999999997 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.77 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.8300000000000001 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.566 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 2.25 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.7599999999999998 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.566 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.6699999999999999 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.1099999999999999 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.9399999999999999 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.73 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 18' ' ' ILE . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.71 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.5800000000000001 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 2.0299999999999998 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 2.1600000000000001 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.76 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 1.27 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.988 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.96 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.8300000000000001 111.521 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.484 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 21.1 m . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.729 0.27 . . . . 1.3200000000000001 111.729 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.6600000000000001 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.51 HG13 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 2.0699999999999998 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 121.638 0.732 . . . . 1.4299999999999999 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.8500000000000001 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 2.27 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.537 HE22 ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.3100000000000001 108.818 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.4 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 4.3499999999999996 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 1.4299999999999999 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.623 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 1.6100000000000001 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.534 ' HB3' HG21 ' A' ' 104' ' ' VAL . 20.6 p80 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 4.3099999999999996 112.314 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 1.042 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.843 -0.428 . . . . 0.87 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.682 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.6699999999999999 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 HG22 ' A' ' 57' ' ' VAL . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 1.54 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.84999999999999998 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.45 112.285 178.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.782 -0.127 . . . . 1.3 112.782 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 1.3600000000000001 110.154 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.8900000000000001 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HD13 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 1.3700000000000001 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.45 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.682 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.6000000000000001 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.042 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 1.3799999999999999 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 2.1299999999999999 107.113 162.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.2799999999999998 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 68' ' ' ILE . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.76 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 1.0900000000000001 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 1.48 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 1.1200000000000001 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 2.2200000000000002 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.522 ' N ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.3599999999999999 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 1.24 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.413 ' H ' HG13 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.3500000000000001 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.6800000000000002 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 1.3200000000000001 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.603 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 1.1299999999999999 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.752 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.2599999999999998 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG13 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 1.45 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 31.4 m-80 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.8999999999999999 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1000000000000001 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.528 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 3.5099999999999998 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.745 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.6100000000000001 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.752 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.8400000000000001 111.892 -170.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.75 110.942 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.44 HG13 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 2.1499999999999999 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.832 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.48 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 3.1000000000000001 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.8100000000000001 110.118 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.832 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.9700000000000002 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 1.4299999999999999 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 4.5199999999999996 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.9300000000000002 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 4.3899999999999997 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.77 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.8300000000000001 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 2.25 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.7599999999999998 111.188 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.533 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.6699999999999999 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.709 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.1099999999999999 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.9399999999999999 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.73 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.71 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.771 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.5800000000000001 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 2.0299999999999998 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 2.1600000000000001 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.76 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.652 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 1.27 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.537 ' HB2' HE22 ' A' ' 14' ' ' GLN . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.96 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.635 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.8300000000000001 108.626 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.893 -0.41 . . . . 1.3200000000000001 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.695 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.6600000000000001 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 31' ' ' PHE . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 2.0699999999999998 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.855 0.36 . . . . 1.4299999999999999 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.8500000000000001 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 2.27 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.437 ' O ' HG13 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.3100000000000001 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 4.3499999999999996 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 1.4299999999999999 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.828 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 1.6100000000000001 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 4.3099999999999996 112.005 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 120.507 0.194 . . . . 0.87 110.639 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.6699999999999999 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.664 HD13 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 1.54 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.84999999999999998 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.45 109.925 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.237 0.303 0 N-CA-C 112.838 -0.105 . . . . 1.3 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.563 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 1.3600000000000001 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.8900000000000001 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 1.3700000000000001 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.45 109.267 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.6000000000000001 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.965 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 1.3799999999999999 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 2.1299999999999999 107.254 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.2799999999999998 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.544 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.76 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.769 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 1.0900000000000001 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 1.48 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 1.1200000000000001 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.48999999999999999 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.782 HD13 HG22 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 2.2200000000000002 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.648 ' N ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.3599999999999999 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 1.24 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.625 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.59999999999999998 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.3500000000000001 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.6800000000000002 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 1.3200000000000001 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.594 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 1.1299999999999999 110.518 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HE2' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 1.45 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.8999999999999999 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1000000000000001 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.636 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 3.5099999999999998 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.87 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.6100000000000001 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.8400000000000001 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.75 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 2.1499999999999999 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.48 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.664 ' HE1' HD13 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 3.1000000000000001 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.8100000000000001 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.659 ' CB ' HG12 ' A' ' 88' ' ' VAL . 6.5 mm100 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.9700000000000002 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 1.4299999999999999 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 4.5199999999999996 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.9300000000000002 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 4.3899999999999997 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.69 HD13 HG22 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.77 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.8300000000000001 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 2.25 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.7599999999999998 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.668 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.6699999999999999 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.1099999999999999 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.9399999999999999 107.369 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.73 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.828 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.71 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.5800000000000001 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 2.0299999999999998 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 2.1600000000000001 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.687 HG21 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.76 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.74 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 1.27 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.96 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.8300000000000001 110.324 174.286 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.69 -1.226 . . . . 1.3200000000000001 107.69 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.6 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.6600000000000001 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 2.0699999999999998 109.988 178.623 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 122.349 1.071 . . . . 1.4299999999999999 111.059 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.8500000000000001 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 2.27 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.3100000000000001 109.765 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.692 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 4.3499999999999996 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 1.4299999999999999 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 1.6100000000000001 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 . . . . . 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 4.3099999999999996 114.335 -171.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 . . . . . 0 C--O 1.222 -0.371 0 N-CA-C 110.468 -0.197 . . . . 0.87 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.6699999999999999 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 1.54 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.84999999999999998 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.45 110.729 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 115.014 0.766 . . . . 1.3 115.014 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 1.3600000000000001 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.8900000000000001 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 1.3700000000000001 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.45 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.6000000000000001 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 1.3799999999999999 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 2.1299999999999999 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.2799999999999998 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.646 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' O ' HG13 ' A' ' 68' ' ' ILE . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.76 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 1.0900000000000001 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 1.48 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 1.1200000000000001 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.48999999999999999 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 2.2200000000000002 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.578 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.3599999999999999 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 59' ' ' ARG . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 1.24 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.59999999999999998 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.3500000000000001 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.6800000000000002 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 HG21 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 1.3200000000000001 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.546 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 1.1299999999999999 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.2599999999999998 111.246 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 1.45 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.612 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.8999999999999999 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1000000000000001 112.928 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 3.5099999999999998 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.6100000000000001 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.778 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.8400000000000001 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.75 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.861 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.48 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.673 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 3.1000000000000001 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.8100000000000001 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.861 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.9700000000000002 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 1.4299999999999999 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.673 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 4.5199999999999996 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.9300000000000002 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 4.3899999999999997 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.742 HD11 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.77 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.742 HG23 HD11 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.8300000000000001 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 2.25 109.213 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.7599999999999998 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.6699999999999999 113.364 -171.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.1099999999999999 111.418 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.9399999999999999 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.73 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.71 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.612 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.5800000000000001 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 2.0299999999999998 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 2.1600000000000001 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.76 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 1.27 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.96 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.466 HE22 ' HA ' ' A' ' 11' ' ' ALA . 17.1 mm-40 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.8300000000000001 110.95 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.601 -0.518 . . . . 1.3200000000000001 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.6600000000000001 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.611 HG13 HD13 ' A' ' 97' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 2.0699999999999998 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.66 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.51 -0.552 . . . . 1.4299999999999999 109.51 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.8500000000000001 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 2.27 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.639 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 5.2 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.3100000000000001 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 4.3499999999999996 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG11 HD22 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 1.4299999999999999 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.834 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 1.6100000000000001 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.556 ' HB2' HG21 ' A' ' 104' ' ' VAL . 10.5 t-160 . . . . . 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 4.3099999999999996 112.234 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.942 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.87 108.302 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.676 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.6699999999999999 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 1.54 110.247 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.84999999999999998 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . . . . . . 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.45 112.091 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.691 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.3 115.042 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 1.3600000000000001 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.8900000000000001 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 1.3700000000000001 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.45 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.6000000000000001 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.942 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 1.3799999999999999 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.476 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 2.1299999999999999 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.2799999999999998 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.546 ' O ' HG13 ' A' ' 68' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.76 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 1.0900000000000001 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 1.48 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 1.1200000000000001 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.48999999999999999 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 2.2200000000000002 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.3599999999999999 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 1.24 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.59999999999999998 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.3500000000000001 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.6800000000000002 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.705 ' HB ' HG23 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 1.3200000000000001 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.574 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 1.1299999999999999 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.043 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.2599999999999998 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 1.45 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.534 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.8999999999999999 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1000000000000001 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.487 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 3.5099999999999998 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.863 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.6100000000000001 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.8400000000000001 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.75 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 2.1499999999999999 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.865 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.48 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.748 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 3.1000000000000001 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.8100000000000001 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.865 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.9700000000000002 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 1.4299999999999999 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.702 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 4.5199999999999996 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.9300000000000002 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 4.3899999999999997 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.77 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.8300000000000001 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 2.25 111.534 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.488 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.7599999999999998 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.6699999999999999 110.089 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.1099999999999999 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.595 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.9399999999999999 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 103' ' ' GLU . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.73 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.71 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.5800000000000001 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.834 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 2.0299999999999998 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 1.043 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 2.1600000000000001 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.76 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 1.27 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.639 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.96 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' A' ' 11' ' ' ALA . 24.5 mm-40 . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.8300000000000001 109.961 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.952 -0.388 . . . . 1.3200000000000001 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.6600000000000001 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 2.0699999999999998 110.347 -172.24 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 N--CA 1.445 -0.708 0 CA-C-O 121.525 0.678 . . . . 1.4299999999999999 110.466 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.8500000000000001 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 2.27 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 9.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 109.946 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' CD ' HD12 ' A' ' 108' ' ' LEU . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 4.3499999999999996 108.806 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 1.4299999999999999 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.798 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.712 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 1.6100000000000001 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' HB3' HG23 ' A' ' 104' ' ' VAL . 26.8 p80 . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 4.3099999999999996 112.25 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.743 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.894 0.378 . . . . 0.87 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.6699999999999999 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 57' ' ' VAL . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 1.54 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.84999999999999998 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.625 ' HA2' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.45 110.14 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 N-CA-C 114.797 0.679 . . . . 1.3 114.797 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.625 HD12 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 1.3600000000000001 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.798 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.8900000000000001 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.738 HG11 ' H ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 1.3700000000000001 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.45 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.582 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.6000000000000001 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.743 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 1.3799999999999999 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 2.1299999999999999 107.907 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.2799999999999998 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.76 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 1.0900000000000001 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 1.48 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 1.1200000000000001 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.48999999999999999 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.832 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 2.2200000000000002 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.832 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.3599999999999999 106.66 -175.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 1.24 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.798 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.59999999999999998 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' OD1' ' HB ' ' A' ' 109' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.3500000000000001 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.678 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.6800000000000002 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.606 ' HA ' HG13 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 1.3200000000000001 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.608 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 1.1299999999999999 111.537 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.882 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.2599999999999998 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.618 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 1.45 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.8999999999999999 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1000000000000001 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.618 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 3.5099999999999998 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.882 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.6100000000000001 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.546 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.8400000000000001 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.75 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.723 HG12 ' NE2' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 2.1499999999999999 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.48 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 3.1000000000000001 111.633 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.8100000000000001 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.866 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.9700000000000002 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 1.4299999999999999 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 4.5199999999999996 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.866 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.9300000000000002 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 4.3899999999999997 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.77 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.58 HG22 HD13 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.8300000000000001 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.694 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 2.25 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.7599999999999998 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.694 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.6699999999999999 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.1099999999999999 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.9399999999999999 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.73 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 18' ' ' ILE . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.71 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.5800000000000001 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.7 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 2.0299999999999998 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 2.1600000000000001 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.644 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.76 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 1.27 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.96 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' A' ' 11' ' ' ALA . 28.6 mm-40 . . . . . 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.8300000000000001 112.612 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.3200000000000001 114.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.535 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.6600000000000001 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.509 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 2.0699999999999998 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.931 0.872 . . . . 1.4299999999999999 110.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.8500000000000001 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 2.27 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 109.599 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' HD13 ' A' ' 108' ' ' LEU . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 4.3499999999999996 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' A' ' 107' ' ' LEU . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 1.4299999999999999 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.723 HG12 ' CD2' ' A' ' 107' ' ' LEU . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 1.6100000000000001 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 . . . . . 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 4.3099999999999996 112.242 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.87 108.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.6699999999999999 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.931 HG23 HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 1.54 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.84999999999999998 113.761 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.45 112.538 174.055 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 114.19 0.436 . . . . 1.3 114.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.609 HG21 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 1.3600000000000001 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.8900000000000001 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.931 HG21 HG23 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 1.3700000000000001 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.45 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.6000000000000001 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.984 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 1.3799999999999999 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 2.1299999999999999 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.2799999999999998 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.76 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HA ' HG21 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 1.0900000000000001 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 1.48 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 1.1200000000000001 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.48999999999999999 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 2.2200000000000002 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.624 HE22 ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.3599999999999999 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 1.24 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.782 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.59999999999999998 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.624 ' HB2' HE22 ' A' ' 72' ' ' GLN . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.3500000000000001 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.872 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.6800000000000002 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.712 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 1.3200000000000001 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.872 ' HE1' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 1.1299999999999999 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.896 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.2599999999999998 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.853 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 1.45 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.8999999999999999 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1000000000000001 113.902 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.682 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 3.5099999999999998 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.896 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.6100000000000001 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.534 ' HG2' HG11 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.8400000000000001 114.526 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.75 110.936 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.584 HG21 ' N ' ' A' ' 89' ' ' THR . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 2.1499999999999999 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.584 ' N ' HG21 ' A' ' 88' ' ' VAL . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.48 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.469 ' HE1' HD12 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 3.1000000000000001 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.8100000000000001 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.9700000000000002 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 1.4299999999999999 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 4.5199999999999996 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.609 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.9300000000000002 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 4.3899999999999997 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.77 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.8300000000000001 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 2.25 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.7599999999999998 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.595 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.6699999999999999 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.1099999999999999 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.9399999999999999 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.71 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.726 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.5800000000000001 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.723 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 2.0299999999999998 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 2.1600000000000001 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.76 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 1.27 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.96 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.8300000000000001 111.879 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.3200000000000001 114.071 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.6600000000000001 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 2.0699999999999998 110.02 177.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 CA-C-O 121.417 0.627 . . . . 1.4299999999999999 110.298 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.8500000000000001 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 2.27 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.499 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.3100000000000001 109.496 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 4.3499999999999996 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.598 HG11 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 1.4299999999999999 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.723 HG12 ' CD2' ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 1.6100000000000001 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HB2' HG21 ' A' ' 104' ' ' VAL . 8.4 t-160 . . . . . 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 4.3099999999999996 110.505 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.859 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.756 -0.091 . . . . 0.87 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.6699999999999999 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 1.54 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.84999999999999998 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.45 112.229 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.319 0.488 . . . . 1.3 114.319 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.568 HD13 ' HD1' ' A' ' 90' ' ' HIS . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 1.3600000000000001 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.8900000000000001 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG21 ' A' ' 33' ' ' ILE . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 1.3700000000000001 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.45 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.6000000000000001 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 1.3799999999999999 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.577 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.2799999999999998 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.76 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 1.0900000000000001 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 1.48 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 1.1200000000000001 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.48999999999999999 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 2.2200000000000002 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.3599999999999999 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 1.24 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.59999999999999998 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.3500000000000001 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.6800000000000002 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.719 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.58 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 1.1299999999999999 109.538 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.044 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 22.2 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.2599999999999998 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 1.45 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.901 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.8999999999999999 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1000000000000001 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 3.5099999999999998 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.995 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.6100000000000001 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.482 ' HB2' ' H ' ' A' ' 86' ' ' THR . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.8400000000000001 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.75 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG11 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 2.1499999999999999 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.765 HG21 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.48 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.598 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 3.1000000000000001 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.8100000000000001 110.544 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.765 ' HG2' HG21 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.9700000000000002 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 1.4299999999999999 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 4.5199999999999996 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.9300000000000002 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.712 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 4.3899999999999997 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.77 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.72 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.8300000000000001 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 2.25 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.7599999999999998 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.477 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.6699999999999999 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.1099999999999999 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.524 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.9399999999999999 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.73 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.71 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.901 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.5800000000000001 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.723 ' CD2' HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 2.0299999999999998 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 2.1600000000000001 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.76 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 1.27 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.552 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.96 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.8300000000000001 108.434 169.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.517 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.8 0.334 . . . . 1.3200000000000001 110.216 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.725 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.6600000000000001 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.514 HG22 ' CE1' ' A' ' 31' ' ' PHE . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 2.0699999999999998 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.05 0 CA-C-O 121.76 0.791 . . . . 1.4299999999999999 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.8500000000000001 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 2.27 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.409 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.738 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 4.3499999999999996 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 1.4299999999999999 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.862 HD11 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 1.6100000000000001 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.744 ' HA ' HG23 ' A' ' 104' ' ' VAL . 14.0 t-160 . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 4.3099999999999996 110.52 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.72 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 110.615 -0.143 . . . . 0.87 110.615 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.893 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.6699999999999999 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 1.54 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.84999999999999998 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.45 111.854 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 114.331 0.493 . . . . 1.3 114.331 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 1.3600000000000001 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.8900000000000001 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 1.3700000000000001 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.45 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.893 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.6000000000000001 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.72 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 1.3799999999999999 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 2.1299999999999999 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.2799999999999998 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.76 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 1.0900000000000001 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 1.48 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 1.1200000000000001 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.48999999999999999 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 2.2200000000000002 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.3599999999999999 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 1.24 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.683 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.59999999999999998 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.581 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.3500000000000001 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.6800000000000002 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.697 HG21 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 1.3200000000000001 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 1.1299999999999999 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.795 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.2599999999999998 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 1.45 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1000000000000001 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.563 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 3.5099999999999998 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.795 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.6100000000000001 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.766 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.8400000000000001 112.397 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.75 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.663 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 2.1499999999999999 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.48 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 3.1000000000000001 110.592 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.721 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.8100000000000001 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.663 ' CB ' HG12 ' A' ' 88' ' ' VAL . 7.5 mm100 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.9700000000000002 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 1.4299999999999999 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.721 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 4.5199999999999996 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.9300000000000002 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 4.3899999999999997 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.705 HD13 HG21 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.77 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.705 HG21 HD13 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.8300000000000001 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 2.25 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.7599999999999998 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.6699999999999999 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.741 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.9399999999999999 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.744 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.73 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 18' ' ' ILE . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.71 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.5800000000000001 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 2.0299999999999998 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.738 ' CD2' ' HG2' ' A' ' 15' ' ' ARG . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 2.1600000000000001 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.76 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 1.27 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.96 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.8300000000000001 109.479 174.468 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.898 -0.038 . . . . 1.3200000000000001 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.684 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.6600000000000001 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 2.0699999999999998 108.584 178.231 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 CA-C-O 121.818 0.818 . . . . 1.4299999999999999 109.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.8500000000000001 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 2.27 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.3100000000000001 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.54 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 4.3499999999999996 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 1.4299999999999999 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 1.6100000000000001 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 . . . . . 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 4.3099999999999996 111.425 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.836 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 . . . . . 0 C--O 1.242 0.659 0 CA-C-O 120.801 0.334 . . . . 0.87 111.479 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.6699999999999999 111.381 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 1.54 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.84999999999999998 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.45 111.265 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.434 -1.472 0 CA-C-O 120.942 0.19 . . . . 1.3 113.356 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 1.3600000000000001 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.8900000000000001 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 1.3700000000000001 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.45 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HA ' HG21 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.6000000000000001 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.836 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 1.3799999999999999 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 2.1299999999999999 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.763 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.2799999999999998 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.56 ' O ' HG13 ' A' ' 68' ' ' ILE . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.76 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 1.0900000000000001 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.763 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 1.48 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 1.1200000000000001 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.48999999999999999 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.857 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 2.2200000000000002 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.857 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 1.24 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.856 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.59999999999999998 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.621 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.3500000000000001 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.6800000000000002 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 1.3200000000000001 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.552 ' HE3' ' HB3' ' A' ' 76' ' ' LYS . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.386 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.2599999999999998 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 1.45 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.8999999999999999 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1000000000000001 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.654 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 3.5099999999999998 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.6100000000000001 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.513 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.8400000000000001 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.75 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.865 HG12 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 2.1499999999999999 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.965 HG23 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.48 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.685 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 3.1000000000000001 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.8100000000000001 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.965 ' HB2' HG23 ' A' ' 89' ' ' THR . 8.6 tp-100 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.9700000000000002 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 1.4299999999999999 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.685 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 4.5199999999999996 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.9300000000000002 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.654 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 4.3899999999999997 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.614 HD13 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.77 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.614 HG23 HD13 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.8300000000000001 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.749 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 2.25 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.7599999999999998 110.974 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.6699999999999999 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.1099999999999999 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.9399999999999999 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.73 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.71 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.5800000000000001 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 2.0299999999999998 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 2.1600000000000001 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.76 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 1.27 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.685 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.96 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.655 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.8300000000000001 109.298 -167.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.615 ' HB2' ' HE1' ' A' ' 90' ' ' HIS . 1.1 m . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 120.27 0.081 . . . . 1.3200000000000001 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.785 ' HE2' HG12 ' A' ' 33' ' ' ILE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.6600000000000001 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 2.0699999999999998 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.818 0.818 . . . . 1.4299999999999999 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.8500000000000001 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 2.27 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.3100000000000001 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 4.3499999999999996 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 1.4299999999999999 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.88 ' HB3' HG22 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.901 HD11 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.863 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 4.3099999999999996 110.949 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.969 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.813 -0.44 . . . . 0.87 109.813 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.6699999999999999 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.84999999999999998 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.45 111.514 179.626 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.3 114.882 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 HG22 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 1.3600000000000001 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.8900000000000001 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.78 HG11 ' H ' ' A' ' 74' ' ' GLY . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 1.3700000000000001 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.45 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HG2' HG21 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.6000000000000001 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.969 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 1.3799999999999999 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 2.1299999999999999 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.2799999999999998 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.76 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 1.0900000000000001 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.625 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 1.48 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 66' ' ' ALA . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 1.1200000000000001 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.48999999999999999 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB2' HD12 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 2.2200000000000002 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.689 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.3599999999999999 108.73 -164.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 1.24 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.78 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.59999999999999998 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.3500000000000001 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.6800000000000002 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 1.3200000000000001 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.573 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 1.1299999999999999 109.962 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.915 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.2599999999999998 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.675 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 1.45 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.764 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.8999999999999999 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 112.465 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.675 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 3.5099999999999998 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.891 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.6100000000000001 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.694 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.8400000000000001 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.75 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 2.1499999999999999 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.48 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 3.1000000000000001 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.8100000000000001 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.9700000000000002 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 1.4299999999999999 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 4.5199999999999996 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.9300000000000002 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.566 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 4.3899999999999997 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.73 HD13 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.77 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.73 HG23 HD13 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.8300000000000001 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HZ1' ' HB3' ' A' ' 101' ' ' SER . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 2.25 107.196 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.7599999999999998 107.751 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.6699999999999999 110.359 -169.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.1099999999999999 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.9399999999999999 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.526 ' CG2' ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.73 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.88 HG22 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.71 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.764 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.5800000000000001 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.901 HD22 HD11 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 2.0299999999999998 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.915 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 2.1600000000000001 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.76 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 1.27 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.96 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.8300000000000001 110.272 -175.886 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.023 0.379 . . . . 1.3200000000000001 112.023 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.6600000000000001 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.543 ' CG1' HD12 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 2.0699999999999998 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.545 0.688 . . . . 1.4299999999999999 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.8500000000000001 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.3100000000000001 110.482 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.635 ' NE ' HD23 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 4.3499999999999996 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 1.4299999999999999 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.915 HG21 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 1.6100000000000001 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.545 ' HB3' HG21 ' A' ' 104' ' ' VAL . 7.4 p80 . . . . . 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 4.3099999999999996 111.965 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.939 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 110.115 -0.328 . . . . 0.87 110.115 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.6699999999999999 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HG22 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 1.54 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.84999999999999998 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.45 111.13 178.345 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 N-CA-C 115.477 0.951 . . . . 1.3 115.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 77' ' ' ILE . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 1.3600000000000001 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.8900000000000001 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 1.3700000000000001 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.45 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.6000000000000001 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 1.3799999999999999 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.453 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 2.1299999999999999 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.2799999999999998 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.76 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.915 ' HA ' HG21 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 1.0900000000000001 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.754 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 1.48 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 1.1200000000000001 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.48999999999999999 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 2.2200000000000002 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.3599999999999999 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 1.24 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.59999999999999998 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD1' HG21 ' A' ' 109' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.732 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.6800000000000002 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 55' ' ' ILE . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 1.3200000000000001 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.565 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 1.1299999999999999 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.884 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.2599999999999998 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 1.45 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1000000000000001 112.626 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 3.5099999999999998 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.884 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.6100000000000001 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 88' ' ' VAL . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.8400000000000001 111.614 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.75 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 85' ' ' MET . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 2.1499999999999999 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.48 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.592 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 3.1000000000000001 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.8100000000000001 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.734 HE21 ' N ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.9700000000000002 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.734 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 1.4299999999999999 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.67 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 4.5199999999999996 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.9300000000000002 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 4.3899999999999997 112.327 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' HB2' HG22 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.77 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.605 HG22 HD11 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.8300000000000001 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 2.25 113.189 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.7599999999999998 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.6699999999999999 111.234 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.1099999999999999 110.464 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.9399999999999999 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.73 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.71 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.702 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.5800000000000001 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.828 HD21 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 2.0299999999999998 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 2.1600000000000001 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.495 HG21 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.76 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 1.27 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.96 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.8300000000000001 109.684 -179.183 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.592 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.775 -0.454 . . . . 1.3200000000000001 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.6600000000000001 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 2.0699999999999998 110.633 -176.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.925 0 CA-C-O 121.71 0.767 . . . . 1.4299999999999999 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.8500000000000001 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 2.27 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.3100000000000001 110.412 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 4.3499999999999996 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.824 HG12 HD11 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 1.4299999999999999 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 1.6100000000000001 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB2' HG21 ' A' ' 104' ' ' VAL . 19.7 t-160 . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 4.3099999999999996 112.339 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 1.023 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.141 0.496 . . . . 0.87 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.6699999999999999 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 1.54 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.84999999999999998 111.188 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.569 ' HA3' ' HD1' ' A' ' 90' ' ' HIS . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.45 110.444 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 115.026 0.771 . . . . 1.3 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 1.3600000000000001 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.8900000000000001 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 1.3700000000000001 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.45 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.6000000000000001 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.023 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 1.3799999999999999 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.561 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 2.1299999999999999 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.2799999999999998 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.76 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 1.0900000000000001 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 1.48 109.006 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 1.1200000000000001 107.423 171.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.48999999999999999 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 2.2200000000000002 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.53 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.3599999999999999 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 1.24 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.59999999999999998 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.722 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.3500000000000001 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.6800000000000002 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.534 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 1.1299999999999999 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.2599999999999998 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 1.45 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.83 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 15.3 m-80 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.8999999999999999 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1000000000000001 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 3.5099999999999998 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.6100000000000001 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.8400000000000001 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.75 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 1.044 HG11 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 2.1499999999999999 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.48 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' HD1' ' HA3' ' A' ' 35' ' ' GLY . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 3.1000000000000001 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.8100000000000001 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 1.044 ' HG3' HG11 ' A' ' 88' ' ' VAL . 6.5 tp-100 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.9700000000000002 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 1.4299999999999999 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 4.5199999999999996 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.9300000000000002 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HD2' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 4.3899999999999997 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.77 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.545 HG23 HD13 ' A' ' 97' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.8300000000000001 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 2.25 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.7599999999999998 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.717 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.6699999999999999 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.1099999999999999 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.9399999999999999 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.73 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.797 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.71 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.83 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.5800000000000001 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.824 HD11 HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 2.0299999999999998 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 2.1600000000000001 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.76 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 1.27 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.722 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.96 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.8300000000000001 109.363 176.195 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.804 -0.443 . . . . 1.3200000000000001 109.804 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.6600000000000001 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 2.0699999999999998 108.084 173.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 1.076 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 121.647 0.737 . . . . 1.4299999999999999 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.8500000000000001 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 2.27 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.543 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 4.3499999999999996 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 1.4299999999999999 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.832 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.882 HG22 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 1.6100000000000001 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.905 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 . . . . . 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 4.3099999999999996 112.401 -173.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.882 ' HE2' HG22 ' A' ' 18' ' ' ILE . 28.2 p90 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 120.685 0.279 . . . . 0.87 111.577 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.6699999999999999 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 1.54 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.84999999999999998 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.45 111.37 177.453 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 114.446 0.538 . . . . 1.3 114.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 1.3600000000000001 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.8900000000000001 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.729 HG13 ' H ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 1.3700000000000001 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.45 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.6000000000000001 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.758 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 1.3799999999999999 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 2.1299999999999999 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.2799999999999998 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.636 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.76 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.098 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 1.0900000000000001 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.792 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 1.48 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 1.1200000000000001 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.48999999999999999 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 1.098 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 2.2200000000000002 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 1.24 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.729 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.59999999999999998 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.3500000000000001 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.573 ' HB3' ' OG1' ' A' ' 110' ' ' THR . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.6800000000000002 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 1.3200000000000001 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.548 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 1.1299999999999999 110.003 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.783 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.2599999999999998 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 1.45 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.648 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 18.2 m-80 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.8999999999999999 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1000000000000001 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.57 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 3.5099999999999998 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.783 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.6100000000000001 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.8400000000000001 112.139 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.75 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 2.1499999999999999 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.75 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.48 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.505 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 38.6 t-80 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 3.1000000000000001 111.025 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.8100000000000001 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.75 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 4.4 mm100 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.9700000000000002 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 1.4299999999999999 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.605 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 4.5199999999999996 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.9300000000000002 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 4.3899999999999997 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.77 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 94' ' ' ARG . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.8300000000000001 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 2.25 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.7599999999999998 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.6699999999999999 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.1099999999999999 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.9399999999999999 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.905 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.73 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 18' ' ' ILE . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.71 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.5800000000000001 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.507 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 2.0299999999999998 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 2.1600000000000001 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 110' ' ' THR . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.76 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 1.076 ' HB ' ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 1.27 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.96 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.8300000000000001 109.185 -157.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.505 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 39.6 m . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.818 -0.438 . . . . 1.3200000000000001 109.818 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.6600000000000001 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.444 HG23 ' OXT' ' B' ' 168' ' ' VAL . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 2.0699999999999998 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.51 -0.587 0 CA-C-O 121.025 0.44 . . . . 1.4299999999999999 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.8500000000000001 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 2.27 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.3100000000000001 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HE ' HD23 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 4.3499999999999996 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 1.4299999999999999 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.908 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.75 ' O ' HG21 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 1.6100000000000001 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 11.3 t-160 . . . . . 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 4.3099999999999996 112.668 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 111.825 0.306 . . . . 0.87 111.825 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.6699999999999999 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 57' ' ' VAL . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 1.54 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.84999999999999998 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.45 112.021 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.689 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 112.335 -0.306 . . . . 1.3 112.335 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.644 HD11 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 1.3600000000000001 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.8900000000000001 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 74' ' ' GLY . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 1.3700000000000001 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.45 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.586 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.6000000000000001 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.773 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 1.3799999999999999 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 2.1299999999999999 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.694 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.2799999999999998 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.735 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.694 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.76 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 1.0900000000000001 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 1.48 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 1.1200000000000001 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.48999999999999999 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.788 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 2.2200000000000002 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.788 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 5.4 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.3599999999999999 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 1.24 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.59999999999999998 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 -172.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.6800000000000002 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 1.3200000000000001 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.551 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 1.1299999999999999 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.048 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.7 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.2599999999999998 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 1.45 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.8999999999999999 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1000000000000001 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.669 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 3.5099999999999998 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.921 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.6100000000000001 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.048 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.8400000000000001 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.75 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.821 HG13 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 2.1499999999999999 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.773 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.48 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 3.1000000000000001 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.821 ' HB2' HG13 ' A' ' 88' ' ' VAL . 5.8 mm100 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.9700000000000002 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.875 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 1.4299999999999999 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.501 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 4.5199999999999996 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.9300000000000002 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.875 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 4.3899999999999997 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.77 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.451 ' N ' HD11 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 2.25 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.7599999999999998 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.6699999999999999 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.1099999999999999 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.9399999999999999 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.73 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.741 HG21 ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.71 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.908 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.5800000000000001 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.707 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 2.0299999999999998 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.829 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 2.1600000000000001 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.76 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.867 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 1.27 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.629 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.96 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.582 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.8300000000000001 108.072 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . 19.9 m . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.04 -0.029 . . . . 1.3200000000000001 110.945 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.6600000000000001 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 2.0699999999999998 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.885 0.85 . . . . 1.4299999999999999 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.8500000000000001 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 2.27 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.3100000000000001 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 4.3499999999999996 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 1.4299999999999999 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.779 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 1.055 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 1.6100000000000001 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.737 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 4.3099999999999996 111.254 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 120.507 0.194 . . . . 0.87 110.947 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.6699999999999999 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 HG13 ' HE2' ' A' ' 90' ' ' HIS . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 1.54 109.788 -173.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.84999999999999998 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.45 109.164 169.346 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 114.323 0.489 . . . . 1.3 114.323 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 1.3600000000000001 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.8900000000000001 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 1.3700000000000001 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.45 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.699 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.6000000000000001 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.699 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 1.3799999999999999 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 2.1299999999999999 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.2799999999999998 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' O ' HG13 ' A' ' 68' ' ' ILE . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.76 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.055 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 1.0900000000000001 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 1.48 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.669 ' CB ' HD13 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 1.1200000000000001 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.48999999999999999 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 2.2200000000000002 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.476 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.3599999999999999 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 HD13 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 1.24 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.687 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.59999999999999998 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.3500000000000001 109.208 -171.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.794 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.6800000000000002 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 1.3200000000000001 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.544 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 1.1299999999999999 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.714 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.2599999999999998 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 1.45 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.8999999999999999 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1000000000000001 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.542 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 3.5099999999999998 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.6100000000000001 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.714 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.8400000000000001 110.745 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 87' ' ' MET . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.75 108.627 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.726 HG12 ' NE2' ' A' ' 92' ' ' GLN . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 2.1499999999999999 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.48 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.531 ' HE2' HG13 ' A' ' 33' ' ' ILE . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 3.1000000000000001 111.499 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.8100000000000001 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.726 ' NE2' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.9700000000000002 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.614 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 1.4299999999999999 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 4.5199999999999996 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.9300000000000002 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.725 HH22 HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 4.3899999999999997 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB3' HG22 ' A' ' 80' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.77 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.8300000000000001 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 2.25 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.7599999999999998 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.6699999999999999 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.1099999999999999 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.9399999999999999 108.729 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.73 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 18' ' ' ILE . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.71 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.779 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.5800000000000001 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 2.0299999999999998 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.602 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 2.1600000000000001 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.76 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.794 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 1.27 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.742 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.96 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 . . . . . 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.8300000000000001 108.405 173.859 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 110.787 -0.079 . . . . 1.3200000000000001 110.787 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.6600000000000001 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.6 HG23 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 2.0699999999999998 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.502 -0.867 0 CA-C-O 122.055 0.931 . . . . 1.4299999999999999 111.759 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.8500000000000001 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 2.27 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.475 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.3100000000000001 109.82 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.509 ' HG2' HD23 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 4.3499999999999996 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 1.4299999999999999 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.659 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 1.6100000000000001 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 4.3099999999999996 111.484 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.881 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 109.717 -0.475 . . . . 0.87 109.717 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.677 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.6699999999999999 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 1.54 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.84999999999999998 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.45 109.692 176.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.3 115.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 1.3600000000000001 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.8900000000000001 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 1.3700000000000001 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.45 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.6000000000000001 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.881 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 1.3799999999999999 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 2.1299999999999999 109.042 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.2799999999999998 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' CD ' ' H ' ' A' ' 66' ' ' ALA . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.76 114.951 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 1.0900000000000001 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 1.48 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 1.1200000000000001 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.48999999999999999 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 2.2200000000000002 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.3599999999999999 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 1.24 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.59999999999999998 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' CB ' HG13 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.3500000000000001 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.6800000000000002 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 1.3200000000000001 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.586 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.296 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.772 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.2599999999999998 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.674 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 1.45 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.8999999999999999 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1000000000000001 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HH2' ' HZ2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 3.5099999999999998 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.772 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.6100000000000001 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.8400000000000001 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.75 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.717 HG23 HE22 ' A' ' 92' ' ' GLN . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 2.1499999999999999 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.588 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.48 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 3.1000000000000001 111.444 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.8100000000000001 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.774 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.9700000000000002 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.775 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 1.4299999999999999 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 4.5199999999999996 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.677 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.9300000000000002 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 4.3899999999999997 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.77 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.8300000000000001 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 2.25 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.556 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.7599999999999998 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.6699999999999999 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.1099999999999999 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.9399999999999999 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.73 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.659 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.71 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.5800000000000001 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 2.0299999999999998 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.74 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 2.1600000000000001 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.458 HG21 ' H ' ' A' ' 110' ' ' THR . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.76 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 1.27 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.96 111.441 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.8300000000000001 111.3 -178.778 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.3200000000000001 112.615 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.6600000000000001 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 2.0699999999999998 109.477 171.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.486 -1.512 0 CA-C-O 122.39 1.09 . . . . 1.4299999999999999 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.8500000000000001 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 2.27 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.3100000000000001 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 4.3499999999999996 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 1.4299999999999999 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 1.6100000000000001 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HB3' HG21 ' A' ' 104' ' ' VAL . 15.8 p80 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 4.3099999999999996 111.667 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.768 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.717 0.294 . . . . 0.87 111.322 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.787 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.6699999999999999 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.871 HG22 HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 1.54 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.84999999999999998 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.45 111.753 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.493 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 115.734 1.054 . . . . 1.3 115.734 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 1.3600000000000001 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.8900000000000001 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 1.3700000000000001 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.45 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.687 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.6000000000000001 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.768 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 1.3799999999999999 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.565 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 2.1299999999999999 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.2799999999999998 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' HIS . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.76 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.802 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 1.0900000000000001 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 1.48 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.453 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 1.1200000000000001 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.48999999999999999 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 2.2200000000000002 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.481 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.3599999999999999 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 1.24 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.718 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.59999999999999998 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.3500000000000001 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.6800000000000002 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.462 HD13 HG23 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 1.3200000000000001 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 1.1299999999999999 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.097 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.2599999999999998 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 1.45 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.8999999999999999 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1000000000000001 112.218 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.682 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 3.5099999999999998 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 1.097 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.6100000000000001 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.539 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.8400000000000001 111.936 -175.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.75 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.894 HG13 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 2.1499999999999999 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.895 HG21 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.48 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.895 ' H ' HG21 ' A' ' 89' ' ' THR . 18.0 t-160 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 3.1000000000000001 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.8100000000000001 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.894 ' HG2' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.9700000000000002 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.851 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 1.4299999999999999 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 4.5199999999999996 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.9300000000000002 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 4.3899999999999997 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.704 HD12 HG23 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.77 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.519 ' N ' HD13 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.8300000000000001 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.703 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 2.25 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.7599999999999998 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.6699999999999999 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.703 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.1099999999999999 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.9399999999999999 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.73 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 18' ' ' ILE . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.71 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.619 ' C ' HD11 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.5800000000000001 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.7 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 2.0299999999999998 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 2.1600000000000001 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.76 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 1.27 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.96 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.635 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.8300000000000001 109.692 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.3200000000000001 113.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.787 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.6600000000000001 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.704 HG23 HD12 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 2.0699999999999998 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.68 0.753 . . . . 1.4299999999999999 110.956 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.8500000000000001 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 2.27 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' NE2' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.3100000000000001 110.223 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 4.3499999999999996 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 1.4299999999999999 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.766 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 1.6100000000000001 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' HB3' HG21 ' A' ' 104' ' ' VAL . 25.2 p80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 4.3099999999999996 112.402 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.707 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.6699999999999999 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.769 HG22 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 1.54 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.84999999999999998 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.45 107.299 162.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 113.916 0.326 . . . . 1.3 113.916 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 1.3600000000000001 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.8900000000000001 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 74' ' ' GLY . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 1.3700000000000001 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.45 111.425 -173.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.6000000000000001 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 1.3799999999999999 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 2.1299999999999999 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.2799999999999998 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.76 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 1.0900000000000001 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 1.48 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 1.1200000000000001 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.48999999999999999 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.664 HD21 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 2.2200000000000002 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.605 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.3599999999999999 107.426 -173.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 1.24 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.832 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.59999999999999998 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.664 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.3500000000000001 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.6800000000000002 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.661 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 1.3200000000000001 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.567 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 1.1299999999999999 110.237 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.014 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 9.9 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.2599999999999998 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.704 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 1.45 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.751 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 38.7 m-80 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.8999999999999999 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1000000000000001 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.581 ' HB2' HG11 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 3.5099999999999998 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 1.014 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.6100000000000001 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.704 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.8400000000000001 112.605 -167.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.75 111.564 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 2.1499999999999999 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.039 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.48 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.412 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 3.1000000000000001 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.8100000000000001 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 1.039 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.9700000000000002 109.486 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.661 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 1.4299999999999999 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.773 HH21 ' HB2' ' B' ' 166' ' ' SER . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 4.5199999999999996 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.9300000000000002 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 4.3899999999999997 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.77 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.694 HG23 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.8300000000000001 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 2.25 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.7599999999999998 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.6699999999999999 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.1099999999999999 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.9399999999999999 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.73 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.71 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.766 ' HG3' ' HG3' ' A' ' 17' ' ' GLU . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.5800000000000001 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 2.0299999999999998 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 HD22 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 2.1600000000000001 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.76 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 1.27 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.664 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.96 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.612 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.8300000000000001 109.566 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.773 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.931 -0.766 . . . . 1.3200000000000001 108.931 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.6600000000000001 110.676 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 2.0699999999999998 109.143 176.936 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.363 0.602 . . . . 1.4299999999999999 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.8500000000000001 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.059 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 2.27 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 13' ' ' VAL . 1.5 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.3100000000000001 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.498 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 4.3499999999999996 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 1.4299999999999999 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.613 ' O ' HG22 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 1.6100000000000001 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 104' ' ' VAL . 48.3 t-80 . . . . . 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 4.3099999999999996 110.678 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.973 0.416 . . . . 0.87 112.038 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.899 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.6699999999999999 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG21 HG21 ' A' ' 57' ' ' VAL . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 1.54 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.84999999999999998 111.197 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.848 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.45 114.244 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 115.235 0.854 . . . . 1.3 115.235 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.848 HD12 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 1.3600000000000001 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.8900000000000001 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 74' ' ' GLY . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 1.3700000000000001 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.45 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.6000000000000001 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 1.3799999999999999 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 2.1299999999999999 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.2799999999999998 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.598 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.546 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.76 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB1' HG12 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 1.0900000000000001 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 1.48 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 1.1200000000000001 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.48999999999999999 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.718 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 2.2200000000000002 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.718 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.3599999999999999 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 1.24 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.59999999999999998 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' OD1' HG21 ' A' ' 109' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.3500000000000001 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.6800000000000002 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 HG23 ' SD ' ' A' ' 85' ' ' MET . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 1.3200000000000001 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.579 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 1.1299999999999999 111.061 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 1.005 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.3 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.2599999999999998 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.647 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 1.45 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 17.4 m-80 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.8999999999999999 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1000000000000001 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.647 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 3.5099999999999998 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 1.005 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.6100000000000001 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.959 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.8400000000000001 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.75 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.623 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 2.1499999999999999 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.698 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.48 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.437 ' NE2' ' HB2' ' B' ' 166' ' ' SER . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 3.1000000000000001 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.8100000000000001 110.488 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.698 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.7 mm100 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.9700000000000002 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 1.4299999999999999 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.777 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 4.5199999999999996 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.9300000000000002 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 4.3899999999999997 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.77 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.8300000000000001 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 2.25 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.7599999999999998 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.6699999999999999 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.741 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.1099999999999999 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.9399999999999999 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.73 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.71 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.5800000000000001 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.64 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 2.0299999999999998 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 2.1600000000000001 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.843 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.76 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.69 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 1.27 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 1.059 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.96 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.45 ' N ' HE21 ' A' ' 112' ' ' GLN . 8.5 mm-40 . . . . . 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.8300000000000001 109.905 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.617 0.969 . . . . 1.3200000000000001 113.617 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' MET . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.6600000000000001 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 2.0699999999999998 110.829 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.031 -0.359 . . . . 18.620000000000001 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 63.85 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.878 0.736 . . . . 15.27 112.2 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 72.73 117.99 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.316 -0.856 . . . . 14.640000000000001 111.693 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 64.6 mt -131.79 104.13 14.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.638 -0.71 . . . . 10.640000000000001 109.626 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 22.2 Cg_exo -68.61 134.71 31.27 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.25 2.633 . . . . 11.31 112.081 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.04 -17.62 34.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.921 -0.657 . . . . 7.8700000000000001 111.975 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -101.05 123.53 44.8 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-O 120.801 0.334 . . . . 7.2000000000000002 110.591 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.75 135.13 37.35 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.825 2.35 . . . . 5.4199999999999999 112.53 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.22 -1.08 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 122.289 1.042 . . . . 3.6499999999999999 109.606 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p 68.4 -65.38 0.27 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.749 -2.478 . . . . 2.5099999999999998 111.971 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.81 113.77 0.95 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.596 -1.184 . . . . 1.4299999999999999 111.085 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.988 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.8500000000000001 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 2.27 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.3100000000000001 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 4.3499999999999996 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG21 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 1.4299999999999999 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.806 HG21 HD23 ' A' ' 29' ' ' LEU . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 1.6100000000000001 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 -109.4 126.75 53.77 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 4.3099999999999996 114.192 -172.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.695 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 20.8 pttp -47.27 155.38 0.32 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.306 -1.315 . . . . 6.1900000000000004 111.062 172.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 42.6 tp -131.79 159.67 37.8 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.693 0.758 . . . . 4.8499999999999996 110.823 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' HD22 ' A' ' 27' ' ' LEU . 13.9 tpt180 -72.54 118.48 15.5 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.509 -1.223 . . . . 5.7199999999999998 113.505 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -136.99 64.24 1.54 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.32 -1.309 . . . . 4.4800000000000004 109.116 167.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.5 -109.41 2.78 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.187 -1.37 . . . . 3.7799999999999998 112.0 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.43 -0.43 55.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.237 -1.024 . . . . 6.8499999999999996 108.237 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 19.5 m-80 -102.69 133.21 48.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 122.993 1.378 . . . . 5.2300000000000004 108.83 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' C ' ' HB2' ' A' ' 20' ' ' LYS . 4.5 mm? -119.58 105.32 11.09 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 112.394 -2.184 . . . . 4.4500000000000002 107.62 168.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -155.72 162.84 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 113.789 1.033 . . . . 3.3599999999999999 113.789 -174.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 18' ' ' ILE . 1.1 mp -97.75 -49.25 4.9 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.06 -1.427 . . . . 4.6699999999999999 109.783 -165.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 95.14 6.75 59.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.656 -0.783 . . . . 1.8200000000000001 113.65 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.971 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 -98.51 167.37 10.86 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.869 -0.789 . . . . 0.87 108.869 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.6699999999999999 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 1.54 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.7 ' HA3' ' CG2' ' A' ' 37' ' ' ILE . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.84999999999999998 112.316 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . -119.52 75.54 0.31 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.45 109.708 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.644 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . 145.33 -9.54 1.71 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.698 -1.239 . . . . 3.0 111.213 -168.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.7 ' CG2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -38.35 -47.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.546 1.313 . . . . 5.2199999999999998 114.546 -168.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -121.32 17.24 11.45 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.323 0.582 . . . . 7.4900000000000002 110.564 -175.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.644 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -119.73 -147.06 0.39 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.741 1.015 . . . . 4.7999999999999998 113.741 -176.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.75 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 8.3 t70 -179.22 172.03 0.62 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 107.027 -1.471 . . . . 5.1399999999999997 107.027 -153.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 74.4 Cg_endo -83.81 -14.51 7.56 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 121.825 1.684 . . . . 6.1200000000000001 112.43 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.3 m -78.34 -8.28 58.24 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.581 -1.191 . . . . 6.5499999999999998 113.042 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.75 ' OE1' ' HB3' ' A' ' 40' ' ' ASP . 1.3 mp0 -91.31 -23.46 20.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.075 0.464 . . . . 5.9299999999999997 111.44 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.6 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 10.9 t30 -53.46 -32.87 11.7 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 115.116 1.524 . . . . 6.46 115.116 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 44' ' ' ASN . 2.4 Cg_endo -45.0 -25.0 1.47 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.703 1.602 . . . . 8.5199999999999996 111.61 167.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' SER . 74.4 m-85 -120.4 -9.87 9.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.521 -0.763 . . . . 9.5399999999999991 112.188 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 24.1 m 69.04 30.39 4.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.253 -0.647 . . . . 5.1299999999999999 109.253 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 15.0 tp10 87.65 -60.06 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.29 -1.777 . . . . 7.4299999999999997 111.101 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.0 t70 -150.46 35.34 0.64 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.589 -0.893 . . . . 7.3899999999999997 108.589 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 26.8 mmtp 71.19 112.73 0.06 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 113.952 -1.476 . . . . 8.0700000000000003 111.285 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p 58.97 12.29 2.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.021 -0.99 . . . . 5.5099999999999998 111.728 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.832 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 4.0 t70 -67.52 -70.18 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.046 -0.979 . . . . 3.9700000000000002 111.117 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' B' ' 161' ' ' LYS . 29.2 mmtp 76.91 -21.17 0.34 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.109 -0.951 . . . . 6.6299999999999999 111.632 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA3' ' OE1' ' A' ' 39' ' ' GLN . . . 66.26 56.31 14.48 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.399 -0.819 . . . . 1.3 113.114 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.626 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 1.3600000000000001 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.8900000000000001 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.768 HG23 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 1.3700000000000001 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.45 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.531 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.6000000000000001 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.971 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 1.3799999999999999 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 2.1299999999999999 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.2799999999999998 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.76 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 1.0900000000000001 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 1.48 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 1.1200000000000001 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.48999999999999999 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 2.2200000000000002 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.3599999999999999 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 1.24 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.59999999999999998 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.453 ' HB2' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.3500000000000001 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.6800000000000002 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 1.3200000000000001 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 1.1299999999999999 111.206 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.973 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.2599999999999998 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG23 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 1.45 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.8999999999999999 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1000000000000001 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 3.5099999999999998 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.96 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.6100000000000001 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.973 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.8400000000000001 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.75 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.838 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 2.1499999999999999 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.686 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.48 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.484 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 59.8 t-80 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 3.1000000000000001 110.912 -174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.594 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.8100000000000001 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.838 ' HB2' HG12 ' A' ' 88' ' ' VAL . 4.9 mm100 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.9700000000000002 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 1.4299999999999999 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.535 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 4.5199999999999996 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.9300000000000002 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.628 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 4.3899999999999997 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.77 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.8300000000000001 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.566 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 2.25 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.7599999999999998 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.566 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.6699999999999999 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.1099999999999999 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.9399999999999999 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.73 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 18' ' ' ILE . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.71 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.5800000000000001 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 2.0299999999999998 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 2.1600000000000001 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.76 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 1.27 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.988 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.96 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 113' ' ' SER . 24.4 mm-40 -100.2 -17.05 17.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.8300000000000001 111.521 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 64.2 m 88.49 -4.38 0.49 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 113.187 -1.824 . . . . 4.7300000000000004 110.438 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 114' ' ' LEU . 3.1 mm? -97.85 69.03 2.08 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.417 -1.72 . . . . 4.7699999999999996 109.184 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.96 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 112.258 -2.247 . . . . 7.2400000000000002 112.496 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.74 118.51 7.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 9.4800000000000004 111.355 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.87 20.99 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.253 -1.388 . . . . 11.58 107.253 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p 30.45 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.112 -2.313 . . . . 12.380000000000001 113.617 -168.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.11 113.0 26.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.172 -0.922 . . . . 14.960000000000001 109.486 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.41 81.41 6.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.944 0.402 . . . . 17.609999999999999 111.153 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 p -110.64 109.46 19.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.019 -0.537 . . . . 19.469999999999999 110.431 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 ttt -132.05 115.32 15.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.369 -0.378 . . . . 21.969999999999999 110.899 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.193 -0.458 . . . . 23.199999999999999 110.097 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.572 . . . . 23.960000000000001 111.283 -176.777 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.686 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 121.14 0.495 . . . . 8.5899999999999999 110.684 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.637 ' HB3' ' N ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -83.86 171.17 13.33 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.432 0.901 . . . . 6.8700000000000001 113.432 -164.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.582 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 28.3 t-20 -45.99 99.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.877 -1.51 . . . . 5.2400000000000002 113.756 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.473 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 2.3 pt? -153.04 120.39 5.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.527 0.679 . . . . 3.2200000000000002 111.212 163.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -111.72 168.46 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.149 -0.685 . . . . 4.9199999999999999 109.149 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.484 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 21.1 m -164.74 141.31 6.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.729 0.27 . . . . 1.3200000000000001 111.729 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.6600000000000001 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.551 ' OXT' ' HB2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 2.0699999999999998 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.872 0.367 . . . . 18.620000000000001 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -122.99 -48.19 2.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.429 -0.582 . . . . 15.27 109.429 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -113.86 132.53 55.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.978 -0.749 . . . . 14.640000000000001 108.978 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.38 97.89 51.01 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.628 -0.26 . . . . 10.640000000000001 110.324 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.95 3.77 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.686 2.924 . . . . 11.31 111.305 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.01 40.49 2.06 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.334 -1.303 . . . . 7.8700000000000001 111.269 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.7 pt20 -63.58 127.85 91.91 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.933 -0.395 . . . . 7.2000000000000002 109.933 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' HG12 ' A' ' 9' ' ' VAL . 40.4 Cg_endo -93.51 -166.85 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.087 2.525 . . . . 5.4199999999999999 113.72 -173.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 8' ' ' PRO . 9.2 p 49.23 157.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.326 1.85 . . . . 3.6499999999999999 114.61 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.435 ' N ' HG23 ' A' ' 9' ' ' VAL . 34.0 p -107.67 -39.85 5.48 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.98 -1.463 . . . . 2.5099999999999998 110.759 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.53 115.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.202 -1.817 . . . . 1.4299999999999999 110.274 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.8500000000000001 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 2.27 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.537 HE22 ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.3100000000000001 108.818 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.4 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 4.3499999999999996 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 1.4299999999999999 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.623 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 1.6100000000000001 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.534 ' HB3' HG21 ' A' ' 104' ' ' VAL . 20.6 p80 -107.89 79.71 1.3 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 4.3099999999999996 112.314 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.885 ' HD3' ' HD2' ' A' ' 31' ' ' PHE . 7.3 mtpm? -136.94 86.9 2.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.531 -1.213 . . . . 6.1900000000000004 109.197 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.714 ' O ' HG12 ' A' ' 28' ' ' ILE . 4.1 pp -152.51 161.61 42.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.403 -0.817 . . . . 4.8499999999999996 109.328 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' HD2' ' HD2' ' A' ' 100' ' ' ARG . 3.6 tmt_? -64.63 108.96 1.84 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.955 -0.387 . . . . 5.7199999999999998 109.955 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.066 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -127.88 64.28 1.38 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.981 0.895 . . . . 4.4800000000000004 110.543 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.76 -96.77 0.96 Allowed Glycine 0 CA--C 1.491 -1.428 0 CA-C-N 113.625 -1.625 . . . . 3.7799999999999998 112.584 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.65 -1.02 53.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.415 -0.957 . . . . 6.8499999999999996 108.415 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 1.066 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.2 m-80 -115.65 130.44 56.86 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-O 122.784 1.278 . . . . 5.2300000000000004 108.968 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' CD1' ' HG2' ' A' ' 22' ' ' ARG . 3.3 mm? -121.7 106.78 11.64 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 112.288 -2.233 . . . . 4.4500000000000002 107.841 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -112.26 127.16 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.892 -1.522 . . . . 3.3599999999999999 106.892 172.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' HA ' ' HA ' ' B' ' 168' ' ' VAL . 12.3 tp -168.98 58.62 0.05 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.376 -1.342 . . . . 4.6699999999999999 107.376 -160.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . -126.48 -54.13 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 116.52 1.368 . . . . 1.8200000000000001 116.52 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 1.042 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 -77.94 147.18 35.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.01 1.405 . . . . 0.87 109.843 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.682 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.6699999999999999 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 1.54 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.84999999999999998 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.96 122.32 2.68 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.45 112.285 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.0 57.25 0.53 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.973 -0.451 . . . . 3.0 111.973 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -132.84 -37.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.791 0.329 . . . . 5.2199999999999998 110.726 176.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -81.77 -4.87 57.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.942 -0.572 . . . . 7.4900000000000002 110.282 -177.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.82 HE22 HD12 ' B' ' 164' ' ' LEU . 12.0 mm-40 -89.86 -79.76 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.745 -0.661 . . . . 4.7999999999999998 112.348 -162.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 13.0 t70 -148.78 140.61 14.51 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.704 -0.68 . . . . 5.1399999999999997 110.153 -168.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 37.5 Cg_endo -60.64 -20.49 65.25 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 123.475 2.783 . . . . 6.1200000000000001 113.116 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -62.28 -28.88 70.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.384 -0.371 . . . . 6.5499999999999998 111.626 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.621 HE22 ' HB2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -89.14 -16.58 31.07 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 116.388 -0.369 . . . . 5.9299999999999997 110.862 -175.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -124.39 91.62 49.25 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.256 -0.577 . . . . 6.46 112.302 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -95.38 17.55 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.292 2.662 . . . . 8.5199999999999996 110.61 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.634 ' HD1' ' HB2' ' A' ' 47' ' ' SER . 42.2 t80 179.13 -41.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.213 -0.903 . . . . 9.5399999999999991 109.96 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.64 ' OG ' ' HD2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -175.68 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.075 -1.083 . . . . 5.1299999999999999 108.075 -170.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 11.8 tp10 -172.87 -89.34 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.493 -1.685 . . . . 7.4299999999999997 108.505 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.46 61.05 0.7 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.548 -0.861 . . . . 7.3899999999999997 110.442 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 65.19 -72.21 0.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.136 . . . . 8.0700000000000003 112.06 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -88.23 15.86 7.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.821 -0.627 . . . . 5.5099999999999998 111.751 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.1 t70 -110.26 -170.27 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.581 -0.525 . . . . 3.9700000000000002 109.581 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.769 ' HG3' HG23 ' A' ' 86' ' ' THR . 15.6 tptm -135.85 -10.77 2.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.253 -0.885 . . . . 6.6299999999999999 108.977 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 -4.2 56.55 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.508 -0.769 . . . . 1.3 112.782 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 37' ' ' ILE . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 1.3600000000000001 110.154 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.8900000000000001 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HD13 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 1.3700000000000001 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.45 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.682 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.6000000000000001 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.042 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 1.3799999999999999 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 2.1299999999999999 107.113 162.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.2799999999999998 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.823 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.76 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 1.0900000000000001 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 1.48 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 1.1200000000000001 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 2.2200000000000002 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' N ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.3599999999999999 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 1.24 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' H ' HG13 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.3500000000000001 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.6800000000000002 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 1.3200000000000001 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.696 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 1.1299999999999999 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.752 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.2599999999999998 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.566 HG13 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 1.45 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 31.4 m-80 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.8999999999999999 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1000000000000001 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.528 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 3.5099999999999998 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.745 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.6100000000000001 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.752 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.769 HG23 ' HG3' ' A' ' 53' ' ' LYS . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.8400000000000001 111.892 -170.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.75 110.942 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.44 HG13 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 2.1499999999999999 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.832 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.48 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 3.1000000000000001 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.8100000000000001 110.118 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.832 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.9700000000000002 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 1.4299999999999999 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 4.5199999999999996 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.9300000000000002 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 4.3899999999999997 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.77 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.8300000000000001 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 2.25 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.605 ' HD2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.7599999999999998 111.188 176.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.533 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.6699999999999999 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.709 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.1099999999999999 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.9399999999999999 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.73 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.71 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.771 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.5800000000000001 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 2.0299999999999998 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 2.1600000000000001 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.76 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.652 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 1.27 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.537 ' HB2' HE22 ' A' ' 14' ' ' GLN . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.96 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.635 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -103.89 -30.76 10.14 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.8300000000000001 108.626 170.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 70.8 m 82.66 2.81 1.14 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 111.087 -2.779 . . . . 4.7300000000000004 111.617 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.1 mm? -123.13 41.85 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.341 -1.3 . . . . 4.7699999999999996 109.023 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.9 137.59 3.14 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.061 -2.336 . . . . 7.2400000000000002 112.71 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.688 ' HB2' ' HZ2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -149.89 154.21 37.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.625 -0.716 . . . . 9.4800000000000004 109.563 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -139.08 27.06 2.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.29 1.043 . . . . 11.58 108.824 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.1 t -123.06 84.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 113.634 -1.621 . . . . 12.380000000000001 109.709 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.18 107.33 8.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.463 -0.789 . . . . 14.960000000000001 110.637 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.52 -17.29 13.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 17.609999999999999 110.489 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.4 p -157.72 151.48 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.93 -0.577 . . . . 19.469999999999999 110.192 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.61 164.4 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.255 -0.429 . . . . 21.969999999999999 110.072 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.58 117.97 6.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.697 0.284 . . . . 23.199999999999999 110.723 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.123 -0.489 . . . . 23.960000000000001 110.442 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 29.9 mtmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.745 0.307 . . . . 8.5899999999999999 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.53 145.12 45.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.206 0.527 . . . . 6.8700000000000001 111.367 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -150.33 3.97 0.51 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.701 -0.681 . . . . 5.2400000000000002 112.678 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.82 HD12 HE22 ' A' ' 39' ' ' GLN . 3.0 mt -96.16 138.44 33.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.464 -0.773 . . . . 3.2200000000000002 111.846 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.6 pt-20 -139.61 172.26 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.226 -1.028 . . . . 4.9199999999999999 108.226 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m -149.97 120.97 7.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.893 -0.41 . . . . 1.3200000000000001 109.893 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.695 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.6600000000000001 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 2.0699999999999998 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.24 -0.652 . . . . 18.620000000000001 109.24 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -132.95 143.22 49.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.985 0.422 . . . . 15.27 111.572 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -78.93 101.43 7.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.883 -0.598 . . . . 14.640000000000001 110.108 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -136.68 99.24 10.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.38 -0.827 . . . . 10.640000000000001 109.58 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.85 116.56 4.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.898 2.399 . . . . 11.31 111.287 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.97 -14.99 5.42 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.845 -0.693 . . . . 7.8700000000000001 111.74 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -105.79 147.46 34.76 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 120.638 0.256 . . . . 7.2000000000000002 110.345 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.57 155.72 56.81 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.292 2.661 . . . . 5.4199999999999999 112.986 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 10' ' ' THR . 9.8 p -84.8 162.94 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.576 0.703 . . . . 3.6499999999999999 110.316 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 9' ' ' VAL . 82.5 p -98.34 -60.04 1.63 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.785 -1.098 . . . . 2.5099999999999998 109.977 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.67 121.7 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.124 -1.398 . . . . 1.4299999999999999 110.475 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.8500000000000001 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 2.27 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.437 ' O ' HG13 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.3100000000000001 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 4.3499999999999996 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 1.4299999999999999 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.828 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 1.6100000000000001 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 -152.74 90.24 1.46 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 4.3099999999999996 112.005 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.501 ' HD2' ' HB ' ' B' ' 168' ' ' VAL . 7.6 ptmm? -61.5 152.56 29.8 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.849 -1.167 . . . . 6.1900000000000004 107.849 167.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' ILE . 2.8 tt -124.32 121.55 35.3 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.383 -1.327 . . . . 4.8499999999999996 113.346 -155.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -87.13 124.14 32.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.785 0.802 . . . . 5.7199999999999998 110.143 167.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -130.77 63.63 1.58 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.597 -1.183 . . . . 4.4800000000000004 110.145 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 77.8 -97.73 1.38 Allowed Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 114.182 -1.372 . . . . 3.7799999999999998 112.26 169.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -77.93 -5.87 52.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.194 -1.039 . . . . 6.8499999999999996 108.194 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.666 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 27.7 m-80 -111.61 131.81 55.0 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-O 123.507 1.622 . . . . 5.2300000000000004 110.682 -175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' O ' ' A' ' 26' ' ' ASN . 4.3 mm? -121.84 114.62 21.3 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 110.905 -2.861 . . . . 4.4500000000000002 105.156 165.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' LEU . 33.3 mm -100.82 117.52 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 118.915 -1.114 . . . . 3.3599999999999999 109.759 -173.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.871 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 7.9 tp -113.03 75.35 0.91 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 110.571 -3.013 . . . . 4.6699999999999999 105.751 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' C ' ' HG ' ' A' ' 61' ' ' SER . . . -85.88 -81.55 1.12 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 113.884 -1.507 . . . . 1.8200000000000001 115.656 -162.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 -77.38 174.27 11.0 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.273 0.537 . . . . 0.87 110.639 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.6699999999999999 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.664 HD13 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 1.54 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.84999999999999998 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' B' ' 164' ' ' LEU . . . -127.01 131.86 7.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.45 109.925 172.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -128.74 -26.37 0.94 Allowed Glycine 0 C--O 1.229 -0.208 0 C-N-CA 119.851 -1.166 . . . . 3.0 113.089 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.673 HG23 ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -58.99 -36.84 64.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.557 0.577 . . . . 5.2199999999999998 112.557 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' CG ' HG21 ' A' ' 89' ' ' THR . 29.3 t70 -105.16 13.79 30.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.49 -0.777 . . . . 7.4900000000000002 110.637 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 31.8 mm-40 -98.26 -83.04 0.41 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.286 -0.566 . . . . 4.7999999999999998 111.241 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' OD1' ' HD2' ' A' ' 41' ' ' PRO . 26.2 t70 -156.29 125.31 3.04 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.051 -0.522 . . . . 5.1399999999999997 110.07 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 74.1 Cg_endo -66.78 -13.04 38.35 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.912 3.075 . . . . 6.1200000000000001 112.056 -175.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.716 ' HB2' ' HG3' ' B' ' 161' ' ' LYS . 12.8 m -61.23 -45.05 96.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.14 -0.936 . . . . 6.5499999999999998 110.141 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' B' ' 162' ' ' GLU . 7.0 pt20 -99.11 -36.78 9.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.001 0.429 . . . . 5.9299999999999997 110.327 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.734 HD21 ' HA ' ' A' ' 48' ' ' GLU . 22.8 m120 -101.57 101.31 16.98 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.868 -0.606 . . . . 6.46 109.636 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.35 -14.45 38.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.039 2.493 . . . . 8.5199999999999996 112.372 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -166.04 -40.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.194 -0.457 . . . . 9.5399999999999991 110.75 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.673 ' HA ' HG23 ' A' ' 37' ' ' ILE . 12.4 p -149.13 -63.92 0.23 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.558 0.694 . . . . 5.1299999999999999 109.87 -170.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.734 ' HA ' HD21 ' A' ' 44' ' ' ASN . 0.4 OUTLIER -171.97 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.009 -1.45 . . . . 7.4299999999999997 108.554 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -142.7 -158.77 0.9 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.748 -1.114 . . . . 7.3899999999999997 108.63 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -64.92 -66.25 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.121 0.486 . . . . 8.0700000000000003 111.429 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -111.28 21.87 15.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.84 -0.618 . . . . 5.5099999999999998 110.966 -175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.617 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 25.6 t70 -70.07 -41.23 74.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.34 0.867 . . . . 3.9700000000000002 113.34 -174.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mptp? 90.25 -37.03 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.53 1.132 . . . . 6.6299999999999999 110.525 -175.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 97.46 0.81 59.32 Favored Glycine 0 C--O 1.237 0.303 0 C-N-CA 120.668 -0.777 . . . . 1.3 112.838 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.563 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 1.3600000000000001 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.8900000000000001 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 1.3700000000000001 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.501 HG23 ' HG2' ' B' ' 165' ' ' GLU . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.45 109.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.6000000000000001 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.965 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 1.3799999999999999 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.478 ' HG ' ' C ' ' A' ' 30' ' ' GLY . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 2.1299999999999999 107.254 168.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.2799999999999998 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.544 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.76 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.769 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 1.0900000000000001 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 1.48 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 1.1200000000000001 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.48999999999999999 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.782 HD13 HG22 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 2.2200000000000002 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.648 ' N ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.3599999999999999 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 1.24 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.625 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.59999999999999998 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.3500000000000001 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.6800000000000002 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 1.3200000000000001 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.594 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 1.1299999999999999 110.518 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HE2' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 1.45 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.8999999999999999 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1000000000000001 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.636 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 3.5099999999999998 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.87 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.6100000000000001 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.8400000000000001 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.75 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 2.1499999999999999 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.48 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.664 ' HE1' HD13 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 3.1000000000000001 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.8100000000000001 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.659 ' CB ' HG12 ' A' ' 88' ' ' VAL . 6.5 mm100 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.9700000000000002 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 1.4299999999999999 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 4.5199999999999996 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.9300000000000002 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 4.3899999999999997 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.69 HD13 HG22 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.77 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.8300000000000001 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 2.25 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.7599999999999998 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.668 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.6699999999999999 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.1099999999999999 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.9399999999999999 107.369 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.73 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.828 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.71 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.5800000000000001 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 2.0299999999999998 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 2.1600000000000001 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.687 HG21 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.76 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.74 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 1.27 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.96 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -88.64 -45.47 9.82 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.8300000000000001 110.324 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.466 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 9.1 t 91.17 -2.88 0.22 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.185 -2.28 . . . . 4.7300000000000004 109.344 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 114' ' ' LEU . 1.7 mm? -120.35 18.27 12.19 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.097 -1.865 . . . . 4.7699999999999996 107.734 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.27 140.28 40.02 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.324 -2.671 . . . . 7.2400000000000002 111.367 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.615 ' HB3' HG23 ' A' ' 118' ' ' VAL . 38.8 mmtm -147.38 161.28 41.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.313 -0.858 . . . . 9.4800000000000004 109.771 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.86 24.02 2.61 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.596 1.188 . . . . 11.58 108.645 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.615 HG23 ' HB3' ' A' ' 116' ' ' LYS . 17.0 m -91.17 25.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 113.096 -1.865 . . . . 12.380000000000001 111.075 -174.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -105.34 141.54 36.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.912 -1.04 . . . . 14.960000000000001 110.09 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.73 171.93 10.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.36 0.6 . . . . 17.609999999999999 111.266 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 m -88.73 123.67 33.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 19.469999999999999 110.765 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.88 -14.42 54.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 21.969999999999999 109.727 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 123' ' ' LEU . 5.7 mp -86.09 129.98 34.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.475 -0.784 . . . . 23.199999999999999 110.185 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.107 -0.497 . . . . 23.960000000000001 109.768 174.378 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.716 ' HG3' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.513 0.673 . . . . 8.5899999999999999 111.667 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.678 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.5 pt-20 -169.53 106.39 0.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 6.8700000000000001 110.142 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -111.45 -100.12 0.41 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.544 -1.207 . . . . 5.2400000000000002 110.716 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 75.6 mt 66.83 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.148 0.905 . . . . 3.2200000000000002 111.522 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.501 ' HG2' HG23 ' A' ' 58' ' ' THR . 34.0 mt-10 -56.87 118.16 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.008 0.908 . . . . 4.9199999999999999 112.912 -171.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m -130.8 114.16 14.98 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.285 -1.325 . . . . 1.3200000000000001 107.69 167.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.605 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.6600000000000001 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.871 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 2.0699999999999998 109.988 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.566 0.222 . . . . 18.620000000000001 111.055 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 4' ' ' ILE . 11.5 p -100.33 20.78 14.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.332 -0.23 . . . . 15.27 111.347 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.9 -31.69 0.22 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.622 0.769 . . . . 14.640000000000001 112.32 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 2' ' ' SER . 49.7 mm 57.7 95.93 0.05 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 124.042 0.937 . . . . 10.640000000000001 112.111 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 135.01 67.43 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.936 2.424 . . . . 11.31 111.913 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.32 -38.72 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.588 -0.605 . . . . 7.8700000000000001 111.588 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 28.2 mt-30 -91.71 147.57 35.4 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 7.2000000000000002 109.99 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.2 Cg_exo -71.73 -175.79 1.77 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.107 2.538 . . . . 5.4199999999999999 112.518 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.809 HG21 ' H ' ' A' ' 10' ' ' THR . 8.0 p -74.34 178.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 3.6499999999999999 110.314 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.809 ' H ' HG21 ' A' ' 9' ' ' VAL . 44.5 p -135.47 113.68 11.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.816 0.817 . . . . 2.5099999999999998 110.547 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -49.19 115.26 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.257 -1.792 . . . . 1.4299999999999999 111.059 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.8500000000000001 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 2.27 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.3100000000000001 109.765 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.692 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 4.3499999999999996 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 1.4299999999999999 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 1.6100000000000001 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 -106.45 89.27 2.99 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 4.3099999999999996 114.335 -171.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.71 ' HE2' ' HG3' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -89.11 162.86 15.73 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.286 -1.325 . . . . 6.1900000000000004 107.457 160.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.724 ' HB3' HE21 ' A' ' 23' ' ' GLN . 42.6 tp -150.73 138.84 20.14 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 116.834 -1.947 . . . . 4.8499999999999996 115.091 -153.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 1.6 tmm_? -81.38 112.49 18.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 5.7199999999999998 108.276 162.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.724 HE21 ' HB3' ' A' ' 21' ' ' LEU . 2.4 mt-30 -112.32 65.84 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.045 0.926 . . . . 4.4800000000000004 109.685 -173.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.66 -102.42 1.75 Allowed Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 113.954 -1.476 . . . . 3.7799999999999998 111.772 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.6 3.04 46.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 6.8499999999999996 109.908 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 36.5 m-80 -105.49 142.99 34.29 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 123.236 1.494 . . . . 5.2300000000000004 109.689 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 26' ' ' ASN . 4.1 mm? -130.22 111.73 12.69 Favored 'General case' 0 C--N 1.256 -3.478 0 CA-C-N 111.238 -2.71 . . . . 4.4500000000000002 107.054 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 21' ' ' LEU . 7.6 mm -106.27 118.17 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 109.504 -0.554 . . . . 3.3599999999999999 109.504 -176.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.815 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 1.7 tp -123.73 80.1 1.77 Allowed 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 127.365 2.916 . . . . 4.6699999999999999 107.475 -173.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.66 -82.58 1.02 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 113.694 -1.594 . . . . 1.8200000000000001 115.97 -166.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 -81.44 165.75 20.98 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 117.266 0.533 . . . . 0.87 110.468 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.6699999999999999 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 1.54 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.84999999999999998 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . -131.4 91.27 0.29 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.45 110.729 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 39' ' ' GLN . . . 150.36 31.43 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.935 -1.126 . . . . 3.0 112.499 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.774 HG12 HE22 ' A' ' 39' ' ' GLN . 16.8 pt -52.58 -48.57 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.621 0.6 . . . . 5.2199999999999998 112.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -125.67 -8.92 6.77 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.076 -0.713 . . . . 7.4900000000000002 109.076 176.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.774 HE22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -139.69 -148.95 0.26 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.511 -1.222 . . . . 4.7999999999999998 110.913 -168.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 9.6 t70 -161.68 137.64 5.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.578 -0.897 . . . . 5.1399999999999997 108.578 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HG3' ' HB2' ' A' ' 90' ' ' HIS . 71.6 Cg_endo -70.23 -18.57 34.72 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.324 2.683 . . . . 6.1200000000000001 113.707 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 m -70.31 -40.89 73.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.221 0.534 . . . . 6.5499999999999998 109.794 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 40' ' ' ASP . 30.2 mt-30 -88.15 -29.3 20.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.765 -0.652 . . . . 5.9299999999999997 110.559 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.656 HD22 ' HA ' ' A' ' 47' ' ' SER . 29.4 t30 -122.05 89.62 48.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.26 -0.882 . . . . 6.46 110.533 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -86.49 33.61 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.212 2.608 . . . . 8.5199999999999996 111.626 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -154.33 -71.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 9.5399999999999991 111.557 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.656 ' HA ' HD22 ' A' ' 44' ' ' ASN . 3.6 m 150.25 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.413 -1.328 . . . . 5.1299999999999999 107.413 -162.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.97 -16.7 31.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.108 -0.637 . . . . 7.4299999999999997 110.409 -172.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.81 5.75 41.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.414 -0.812 . . . . 7.3899999999999997 109.876 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 52' ' ' ASP . 21.3 mmtt 70.78 -66.23 0.3 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.202 -0.908 . . . . 8.0700000000000003 111.09 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -83.11 20.04 1.32 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.213 -0.903 . . . . 5.5099999999999998 109.735 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 50' ' ' LYS . 4.6 t70 -39.55 -71.11 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 113.654 -1.612 . . . . 3.9700000000000002 110.992 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.609 ' HG3' ' SD ' ' A' ' 78' ' ' MET . 5.1 mptp? 56.36 38.12 29.45 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.942 0.877 . . . . 6.6299999999999999 108.783 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 37' ' ' ILE . . . -56.54 -3.96 0.77 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.494 -1.685 . . . . 1.3 115.014 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 1.3600000000000001 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.8900000000000001 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 1.3700000000000001 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.45 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.6000000000000001 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 1.3799999999999999 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 2.1299999999999999 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.2799999999999998 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.646 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.71 ' HG3' ' HE2' ' A' ' 20' ' ' LYS . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.76 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 1.0900000000000001 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 1.48 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 1.1200000000000001 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.48999999999999999 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 2.2200000000000002 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.578 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.3599999999999999 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 59' ' ' ARG . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 1.24 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.59999999999999998 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.3500000000000001 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.6800000000000002 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 HG21 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 1.3200000000000001 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.609 ' SD ' ' HG3' ' A' ' 53' ' ' LYS . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 1.1299999999999999 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.2599999999999998 111.246 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 1.45 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.612 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.8999999999999999 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1000000000000001 112.928 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 3.5099999999999998 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.6100000000000001 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.778 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.8400000000000001 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.75 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.861 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.48 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.673 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 3.1000000000000001 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.8100000000000001 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.861 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.9700000000000002 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 1.4299999999999999 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.673 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 4.5199999999999996 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.9300000000000002 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 4.3899999999999997 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.742 HD11 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.77 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.742 HG23 HD11 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.8300000000000001 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 2.25 109.213 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.7599999999999998 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.6699999999999999 113.364 -171.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.1099999999999999 111.418 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.9399999999999999 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.73 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.71 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.612 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.5800000000000001 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 2.0299999999999998 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 2.1600000000000001 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.76 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 1.27 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.96 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.466 HE22 ' HA ' ' A' ' 11' ' ' ALA . 17.1 mm-40 -94.74 -17.6 22.04 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.8300000000000001 110.95 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.46 -5.35 0.62 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 111.728 -2.487 . . . . 4.7300000000000004 109.9 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.504 HD22 HG22 ' A' ' 9' ' ' VAL . 2.9 mm? -99.64 55.45 0.96 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.366 -1.743 . . . . 4.7699999999999996 109.3 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.36 142.62 55.41 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 112.231 -2.259 . . . . 7.2400000000000002 111.272 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HE2' ' OE1' ' A' ' 119' ' ' GLN . 2.8 mmmm -117.53 108.97 16.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.696 -0.683 . . . . 9.4800000000000004 109.912 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -116.84 15.77 15.27 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.747 1.261 . . . . 11.58 108.089 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.23 83.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.544 -2.116 . . . . 12.380000000000001 108.431 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.493 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 15.6 mm100 -120.76 165.37 15.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.477 -0.783 . . . . 14.960000000000001 111.114 -172.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -161.69 174.06 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.89 -0.782 . . . . 17.609999999999999 108.89 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.1 t 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.025 0.828 . . . . 19.469999999999999 111.131 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.4 mtt -140.98 111.44 6.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.968 -0.56 . . . . 21.969999999999999 109.519 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -118.91 141.1 48.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.407 . . . . 23.199999999999999 111.057 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 23.960000000000001 110.215 175.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.668 ' HZ3' ' HB3' ' B' ' 164' ' ' LEU . 22.0 tptp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.668 -0.493 . . . . 8.5899999999999999 109.668 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.77 104.56 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.286 0.565 . . . . 6.8700000000000001 111.856 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 57.2 t30 66.77 139.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.201 -1.363 . . . . 5.2400000000000002 112.514 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.668 ' HB3' ' HZ3' ' B' ' 161' ' ' LYS . 2.4 pp -155.11 150.58 27.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.479 -0.563 . . . . 3.2200000000000002 109.479 174.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.95 -179.73 3.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.98 0.419 . . . . 4.9199999999999999 110.177 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -158.51 125.92 5.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.3200000000000001 109.601 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.685 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.6600000000000001 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 2.0699999999999998 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.651 0.263 . . . . 18.620000000000001 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -84.83 -30.13 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.597 -0.274 . . . . 15.27 110.688 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 51.64 70.42 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.673 0.608 . . . . 14.640000000000001 112.227 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.5 92.13 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.918 -1.037 . . . . 10.640000000000001 111.266 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.32 95.34 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.5 2.133 . . . . 11.31 110.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 171.48 -33.86 0.15 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.827 -0.701 . . . . 7.8700000000000001 112.198 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -90.03 106.5 14.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 7.2000000000000002 111.288 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 7.0 Cg_exo -73.36 141.44 31.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.853 2.368 . . . . 5.4199999999999999 111.336 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.495 HG23 ' H ' ' A' ' 10' ' ' THR . 7.7 p -73.98 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.475 0.655 . . . . 3.6499999999999999 109.793 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.495 ' H ' HG23 ' A' ' 9' ' ' VAL . 70.0 p -81.69 -56.38 4.04 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.808 -1.087 . . . . 2.5099999999999998 110.888 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.66 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -170.46 131.53 0.93 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.427 -1.26 . . . . 1.4299999999999999 109.51 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.8500000000000001 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 2.27 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.639 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 5.2 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.3100000000000001 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 4.3499999999999996 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG11 HD22 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 1.4299999999999999 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.834 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 1.6100000000000001 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.556 ' HB2' HG21 ' A' ' 104' ' ' VAL . 10.5 t-160 -121.08 96.66 5.19 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 4.3099999999999996 112.234 176.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HZ2' ' HB ' ' B' ' 168' ' ' VAL . 0.0 OUTLIER -108.59 117.9 35.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.166 -1.379 . . . . 6.1900000000000004 109.516 174.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 28' ' ' ILE . 14.1 tp -153.76 158.6 41.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.401 -0.818 . . . . 4.8499999999999996 109.973 -165.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' CZ ' HD21 ' A' ' 27' ' ' LEU . 3.9 tpp180 -62.45 108.32 1.1 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.446 -0.797 . . . . 5.7199999999999998 109.695 161.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -122.72 60.3 1.03 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.205 1.002 . . . . 4.4800000000000004 108.851 174.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.99 -100.42 1.36 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 113.563 -1.653 . . . . 3.7799999999999998 111.73 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -72.1 -10.29 59.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.846 0.832 . . . . 6.8499999999999996 109.486 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.642 ' HB3' HD12 ' A' ' 28' ' ' ILE . 26.7 m-80 -109.63 128.52 55.29 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 123.088 1.423 . . . . 5.2300000000000004 110.041 -172.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 26' ' ' ASN . 3.2 mm? -123.63 109.34 13.62 Favored 'General case' 0 C--N 1.254 -3.568 0 CA-C-N 111.648 -2.523 . . . . 4.4500000000000002 107.171 167.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -108.64 123.81 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 C-N-CA 119.691 -0.804 . . . . 3.3599999999999999 109.122 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' B' ' 168' ' ' VAL . 1.2 mt -177.56 61.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.067 -2.197 . . . . 4.6699999999999999 105.067 -166.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.63 -48.85 0.11 Allowed Glycine 0 C--N 1.314 -0.665 0 CA-C-N 113.709 -1.587 . . . . 1.8200000000000001 115.135 -161.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.942 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 -69.08 151.67 46.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.87 108.302 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.676 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.6699999999999999 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 1.54 110.247 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.84999999999999998 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . -138.2 140.19 10.94 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.45 112.091 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.6 63.98 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.786 -0.721 . . . . 3.0 112.309 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.722 HG12 ' H ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -112.52 -66.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.813 0.34 . . . . 5.2199999999999998 111.181 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.722 ' H ' HG12 ' A' ' 37' ' ' ILE . 34.3 t70 -92.24 7.6 41.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.147 0.975 . . . . 7.4900000000000002 109.224 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -82.62 -76.13 0.28 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.935 -1.029 . . . . 4.7999999999999998 111.287 -171.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.689 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 8.5 t70 -138.76 119.63 9.93 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.716 -0.675 . . . . 5.1399999999999997 110.491 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -91.8 -8.93 2.86 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 C-N-CA 123.571 2.847 . . . . 6.1200000000000001 112.037 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 m -63.24 -27.91 69.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.754 -1.112 . . . . 6.5499999999999998 112.517 -166.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -98.42 2.55 47.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.491 0.662 . . . . 5.9299999999999997 111.016 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.716 HD22 ' HB2' ' A' ' 47' ' ' SER . 56.6 t30 -137.21 88.53 17.28 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 6.46 110.041 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.44 0.05 9.62 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.74 2.294 . . . . 8.5199999999999996 111.274 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -94.17 -35.84 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.901 . . . . 9.5399999999999991 110.358 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.716 ' HB2' HD22 ' A' ' 44' ' ' ASN . 59.0 m -140.38 -168.25 2.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 120.85 -0.34 . . . . 5.1299999999999999 110.112 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 1.087 ' HA ' ' HE3' ' B' ' 161' ' ' LYS . 12.5 pt-20 179.2 -33.21 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 7.4299999999999997 108.966 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.06 -38.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.017 -0.992 . . . . 7.3899999999999997 110.649 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.4 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.32 -0.854 . . . . 8.0700000000000003 112.984 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 t -102.54 16.12 27.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.258 0.551 . . . . 5.5099999999999998 109.772 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -75.28 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.297 -0.865 . . . . 3.9700000000000002 111.534 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 0.2 OUTLIER 70.25 -48.1 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.629 -0.714 . . . . 6.6299999999999999 110.379 -174.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.691 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 57.41 21.93 42.99 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.3 115.042 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 1.3600000000000001 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.8900000000000001 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 1.3700000000000001 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.45 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.6000000000000001 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.942 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 1.3799999999999999 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.476 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 2.1299999999999999 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.2799999999999998 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HG3' HG22 ' A' ' 28' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.76 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 1.0900000000000001 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 1.48 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 1.1200000000000001 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.48999999999999999 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 2.2200000000000002 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.3599999999999999 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 1.24 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.59999999999999998 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.3500000000000001 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.6800000000000002 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.705 ' HB ' HG23 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 1.3200000000000001 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.574 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 1.1299999999999999 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.043 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.2599999999999998 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 1.45 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.534 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.8999999999999999 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1000000000000001 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.487 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 3.5099999999999998 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.863 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.6100000000000001 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.8400000000000001 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.75 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 2.1499999999999999 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.865 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.48 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.748 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 3.1000000000000001 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.8100000000000001 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.865 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.9700000000000002 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 1.4299999999999999 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.702 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 4.5199999999999996 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.9300000000000002 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 4.3899999999999997 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.77 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.8300000000000001 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 2.25 111.534 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.488 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.7599999999999998 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.6699999999999999 110.089 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.1099999999999999 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.595 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.9399999999999999 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 103' ' ' GLU . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.73 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.71 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.5800000000000001 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.834 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 2.0299999999999998 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 1.043 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 2.1600000000000001 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.76 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 1.27 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.639 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.96 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' A' ' 11' ' ' ALA . 24.5 mm-40 -108.04 -58.91 1.92 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.8300000000000001 109.961 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.4 m 73.47 15.9 4.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.293 -1.776 . . . . 4.7300000000000004 111.618 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.1 mm? -123.69 36.99 4.51 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.913 1.34 . . . . 4.7699999999999996 109.478 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -71.02 159.43 34.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 111.923 -2.399 . . . . 7.2400000000000002 110.34 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.4 101.82 9.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 9.4800000000000004 110.417 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.53 7.58 35.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.625 1.678 . . . . 11.58 106.705 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.3 t -109.17 -15.37 9.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.861 -2.881 . . . . 12.380000000000001 108.613 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 56.45 -166.51 0.12 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.468 -2.151 . . . . 14.960000000000001 112.271 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -160.98 132.59 5.67 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.755 -0.657 . . . . 17.609999999999999 109.359 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.6 p -108.88 -21.88 12.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.879 0.325 . . . . 19.469999999999999 111.879 -175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -121.34 147.14 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.813 0.34 . . . . 21.969999999999999 110.68 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.85 86.99 2.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 23.199999999999999 109.721 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 23.960000000000001 111.092 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 1.087 ' HE3' ' HA ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.561 -0.163 . . . . 8.5899999999999999 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 10.0 tp10 75.04 145.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.463 0.705 . . . . 6.8700000000000001 110.619 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.43 99.7 6.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 5.2400000000000002 112.129 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' B' ' 164' ' ' LEU . 1.9 tp -114.84 104.29 11.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.26 -1.015 . . . . 3.2200000000000002 108.26 168.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.3 pt-20 -102.96 156.28 17.77 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.209 -0.663 . . . . 4.9199999999999999 109.209 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m -145.73 126.49 14.36 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.233 -0.439 . . . . 1.3200000000000001 109.952 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.6600000000000001 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 1.068 ' HA ' HD23 ' A' ' 29' ' ' LEU . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 2.0699999999999998 110.347 -172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.928 0.394 . . . . 18.620000000000001 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -101.82 121.01 41.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.165 0.507 . . . . 15.27 111.213 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.79 152.79 30.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.335 -0.848 . . . . 14.640000000000001 109.304 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.96 103.04 15.77 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.731 0.3 . . . . 10.640000000000001 110.472 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.25 9.99 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.279 2.652 . . . . 11.31 112.005 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.8 54.14 0.6 Allowed Glycine 0 C--N 1.312 -0.765 0 CA-C-N 114.838 -1.074 . . . . 7.8700000000000001 111.471 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.43 152.87 95.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.665 0.269 . . . . 7.2000000000000002 110.665 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -58.01 160.71 14.83 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.034 2.49 . . . . 5.4199999999999999 113.106 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 m -59.86 176.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 115.391 -0.822 . . . . 3.6499999999999999 112.274 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -113.42 100.09 8.27 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.08 1.419 . . . . 2.5099999999999998 110.949 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -70.97 110.68 5.82 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 111.964 -2.38 . . . . 1.4299999999999999 110.466 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.8500000000000001 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 2.27 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 9.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 109.946 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' CD ' HD12 ' A' ' 108' ' ' LEU . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 4.3499999999999996 108.806 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 1.4299999999999999 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.798 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.712 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 1.6100000000000001 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' HB3' HG23 ' A' ' 104' ' ' VAL . 26.8 p80 -123.31 96.25 4.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 4.3099999999999996 112.25 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.634 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 47.7 tptt -77.23 -104.66 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.144 -0.688 . . . . 6.1900000000000004 109.144 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.757 ' HB3' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -151.2 116.52 5.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.772 -0.771 . . . . 4.8499999999999996 112.199 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -81.05 108.92 15.13 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.089 -1.448 . . . . 5.7199999999999998 107.089 160.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.757 HE21 ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.71 63.02 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.887 0.851 . . . . 4.4800000000000004 108.794 -173.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 72.29 -98.53 0.82 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.016 -1.447 . . . . 3.7799999999999998 111.971 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.09 -2.9 39.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.715 -0.742 . . . . 6.8499999999999996 109.544 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.67 ' HB3' HD11 ' A' ' 28' ' ' ILE . 31.6 m-80 -110.39 138.84 46.24 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 123.109 1.433 . . . . 5.2300000000000004 110.51 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HG2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.25 108.76 12.05 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 111.46 -2.609 . . . . 4.4500000000000002 106.854 170.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.67 HD11 ' HB3' ' A' ' 26' ' ' ASN . 2.5 mm -121.82 131.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.66 -0.7 . . . . 3.3599999999999999 110.497 -176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.863 HD22 HG11 ' A' ' 105' ' ' VAL . 7.1 tp -111.19 -29.35 7.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.218 -1.03 . . . . 4.6699999999999999 108.218 167.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.28 -57.32 1.72 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.306 -0.861 . . . . 1.8200000000000001 113.502 167.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.743 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 -74.37 178.02 5.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.894 0.378 . . . . 0.87 110.981 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.6699999999999999 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.905 HG13 ' HG3' ' B' ' 165' ' ' GLU . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 1.54 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.84999999999999998 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.625 ' HA2' HD12 ' A' ' 55' ' ' ILE . . . -117.97 85.74 0.39 Allowed Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.45 110.14 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA2' HE22 ' A' ' 39' ' ' GLN . . . 147.07 -4.86 1.02 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 119.672 -1.251 . . . . 3.0 111.567 -166.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -68.69 -46.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.362 0.875 . . . . 5.2199999999999998 113.362 -170.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 37' ' ' ILE . 4.1 t0 -109.63 -1.14 18.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.777 0.799 . . . . 7.4900000000000002 110.35 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.696 ' CD ' ' HA2' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -158.25 -173.08 4.15 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.586 -0.734 . . . . 4.7999999999999998 110.576 -173.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.985 ' OD1' ' HA ' ' B' ' 162' ' ' GLU . 0.2 OUTLIER 169.69 154.33 0.17 Allowed Pre-proline 0 C--N 1.316 -0.862 0 O-C-N 124.958 1.411 . . . . 5.1399999999999997 108.291 -172.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.68 ' HD3' ' N ' ' B' ' 162' ' ' GLU . 90.8 Cg_endo -81.84 -26.67 2.91 Favored 'Trans proline' 0 CA--C 1.502 -1.098 0 C-N-CA 122.196 1.93 . . . . 6.1200000000000001 111.203 -167.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -95.34 -23.39 17.21 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.081 -1.418 . . . . 6.5499999999999998 109.978 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.802 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -124.2 -4.21 7.93 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 120.021 -0.672 . . . . 5.9299999999999997 111.309 -172.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -143.31 74.42 17.38 Favored Pre-proline 0 C--O 1.233 0.225 0 C-N-CA 120.893 -0.323 . . . . 6.46 110.803 166.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.47 7.59 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.23 1.954 . . . . 8.5199999999999996 110.031 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -88.47 -29.06 20.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.176 . . . . 9.5399999999999991 109.521 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.522 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 24.5 p -88.24 -159.64 0.56 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.067 -0.716 . . . . 5.1299999999999999 109.067 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 40.8 tt0 65.45 0.97 1.52 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.28 0.562 . . . . 7.4299999999999997 111.239 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -76.36 -55.45 5.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.33 -0.395 . . . . 7.3899999999999997 111.949 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -86.64 -95.61 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.125 -0.489 . . . . 8.0700000000000003 111.309 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -115.55 -4.03 12.3 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.222 -1.399 . . . . 5.5099999999999998 107.222 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 35.2 t0 58.4 168.55 0.05 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.657 -1.61 . . . . 3.9700000000000002 112.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.19 22.76 13.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.425 -1.261 . . . . 6.6299999999999999 108.461 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.696 ' HA2' ' CD ' ' A' ' 39' ' ' GLN . . . -46.22 -53.69 9.11 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 113.94 -1.482 . . . . 1.3 114.797 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.625 HD12 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 1.3600000000000001 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.798 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.8900000000000001 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG11 ' H ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 1.3700000000000001 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.45 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.582 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.6000000000000001 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.743 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 1.3799999999999999 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 2.1299999999999999 107.907 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.2799999999999998 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.634 ' HA2' ' HD3' ' A' ' 20' ' ' LYS . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.76 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 1.0900000000000001 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 1.48 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 1.1200000000000001 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.48999999999999999 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.832 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 2.2200000000000002 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.832 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.3599999999999999 106.66 -175.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 1.24 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.798 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.59999999999999998 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.644 ' OD1' ' HB ' ' A' ' 109' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.3500000000000001 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.678 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.6800000000000002 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.606 ' HA ' HG13 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 1.3200000000000001 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.608 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 1.1299999999999999 111.537 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.882 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.2599999999999998 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.618 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 1.45 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.8999999999999999 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1000000000000001 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.618 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 3.5099999999999998 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.882 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.6100000000000001 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.546 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.8400000000000001 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.75 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.723 HG12 ' NE2' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 2.1499999999999999 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.48 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 1.041 ' HB2' HD12 ' B' ' 164' ' ' LEU . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 3.1000000000000001 111.633 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.8100000000000001 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.866 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.9700000000000002 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 1.4299999999999999 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 4.5199999999999996 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.866 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.9300000000000002 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 4.3899999999999997 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.77 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.58 HG22 HD13 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.8300000000000001 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.694 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 2.25 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.7599999999999998 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.694 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.6699999999999999 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.1099999999999999 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.9399999999999999 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.73 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.863 HG11 HD22 ' A' ' 29' ' ' LEU . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.71 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.5800000000000001 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.7 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 2.0299999999999998 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 2.1600000000000001 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.644 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.76 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 1.27 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.96 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' A' ' 11' ' ' ALA . 28.6 mm-40 -104.8 -39.85 6.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.8300000000000001 112.612 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 72.0 m 75.66 13.43 2.92 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.676 1.235 . . . . 4.7300000000000004 109.499 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 56.91 26.15 11.36 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.504 -1.68 . . . . 4.7699999999999996 112.072 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.564 HE22 ' HB1' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -99.14 171.47 8.0 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.372 -1.74 . . . . 7.2400000000000002 111.424 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -136.95 135.84 38.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.52 -0.764 . . . . 9.4800000000000004 109.29 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.564 ' HB1' HE22 ' A' ' 115' ' ' GLN . . . -142.43 19.85 2.05 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.228 1.013 . . . . 11.58 109.291 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.37 77.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.78 -1.555 . . . . 12.380000000000001 109.721 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -124.2 24.84 7.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.972 -1.467 . . . . 14.960000000000001 110.533 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -82.24 131.69 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.299 -0.864 . . . . 17.609999999999999 109.199 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.7 m -148.42 114.2 5.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.211 -0.195 . . . . 19.469999999999999 111.392 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.7 ptt? 46.36 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.449 1.1 . . . . 21.969999999999999 113.3 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 123' ' ' LEU . 6.9 mp -75.04 116.62 15.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.853 -0.612 . . . . 23.199999999999999 110.661 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.014 -0.539 . . . . 23.960000000000001 110.718 178.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 40' ' ' ASP . 7.4 tppt? . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.981 -0.748 . . . . 8.5899999999999999 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.985 ' HA ' ' OD1' ' A' ' 40' ' ' ASP . 1.6 pm0 -64.38 154.55 35.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 6.8700000000000001 110.397 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -47.38 105.95 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.343 0.497 . . . . 5.2400000000000002 112.343 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 1.041 HD12 ' HB2' ' A' ' 90' ' ' HIS . 3.5 pp -152.28 -179.53 7.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.749 -0.205 . . . . 3.2200000000000002 111.461 175.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.905 ' HG3' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 113.57 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.184 1.794 . . . . 4.9199999999999999 112.161 172.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m -154.81 178.57 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.3200000000000001 114.081 -154.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.535 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.6600000000000001 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.819 HG22 ' HB3' ' A' ' 29' ' ' LEU . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 2.0699999999999998 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.562 0.22 . . . . 18.620000000000001 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -99.79 169.9 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.844 0.354 . . . . 15.27 111.275 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.89 148.1 23.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.819 -0.808 . . . . 14.640000000000001 108.819 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -119.95 96.75 49.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.111 0.482 . . . . 10.640000000000001 110.468 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.91 112.47 2.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.242 2.628 . . . . 11.31 111.17 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 50.98 5.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.576 -0.821 . . . . 7.8700000000000001 111.715 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -69.21 127.87 92.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 7.2000000000000002 110.753 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 152.5 81.9 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 5.4199999999999999 113.191 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.733 HG21 ' H ' ' A' ' 10' ' ' THR . 9.8 p -82.94 174.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.491 -0.777 . . . . 3.6499999999999999 109.841 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.733 ' H ' HG21 ' A' ' 9' ' ' VAL . 34.2 p -128.88 110.1 11.83 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.8 1.286 . . . . 2.5099999999999998 111.225 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.32 113.54 21.21 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 112.938 -1.937 . . . . 1.4299999999999999 110.024 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.8500000000000001 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 2.27 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 109.599 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' HD13 ' A' ' 108' ' ' LEU . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 4.3499999999999996 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' A' ' 107' ' ' LEU . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 1.4299999999999999 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.723 HG12 ' CD2' ' A' ' 107' ' ' LEU . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 1.6100000000000001 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 -98.13 119.15 36.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 4.3099999999999996 112.242 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HB3' ' C ' ' A' ' 27' ' ' LEU . 49.4 mtmt -54.77 163.66 0.92 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 112.746 -2.025 . . . . 6.1900000000000004 111.37 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 59.8 tp -130.54 156.75 44.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 122.044 0.926 . . . . 4.8499999999999996 110.786 -165.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -74.56 116.03 14.79 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.577 -1.192 . . . . 5.7199999999999998 113.016 -168.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.78 70.4 1.38 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.156 0.979 . . . . 4.4800000000000004 109.584 167.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 -115.82 5.3 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 113.699 -1.591 . . . . 3.7799999999999998 110.767 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -81.09 -1.66 45.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.585 0.707 . . . . 6.8499999999999996 109.183 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' C ' HD22 ' A' ' 27' ' ' LEU . 27.7 m-80 -106.55 135.71 47.58 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-O 122.699 1.237 . . . . 5.2300000000000004 109.495 -172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' C ' ' HB3' ' A' ' 20' ' ' LYS . 4.6 mm? -118.3 103.54 9.91 Favored 'General case' 0 C--N 1.263 -3.164 0 CA-C-N 112.397 -2.183 . . . . 4.4500000000000002 107.792 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.663 ' HB ' ' OXT' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -161.72 171.0 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.78 1.232 . . . . 3.3599999999999999 109.23 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' CD2' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -129.2 -31.39 2.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.568 -0.853 . . . . 4.6699999999999999 113.039 -175.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 105.19 18.62 11.79 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.999 -1.096 . . . . 1.8200000000000001 114.02 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 -87.72 152.98 21.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.87 108.028 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.6699999999999999 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.931 HG23 HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 1.54 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA2' ' CB ' ' B' ' 165' ' ' GLU . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.84999999999999998 113.761 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.76 -115.6 1.45 Allowed Glycine 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.45 112.538 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . 150.84 -61.3 0.41 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.507 -1.037 . . . . 3.0 110.507 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG13 ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -159.26 -58.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.346 -0.927 . . . . 5.2199999999999998 110.249 -176.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -149.98 -48.49 0.13 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.198 -1.365 . . . . 7.4900000000000002 109.044 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.496 ' NE2' ' HA3' ' A' ' 36' ' ' GLY . 40.0 mm-40 53.04 -71.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.198 -1.364 . . . . 4.7999999999999998 114.287 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.6 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 9.8 t70 -143.25 134.48 12.67 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 114.659 -1.155 . . . . 5.1399999999999997 110.523 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.829 ' HA ' ' HB3' ' A' ' 44' ' ' ASN . 74.5 Cg_endo -67.42 -3.97 11.03 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.282 3.322 . . . . 6.1200000000000001 112.469 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.951 ' HB3' ' HG2' ' B' ' 161' ' ' LYS . 35.8 t -63.88 -45.29 90.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.357 -0.838 . . . . 6.5499999999999998 109.694 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.631 HE21 ' HG3' ' B' ' 161' ' ' LYS . 6.9 pt20 -87.57 -28.97 21.62 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.448 -0.796 . . . . 5.9299999999999997 109.6 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.829 ' HB3' ' HA ' ' A' ' 41' ' ' PRO . 12.8 t-20 -73.41 104.72 1.23 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.766 -1.106 . . . . 6.46 109.612 172.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.599 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -72.45 -30.38 12.5 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.969 2.446 . . . . 8.5199999999999996 112.501 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.69 11.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 113.039 0.755 . . . . 9.5399999999999991 113.039 -169.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 11.1 t -126.54 -137.19 0.26 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.81 -0.756 . . . . 5.1299999999999999 109.325 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 47' ' ' SER . 13.1 pt-20 166.44 -29.95 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.081 0 O-C-N 124.302 1.001 . . . . 7.4299999999999997 109.596 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 10.1 m-20 -146.69 155.32 42.33 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.637 -0.711 . . . . 7.3899999999999997 109.313 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.468 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 51.5 tptt 68.81 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.312 0.856 . . . . 8.0700000000000003 113.312 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -83.57 9.13 12.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.962 -0.563 . . . . 5.5099999999999998 112.231 -168.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.576 ' OD1' ' HD2' ' A' ' 45' ' ' PRO . 7.1 t70 -87.3 -161.81 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.026 -0.67 . . . . 3.9700000000000002 109.926 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HD3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -109.99 22.9 15.05 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.021 -0.733 . . . . 6.6299999999999999 109.021 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.12 -37.14 7.61 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 114.655 -1.157 . . . . 1.3 114.19 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.609 HG21 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 1.3600000000000001 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.8900000000000001 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.931 HG21 HG23 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 1.3700000000000001 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.45 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.6000000000000001 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.984 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 1.3799999999999999 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 2.1299999999999999 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.2799999999999998 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.76 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HA ' HG21 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 1.0900000000000001 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 1.48 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 1.1200000000000001 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.48999999999999999 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 2.2200000000000002 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.624 HE22 ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.3599999999999999 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 1.24 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.782 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.59999999999999998 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.624 ' HB2' HE22 ' A' ' 72' ' ' GLN . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.3500000000000001 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.872 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.6800000000000002 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.712 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 1.3200000000000001 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.872 ' HE1' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 1.1299999999999999 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.896 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.2599999999999998 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.853 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 1.45 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.8999999999999999 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1000000000000001 113.902 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.682 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 3.5099999999999998 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.896 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.6100000000000001 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.534 ' HG2' HG11 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 50' ' ' LYS . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.8400000000000001 114.526 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 49' ' ' ASP . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.75 110.936 -174.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.584 HG21 ' N ' ' A' ' 89' ' ' THR . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 2.1499999999999999 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.584 ' N ' HG21 ' A' ' 88' ' ' VAL . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.48 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' HE1' HD12 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 3.1000000000000001 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.8100000000000001 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.9700000000000002 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 1.4299999999999999 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 4.5199999999999996 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.609 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.9300000000000002 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 4.3899999999999997 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.77 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.8300000000000001 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 2.25 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.7599999999999998 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.595 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.6699999999999999 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.1099999999999999 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.9399999999999999 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.71 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.726 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.5800000000000001 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.723 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 2.0299999999999998 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 2.1600000000000001 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.76 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 1.27 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.96 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.699 ' HB3' ' HG ' ' A' ' 114' ' ' LEU . 2.5 mp0 -83.5 -64.48 1.16 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.8300000000000001 111.879 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 73.7 m 80.97 17.39 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.398 -1.728 . . . . 4.7300000000000004 111.281 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 2.6 pp -123.55 9.54 9.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.052 1.406 . . . . 4.7699999999999996 111.216 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.434 ' HG2' HD11 ' A' ' 114' ' ' LEU . 15.6 mm-40 -132.47 158.5 41.9 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.203 -2.271 . . . . 7.2400000000000002 110.894 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.714 ' HZ3' ' HB2' ' A' ' 116' ' ' LYS . 10.3 mtmp? -88.0 131.81 34.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.504 -0.554 . . . . 9.4800000000000004 109.504 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.46 18.18 6.94 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.54 1.162 . . . . 11.58 108.473 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.22 80.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 113.124 -1.853 . . . . 12.380000000000001 109.472 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.52 20.38 7.95 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.457 -0.792 . . . . 14.960000000000001 109.307 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -90.61 133.25 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.252 -0.885 . . . . 17.609999999999999 111.391 -173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -132.86 103.6 6.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.691 -0.855 . . . . 19.469999999999999 108.691 171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.4 mmm -96.83 161.98 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.293 0.568 . . . . 21.969999999999999 111.723 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -127.69 142.0 51.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 23.199999999999999 109.619 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.952 0.406 . . . . 23.960000000000001 110.408 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.951 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 16.8 tppt? . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.955 0.407 . . . . 8.5899999999999999 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.86 140.98 58.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.881 0.372 . . . . 6.8700000000000001 110.419 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.53 -35.28 8.8 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.553 0.575 . . . . 5.2400000000000002 112.553 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' B' ' 165' ' ' GLU . 1.9 pp -139.75 159.6 41.79 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.776 -0.453 . . . . 3.2200000000000002 109.776 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.711 ' HB2' ' O ' ' B' ' 164' ' ' LEU . 0.3 OUTLIER 164.7 -151.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.45 1.094 . . . . 4.9199999999999999 111.239 166.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m -159.71 171.64 19.17 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.3200000000000001 114.071 -165.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.6600000000000001 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.663 ' OXT' ' HB ' ' A' ' 28' ' ' ILE . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 2.0699999999999998 110.02 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HG2' ' H ' ' A' ' 2' ' ' SER . 9.4 ttt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.453 -0.573 . . . . 18.620000000000001 109.453 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.546 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.9 m -67.97 -38.99 83.42 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.105 0.409 . . . . 15.27 112.105 -176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 2' ' ' SER . 63.4 m-85 71.03 164.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.563 0.539 . . . . 14.640000000000001 111.056 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.3 mt -117.7 91.82 39.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 10.640000000000001 109.737 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.11 133.26 14.79 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.043 2.495 . . . . 11.31 111.855 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.8 -29.65 5.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.818 -0.706 . . . . 7.8700000000000001 112.273 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -114.01 95.81 39.49 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.66 0.267 . . . . 7.2000000000000002 110.73 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -94.88 -172.31 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.165 2.576 . . . . 5.4199999999999999 112.432 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.38 161.08 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 3.6499999999999999 110.057 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -89.56 -60.36 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 2.5099999999999998 111.428 -172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.76 125.65 2.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.698 -1.137 . . . . 1.4299999999999999 110.298 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.8500000000000001 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 2.27 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.499 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.3100000000000001 109.496 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 4.3499999999999996 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.598 HG11 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 1.4299999999999999 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.723 HG12 ' CD2' ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 1.6100000000000001 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HB2' HG21 ' A' ' 104' ' ' VAL . 8.4 t-160 -107.38 82.2 1.64 Allowed 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 4.3099999999999996 110.505 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HE2' HG21 ' A' ' 98' ' ' THR . 18.3 pttp -57.11 173.52 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.266 -1.334 . . . . 6.1900000000000004 109.771 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.594 HD12 ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -123.73 147.72 47.23 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 118.799 -1.16 . . . . 4.8499999999999996 111.833 -166.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HG2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -121.73 110.25 15.71 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.768 -1.56 . . . . 5.7199999999999998 108.275 169.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 3.3 mt-30 -113.2 63.4 0.64 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.464 -0.335 . . . . 4.4800000000000004 111.513 -174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 20.34 66.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.781 0 O-C-N 125.36 1.662 . . . . 3.7799999999999998 116.113 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 142.8 -26.22 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.1 -2.556 . . . . 6.8499999999999996 104.1 -171.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.2 m-80 -126.11 149.62 48.8 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 112.4 -2.182 . . . . 5.2300000000000004 110.681 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 26' ' ' ASN . 4.2 mm? -128.81 125.99 38.95 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 110.408 -3.087 . . . . 4.4500000000000002 104.734 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.401 HG13 ' NE2' ' A' ' 23' ' ' GLN . 32.7 mm -104.87 119.51 53.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.318 0.58 . . . . 3.3599999999999999 109.778 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.769 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 3.0 tp -124.35 73.66 1.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 127.656 3.097 . . . . 4.6699999999999999 105.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.89 -87.78 0.67 Allowed Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.322 -1.308 . . . . 1.8200000000000001 115.355 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.859 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 -69.41 164.29 23.34 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.529 0.164 . . . . 0.87 110.756 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.6699999999999999 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 1.54 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.84999999999999998 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 55' ' ' ILE . . . -137.99 122.96 2.56 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.45 112.229 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' HA3' ' OE1' ' A' ' 48' ' ' GLU . . . -152.15 84.69 0.15 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.76 -0.733 . . . . 3.0 111.979 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.709 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -150.29 -65.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.218 0.532 . . . . 5.2199999999999998 111.478 176.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -107.58 19.61 19.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.873 1.321 . . . . 7.4900000000000002 108.004 -175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.709 ' HG2' ' H ' ' A' ' 37' ' ' ILE . 4.1 mm100 -81.7 -74.54 0.33 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.861 -1.518 . . . . 4.7999999999999998 111.34 -172.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 42' ' ' SER . 38.7 t70 -149.35 125.17 5.06 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.321 -0.854 . . . . 5.1399999999999997 110.474 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.08 -16.99 40.85 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.682 2.921 . . . . 6.1200000000000001 112.512 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.606 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 22.9 t -68.6 -28.62 67.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.725 . . . . 6.5499999999999998 109.989 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.681 ' HG2' ' HG3' ' B' ' 161' ' ' LYS . 5.5 mt-30 -90.05 -57.33 2.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.22 -0.9 . . . . 5.9299999999999997 109.575 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.978 HD21 ' HA ' ' A' ' 48' ' ' GLU . 9.4 m120 -96.33 101.18 8.14 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-N 113.67 -1.605 . . . . 6.46 111.017 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 -30.76 20.1 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.822 2.348 . . . . 8.5199999999999996 112.538 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.89 -47.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.394 -0.366 . . . . 9.5399999999999991 111.358 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 3.2 m -159.38 -63.98 0.08 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.944 -1.502 . . . . 5.1299999999999999 106.944 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.978 ' HA ' HD21 ' A' ' 44' ' ' ASN . 10.6 tp10 -139.93 -64.91 0.47 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.11 -1.859 . . . . 7.4299999999999997 106.494 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.71 -94.78 0.49 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.017 -1.447 . . . . 7.3899999999999997 107.929 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -127.51 -66.01 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.259 0.552 . . . . 8.0700000000000003 110.519 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -92.65 5.04 52.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.498 -0.774 . . . . 5.5099999999999998 111.814 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.9 t70 -83.78 172.61 12.03 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.752 0.787 . . . . 3.9700000000000002 109.96 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -117.81 -7.13 11.0 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.111 -1.404 . . . . 6.6299999999999999 109.589 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA3' HG22 ' A' ' 37' ' ' ILE . . . 86.5 -45.47 3.45 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.863 -0.608 . . . . 1.3 114.319 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.568 HD13 ' HD1' ' A' ' 90' ' ' HIS . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 1.3600000000000001 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.8900000000000001 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG21 ' A' ' 33' ' ' ILE . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 1.3700000000000001 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.45 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.6000000000000001 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 1.3799999999999999 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.577 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.2799999999999998 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.76 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 1.0900000000000001 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 1.48 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 1.1200000000000001 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.48999999999999999 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 2.2200000000000002 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.3599999999999999 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 1.24 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.59999999999999998 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.3500000000000001 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.6800000000000002 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.719 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.58 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 1.1299999999999999 109.538 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.044 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 22.2 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.2599999999999998 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 1.45 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.901 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.8999999999999999 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1000000000000001 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 3.5099999999999998 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.995 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.6100000000000001 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.482 ' HB2' ' H ' ' A' ' 86' ' ' THR . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.8400000000000001 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.75 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG11 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 2.1499999999999999 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.765 HG21 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.48 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.598 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 3.1000000000000001 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.8100000000000001 110.544 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.765 ' HG2' HG21 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.9700000000000002 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 1.4299999999999999 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 4.5199999999999996 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.9300000000000002 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.712 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 4.3899999999999997 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.77 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.72 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.8300000000000001 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 2.25 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.7599999999999998 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.477 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.6699999999999999 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.1099999999999999 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.524 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.9399999999999999 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.73 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.71 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.901 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.5800000000000001 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.723 ' CD2' HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 2.0299999999999998 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 2.1600000000000001 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.76 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 1.27 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.552 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.96 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 mp0 -86.56 -47.28 9.36 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.8300000000000001 108.434 169.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 t 95.77 17.15 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 112.301 -2.227 . . . . 4.7300000000000004 109.806 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.44 -30.05 0.21 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.406 -1.724 . . . . 4.7699999999999996 108.299 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 112' ' ' GLN . 41.2 mt-30 -97.31 120.97 38.64 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.976 -1.92 . . . . 7.2400000000000002 109.584 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -99.15 169.73 9.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.212 -0.449 . . . . 9.4800000000000004 110.318 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.08 26.39 4.9 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.134 0.968 . . . . 11.58 109.377 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.404 ' O ' HG11 ' A' ' 118' ' ' VAL . 7.1 p -103.4 78.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.694 -1.594 . . . . 12.380000000000001 109.582 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -106.73 36.47 2.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.056 -1.429 . . . . 14.960000000000001 111.306 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -64.01 102.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.09 0.471 . . . . 17.609999999999999 110.096 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.6 m -88.67 -21.45 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 19.469999999999999 111.385 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.8 tpp -128.38 129.38 46.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 21.969999999999999 110.63 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -85.87 121.19 28.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 23.199999999999999 109.743 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 23.960000000000001 111.463 -177.079 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.681 ' HG3' ' HG2' ' A' ' 43' ' ' GLN . 10.1 tptp . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 119.452 -0.308 . . . . 8.5899999999999999 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 176.68 166.09 0.49 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.357 0.411 . . . . 6.8700000000000001 111.652 165.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 30.8 t30 57.32 99.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 124.537 1.148 . . . . 5.2400000000000002 113.432 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -90.71 125.96 35.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.165 -1.05 . . . . 3.2200000000000002 108.165 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 158.85 22.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.401 -0.592 . . . . 4.9199999999999999 109.401 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.517 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m -152.85 105.48 2.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.309 -0.405 . . . . 1.3200000000000001 110.216 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.743 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.6600000000000001 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 2.0699999999999998 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.431 0.634 . . . . 18.620000000000001 109.696 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -77.11 109.12 10.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.678 -0.692 . . . . 15.27 110.826 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.09 167.68 21.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 14.640000000000001 111.133 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.61 98.62 31.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.414 -0.587 . . . . 10.640000000000001 109.414 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.71 122.72 8.0 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.122 2.548 . . . . 11.31 112.787 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.68 -15.97 56.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.77 -0.729 . . . . 7.8700000000000001 113.005 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.3 94.49 42.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.968 0.384 . . . . 7.2000000000000002 111.149 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -98.67 -168.82 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.344 2.696 . . . . 5.4199999999999999 113.159 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.797 HG23 ' H ' ' A' ' 10' ' ' THR . 4.6 p -130.94 -166.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.966 -1.016 . . . . 3.6499999999999999 108.483 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.797 ' H ' HG23 ' A' ' 9' ' ' VAL . 70.6 p -104.07 -97.28 0.31 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.016 0.436 . . . . 2.5099999999999998 111.437 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.13 135.23 0.98 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.358 -0.837 . . . . 1.4299999999999999 111.02 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.8500000000000001 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 2.27 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.409 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.738 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 4.3499999999999996 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 1.4299999999999999 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.862 HD11 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 1.6100000000000001 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.744 ' HA ' HG23 ' A' ' 104' ' ' VAL . 14.0 t-160 -87.48 93.28 9.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 4.3099999999999996 110.52 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.8 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -75.35 161.23 29.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.113 -1.403 . . . . 6.1900000000000004 110.38 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 tp -139.14 121.82 16.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.055 0.455 . . . . 4.8499999999999996 111.589 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.708 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -76.49 132.29 39.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.64 0.733 . . . . 5.7199999999999998 110.304 170.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.426 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.34 64.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.19 0.995 . . . . 4.4800000000000004 110.172 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.532 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 78.75 -102.47 1.89 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.632 -1.622 . . . . 3.7799999999999998 111.572 174.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.84 -2.05 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.428 -0.582 . . . . 6.8499999999999996 109.428 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.652 ' HB3' HD13 ' A' ' 28' ' ' ILE . 32.7 m-80 -109.74 136.83 48.46 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 123.306 1.527 . . . . 5.2300000000000004 110.573 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.708 HD12 ' HB2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.66 108.85 11.95 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.186 -2.733 . . . . 4.4500000000000002 106.567 170.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.8 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.0 mm -116.38 122.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 118.893 -0.575 . . . . 3.3599999999999999 111.95 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.688 HD12 ' HB ' ' B' ' 168' ' ' VAL . 6.7 mp -101.13 -24.81 14.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.479 -1.304 . . . . 4.6699999999999999 107.479 159.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.89 36.49 21.97 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 113.686 -1.597 . . . . 1.8200000000000001 114.451 161.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.72 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 -162.76 177.57 9.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.497 0.648 . . . . 0.87 110.615 167.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.893 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.6699999999999999 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 1.54 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.84999999999999998 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.3 121.38 4.05 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.45 111.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' B' ' 162' ' ' GLU . . . -151.25 60.91 0.41 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.783 -0.722 . . . . 3.0 113.413 -175.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.663 HG21 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -119.78 -57.55 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.523 0.564 . . . . 5.2199999999999998 112.523 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' H ' HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.99 20.33 3.47 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.136 -0.69 . . . . 7.4900000000000002 109.136 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.584 ' OE1' HD13 ' B' ' 164' ' ' LEU . 36.5 mm-40 -58.39 -76.32 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.669 -1.15 . . . . 4.7999999999999998 111.794 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' B' ' 161' ' ' LYS . 2.8 t0 -147.8 115.79 4.12 Favored Pre-proline 0 C--N 1.315 -0.903 0 C-N-CA 120.234 -0.586 . . . . 5.1399999999999997 110.654 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.883 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 56.1 Cg_endo -61.74 -10.1 15.96 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.75 2.967 . . . . 6.1200000000000001 111.193 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 22.6 t -47.44 -55.56 8.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.052 -1.885 . . . . 6.5499999999999998 111.84 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.528 HE22 ' N ' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -97.32 -21.46 17.21 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.774 -0.648 . . . . 5.9299999999999997 112.375 -161.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 7.3 t-20 -159.62 109.66 1.48 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.896 0.379 . . . . 6.46 110.832 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.4 -13.42 15.11 Favored 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.837 2.358 . . . . 8.5199999999999996 113.649 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.644 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 11.4 t80 -141.0 -20.91 0.79 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.912 0.708 . . . . 9.5399999999999991 112.912 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 89.5 p 57.35 -88.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.85 1.26 . . . . 5.1299999999999999 110.519 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 46' ' ' PHE . 41.0 tt0 62.06 15.39 7.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 7.4299999999999997 111.046 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.3 72.31 0.93 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.565 0.698 . . . . 7.3899999999999997 110.246 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 55.29 71.37 0.55 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.135 -1.393 . . . . 8.0700000000000003 111.897 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.2 t 50.64 35.62 12.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.619 -1.173 . . . . 5.5099999999999998 109.926 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 54' ' ' GLY . 31.3 t70 -34.43 -58.21 0.49 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.684 -1.598 . . . . 3.9700000000000002 113.047 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.462 ' HG3' HG23 ' A' ' 86' ' ' THR . 52.1 tptt 77.8 -25.97 0.19 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.071 0.857 . . . . 6.6299999999999999 110.553 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.663 ' HA3' HG21 ' A' ' 37' ' ' ILE . . . 97.87 -7.53 62.95 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.941 -0.572 . . . . 1.3 114.331 166.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 1.3600000000000001 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.8900000000000001 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 1.3700000000000001 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.45 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.893 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.6000000000000001 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.72 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 1.3799999999999999 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 2.1299999999999999 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.2799999999999998 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.684 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.76 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 1.0900000000000001 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 1.48 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 1.1200000000000001 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.48999999999999999 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 2.2200000000000002 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.3599999999999999 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 1.24 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.683 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.59999999999999998 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.581 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.3500000000000001 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.6800000000000002 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.697 HG21 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 1.3200000000000001 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 1.1299999999999999 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.795 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.2599999999999998 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 1.45 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1000000000000001 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.563 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 3.5099999999999998 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.795 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.6100000000000001 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.766 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.462 HG23 ' HG3' ' A' ' 53' ' ' LYS . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.8400000000000001 112.397 -169.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.75 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.663 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 2.1499999999999999 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.48 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.45 ' HB2' HE22 ' A' ' 39' ' ' GLN . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 3.1000000000000001 110.592 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.721 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.8100000000000001 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.663 ' CB ' HG12 ' A' ' 88' ' ' VAL . 7.5 mm100 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.9700000000000002 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 1.4299999999999999 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.721 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 4.5199999999999996 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.9300000000000002 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 4.3899999999999997 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.705 HD13 HG21 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.77 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.705 HG21 HD13 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.8300000000000001 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 2.25 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.7599999999999998 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.6699999999999999 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.741 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.9399999999999999 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.744 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.73 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.617 HG12 HD22 ' A' ' 29' ' ' LEU . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.71 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.5800000000000001 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 2.0299999999999998 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.738 ' CD2' ' HG2' ' A' ' 15' ' ' ARG . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 2.1600000000000001 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.76 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 1.27 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.96 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.504 ' HB3' HD23 ' A' ' 114' ' ' LEU . 21.8 mm-40 -96.12 -29.88 13.83 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.8300000000000001 109.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.6 t 80.81 18.96 0.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.027 -1.897 . . . . 4.7300000000000004 111.752 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 112' ' ' GLN . 1.3 pp -115.59 33.77 5.29 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.685 1.231 . . . . 4.7699999999999996 110.424 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.59 73.52 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.278 -2.237 . . . . 7.2400000000000002 112.911 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 73.44 146.87 0.08 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.938 0.895 . . . . 9.4800000000000004 112.155 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.48 37.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.789 0.804 . . . . 11.58 109.175 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.21 84.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.668 -1.151 . . . . 12.380000000000001 109.809 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -130.81 133.26 45.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.8 -1.091 . . . . 14.960000000000001 110.439 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 54.15 81.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.877 0.736 . . . . 17.609999999999999 112.673 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 m -82.88 -7.62 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 19.469999999999999 111.151 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -89.98 -38.36 13.69 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.921 0.391 . . . . 21.969999999999999 111.101 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.09 104.69 14.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.011 -0.54 . . . . 23.199999999999999 110.346 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.546 . . . . 23.960000000000001 110.643 178.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.883 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 1.9 mptt . . . . . 0 C--O 1.225 -0.218 0 CA-C-O 119.409 -0.329 . . . . 8.5899999999999999 110.451 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.61 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 16.5 tt0 -120.07 130.17 54.55 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 6.8700000000000001 114.25 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -166.7 15.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.97 -1.013 . . . . 5.2400000000000002 110.274 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.584 HD13 ' OE1' ' A' ' 39' ' ' GLN . 4.7 mt -110.68 133.17 53.56 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 113.302 0.853 . . . . 3.2200000000000002 113.302 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.12 156.63 33.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.543 -1.208 . . . . 4.9199999999999999 108.842 164.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m -158.64 121.14 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.53 -0.305 . . . . 1.3200000000000001 110.898 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.684 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.6600000000000001 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.688 ' HB ' HD12 ' A' ' 29' ' ' LEU . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 2.0699999999999998 108.584 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.0 mtm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.519 0.199 . . . . 18.620000000000001 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -84.33 -66.72 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.591 0.234 . . . . 15.27 110.606 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -111.98 -175.48 2.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.321 . . . . 14.640000000000001 110.536 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.05 98.75 26.41 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.232 -0.44 . . . . 10.640000000000001 110.141 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.58 141.4 22.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.836 2.357 . . . . 11.31 111.789 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.45 -36.13 3.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.268 -0.968 . . . . 7.8700000000000001 112.624 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -116.87 85.12 16.9 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.384 0.512 . . . . 7.2000000000000002 112.384 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -100.9 152.16 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.168 2.579 . . . . 5.4199999999999999 111.707 168.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.89 152.2 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 3.6499999999999999 109.693 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 117' ' ' ALA . 76.2 p -88.58 -54.47 4.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.914 -1.039 . . . . 2.5099999999999998 110.9 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.51 145.79 3.26 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.863 -1.517 . . . . 1.4299999999999999 109.036 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.8500000000000001 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 2.27 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.3100000000000001 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.54 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 4.3499999999999996 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 1.4299999999999999 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 1.6100000000000001 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 -142.98 116.01 8.86 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 4.3099999999999996 111.425 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.728 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 5.7 tmtm? -85.95 -81.18 0.21 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.034 -0.358 . . . . 6.1900000000000004 110.034 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 tp -151.24 120.23 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.055 -0.52 . . . . 4.8499999999999996 111.952 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 1.3 tmm_? -77.59 112.7 14.66 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.931 -0.766 . . . . 5.7199999999999998 108.931 166.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.908 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -123.04 68.31 0.98 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.225 1.012 . . . . 4.4800000000000004 110.703 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 73.34 -99.54 0.99 Allowed Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.555 -1.657 . . . . 3.7799999999999998 112.228 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.74 -8.13 56.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.757 -0.721 . . . . 6.8499999999999996 109.509 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.908 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 33.1 m-80 -112.51 134.78 53.85 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.362 1.553 . . . . 5.2300000000000004 110.69 -172.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 26' ' ' ASN . 4.0 mm? -122.31 110.72 16.03 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 111.066 -2.788 . . . . 4.4500000000000002 106.006 167.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.643 HG13 ' NE2' ' A' ' 23' ' ' GLN . 42.0 mm -107.65 132.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.048 -0.523 . . . . 3.3599999999999999 111.555 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.577 HD21 HG12 ' A' ' 105' ' ' VAL . 5.7 mp -104.39 -31.87 9.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.584 -1.189 . . . . 4.6699999999999999 108.511 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -56.26 4.99 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 114.185 -1.371 . . . . 1.8200000000000001 114.574 172.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.836 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 -72.42 -174.88 1.44 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.684 0.394 . . . . 0.87 111.479 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.607 ' HB3' ' HG3' ' B' ' 165' ' ' GLU . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.6699999999999999 111.381 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 1.54 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.84999999999999998 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . -163.89 125.67 1.42 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.45 111.265 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' B' ' 163' ' ' ASN . . . 144.35 -22.22 2.06 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.745 -1.217 . . . . 3.0 112.263 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.86 ' HA ' ' HB3' ' B' ' 163' ' ' ASN . 5.4 pt -46.95 -47.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.326 0.862 . . . . 5.2199999999999998 113.326 -161.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -135.78 2.53 2.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.213 -1.032 . . . . 7.4900000000000002 108.213 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.776 ' OE1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -107.29 -15.54 14.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.078 1.14 . . . . 4.7999999999999998 114.078 -169.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER -54.04 128.6 56.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 121.203 0.525 . . . . 5.1399999999999997 110.138 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 38.8 Cg_endo -61.61 -17.35 53.83 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 124.205 3.27 . . . . 6.1200000000000001 111.929 -172.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 4.4 m -72.29 -40.3 67.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.41 -0.814 . . . . 6.5499999999999998 110.019 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 40' ' ' ASP . 7.2 pt20 -100.75 -18.15 16.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.858 0.837 . . . . 5.9299999999999997 110.636 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.0 t-20 -137.64 88.09 16.76 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.391 -1.277 . . . . 6.46 109.777 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -7.95 17.96 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.903 2.402 . . . . 8.5199999999999996 111.804 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 47' ' ' SER . 88.2 m-85 -94.29 -66.73 0.9 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.667 -0.697 . . . . 9.5399999999999991 109.994 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 6.2 t 161.57 -72.75 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.338 -0.986 . . . . 5.1299999999999999 108.338 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' SER . 3.9 tm-20 174.08 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.648 -1.242 . . . . 7.4299999999999997 107.648 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 7.5 t70 -118.17 -78.36 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.718 -1.128 . . . . 7.3899999999999997 108.486 174.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD2' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -176.01 -38.1 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.393 -0.821 . . . . 8.0700000000000003 109.149 170.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -96.63 6.23 49.13 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.895 -1.048 . . . . 5.5099999999999998 108.857 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 38.6 t70 -76.2 -67.8 0.65 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.787 -0.642 . . . . 3.9700000000000002 111.064 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER 77.22 -45.93 0.48 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.937 0.895 . . . . 6.6299999999999999 108.813 -177.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.646 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 79.24 22.88 64.36 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.649 -1.16 . . . . 1.3 113.356 170.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 1.3600000000000001 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.8900000000000001 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 1.3700000000000001 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.45 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HA ' HG21 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.6000000000000001 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.836 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 1.3799999999999999 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 2.1299999999999999 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.763 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.2799999999999998 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.728 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.76 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 1.0900000000000001 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.763 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 1.48 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 1.1200000000000001 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.48999999999999999 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.857 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 2.2200000000000002 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.857 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 1.24 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.856 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.59999999999999998 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.621 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.3500000000000001 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.6800000000000002 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 1.3200000000000001 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.552 ' HE3' ' HB3' ' A' ' 76' ' ' LYS . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.386 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.2599999999999998 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 1.45 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.8999999999999999 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1000000000000001 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.654 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 3.5099999999999998 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.6100000000000001 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.513 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.8400000000000001 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.75 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.865 HG12 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 2.1499999999999999 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.965 HG23 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.48 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.96 ' HB3' HD12 ' B' ' 164' ' ' LEU . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 3.1000000000000001 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.8100000000000001 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.965 ' HB2' HG23 ' A' ' 89' ' ' THR . 8.6 tp-100 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.9700000000000002 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 1.4299999999999999 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.685 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 4.5199999999999996 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.9300000000000002 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.654 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 4.3899999999999997 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.614 HD13 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.77 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.614 HG23 HD13 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.8300000000000001 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.749 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 2.25 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HD3' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.7599999999999998 110.974 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.6699999999999999 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.1099999999999999 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.9399999999999999 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.73 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 29' ' ' LEU . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.71 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.5800000000000001 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 2.0299999999999998 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 2.1600000000000001 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.76 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 1.27 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.685 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.96 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.655 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER 54.54 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.8300000000000001 109.298 -167.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ARG . 44.0 t 53.69 29.28 9.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.659 -2.519 . . . . 4.7300000000000004 111.271 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 112' ' ' GLN . 2.7 pp -129.02 5.35 5.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 123.506 1.622 . . . . 4.7699999999999996 109.419 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -88.83 -176.08 5.09 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 111.478 -2.601 . . . . 7.2400000000000002 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -65.51 125.99 26.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.603 -0.517 . . . . 9.4800000000000004 109.603 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.588 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -133.92 25.26 3.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.332 1.063 . . . . 11.58 109.063 -173.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.97 80.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.684 -1.598 . . . . 12.380000000000001 109.806 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -111.7 28.0 9.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.948 -1.478 . . . . 14.960000000000001 110.403 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -78.06 65.93 3.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.47 0.652 . . . . 17.609999999999999 110.342 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -105.81 -36.62 6.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.561 -0.745 . . . . 19.469999999999999 109.762 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -131.32 113.76 14.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 21.969999999999999 110.048 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.739 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.4 pt? -104.26 101.39 11.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.237 -0.438 . . . . 23.199999999999999 109.857 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 23.960000000000001 110.258 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' SER . 27.7 mtmm . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.958 0.409 . . . . 8.5899999999999999 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.417 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 34.7 mt-10 73.04 -170.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.918 -1.037 . . . . 6.8700000000000001 112.839 173.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.86 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 8.4 p30 -123.58 154.86 38.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.873 -1.058 . . . . 5.2400000000000002 111.346 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.96 HD12 ' HB3' ' A' ' 90' ' ' HIS . 4.3 mp -139.88 162.73 34.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.938 0.399 . . . . 3.2200000000000002 111.194 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.7 118.17 20.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.9199999999999999 108.56 166.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.615 ' HB2' ' HE1' ' A' ' 90' ' ' HIS . 1.1 m -157.11 150.35 23.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.694 . . . . 1.3200000000000001 111.193 -167.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.785 ' HE2' HG12 ' A' ' 33' ' ' ILE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.6600000000000001 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 2.0699999999999998 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.543 -0.54 . . . . 18.620000000000001 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -115.75 -7.92 12.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.794 0.331 . . . . 15.27 110.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -120.44 136.83 54.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.323 -0.399 . . . . 14.640000000000001 110.224 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mt -113.38 96.28 39.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.954 0.407 . . . . 10.640000000000001 110.055 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.1 20.95 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.606 2.871 . . . . 11.31 112.832 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.84 -11.67 10.98 Favored Glycine 0 C--N 1.315 -0.629 0 C-N-CA 120.71 -0.757 . . . . 7.8700000000000001 112.736 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.18 147.22 33.21 Favored Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 110.002 -0.369 . . . . 7.2000000000000002 110.002 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.13 141.07 96.25 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.064 2.509 . . . . 5.4199999999999999 112.826 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.95 -2.32 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 122.92 1.343 . . . . 3.6499999999999999 108.936 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p 68.0 102.45 0.05 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.123 -2.762 . . . . 2.5099999999999998 112.008 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.29 109.76 19.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.768 -2.015 . . . . 1.4299999999999999 109.747 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.8500000000000001 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 2.27 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.3100000000000001 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 4.3499999999999996 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 1.4299999999999999 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.88 ' HB3' HG22 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.901 HD11 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 1.6100000000000001 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.863 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -147.14 167.94 22.88 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 4.3099999999999996 110.949 164.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.563 ' HA ' HD22 ' A' ' 29' ' ' LEU . 66.6 mttm -28.13 144.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 125.497 1.748 . . . . 6.1900000000000004 114.358 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 57.8 tp -125.9 128.87 48.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.219 -0.9 . . . . 4.8499999999999996 110.209 -168.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.875 ' HD3' ' HB3' ' A' ' 27' ' ' LEU . 2.9 tpp180 -60.86 120.77 10.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.864 -1.062 . . . . 5.7199999999999998 113.366 -173.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.455 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -135.41 71.17 1.43 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.136 -1.393 . . . . 4.4800000000000004 110.184 171.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.72 -107.81 2.37 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 113.469 -1.696 . . . . 3.7799999999999998 112.119 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.99 -2.17 54.53 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.883 -0.784 . . . . 6.8499999999999996 108.883 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.657 ' C ' HD12 ' A' ' 27' ' ' LEU . 20.7 m-80 -115.67 153.27 31.62 Favored 'General case' 0 N--CA 1.405 -2.709 0 N-CA-C 108.186 -1.042 . . . . 5.2300000000000004 108.186 -173.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.875 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.21 111.09 5.03 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 112.834 -1.985 . . . . 4.4500000000000002 108.946 162.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG13 ' NE2' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -154.14 157.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 112.812 -1.994 . . . . 3.3599999999999999 112.927 -170.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.852 ' HB3' ' HD1' ' A' ' 31' ' ' PHE . 3.5 mm? -75.68 -61.15 2.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.337 -0.847 . . . . 4.6699999999999999 109.848 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.89 -5.74 72.83 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.337 -0.847 . . . . 1.8200000000000001 112.449 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.969 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 -94.14 167.33 11.63 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.208 0.504 . . . . 0.87 109.813 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.6699999999999999 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.84999999999999998 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.735 ' O ' ' HG3' ' A' ' 39' ' ' GLN . . . -130.74 131.97 6.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.45 111.514 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' CA ' ' HA ' ' B' ' 162' ' ' GLU . . . -132.13 13.08 5.25 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.873 -0.68 . . . . 3.0 112.752 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG13 ' H ' ' A' ' 38' ' ' ASP . 5.3 pt -54.1 -72.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.374 0.669 . . . . 5.2199999999999998 112.797 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.827 ' H ' HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -101.66 10.35 40.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.152 0.501 . . . . 7.4900000000000002 109.836 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.735 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 28.4 mm-40 -78.57 -101.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.07 -0.968 . . . . 4.7999999999999998 113.329 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.635 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -125.5 102.43 29.66 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 120.48 -0.488 . . . . 5.1399999999999997 111.674 -168.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.575 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 55.7 Cg_endo -63.19 -10.9 22.67 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 123.47 2.78 . . . . 6.1200000000000001 109.468 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.8 m -52.74 -39.4 62.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.014 -1.903 . . . . 6.5499999999999998 110.791 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 1.003 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 37.7 mt-30 -91.64 -12.77 33.24 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 120.495 -0.482 . . . . 5.9299999999999997 111.275 -170.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.585 ' HB2' ' HB2' ' B' ' 161' ' ' LYS . 7.8 t-20 -152.58 97.77 2.9 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.572 -0.74 . . . . 6.46 111.385 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.62 -12.07 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.703 2.269 . . . . 8.5199999999999996 111.645 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -89.58 -44.72 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 9.5399999999999991 111.301 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 p -135.29 -176.55 4.3 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.796 0.332 . . . . 5.1299999999999999 110.778 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.6 -34.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 7.4299999999999997 110.011 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 19.9 t70 -176.15 61.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.369 1.08 . . . . 7.3899999999999997 109.207 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HD2' ' C ' ' A' ' 49' ' ' ASP . 12.0 mptt -128.75 -52.09 1.24 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.672 -1.149 . . . . 8.0700000000000003 108.306 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.2 p -116.42 8.37 14.08 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.732 -1.122 . . . . 5.5099999999999998 110.268 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 12.9 t70 -124.57 -60.33 1.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.109 1.152 . . . . 3.9700000000000002 114.109 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 4.5 mptp? 90.76 -16.52 0.2 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.444 1.09 . . . . 6.6299999999999999 111.938 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.35 -4.0 82.83 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.3 114.882 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 HG22 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 1.3600000000000001 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.8900000000000001 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.78 HG11 ' H ' ' A' ' 74' ' ' GLY . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 1.3700000000000001 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.45 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HG2' HG21 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.6000000000000001 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.969 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 1.3799999999999999 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 2.1299999999999999 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.2799999999999998 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.76 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 1.0900000000000001 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.625 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 1.48 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 66' ' ' ALA . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 1.1200000000000001 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.48999999999999999 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB2' HD12 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 2.2200000000000002 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.689 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.3599999999999999 108.73 -164.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 1.24 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.78 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.59999999999999998 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.3500000000000001 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.6800000000000002 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 1.3200000000000001 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.573 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 1.1299999999999999 109.962 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.915 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.2599999999999998 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.675 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 1.45 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.764 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.8999999999999999 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 112.465 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.675 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 3.5099999999999998 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.891 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.6100000000000001 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.694 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.8400000000000001 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.75 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 2.1499999999999999 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.48 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 3.1000000000000001 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.8100000000000001 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.9700000000000002 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 1.4299999999999999 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 4.5199999999999996 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.9300000000000002 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 4.3899999999999997 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.73 HD13 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.77 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.73 HG23 HD13 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.8300000000000001 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HZ1' ' HB3' ' A' ' 101' ' ' SER . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 2.25 107.196 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.7599999999999998 107.751 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.6699999999999999 110.359 -169.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.1099999999999999 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.9399999999999999 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.526 ' CG2' ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.73 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.88 HG22 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.71 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.764 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.5800000000000001 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.901 HD22 HD11 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 2.0299999999999998 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.915 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 2.1600000000000001 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.76 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 1.27 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.96 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . 13.8 mm-40 -93.93 -46.02 7.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.8300000000000001 110.272 -175.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 38.9 m 79.18 9.38 1.72 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.453 -1.703 . . . . 4.7300000000000004 110.953 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.32 5.76 1.47 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 124.008 1.861 . . . . 4.7699999999999996 108.063 176.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 14.8 pt20 -63.6 166.01 7.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 110.206 -3.179 . . . . 7.2400000000000002 112.43 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -105.86 134.64 48.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.066 -0.97 . . . . 9.4800000000000004 109.228 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.11 19.96 7.61 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 122.357 1.075 . . . . 11.58 108.634 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 118' ' ' VAL . 7.7 p -135.09 86.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.091 -1.868 . . . . 12.380000000000001 110.027 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.44 178.85 7.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.704 -0.68 . . . . 14.960000000000001 110.42 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.59 131.23 56.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.001 0.429 . . . . 17.609999999999999 110.709 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.9 p -145.28 103.76 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.823 -0.626 . . . . 19.469999999999999 110.425 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.78 132.06 34.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.163 -0.471 . . . . 21.969999999999999 110.229 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.76 157.34 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 23.199999999999999 110.563 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.94 -0.573 . . . . 23.960000000000001 110.214 178.323 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 1.003 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 42.0 tttm . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 122.043 0.925 . . . . 8.5899999999999999 109.817 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.639 ' C ' HE22 ' A' ' 43' ' ' GLN . 8.6 pt-20 -98.82 133.12 43.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 115.097 1.517 . . . . 6.8700000000000001 115.097 -168.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 39' ' ' GLN . 46.4 t-20 -111.21 -30.87 7.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.604 0.716 . . . . 5.2400000000000002 109.198 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.78 123.09 42.79 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.875 -1.057 . . . . 3.2200000000000002 113.097 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -112.27 159.41 18.65 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.608 -1.256 . . . . 4.9199999999999999 107.608 169.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m -152.74 122.47 6.9 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.171 -0.612 . . . . 1.3200000000000001 112.023 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.6600000000000001 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.543 ' CG1' HD12 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 2.0699999999999998 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.391 -0.596 . . . . 18.620000000000001 109.391 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -119.76 143.17 47.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.365 -0.38 . . . . 15.27 111.409 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 71.14 143.42 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.038 0.837 . . . . 14.640000000000001 111.992 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mm -122.16 95.67 47.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 10.640000000000001 110.827 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.67 124.18 6.8 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.024 2.483 . . . . 11.31 111.734 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.69 42.81 38.18 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.897 -0.668 . . . . 7.8700000000000001 111.984 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 pt20 -62.62 125.97 87.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 7.2000000000000002 111.841 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 16.9 Cg_exo -67.57 167.81 19.88 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.011 2.474 . . . . 5.4199999999999999 112.542 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -97.33 6.5 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.188 0.994 . . . . 3.6499999999999999 110.485 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p 74.26 -54.66 0.67 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.482 -2.145 . . . . 2.5099999999999998 112.178 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -163.23 120.69 1.9 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.784 -1.098 . . . . 1.4299999999999999 111.042 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.8500000000000001 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.3100000000000001 110.482 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.635 ' NE ' HD23 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 4.3499999999999996 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 1.4299999999999999 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.915 HG21 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 1.6100000000000001 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.545 ' HB3' HG21 ' A' ' 104' ' ' VAL . 7.4 p80 -94.42 82.22 4.03 Favored 'General case' 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 4.3099999999999996 111.965 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.93 ' HD3' ' HG2' ' A' ' 65' ' ' PRO . 3.0 mmmp? -127.88 99.28 5.46 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 112.845 -1.98 . . . . 6.1900000000000004 108.499 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 28' ' ' ILE . 55.3 tp -157.09 156.22 32.42 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.92 -0.582 . . . . 4.8499999999999996 110.352 -162.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.924 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -80.67 109.89 15.63 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.879 0.847 . . . . 5.7199999999999998 109.866 160.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.003 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 1.4 pt20 -138.12 69.83 1.39 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.228 -1.351 . . . . 4.4800000000000004 111.492 -175.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.14 -100.46 0.86 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-N 114.07 -1.423 . . . . 3.7799999999999998 112.861 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.13 -13.11 60.2 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.513 -0.921 . . . . 6.8499999999999996 108.513 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 1.003 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.6 m-80 -108.01 120.85 43.48 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.791 1.281 . . . . 5.2300000000000004 110.02 -171.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -117.24 107.12 14.04 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 112.488 -2.142 . . . . 4.4500000000000002 107.565 169.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.832 HD13 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -127.23 121.08 56.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.833 -0.803 . . . . 3.3599999999999999 108.833 174.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.03 HD11 ' HA ' ' B' ' 168' ' ' VAL . 34.7 tp -162.03 73.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 125.929 2.018 . . . . 4.6699999999999999 107.256 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' N ' ' HZ3' ' A' ' 20' ' ' LYS . . . -131.7 -60.5 0.09 OUTLIER Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.968 1.147 . . . . 1.8200000000000001 115.968 -166.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.939 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 -69.67 156.86 38.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.471 1.135 . . . . 0.87 110.115 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.6699999999999999 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HG22 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 1.54 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.84999999999999998 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' HB2' ' B' ' 163' ' ' ASN . . . -136.06 131.16 5.59 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.45 111.13 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -148.33 57.12 0.48 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.605 -0.807 . . . . 3.0 112.88 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.488 HG21 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -126.34 -43.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.559 0.218 . . . . 5.2199999999999998 111.218 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -98.23 7.46 46.22 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.119 -0.696 . . . . 7.4900000000000002 109.119 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.561 ' HG2' ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -111.73 -67.3 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.011 -0.995 . . . . 4.7999999999999998 111.838 -175.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 13.3 t70 -128.73 128.07 23.5 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.697 -0.483 . . . . 5.1399999999999997 109.697 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.63 -16.02 11.95 Favored 'Trans proline' 0 CA--C 1.514 -0.509 0 C-N-CA 123.204 2.603 . . . . 6.1200000000000001 111.902 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' B' ' 161' ' ' LYS . 17.8 t -84.34 -9.61 58.3 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.592 -0.731 . . . . 6.5499999999999998 110.107 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' B' ' 163' ' ' ASN . 34.7 mm-40 -54.63 -30.91 56.31 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.871 0.843 . . . . 5.9299999999999997 109.118 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -135.71 89.58 21.32 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.029 -1.442 . . . . 6.46 111.584 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.93 8.51 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.756 2.304 . . . . 8.5199999999999996 111.733 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.42 -22.34 7.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 9.5399999999999991 111.112 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HG ' ' HB2' ' A' ' 52' ' ' ASP . 21.4 t -148.97 -153.66 0.51 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.184 -1.043 . . . . 5.1299999999999999 108.184 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.39 -39.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.541 0.686 . . . . 7.4299999999999997 110.101 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 14.0 t0 -173.04 -177.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.776 -1.194 . . . . 7.3899999999999997 107.776 -170.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 9.2 mptt 68.56 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.198 0.599 . . . . 8.0700000000000003 110.478 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -83.03 -7.92 59.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 5.5099999999999998 110.006 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.582 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 2.4 t0 -120.76 170.86 9.05 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.609 -0.886 . . . . 3.9700000000000002 108.609 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 3.3 mptp? -136.44 -21.74 1.33 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.66 -1.154 . . . . 6.6299999999999999 108.899 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' HA3' HG21 ' A' ' 37' ' ' ILE . . . 58.22 22.24 49.49 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.005 -0.998 . . . . 1.3 115.477 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 77' ' ' ILE . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 1.3600000000000001 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.8900000000000001 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 1.3700000000000001 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.45 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.6000000000000001 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 1.3799999999999999 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.453 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 2.1299999999999999 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.2799999999999998 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.93 ' HG2' ' HD3' ' A' ' 20' ' ' LYS . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.76 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.915 ' HA ' HG21 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 1.0900000000000001 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.754 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 1.48 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 1.1200000000000001 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.48999999999999999 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 2.2200000000000002 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.3599999999999999 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 1.24 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.59999999999999998 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD1' HG21 ' A' ' 109' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.732 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.6800000000000002 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 55' ' ' ILE . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 1.3200000000000001 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.565 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 1.1299999999999999 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.884 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.2599999999999998 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 1.45 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.702 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1000000000000001 112.626 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 3.5099999999999998 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.884 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.6100000000000001 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 88' ' ' VAL . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.8400000000000001 111.614 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.75 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 85' ' ' MET . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 2.1499999999999999 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.48 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.592 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 3.1000000000000001 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.8100000000000001 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.734 HE21 ' N ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.9700000000000002 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.734 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 1.4299999999999999 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.67 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 4.5199999999999996 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.9300000000000002 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 4.3899999999999997 112.327 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' HB2' HG22 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.77 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.605 HG22 HD11 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.8300000000000001 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 2.25 113.189 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.7599999999999998 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.6699999999999999 111.234 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' HG2' HD21 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.1099999999999999 110.464 -177.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.9399999999999999 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.73 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.71 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.702 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.5800000000000001 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.828 HD21 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 2.0299999999999998 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.875 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 2.1600000000000001 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.495 HG21 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.76 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 1.27 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.96 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 113' ' ' SER . 18.0 mm-40 -100.01 -35.59 9.66 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.8300000000000001 109.684 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.7 m 104.13 22.97 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 110.975 -2.829 . . . . 4.7300000000000004 109.589 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 114' ' ' LEU . 2.7 mm? 54.72 71.8 0.51 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.512 -1.676 . . . . 4.7699999999999996 112.301 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.68 115.78 8.44 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.957 -1.474 . . . . 7.2400000000000002 109.408 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 68.89 125.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.227 -0.897 . . . . 9.4800000000000004 109.778 -168.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 119' ' ' GLN . . . -133.52 26.59 4.08 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.239 1.019 . . . . 11.58 109.324 -167.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 m -79.94 26.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.51 -1.677 . . . . 12.380000000000001 112.174 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 117' ' ' ALA . 92.0 mt-30 -110.78 94.48 5.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.547 -0.751 . . . . 14.960000000000001 110.107 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -89.86 -97.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.601 -0.272 . . . . 17.609999999999999 110.735 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.6 m -161.53 136.45 7.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.077 0.151 . . . . 19.469999999999999 110.621 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.2 mtt 66.96 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.463 0.705 . . . . 21.969999999999999 112.34 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.9 tp -135.52 166.62 22.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 23.199999999999999 109.865 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.947 0.403 . . . . 23.960000000000001 110.514 178.123 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.669 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 12.6 ttpp . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.324 0.583 . . . . 8.5899999999999999 111.551 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.07 128.07 10.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 6.8700000000000001 111.199 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 10.1 p30 -99.18 -166.38 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.539 -0.755 . . . . 5.2400000000000002 110.55 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.431 HD21 ' ND1' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -128.02 136.51 51.35 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.415 -0.514 . . . . 3.2200000000000002 110.249 175.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.1 157.5 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.571 -0.9 . . . . 4.9199999999999999 108.571 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.592 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t -137.11 118.82 15.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.775 -0.454 . . . . 1.3200000000000001 109.775 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.6600000000000001 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 1.03 ' HA ' HD11 ' A' ' 29' ' ' LEU . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 2.0699999999999998 110.633 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.026 -0.361 . . . . 18.620000000000001 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -72.32 78.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.288 0.477 . . . . 15.27 112.288 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -132.42 5.72 4.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.779 -0.646 . . . . 14.640000000000001 109.369 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.3 mt 57.5 81.36 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.796 -1.093 . . . . 10.640000000000001 111.488 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.57 105.62 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.687 2.258 . . . . 11.31 111.183 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 47.52 2.49 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.66 -0.781 . . . . 7.8700000000000001 111.535 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -63.58 126.68 90.14 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.9 0.381 . . . . 7.2000000000000002 111.234 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.27 135.67 51.57 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.854 2.369 . . . . 5.4199999999999999 111.256 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -83.33 174.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.259 0.552 . . . . 3.6499999999999999 110.318 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.515 ' H ' HG23 ' A' ' 9' ' ' VAL . 76.4 p -96.22 -113.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.024 -0.989 . . . . 2.5099999999999998 111.602 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -171.99 143.63 1.6 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.681 -1.145 . . . . 1.4299999999999999 110.985 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.8500000000000001 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 2.27 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.3100000000000001 110.412 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 4.3499999999999996 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.824 HG12 HD11 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 1.4299999999999999 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 1.6100000000000001 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB2' HG21 ' A' ' 104' ' ' VAL . 19.7 t-160 -143.89 110.57 5.6 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 4.3099999999999996 112.339 -172.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.734 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 23.1 mmtp -129.52 -161.67 1.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.836 -1.542 . . . . 6.1900000000000004 106.836 161.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 22' ' ' ARG . 25.9 tp -150.51 135.75 17.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 119.685 1.129 . . . . 4.8499999999999996 112.04 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.955 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.64 136.31 43.86 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.006 -0.739 . . . . 5.7199999999999998 109.006 168.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 2.2 mt-30 -130.2 61.32 1.59 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.595 0.712 . . . . 4.4800000000000004 109.514 -175.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.596 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 71.18 -94.01 0.53 Allowed Glycine 0 CA--C 1.502 -0.72 0 CA-C-N 114.337 -1.301 . . . . 3.7799999999999998 112.216 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -71.42 -10.2 59.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.64 0.733 . . . . 6.8499999999999996 109.656 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.574 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.7 m-80 -113.99 143.9 43.97 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-O 123.21 1.481 . . . . 5.2300000000000004 110.39 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 22' ' ' ARG . 4.6 mm? -126.7 107.81 10.5 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 111.346 -2.661 . . . . 4.4500000000000002 105.898 168.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 26' ' ' ASN . 13.5 mm -113.08 122.39 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 120.687 -0.405 . . . . 3.3599999999999999 111.25 -174.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.734 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 50.0 tp -143.3 -52.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.266 -1.383 . . . . 4.6699999999999999 107.266 165.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 102.51 -15.79 55.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 114.888 0.715 . . . . 1.8200000000000001 114.888 159.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 1.023 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 -96.26 162.92 13.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.522 1.161 . . . . 0.87 110.973 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.6699999999999999 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 1.54 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' B' ' 165' ' ' GLU . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.84999999999999998 111.188 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.569 ' HA3' ' HD1' ' A' ' 90' ' ' HIS . . . -104.42 103.61 2.28 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.45 110.444 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.667 ' CA ' ' HG3' ' A' ' 41' ' ' PRO . . . -156.57 67.74 0.29 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.717 -1.23 . . . . 3.0 113.221 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG13 ' H ' ' A' ' 38' ' ' ASP . 1.6 pt -99.79 -76.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.411 0.624 . . . . 5.2199999999999998 110.792 176.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.786 ' H ' HG13 ' A' ' 37' ' ' ILE . 28.0 t70 -115.67 14.46 16.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.277 1.037 . . . . 7.4900000000000002 108.539 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.437 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 42.8 mm-40 -67.38 -72.1 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.952 -1.477 . . . . 4.7999999999999998 111.303 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.893 ' H ' ' HD2' ' A' ' 41' ' ' PRO . 47.7 m-20 -144.54 -39.92 0.01 OUTLIER Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 113.898 -1.501 . . . . 5.1399999999999997 109.522 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.893 ' HD2' ' H ' ' A' ' 40' ' ' ASP . 11.1 Cg_endo -47.71 -10.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.474 3.45 . . . . 6.1200000000000001 111.582 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 40' ' ' ASP . 41.0 t -46.92 -24.84 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.15 -1.841 . . . . 6.5499999999999998 110.673 163.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.684 ' OE1' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.9 -18.74 58.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.213 0.53 . . . . 5.9299999999999997 111.255 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.511 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 2.4 t-20 -84.71 110.45 27.7 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.015 -0.993 . . . . 6.46 111.353 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 47.3 Cg_endo -71.21 -8.61 23.84 Favored 'Trans proline' 0 C--N 1.334 -0.231 0 C-N-CA 123.251 2.634 . . . . 8.5199999999999996 111.526 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -84.28 -21.3 31.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.571 -0.74 . . . . 9.5399999999999991 110.244 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' ' 44' ' ' ASN . 13.4 p -98.78 -167.79 1.54 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.574 -0.898 . . . . 5.1299999999999999 108.574 168.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 58.91 11.61 1.97 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.784 0.802 . . . . 7.4299999999999997 110.298 -171.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -138.75 120.09 14.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.965 -1.016 . . . . 7.3899999999999997 109.684 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' ASP . 42.7 mmtm 52.49 90.2 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 124.484 1.115 . . . . 8.0700000000000003 111.751 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 53' ' ' LYS . 31.8 p 75.33 -16.16 0.61 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.506 -1.225 . . . . 5.5099999999999998 111.675 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.598 ' OD2' ' HA ' ' A' ' 37' ' ' ILE . 38.0 t70 69.45 -34.03 0.27 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.062 0.945 . . . . 3.9700000000000002 112.419 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.561 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 5.2 mptt 67.76 13.73 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.793 0.837 . . . . 6.6299999999999999 109.454 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 36' ' ' GLY . . . -62.6 -53.67 39.74 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.924 -1.035 . . . . 1.3 115.026 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 1.3600000000000001 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.8900000000000001 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 1.3700000000000001 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.45 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.6000000000000001 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.023 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 1.3799999999999999 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.561 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 2.1299999999999999 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.2799999999999998 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.515 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.76 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 1.0900000000000001 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 1.48 109.006 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 1.1200000000000001 107.423 171.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.48999999999999999 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 2.2200000000000002 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.53 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.3599999999999999 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 1.24 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.59999999999999998 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.3500000000000001 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.6800000000000002 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.534 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 1.1299999999999999 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.2599999999999998 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 1.45 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.83 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 15.3 m-80 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.8999999999999999 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1000000000000001 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 3.5099999999999998 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.6100000000000001 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.8400000000000001 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.75 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 1.044 HG11 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 2.1499999999999999 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.48 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.569 ' HD1' ' HA3' ' A' ' 35' ' ' GLY . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 3.1000000000000001 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.8100000000000001 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 1.044 ' HG3' HG11 ' A' ' 88' ' ' VAL . 6.5 tp-100 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.9700000000000002 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 1.4299999999999999 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 4.5199999999999996 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.9300000000000002 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HD2' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 4.3899999999999997 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.77 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.545 HG23 HD13 ' A' ' 97' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.8300000000000001 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.717 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 2.25 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.7599999999999998 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.717 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.6699999999999999 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.1099999999999999 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.9399999999999999 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.73 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.797 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.71 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.83 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.5800000000000001 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.824 HD11 HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 2.0299999999999998 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 2.1600000000000001 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.76 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 1.27 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.722 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.96 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' A' ' 113' ' ' SER . 1.7 mp0 -85.66 -44.11 12.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.8300000000000001 109.363 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 63.6 m 86.75 12.88 0.13 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.254 -2.248 . . . . 4.7300000000000004 109.956 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.49 32.79 5.84 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.622 -1.626 . . . . 4.7699999999999996 108.361 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 13.9 mm-40 -79.12 -177.5 5.67 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 111.781 -2.463 . . . . 7.2400000000000002 111.127 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 116' ' ' LYS . 3.3 ptpp? -113.5 129.85 56.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.091 0.472 . . . . 9.4800000000000004 111.415 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.13 23.28 3.02 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.607 1.194 . . . . 11.58 107.904 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.28 84.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 113.333 -1.758 . . . . 12.380000000000001 109.564 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -118.6 158.76 24.83 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.06 -1.427 . . . . 14.960000000000001 110.138 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -86.34 80.63 8.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.554 -0.535 . . . . 17.609999999999999 109.554 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.1 p -76.09 102.03 5.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 19.469999999999999 110.028 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -77.76 46.0 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.679 -0.691 . . . . 21.969999999999999 111.213 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -172.1 -51.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.809 -0.811 . . . . 23.199999999999999 108.809 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 115.381 -0.827 . . . . 23.960000000000001 110.682 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.871 ' HE3' ' HA ' ' A' ' 40' ' ' ASP . 23.2 tptt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.333 -0.617 . . . . 8.5899999999999999 109.333 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.44 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 39.9 tt0 -166.03 156.66 12.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.849 0.357 . . . . 6.8700000000000001 110.998 174.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.02 158.71 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.637 -0.711 . . . . 5.2400000000000002 112.73 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.524 HD23 ' H ' ' B' ' 164' ' ' LEU . 2.2 pt? -113.18 125.83 54.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.531 -0.759 . . . . 3.2200000000000002 111.046 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.414 ' HG3' ' HA2' ' A' ' 34' ' ' GLY . 3.0 mp0 -104.65 161.56 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.642 -0.708 . . . . 4.9199999999999999 110.843 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m -159.32 162.39 35.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.702 -0.681 . . . . 1.3200000000000001 109.804 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.6600000000000001 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.652 ' OXT' ' HB3' ' A' ' 29' ' ' LEU . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 2.0699999999999998 108.084 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.72 0.295 . . . . 18.620000000000001 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -108.04 98.81 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.766 0.317 . . . . 15.27 110.647 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.05 142.86 30.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.097 0.475 . . . . 14.640000000000001 110.867 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.4 mt -137.27 97.33 10.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.242 -0.651 . . . . 10.640000000000001 109.242 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.38 104.95 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.618 2.212 . . . . 11.31 112.161 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.36 -47.14 0.81 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.792 -0.718 . . . . 7.8700000000000001 112.017 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -128.81 83.33 66.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.717 0.294 . . . . 7.2000000000000002 111.008 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.38 128.28 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.181 2.588 . . . . 5.4199999999999999 111.724 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.88 126.47 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.694 0.759 . . . . 3.6499999999999999 111.434 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 63.6 p -91.56 -46.17 8.1 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.487 -1.233 . . . . 2.5099999999999998 111.083 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 1.076 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -157.68 130.62 7.52 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.302 -1.317 . . . . 1.4299999999999999 111.248 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.8500000000000001 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 2.27 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.543 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 4.3499999999999996 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 1.4299999999999999 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.832 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.882 HG22 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 1.6100000000000001 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.905 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 -94.07 96.36 9.61 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 4.3099999999999996 112.401 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.792 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -61.25 177.52 0.35 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.345 -1.298 . . . . 6.1900000000000004 111.122 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.745 HD13 ' HG2' ' A' ' 23' ' ' GLN . 0.7 OUTLIER -148.9 118.89 7.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.215 -0.594 . . . . 4.8499999999999996 111.087 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.2 ttt180 -69.85 145.57 51.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.255 -0.884 . . . . 5.7199999999999998 110.472 167.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.916 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 9.2 mt-30 -139.09 61.71 1.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.519 -0.764 . . . . 4.4800000000000004 109.627 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.93 -97.32 0.25 Allowed Glycine 0 CA--C 1.495 -1.209 0 CA-C-N 113.91 -1.495 . . . . 3.7799999999999998 112.146 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -79.95 1.75 26.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.569 -0.816 . . . . 6.8499999999999996 109.871 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.916 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 47.6 m-80 -117.26 147.73 42.29 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 122.664 1.221 . . . . 5.2300000000000004 109.869 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 26' ' ' ASN . 4.0 mm? -133.49 109.92 9.61 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 111.8 -2.454 . . . . 4.4500000000000002 106.691 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.792 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.9 mm -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.612 -0.884 . . . . 3.3599999999999999 108.612 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.628 ' HB2' ' C ' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -95.85 -33.57 12.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.479 -0.934 . . . . 4.6699999999999999 108.479 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.7 -63.95 0.35 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.023 -1.084 . . . . 1.8200000000000001 115.786 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.882 ' HE2' HG22 ' A' ' 18' ' ' ILE . 28.2 p90 -160.16 -177.35 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.38 0.59 . . . . 0.87 111.577 -162.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.6699999999999999 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 1.54 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.84999999999999998 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . -108.75 134.84 12.48 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.45 111.37 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.527 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -143.24 60.61 0.52 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.313 -1.115 . . . . 3.0 110.313 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 HG21 ' O ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -124.02 -37.3 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.449 0.642 . . . . 5.2199999999999998 110.746 -172.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' N ' HG12 ' A' ' 37' ' ' ILE . 1.2 p30 -119.89 25.07 10.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.298 -0.864 . . . . 7.4900000000000002 109.755 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 68.1 mm-40 -91.23 -83.61 0.27 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.727 0.775 . . . . 4.7999999999999998 112.45 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -150.17 144.57 17.68 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 114.639 -1.164 . . . . 5.1399999999999997 111.097 -165.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.81 -12.15 13.62 Favored 'Trans proline' 0 C--N 1.336 -0.127 0 C-N-CA 123.389 2.726 . . . . 6.1200000000000001 112.079 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.466 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 4.5 t -73.04 -21.0 60.87 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.572 -0.74 . . . . 6.5499999999999998 111.022 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -82.9 -8.88 59.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.526 0.679 . . . . 5.9299999999999997 110.059 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -177.3 108.54 0.23 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 114.545 -1.207 . . . . 6.46 109.611 176.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 9.8 Cg_endo -53.91 -17.01 9.82 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.063 2.509 . . . . 8.5199999999999996 112.571 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -166.16 -46.14 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.07 -0.514 . . . . 9.5399999999999991 111.018 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 117' ' ' ALA . 26.7 t 159.19 147.85 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 109.185 -0.672 . . . . 5.1299999999999999 109.185 -157.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -138.32 4.69 2.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.887 -0.597 . . . . 7.4299999999999997 110.62 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -153.17 23.29 0.55 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.75 0.786 . . . . 7.3899999999999997 109.786 173.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 20.4 mmtm 74.94 -88.1 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.209 1.189 . . . . 8.0700000000000003 114.209 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.0 p -99.69 36.84 1.71 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.669 -0.696 . . . . 5.5099999999999998 111.574 -165.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 43.0 t0 -74.32 155.38 38.26 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.538 1.161 . . . . 3.9700000000000002 110.125 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 32.0 mmtp -94.89 -37.0 11.39 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.899 -1.955 . . . . 6.6299999999999999 108.86 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 32.05 20.17 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 114.789 -1.096 . . . . 1.3 114.446 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 1.3600000000000001 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.8900000000000001 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.729 HG13 ' H ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 1.3700000000000001 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.45 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.6000000000000001 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.758 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 1.3799999999999999 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 2.1299999999999999 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.2799999999999998 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.636 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.76 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.098 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 1.0900000000000001 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.792 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 1.48 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 1.1200000000000001 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.48999999999999999 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 1.098 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 2.2200000000000002 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 1.24 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.729 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.59999999999999998 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.3500000000000001 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.709 ' HE2' ' HG3' ' A' ' 115' ' ' GLN . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.6800000000000002 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 1.3200000000000001 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.548 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 1.1299999999999999 110.003 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.783 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.2599999999999998 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 1.45 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.648 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 18.2 m-80 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.8999999999999999 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1000000000000001 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.57 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 3.5099999999999998 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.783 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.6100000000000001 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 53' ' ' LYS . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.8400000000000001 112.139 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.75 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 2.1499999999999999 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.75 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.48 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.68 ' HB2' HD22 ' B' ' 164' ' ' LEU . 38.6 t-80 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 3.1000000000000001 111.025 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.8100000000000001 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.75 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 4.4 mm100 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.9700000000000002 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 1.4299999999999999 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.605 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 4.5199999999999996 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.9300000000000002 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 4.3899999999999997 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.77 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.497 HG21 HD11 ' A' ' 29' ' ' LEU . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.8300000000000001 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 2.25 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.7599999999999998 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.6699999999999999 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.1099999999999999 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.9399999999999999 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.905 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.73 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG22 ' HZ2' ' A' ' 20' ' ' LYS . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.71 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.5800000000000001 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.507 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 2.0299999999999998 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.695 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 2.1600000000000001 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 110' ' ' THR . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.76 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 1.076 ' HB ' ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 1.27 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.96 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER 70.13 -62.53 0.43 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.8300000000000001 109.185 -157.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 76' ' ' LYS . 33.2 t 68.73 19.56 8.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.27 -2.241 . . . . 4.7300000000000004 111.391 170.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -88.76 26.42 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.533 -1.212 . . . . 4.7699999999999996 112.268 -167.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.709 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 6.7 pt20 -112.2 144.72 41.13 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.025 -1.898 . . . . 7.2400000000000002 109.721 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.659 ' HA ' ' OD2' ' A' ' 52' ' ' ASP . 26.4 mtpp -141.5 160.91 39.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.458 0.171 . . . . 9.4800000000000004 111.451 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.86 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . . . 168.1 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.179 0.992 . . . . 11.58 108.726 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 118' ' ' VAL . 12.2 p -77.06 33.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.563 1.173 . . . . 12.380000000000001 110.278 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 117' ' ' ALA . 16.2 mm100 -109.12 91.11 3.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.228 -0.896 . . . . 14.960000000000001 112.206 -172.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -118.15 166.05 13.04 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.04 -0.527 . . . . 17.609999999999999 110.12 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -85.14 142.24 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.053 -0.351 . . . . 19.469999999999999 110.053 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -97.78 118.68 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.235 -0.438 . . . . 21.969999999999999 110.66 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.5 pp -90.82 167.66 12.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.092 -0.504 . . . . 23.199999999999999 110.273 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.096 0.474 . . . . 23.960000000000001 110.752 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 14.1 mptt . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.604 -0.236 . . . . 8.5899999999999999 110.582 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' B' ' 161' ' ' LYS . 1.3 pm0 -76.36 112.07 12.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.859 -0.737 . . . . 6.8700000000000001 111.04 -173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.47 27.26 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.938 -1.028 . . . . 5.2400000000000002 113.047 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.68 HD22 ' HB2' ' A' ' 90' ' ' HIS . 2.8 tp -100.31 86.07 3.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.584 -0.697 . . . . 3.2200000000000002 109.459 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.7 mt-10 -109.27 162.75 14.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.447 0.641 . . . . 4.9199999999999999 111.759 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.505 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 39.6 m -156.93 125.78 5.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.785 -1.098 . . . . 1.3200000000000001 109.818 171.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.6600000000000001 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.628 ' C ' ' HB2' ' A' ' 29' ' ' LEU . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 2.0699999999999998 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.074 -0.343 . . . . 18.620000000000001 110.074 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 72.03 176.09 0.28 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.801 0.688 . . . . 15.27 111.727 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -123.45 141.64 51.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.997 -0.742 . . . . 14.640000000000001 108.997 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.84 94.03 45.27 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.399 . . . . 10.640000000000001 110.509 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.94 96.73 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.887 2.392 . . . . 11.31 111.571 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.01 -41.15 0.29 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.028 -0.987 . . . . 7.8700000000000001 110.722 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -93.38 127.36 46.83 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 115.403 -0.398 . . . . 7.2000000000000002 110.266 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 3.0 Cg_exo -76.05 144.39 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.761 2.307 . . . . 5.4199999999999999 111.887 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG21 ' H ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -80.31 177.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.32 -0.622 . . . . 3.6499999999999999 109.32 175.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.585 ' H ' HG21 ' A' ' 9' ' ' VAL . 78.4 p -92.76 -119.05 0.09 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.249 -0.887 . . . . 2.5099999999999998 110.397 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -171.74 125.36 0.58 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.828 -1.078 . . . . 1.4299999999999999 110.559 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.8500000000000001 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 2.27 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.3100000000000001 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HE ' HD23 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 4.3499999999999996 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 1.4299999999999999 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.908 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.75 ' O ' HG21 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 1.6100000000000001 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 11.3 t-160 -131.95 123.49 27.48 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 4.3099999999999996 112.668 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.899 ' HD3' HG12 ' A' ' 105' ' ' VAL . 11.7 mmmm -46.01 160.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.523 -1.672 . . . . 6.1900000000000004 110.989 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' H ' ' N ' ' A' ' 28' ' ' ILE . 42.3 tp -126.12 136.81 53.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.947 0.879 . . . . 4.8499999999999996 111.665 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.565 HH11 HD21 ' A' ' 27' ' ' LEU . 3.7 tpt180 -59.41 118.6 6.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.801 -1.545 . . . . 5.7199999999999998 113.332 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -139.69 69.79 1.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.361 -1.291 . . . . 4.4800000000000004 110.393 167.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 46.81 78.42 0.09 OUTLIER Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 114.319 -1.31 . . . . 3.7799999999999998 113.915 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.5 mm-40 89.21 -3.85 0.41 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.122 1.369 . . . . 6.8499999999999996 107.743 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' C ' HD23 ' A' ' 27' ' ' LEU . 16.8 m-80 -117.35 140.89 48.99 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 114.952 -1.022 . . . . 5.2300000000000004 109.473 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 4.6 mm? -123.32 102.87 8.16 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.118 -1.855 . . . . 4.4500000000000002 107.655 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.683 ' HB ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 pt -163.56 177.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 115.348 1.61 . . . . 3.3599999999999999 115.348 -174.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.683 ' HG ' ' HB ' ' A' ' 28' ' ' ILE . 69.9 mt 74.48 77.6 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 112.119 -2.31 . . . . 4.6699999999999999 112.481 156.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.32 -50.48 0.66 Allowed Glycine 0 C--N 1.298 -1.538 0 CA-C-N 111.093 -2.776 . . . . 1.8200000000000001 113.102 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 -158.42 -179.13 7.81 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.856 -0.791 . . . . 0.87 111.825 -169.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.6699999999999999 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 1.54 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.84999999999999998 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -151.17 120.21 1.08 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.45 112.021 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' HA2' HE22 ' A' ' 39' ' ' GLN . . . 146.05 -4.31 1.16 Allowed Glycine 0 C--O 1.224 -0.511 0 C-N-CA 119.498 -1.334 . . . . 3.0 112.544 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG13 ' H ' ' A' ' 38' ' ' ASP . 11.1 pt -41.03 -65.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 115.759 1.763 . . . . 5.2199999999999998 115.759 -164.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.609 ' H ' HG13 ' A' ' 37' ' ' ILE . 23.5 t70 -131.8 -8.38 3.56 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.686 0.755 . . . . 7.4900000000000002 109.958 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.504 HE22 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -117.96 -16.21 9.9 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.211 1.189 . . . . 4.7999999999999998 114.211 -163.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 13.3 t70 -53.94 137.87 55.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.505 -0.771 . . . . 5.1399999999999997 110.647 -175.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 58.8 Cg_endo -59.48 -16.31 35.0 Favored 'Trans proline' 0 N--CA 1.475 0.406 0 C-N-CA 124.345 3.363 . . . . 6.1200000000000001 113.014 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -75.23 -34.7 61.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.078 -0.712 . . . . 6.5499999999999998 109.078 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.645 ' OE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -106.33 -48.36 3.59 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.722 0.772 . . . . 5.9299999999999997 110.636 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.517 ' H ' ' HG2' ' A' ' 43' ' ' GLN . 9.2 t-20 -122.46 81.55 46.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.182 -1.372 . . . . 6.46 111.758 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.59 -3.78 14.11 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.049 1.833 . . . . 8.5199999999999996 111.464 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -83.74 -22.88 31.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.915 -0.772 . . . . 9.5399999999999991 108.915 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 49' ' ' ASP . 74.6 m -96.51 -161.37 0.86 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.668 -0.696 . . . . 5.1299999999999999 109.145 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 47' ' ' SER . 44.3 tt0 69.52 -20.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.176 0.513 . . . . 7.4299999999999997 110.856 -175.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 47' ' ' SER . 16.1 t70 -64.95 -28.94 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 7.3899999999999997 110.446 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 0.67 17.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.033 -0.985 . . . . 8.0700000000000003 110.318 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 49' ' ' ASP . 15.3 p 62.45 27.58 16.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.335 1.022 . . . . 5.5099999999999998 108.34 -164.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -51.5 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.043 -1.435 . . . . 3.9700000000000002 111.33 -178.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt 69.39 -23.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.783 1.233 . . . . 6.6299999999999999 112.468 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.689 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 58.38 50.23 68.72 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 1.3 112.335 170.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.644 HD11 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 1.3600000000000001 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.8900000000000001 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 74' ' ' GLY . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 1.3700000000000001 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.45 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.586 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.6000000000000001 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.773 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 1.3799999999999999 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 2.1299999999999999 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.694 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.2799999999999998 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.735 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.694 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.76 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 1.0900000000000001 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 1.48 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 1.1200000000000001 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.48999999999999999 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.788 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 2.2200000000000002 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.788 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 5.4 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.3599999999999999 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 1.24 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HG11 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.59999999999999998 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 -172.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.6800000000000002 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 1.3200000000000001 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.551 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 1.1299999999999999 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.048 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.7 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.2599999999999998 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 1.45 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.8999999999999999 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1000000000000001 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.669 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 3.5099999999999998 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.921 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.6100000000000001 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.048 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.8400000000000001 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.75 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.821 HG13 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 2.1499999999999999 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.773 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.48 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 3.1000000000000001 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.821 ' HB2' HG13 ' A' ' 88' ' ' VAL . 5.8 mm100 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.9700000000000002 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.875 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 1.4299999999999999 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.501 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 4.5199999999999996 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.9300000000000002 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.875 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 4.3899999999999997 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.77 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.451 ' N ' HD11 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 2.25 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.7599999999999998 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.6699999999999999 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.1099999999999999 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.9399999999999999 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.73 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.899 HG12 ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.71 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.908 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.5800000000000001 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.707 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 2.0299999999999998 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.829 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 2.1600000000000001 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.76 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.867 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 1.27 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.629 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.96 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.582 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -92.99 -45.73 7.8 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.8300000000000001 108.072 171.028 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 56.7 m 69.08 6.25 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.817 -1.992 . . . . 4.7300000000000004 110.428 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 113' ' ' SER . 1.7 mm? -133.73 29.8 3.81 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.699 -2.046 . . . . 4.7699999999999996 107.396 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -53.27 114.79 1.6 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 111.197 -2.729 . . . . 7.2400000000000002 110.347 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -87.11 132.06 33.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 9.4800000000000004 112.143 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.41 24.03 0.24 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.509 -1.223 . . . . 11.58 109.238 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.41 81.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.152 -1.385 . . . . 12.380000000000001 110.209 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -103.66 97.8 7.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.435 -1.257 . . . . 14.960000000000001 109.208 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -104.64 -0.76 27.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.861 0.319 . . . . 17.609999999999999 111.861 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.2 m 57.97 41.02 25.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.3 0.571 . . . . 19.469999999999999 111.223 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 62.9 mtm -76.51 92.23 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 21.969999999999999 110.67 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -62.28 -45.01 95.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.685 -0.688 . . . . 23.199999999999999 111.129 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.533 0.322 0 O-C-N 123.803 0.689 . . . . 23.960000000000001 111.341 -179.455 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.814 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 10.3 mmpt? . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 110.198 -0.297 . . . . 8.5899999999999999 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.415 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 32.3 tt0 -173.96 -116.35 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 112.11 0.411 . . . . 6.8700000000000001 112.11 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -176.47 157.91 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 5.2400000000000002 109.412 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.34 123.38 48.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.917 0.389 . . . . 3.2200000000000002 111.552 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 22.7 mt-10 -113.29 148.5 35.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 4.9199999999999999 109.992 172.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . 19.9 m -159.78 141.97 13.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.088 -0.505 . . . . 1.3200000000000001 110.945 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.6600000000000001 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 2.0699999999999998 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.301 . . . . 18.620000000000001 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -101.45 117.05 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 15.27 110.066 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.403 ' O ' ' HB ' ' A' ' 4' ' ' ILE . 36.8 p90 -116.5 30.43 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 14.640000000000001 109.439 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 80.1 mt 73.36 88.92 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.083 -1.417 . . . . 10.640000000000001 110.149 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.77 95.47 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.672 2.248 . . . . 11.31 112.247 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.75 -46.2 0.45 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.046 -0.979 . . . . 7.8700000000000001 110.666 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.5 mt-30 -135.57 99.0 11.92 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.804 -0.443 . . . . 7.2000000000000002 109.804 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 7' ' ' GLN . 16.7 Cg_endo -57.84 130.19 37.19 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.053 2.502 . . . . 5.4199999999999999 113.184 -176.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG23 ' H ' ' A' ' 10' ' ' THR . 4.2 p -147.23 178.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.691 -0.686 . . . . 3.6499999999999999 109.411 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.699 ' H ' HG23 ' A' ' 9' ' ' VAL . 48.2 p -131.77 103.86 6.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.224 1.012 . . . . 2.5099999999999998 110.558 -172.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.17 99.22 8.43 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.101 -1.863 . . . . 1.4299999999999999 110.39 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.8500000000000001 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 2.27 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.3100000000000001 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 4.3499999999999996 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 1.4299999999999999 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.779 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 1.055 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 1.6100000000000001 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.737 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -121.69 112.69 18.73 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 4.3099999999999996 111.254 174.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.951 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 1.8 tmtt? -91.77 -99.01 0.12 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.505 -0.77 . . . . 6.1900000000000004 109.44 173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 24.5 tp -153.89 123.65 6.75 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.192 0.812 . . . . 4.8499999999999996 113.192 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.956 ' HB2' ' HB3' ' A' ' 103' ' ' GLU . 5.7 tmm_? -79.27 107.16 11.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.549 -0.908 . . . . 5.7199999999999998 108.549 164.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -112.82 65.87 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.208 1.004 . . . . 4.4800000000000004 109.868 -176.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 80.33 -104.22 2.24 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.584 -1.644 . . . . 3.7799999999999998 111.481 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.69 -7.19 56.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.864 -0.791 . . . . 6.8499999999999996 108.864 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.541 ' C ' HD22 ' A' ' 27' ' ' LEU . 34.3 m-80 -101.72 134.82 44.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.179 1.466 . . . . 5.2300000000000004 110.365 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 ' HG2' ' A' ' 22' ' ' ARG . 4.3 mm? -122.88 109.89 14.73 Favored 'General case' 0 C--N 1.256 -3.467 0 CA-C-N 111.256 -2.702 . . . . 4.4500000000000002 105.767 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG13 ' NE2' ' A' ' 23' ' ' GLN . 35.6 mm -109.17 124.13 65.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.996 -0.547 . . . . 3.3599999999999999 110.95 -172.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD13 HG12 ' A' ' 105' ' ' VAL . 1.2 tt -100.51 -28.05 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 124.607 1.192 . . . . 4.6699999999999999 109.369 172.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -57.17 4.03 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.989 -0.624 . . . . 1.8200000000000001 114.426 169.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 -81.72 177.98 8.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 117.423 0.612 . . . . 0.87 110.947 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.6699999999999999 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 1.54 109.788 -173.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.84999999999999998 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' B' ' 164' ' ' LEU . . . -83.53 100.61 2.28 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.45 109.164 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' HA3' ' HE1' ' A' ' 56' ' ' TYR . . . -121.81 38.07 2.72 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.993 -0.843 . . . . 3.0 110.993 -167.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -55.89 -47.94 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 CA-C-N 114.652 -0.774 . . . . 5.2199999999999998 111.092 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.577 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 30.4 t70 163.55 -23.75 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.916 -1.493 . . . . 7.4900000000000002 107.448 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 2.2 mp0 69.48 160.23 0.19 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 113.769 -1.559 . . . . 4.7999999999999998 112.751 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 22.2 t70 74.76 162.37 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.062 -1.881 . . . . 5.1399999999999997 108.802 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.912 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 1.0 OUTLIER -42.76 -24.23 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.917 3.078 . . . . 6.1200000000000001 111.938 175.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' GLN . 40.5 t -44.98 -38.91 5.08 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.006 -2.361 . . . . 6.5499999999999998 112.328 172.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.775 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 5.6 pt20 -80.13 -20.9 43.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.887 -0.597 . . . . 5.9299999999999997 110.526 -167.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.602 HD22 ' HB2' ' A' ' 46' ' ' PHE . 3.7 t-20 52.72 92.16 0.06 OUTLIER Pre-proline 0 C--O 1.216 -0.668 0 O-C-N 124.642 1.213 . . . . 6.46 113.423 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.557 ' CG ' ' HD2' ' B' ' 161' ' ' LYS . 71.9 Cg_endo -76.13 11.96 1.63 Allowed 'Trans proline' 0 CA--C 1.521 -0.162 0 C-N-CA 122.534 2.156 . . . . 8.5199999999999996 110.708 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' HB2' HD22 ' A' ' 44' ' ' ASN . 86.2 m-85 -98.6 -15.47 19.46 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.846 -1.07 . . . . 9.5399999999999991 109.151 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -84.28 -91.82 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.029 -0.668 . . . . 5.1299999999999999 109.216 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' OE2' ' HA ' ' A' ' 89' ' ' THR . 47.2 mt-10 47.1 34.18 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.771 0.796 . . . . 7.4299999999999997 109.355 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -98.01 -30.95 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.728 -1.124 . . . . 7.3899999999999997 113.31 -166.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER 175.15 -64.15 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.568 0.699 . . . . 8.0700000000000003 112.24 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -68.43 -15.08 63.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.425 -1.261 . . . . 5.5099999999999998 110.464 -170.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.28 -61.62 2.18 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.366 -1.288 . . . . 3.9700000000000002 110.636 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tptm 59.86 22.67 11.64 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.541 -0.754 . . . . 6.6299999999999999 109.635 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 37' ' ' ILE . . . -89.59 30.04 5.92 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.821 -1.081 . . . . 1.3 114.323 -169.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 1.3600000000000001 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.8900000000000001 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 1.3700000000000001 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.45 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.699 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.6000000000000001 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.699 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 1.3799999999999999 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 2.1299999999999999 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.2799999999999998 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.951 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.76 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.055 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 1.0900000000000001 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 1.48 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.669 ' CB ' HD13 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 1.1200000000000001 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.48999999999999999 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 2.2200000000000002 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.476 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.3599999999999999 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 HD13 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 1.24 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.687 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.59999999999999998 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.3500000000000001 109.208 -171.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.794 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.6800000000000002 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 1.3200000000000001 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.544 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 1.1299999999999999 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.714 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.2599999999999998 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 1.45 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.8999999999999999 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1000000000000001 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.542 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 3.5099999999999998 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.6100000000000001 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.714 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.421 ' OG1' ' HE2' ' A' ' 50' ' ' LYS . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.8400000000000001 110.745 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 87' ' ' MET . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.75 108.627 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.726 HG12 ' NE2' ' A' ' 92' ' ' GLN . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 2.1499999999999999 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.48 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.732 ' HD1' HD12 ' B' ' 164' ' ' LEU . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 3.1000000000000001 111.499 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.8100000000000001 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.726 ' NE2' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.9700000000000002 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.614 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 1.4299999999999999 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 4.5199999999999996 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.9300000000000002 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.725 HH22 HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 4.3899999999999997 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB3' HG22 ' A' ' 80' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.77 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.8300000000000001 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 2.25 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.7599999999999998 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.6699999999999999 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.1099999999999999 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' A' ' 22' ' ' ARG . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.9399999999999999 108.729 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.73 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.689 HG12 HD13 ' A' ' 29' ' ' LEU . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.71 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.779 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.5800000000000001 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 2.0299999999999998 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.602 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 2.1600000000000001 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.76 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.794 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 1.27 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.742 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.96 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.44 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 14.2 mm-40 -101.84 -34.35 9.44 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.8300000000000001 108.405 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.9 m 67.42 19.3 10.08 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.417 -2.174 . . . . 4.7300000000000004 112.22 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.605 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.03 3.16 1.04 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.75 1.262 . . . . 4.7699999999999996 108.536 177.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 112' ' ' GLN . 9.4 mm100 4.43 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.082 -3.235 . . . . 7.2400000000000002 114.17 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -106.8 149.83 26.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.006 -0.543 . . . . 9.4800000000000004 109.802 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.07 19.0 1.77 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.185 -1.042 . . . . 11.58 108.185 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 118' ' ' VAL . 11.6 p 31.85 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 112.049 -2.341 . . . . 12.380000000000001 114.337 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -113.54 33.64 5.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.736 -1.12 . . . . 14.960000000000001 109.874 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.99 140.61 52.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.228 -0.896 . . . . 17.609999999999999 109.252 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t 62.58 79.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.842 0.714 . . . . 19.469999999999999 109.235 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.4 mmt 67.14 -166.31 0.21 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.105 -0.952 . . . . 21.969999999999999 109.301 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.24 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.407 0.622 . . . . 23.199999999999999 111.818 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.524 . . . . 23.960000000000001 110.704 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.912 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.996 0.369 . . . . 8.5899999999999999 111.996 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -173.7 -176.92 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 6.8700000000000001 110.961 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -55.42 125.9 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 5.2400000000000002 110.491 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.732 HD12 ' HD1' ' A' ' 90' ' ' HIS . 7.9 mt -113.48 148.9 35.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.25 0.548 . . . . 3.2200000000000002 112.321 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 15.0 mt-10 -144.56 155.04 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.151 -0.931 . . . . 4.9199999999999999 109.855 169.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -158.35 101.09 1.7 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.997 -0.547 . . . . 1.3200000000000001 110.787 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.6600000000000001 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.605 HG21 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 2.0699999999999998 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.148 -0.316 . . . . 18.620000000000001 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 67.02 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.729 0.643 . . . . 15.27 110.935 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -133.5 141.49 47.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 14.640000000000001 109.603 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm 49.82 85.48 0.18 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.87 0.731 . . . . 10.640000000000001 112.105 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.9 109.17 0.39 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.841 2.361 . . . . 11.31 112.11 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.18 -28.11 3.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.022 -0.609 . . . . 7.8700000000000001 112.167 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -121.9 102.03 41.56 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-O 120.939 0.4 . . . . 7.2000000000000002 111.624 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -91.91 -167.53 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.089 2.526 . . . . 5.4199999999999999 112.619 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 10' ' ' THR . 2.9 p -128.68 -176.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.259 -0.645 . . . . 3.6499999999999999 109.259 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.752 ' H ' HG23 ' A' ' 9' ' ' VAL . 57.1 p -111.17 -88.56 0.51 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.107 0.479 . . . . 2.5099999999999998 111.424 -175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 110' ' ' THR . . . -170.8 142.04 1.87 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.055 0.931 . . . . 1.4299999999999999 111.759 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.8500000000000001 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 2.27 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.475 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.3100000000000001 109.82 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.509 ' HG2' HD23 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 4.3499999999999996 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 1.4299999999999999 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.659 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 1.6100000000000001 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 -146.67 119.01 8.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 4.3099999999999996 111.484 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.934 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 27.5 tptp -95.22 -80.06 0.42 Allowed 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 121.997 -0.439 . . . . 6.1900000000000004 110.504 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 22.6 tp -149.9 117.26 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.148 0.499 . . . . 4.8499999999999996 111.618 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 24' ' ' GLY . 2.3 tmt_? -79.71 112.03 16.58 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.772 -0.825 . . . . 5.7199999999999998 108.772 167.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.92 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.6 64.84 0.84 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.858 0.837 . . . . 4.4800000000000004 110.232 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.561 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 75.9 -98.24 1.18 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 113.799 -1.546 . . . . 3.7799999999999998 112.114 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.12 0.92 38.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.802 -0.699 . . . . 6.8499999999999996 109.569 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.92 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 24.3 m-80 -115.47 132.98 56.45 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-O 123.076 1.417 . . . . 5.2300000000000004 110.515 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 101' ' ' SER . 3.8 mm? -120.58 110.94 17.04 Favored 'General case' 0 C--N 1.261 -3.254 0 CA-C-N 111.524 -2.58 . . . . 4.4500000000000002 105.881 166.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.679 HG13 ' NE2' ' A' ' 23' ' ' GLN . 51.9 mm -107.25 128.32 62.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.7 -0.682 . . . . 3.3599999999999999 112.087 -169.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.645 ' HB2' HG22 ' B' ' 168' ' ' VAL . 2.9 mm? -114.76 -49.53 2.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.793 -1.094 . . . . 4.6699999999999999 108.511 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.11 -40.33 2.99 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.599 -0.728 . . . . 1.8200000000000001 113.366 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.881 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 -70.05 167.9 16.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.717 -0.475 . . . . 0.87 109.717 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.677 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.6699999999999999 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 1.54 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.84999999999999998 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' H ' ' B' ' 164' ' ' LEU . . . 140.61 170.85 12.23 Favored Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.45 109.692 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . 149.4 -124.38 1.79 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.313 -1.422 . . . . 3.0 113.973 169.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.664 HG23 HD21 ' B' ' 164' ' ' LEU . 0.4 OUTLIER 17.44 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 127.353 2.261 . . . . 5.2199999999999998 115.837 -178.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 37' ' ' ILE . 12.1 t70 166.4 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.969 -1.123 . . . . 7.4900000000000002 107.969 -170.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 1.057 ' HG2' ' HB3' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -2.5 -104.23 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 N-CA-C 116.032 1.864 . . . . 4.7999999999999998 116.032 -168.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' B' ' 161' ' ' LYS . 1.3 t70 -138.67 132.98 16.52 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 112.492 0.553 . . . . 5.1399999999999997 112.492 -169.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.637 ' HA ' ' CG ' ' B' ' 161' ' ' LYS . 56.7 Cg_endo -80.5 -12.8 12.44 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 124.034 3.156 . . . . 6.1200000000000001 112.639 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 36.2 t -44.84 -43.09 8.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.016 0.926 . . . . 6.5499999999999998 112.694 -172.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.704 HE22 ' HB2' ' B' ' 162' ' ' GLU . 6.7 pt20 -90.08 -0.03 57.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.755 -0.657 . . . . 5.9299999999999997 112.304 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.66 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -33.8 109.61 0.35 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 114.33 1.233 . . . . 6.46 114.33 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.4 -8.86 12.65 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.883 2.389 . . . . 8.5199999999999996 111.446 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CE2' ' HA ' ' A' ' 48' ' ' GLU . 19.9 t80 -155.74 -54.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.754 -0.657 . . . . 9.5399999999999991 110.587 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.814 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 3.8 t 69.09 11.43 8.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.465 0.706 . . . . 5.1299999999999999 110.651 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.794 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 7.2 mm-40 70.32 -59.64 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.955 0.785 . . . . 7.4299999999999997 112.023 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t70 161.77 -38.82 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.64 -1.615 . . . . 7.3899999999999997 106.64 -169.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.794 ' HE3' ' HB3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -98.27 -97.75 0.21 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.131 -1.85 . . . . 8.0700000000000003 110.061 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -137.18 12.89 3.06 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.894 -1.15 . . . . 5.5099999999999998 107.894 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.717 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 20.9 t0 66.26 165.82 0.2 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.114 -1.403 . . . . 3.9700000000000002 110.912 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HG2' ' SD ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -81.06 -23.33 38.61 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.909 -1.042 . . . . 6.6299999999999999 110.491 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.27 10.05 86.4 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.3 115.712 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 1.3600000000000001 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.8900000000000001 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 1.3700000000000001 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.45 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.6000000000000001 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.881 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 1.3799999999999999 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 2.1299999999999999 109.042 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.2799999999999998 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.934 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.76 114.951 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 1.0900000000000001 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 1.48 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 1.1200000000000001 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.48999999999999999 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 2.2200000000000002 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.3599999999999999 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 1.24 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.59999999999999998 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' CB ' HG13 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.3500000000000001 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.6800000000000002 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 1.3200000000000001 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.598 ' SD ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.296 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.772 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.2599999999999998 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.674 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 1.45 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.8999999999999999 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1000000000000001 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HH2' ' HZ2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 3.5099999999999998 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.772 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.6100000000000001 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.8400000000000001 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.75 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.717 HG23 HE22 ' A' ' 92' ' ' GLN . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 2.1499999999999999 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.588 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.48 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.925 ' HB2' HD12 ' B' ' 164' ' ' LEU . 1.9 t-160 -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 3.1000000000000001 111.444 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.8100000000000001 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.774 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.9700000000000002 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.775 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 1.4299999999999999 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 4.5199999999999996 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.677 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.9300000000000002 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 4.3899999999999997 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.77 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.8300000000000001 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 2.25 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.556 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.7599999999999998 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.6699999999999999 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.1099999999999999 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.9399999999999999 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.73 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.659 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.71 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.5800000000000001 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 2.0299999999999998 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.74 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 2.1600000000000001 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.458 HG21 ' H ' ' A' ' 110' ' ' THR . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.76 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 1.27 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' NH1' HD13 ' A' ' 114' ' ' LEU . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.96 111.441 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -99.24 9.73 42.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.8300000000000001 111.3 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t 80.2 26.06 0.33 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.692 -2.049 . . . . 4.7300000000000004 110.157 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 114' ' ' LEU . 2.7 mm? 60.63 57.84 2.61 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.195 -1.366 . . . . 4.7699999999999996 110.495 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.427 ' NE2' ' HB ' ' A' ' 9' ' ' VAL . 53.5 mm-40 -39.7 105.76 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.528 -2.123 . . . . 7.2400000000000002 114.043 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.69 142.85 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.508 -1.224 . . . . 9.4800000000000004 108.165 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.23 20.29 7.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.428 1.109 . . . . 11.58 108.872 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.68 82.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 113.299 -1.773 . . . . 12.380000000000001 108.578 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -115.12 177.77 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.694 -1.139 . . . . 14.960000000000001 110.543 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -106.58 130.2 54.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.632 -0.713 . . . . 17.609999999999999 109.217 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -84.48 170.1 13.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.514 -0.312 . . . . 19.469999999999999 110.181 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 5.2 mpp? 72.27 105.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.932 0.77 . . . . 21.969999999999999 111.401 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.7 -171.55 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.077 -0.965 . . . . 23.199999999999999 111.369 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.607 -0.724 . . . . 23.960000000000001 110.445 -178.231 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.814 ' HE2' ' HA ' ' A' ' 47' ' ' SER . 11.8 mmtp . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.525 0.202 . . . . 8.5899999999999999 110.985 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 1.057 ' HB3' ' HG2' ' A' ' 39' ' ' GLN . 27.7 tt0 -79.8 156.23 27.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.179 0.514 . . . . 6.8700000000000001 110.013 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.405 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 7.3 p30 -87.7 128.48 35.3 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.134 -0.939 . . . . 5.2400000000000002 113.17 -168.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.925 HD12 ' HB2' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -120.69 163.65 17.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.511 -1.292 . . . . 3.2200000000000002 107.511 168.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.618 ' OE1' ' HA ' ' A' ' 90' ' ' HIS . 4.9 tp10 89.49 -145.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.107 0.963 . . . . 4.9199999999999999 112.132 172.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' B' ' 165' ' ' GLU . 63.7 m -173.35 -169.03 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.3200000000000001 112.615 -148.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.6600000000000001 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.645 HG22 ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 2.0699999999999998 109.477 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.307 0.099 . . . . 18.620000000000001 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t 67.91 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.39 0.614 . . . . 15.27 111.093 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -137.46 103.82 5.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.941 -0.572 . . . . 14.640000000000001 110.073 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.58 103.43 6.46 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.691 . . . . 10.640000000000001 110.754 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.82 -154.03 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.249 2.632 . . . . 11.31 111.417 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.0 50.12 1.87 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.032 -0.604 . . . . 7.8700000000000001 112.37 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 20.92 86.81 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.49 1.516 . . . . 7.2000000000000002 114.998 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -91.29 -169.05 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.479 2.786 . . . . 5.4199999999999999 112.312 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 p -85.68 -10.37 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 122.567 1.175 . . . . 3.6499999999999999 109.412 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p 69.08 109.55 0.05 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 111.693 -2.503 . . . . 2.5099999999999998 112.439 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -55.92 137.22 50.96 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 113.008 -1.906 . . . . 1.4299999999999999 110.814 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.8500000000000001 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 2.27 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.3100000000000001 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 4.3499999999999996 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 1.4299999999999999 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 1.6100000000000001 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HB3' HG21 ' A' ' 104' ' ' VAL . 15.8 p80 -130.29 104.63 7.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 4.3099999999999996 111.667 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.74 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 5.4 tmtt? -79.64 -100.77 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.561 -0.533 . . . . 6.1900000000000004 109.561 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 21.9 tp -154.47 134.07 12.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.533 -0.467 . . . . 4.8499999999999996 111.524 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.62 132.78 39.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.109 -0.7 . . . . 5.7199999999999998 109.109 167.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.878 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 14.8 mt-30 -128.92 62.4 1.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.014 0.911 . . . . 4.4800000000000004 109.91 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.69 -99.6 0.85 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 113.581 -1.645 . . . . 3.7799999999999998 111.91 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.64 -5.06 43.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.777 0.799 . . . . 6.8499999999999996 109.697 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.878 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 39.6 m-80 -109.57 146.42 34.71 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 123.228 1.49 . . . . 5.2300000000000004 110.308 -175.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.707 HD22 ' O ' ' A' ' 26' ' ' ASN . 3.9 mm? -135.43 110.24 8.71 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 110.815 -2.902 . . . . 4.4500000000000002 104.98 172.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.821 HG13 HE21 ' A' ' 23' ' ' GLN . 43.1 mm -107.49 129.51 61.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.359 0.6 . . . . 3.3599999999999999 111.815 -168.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD12 ' CE2' ' A' ' 31' ' ' PHE . 7.6 tp -93.47 -41.05 10.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.413 -1.721 . . . . 4.6699999999999999 108.849 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' HA3' ' HG ' ' A' ' 61' ' ' SER . . . 98.52 -48.73 1.36 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.618 -0.801 . . . . 1.8200000000000001 114.036 173.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.768 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 -88.03 173.81 8.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.6 0.7 . . . . 0.87 111.322 -173.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.787 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.6699999999999999 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.99 HD11 ' HG3' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 1.54 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.84999999999999998 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -134.01 155.5 21.86 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.45 111.753 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.88 60.64 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.292 -0.48 . . . . 3.0 112.492 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.769 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -124.21 -58.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 5.2199999999999998 111.272 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.711 ' H ' HG12 ' A' ' 37' ' ' ILE . 19.9 t70 -109.26 16.63 22.28 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.434 -0.95 . . . . 7.4900000000000002 108.434 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.611 ' HB3' HD22 ' B' ' 164' ' ' LEU . 33.3 mm-40 -85.14 -75.26 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.485 -1.234 . . . . 4.7999999999999998 111.222 -174.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 1.5 t70 -130.78 127.17 22.13 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.809 -1.087 . . . . 5.1399999999999997 109.557 -176.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.53 -17.99 26.16 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 123.197 2.598 . . . . 6.1200000000000001 111.747 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 3.6 m -67.16 -37.32 83.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.109 -0.951 . . . . 6.5499999999999998 110.77 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -86.66 -33.93 19.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.428 0.632 . . . . 5.9299999999999997 110.543 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.937 HD22 ' HA ' ' A' ' 48' ' ' GLU . 2.3 t-20 -162.66 97.95 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 114.867 -1.061 . . . . 6.46 111.098 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.97 6.87 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.707 2.271 . . . . 8.5199999999999996 111.326 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -119.51 -73.14 0.66 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.565 -0.743 . . . . 9.5399999999999991 110.66 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.649 ' HA ' HG21 ' A' ' 37' ' ' ILE . 1.6 m 171.33 -47.95 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.309 -0.997 . . . . 5.1299999999999999 108.309 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.937 ' HA ' HD22 ' A' ' 44' ' ' ASN . 0.0 OUTLIER 170.61 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.069 -1.878 . . . . 7.4299999999999997 108.53 178.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 24.8 t0 -111.37 37.31 2.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.401 -0.963 . . . . 7.3899999999999997 108.401 174.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tptm 72.3 -65.58 0.34 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.36 -1.291 . . . . 8.0700000000000003 111.219 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 10.16 8.0 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.719 -1.128 . . . . 5.5099999999999998 112.199 -172.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.27 -174.31 4.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.69 -0.856 . . . . 3.9700000000000002 108.69 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.708 ' HD2' ' HB ' ' A' ' 86' ' ' THR . 69.9 mmtt -127.33 -16.17 4.99 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.282 -0.872 . . . . 6.6299999999999999 110.088 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.769 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 70.92 -5.29 8.08 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.795 -1.093 . . . . 1.3 115.734 171.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 1.3600000000000001 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.8900000000000001 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.871 HG22 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 1.3700000000000001 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.45 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.687 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.6000000000000001 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.768 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 1.3799999999999999 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.565 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 2.1299999999999999 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.2799999999999998 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.74 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.76 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.802 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 1.0900000000000001 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 1.48 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.453 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 1.1200000000000001 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.48999999999999999 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 2.2200000000000002 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.3599999999999999 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 1.24 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.718 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.59999999999999998 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.3500000000000001 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.6800000000000002 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.462 HD13 HG23 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 1.3200000000000001 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 1.1299999999999999 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.097 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.2599999999999998 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 1.45 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.8999999999999999 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1000000000000001 112.218 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.682 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 3.5099999999999998 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 1.097 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.6100000000000001 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.539 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.708 ' HB ' ' HD2' ' A' ' 53' ' ' LYS . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.8400000000000001 111.936 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.75 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.894 HG13 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 2.1499999999999999 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.895 HG21 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.48 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.895 ' H ' HG21 ' A' ' 89' ' ' THR . 18.0 t-160 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 3.1000000000000001 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.8100000000000001 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.894 ' HG2' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.9700000000000002 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.851 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 1.4299999999999999 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 4.5199999999999996 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.9300000000000002 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 4.3899999999999997 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.704 HD12 HG23 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.77 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.519 ' N ' HD13 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.8300000000000001 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.703 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 2.25 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.7599999999999998 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.6699999999999999 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.703 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.1099999999999999 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.9399999999999999 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.73 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 29' ' ' LEU . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.71 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.619 ' C ' HD11 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.5800000000000001 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.7 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 2.0299999999999998 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 2.1600000000000001 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.76 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 1.27 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.96 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.635 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER 61.64 11.51 3.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.8300000000000001 109.692 -173.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 111' ' ' ARG . 8.5 t -102.17 14.31 32.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 111.388 -2.642 . . . . 4.7300000000000004 109.137 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.713 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -110.69 17.73 20.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.708 -1.587 . . . . 4.7699999999999996 110.386 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -73.9 90.22 1.91 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 112.804 -1.998 . . . . 7.2400000000000002 111.814 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -112.13 128.49 56.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.566 -0.743 . . . . 9.4800000000000004 109.604 172.34 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.22 22.57 3.77 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.447 1.118 . . . . 11.58 108.893 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 118' ' ' VAL . 5.7 p -128.51 90.15 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 113.311 -1.768 . . . . 12.380000000000001 110.049 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -116.55 125.25 51.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.017 -0.992 . . . . 14.960000000000001 109.257 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -88.36 99.35 12.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 17.609999999999999 110.275 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 52.6 m 71.62 134.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.054 0.846 . . . . 19.469999999999999 111.258 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 84.3 mtp -104.27 119.48 39.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 21.969999999999999 111.672 -173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.4 mt 56.73 42.71 26.41 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.977 -0.556 . . . . 23.199999999999999 111.777 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.466 0.374 0 O-C-N 123.725 0.64 . . . . 23.960000000000001 110.946 -179.324 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 14.0 tppt? . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.324 -0.991 . . . . 8.5899999999999999 108.324 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.528 ' HA ' ' NE2' ' A' ' 43' ' ' GLN . 2.3 pt-20 -84.47 111.96 19.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.409 -1.268 . . . . 6.8700000000000001 111.67 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 175.78 89.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.448 -0.796 . . . . 5.2400000000000002 110.928 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -163.93 138.42 5.82 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.796 -0.446 . . . . 3.2200000000000002 109.796 164.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.99 ' HG3' HD11 ' A' ' 33' ' ' ILE . 6.8 tp10 167.52 -37.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.618 1.198 . . . . 4.9199999999999999 108.039 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m 80.05 -175.34 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.3200000000000001 113.436 159.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.787 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.6600000000000001 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.704 HG23 HD12 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 2.0699999999999998 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.68 0.276 . . . . 18.620000000000001 110.603 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -133.38 -70.35 0.53 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.086 -0.709 . . . . 15.27 109.086 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 61.47 122.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.106 0.879 . . . . 14.640000000000001 111.941 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.0 mt 64.94 103.86 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.181 -0.918 . . . . 10.640000000000001 110.563 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.94 -135.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.863 2.375 . . . . 11.31 111.589 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.728 -0.749 . . . . 7.8700000000000001 111.335 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -16.46 100.86 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 125.141 1.377 . . . . 7.2000000000000002 113.738 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -92.03 -171.92 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.161 2.574 . . . . 5.4199999999999999 112.328 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG21 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -93.84 179.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.468 -0.567 . . . . 3.6499999999999999 109.468 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.613 ' H ' HG21 ' A' ' 9' ' ' VAL . 75.1 p -90.26 -113.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.6 0.714 . . . . 2.5099999999999998 111.561 -174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -170.88 130.44 0.8 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.719 -1.128 . . . . 1.4299999999999999 110.956 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.8500000000000001 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 2.27 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' NE2' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.3100000000000001 110.223 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 4.3499999999999996 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 1.4299999999999999 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.766 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 1.6100000000000001 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' HB3' HG21 ' A' ' 104' ' ' VAL . 25.2 p80 -104.88 72.36 1.01 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 4.3099999999999996 112.402 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.92 ' HG3' ' HD2' ' A' ' 31' ' ' PHE . 17.2 mmtt -106.68 95.83 6.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 113.913 -1.494 . . . . 6.1900000000000004 109.219 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.0 tp -158.4 146.58 18.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.235 -0.893 . . . . 4.8499999999999996 111.308 -161.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.675 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.34 116.7 6.93 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.729 0.776 . . . . 5.7199999999999998 108.915 159.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.093 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 2.0 pt20 -143.61 60.65 1.38 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.697 0.761 . . . . 4.4800000000000004 110.487 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.46 -91.66 0.21 Allowed Glycine 0 CA--C 1.497 -1.042 0 CA-C-N 113.733 -1.576 . . . . 3.7799999999999998 113.291 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -71.15 -12.73 61.65 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.49 -0.93 . . . . 6.8499999999999996 108.49 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 1.093 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 13.1 m-80 -125.84 136.4 53.05 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.331 -1.304 . . . . 5.2300000000000004 108.215 -174.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -135.03 108.37 7.8 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 113.493 -1.685 . . . . 4.4500000000000002 108.174 167.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.838 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -117.69 119.86 62.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.119 -1.4 . . . . 3.3599999999999999 107.445 176.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' B' ' 168' ' ' VAL . 56.5 tp -162.15 75.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 125.782 1.926 . . . . 4.6699999999999999 109.081 -169.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' B' ' 167' ' ' MET . . . 177.08 31.22 0.05 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 118.705 -1.712 . . . . 1.8200000000000001 116.576 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.92 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -109.65 139.63 44.45 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 168.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.6699999999999999 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.769 HG22 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 1.54 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' B' ' 165' ' ' GLU . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.84999999999999998 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' A' ' 55' ' ' ILE . . . -71.5 133.47 21.57 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.45 107.299 162.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.45 -25.3 71.32 Favored Glycine 0 CA--C 1.489 -1.582 0 O-C-N 124.992 1.054 . . . . 3.0 112.12 -157.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG13 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -141.35 -137.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 121.793 0.806 . . . . 5.2199999999999998 112.255 -172.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.519 ' H ' ' HB ' ' A' ' 37' ' ' ILE . 12.0 p-10 -131.46 21.52 4.74 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.257 -1.338 . . . . 7.4900000000000002 108.111 -170.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.79 HE22 ' HB2' ' B' ' 163' ' ' ASN . 0.0 OUTLIER -60.37 -138.16 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.23 -2.259 . . . . 4.7999999999999998 111.319 171.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.662 ' OD1' ' HB2' ' B' ' 161' ' ' LYS . 33.0 t70 163.15 -67.58 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.852 -0.613 . . . . 5.1399999999999997 111.869 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.603 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 93.8 Cg_endo -71.2 -6.83 20.05 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.088 1.859 . . . . 6.1200000000000001 109.096 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' ASP . 45.3 t -69.58 -39.73 77.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.125 -2.307 . . . . 6.5499999999999998 110.927 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.723 ' NE2' ' HB3' ' B' ' 161' ' ' LYS . 5.8 pt20 -82.5 3.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.322 -0.854 . . . . 5.9299999999999997 111.146 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 9.1 t-20 -23.41 138.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 125.571 1.548 . . . . 6.46 114.151 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.654 ' HA ' ' OG1' ' A' ' 86' ' ' THR . 11.9 Cg_endo -60.1 -19.69 57.6 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 124.209 3.273 . . . . 8.5199999999999996 112.8 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -92.86 -22.68 19.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.798 -0.816 . . . . 9.5399999999999991 108.798 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t 74.37 142.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.335 -1.302 . . . . 5.1299999999999999 110.717 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -54.82 -35.08 63.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.213 -0.903 . . . . 7.4299999999999997 111.587 -176.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.41 41.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.094 -0.706 . . . . 7.3899999999999997 109.094 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.69 -80.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.808 -1.087 . . . . 8.0700000000000003 110.414 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.622 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 13.4 t -91.97 40.32 1.04 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.837 0.827 . . . . 5.5099999999999998 109.236 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' CG ' ' HB3' ' A' ' 48' ' ' GLU . 14.4 t70 -77.15 7.92 4.54 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.061 0.934 . . . . 3.9700000000000002 111.898 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.622 ' HD3' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 70.4 10.5 7.24 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.253 -1.339 . . . . 6.6299999999999999 111.014 172.555 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -42.42 -49.19 5.74 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 124.096 0.872 . . . . 1.3 113.916 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 1.3600000000000001 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.8900000000000001 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 74' ' ' GLY . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 1.3700000000000001 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.71 HG21 ' HG2' ' B' ' 165' ' ' GLU . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.45 111.425 -173.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.6000000000000001 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 1.3799999999999999 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 2.1299999999999999 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.2799999999999998 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.896 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.76 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HA ' HG22 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 1.0900000000000001 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 1.48 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 1.1200000000000001 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.48999999999999999 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.664 HD21 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 2.2200000000000002 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.605 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.3599999999999999 107.426 -173.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 1.24 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.832 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.59999999999999998 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.664 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.3500000000000001 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.6800000000000002 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.661 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 1.3200000000000001 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.567 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 1.1299999999999999 110.237 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.014 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 9.9 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.2599999999999998 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.704 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 1.45 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.751 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 38.7 m-80 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.8999999999999999 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1000000000000001 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.581 ' HB2' HG11 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 3.5099999999999998 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 1.014 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.6100000000000001 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.704 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.654 ' OG1' ' HA ' ' A' ' 45' ' ' PRO . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.8400000000000001 112.605 -167.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.503 ' HB3' ' HB3' ' A' ' 45' ' ' PRO . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.75 111.564 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 2.1499999999999999 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.039 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.48 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.412 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 3.1000000000000001 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.8100000000000001 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 1.039 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.9700000000000002 109.486 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.661 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 1.4299999999999999 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.773 HH21 ' HB2' ' B' ' 166' ' ' SER . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 4.5199999999999996 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.9300000000000002 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 4.3899999999999997 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.77 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.694 HG23 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.8300000000000001 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 2.25 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.7599999999999998 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.6699999999999999 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.1099999999999999 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.9399999999999999 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.73 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.71 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.766 ' HG3' ' HG3' ' A' ' 17' ' ' GLU . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.5800000000000001 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 2.0299999999999998 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 HD22 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 2.1600000000000001 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.76 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 1.27 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.664 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.96 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.612 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -90.44 -37.33 14.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.8300000000000001 109.566 173.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -171.82 19.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.557 -1.656 . . . . 4.7300000000000004 110.731 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -96.6 42.13 1.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.413 1.101 . . . . 4.7699999999999996 109.81 -174.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.576 ' HB3' HG12 ' A' ' 12' ' ' VAL . 29.3 pt20 -84.27 161.51 20.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.362 -1.745 . . . . 7.2400000000000002 111.141 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -115.93 138.89 50.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.985 -0.552 . . . . 9.4800000000000004 110.56 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -142.33 27.41 1.74 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.327 1.061 . . . . 11.58 108.499 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.2 t -131.61 90.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.49 -1.687 . . . . 12.380000000000001 109.161 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -100.97 130.16 46.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.519 -0.764 . . . . 14.960000000000001 110.617 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' C ' ' HG ' ' A' ' 121' ' ' SER . 35.8 tt0 -82.01 -11.4 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.938 -0.574 . . . . 17.609999999999999 109.69 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 120' ' ' GLN . 24.2 p 51.1 70.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.002 -0.999 . . . . 19.469999999999999 112.159 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.4 mmt -104.63 161.58 14.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.32 -0.855 . . . . 21.969999999999999 109.242 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.57 12.54 1.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.615 -0.266 . . . . 23.199999999999999 111.645 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.196 0.522 . . . . 23.960000000000001 110.311 175.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.797 ' HZ2' ' HB2' ' B' ' 161' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 110.25 -0.278 . . . . 8.5899999999999999 110.25 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . 0.444 ' N ' HE22 ' A' ' 43' ' ' GLN . 31.4 mm-40 63.84 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.091 1.145 . . . . 6.8700000000000001 114.091 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.79 ' HB2' HE22 ' A' ' 39' ' ' GLN . 29.9 m-20 -147.33 -178.39 6.2 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.933 0.716 . . . . 5.2400000000000002 112.933 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' B' ' 163' ' ' ASN . 1.7 pt? 160.74 162.66 0.01 OUTLIER 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.225 -1.028 . . . . 3.2200000000000002 108.225 -165.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.71 ' HG2' HG21 ' A' ' 58' ' ' THR . 22.1 mt-10 -87.51 157.21 19.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.296 -0.561 . . . . 4.9199999999999999 109.958 170.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.773 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m -153.75 155.21 35.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.931 -0.766 . . . . 1.3200000000000001 108.931 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.469 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.6600000000000001 110.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.998 ' HA ' HD12 ' A' ' 29' ' ' LEU . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 2.0699999999999998 109.143 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.665 0.269 . . . . 18.620000000000001 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -164.64 143.25 6.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 15.27 110.091 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.57 141.58 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.821 -0.437 . . . . 14.640000000000001 109.821 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -116.15 99.48 52.7 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 10.640000000000001 109.83 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.73 111.95 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.041 2.494 . . . . 11.31 111.453 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.56 2.71 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 7.8700000000000001 112.078 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -81.7 120.49 77.95 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.365 . . . . 7.2000000000000002 110.377 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -91.48 -167.84 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.777 2.318 . . . . 5.4199999999999999 113.291 -176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.84 HG12 ' HB3' ' A' ' 112' ' ' GLN . 1.0 OUTLIER -149.47 -179.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.306 -0.861 . . . . 3.6499999999999999 108.995 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.601 ' H ' HG21 ' A' ' 9' ' ' VAL . 59.3 p -92.84 -123.84 0.09 Allowed 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.27 -0.877 . . . . 2.5099999999999998 110.119 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . -171.89 119.75 0.44 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.299 -0.864 . . . . 1.4299999999999999 111.583 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.8500000000000001 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.059 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 2.27 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 13' ' ' VAL . 1.5 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.3100000000000001 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.498 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 4.3499999999999996 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 1.4299999999999999 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.613 ' O ' HG22 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 1.6100000000000001 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 104' ' ' VAL . 48.3 t-80 -78.4 83.26 4.63 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 4.3099999999999996 110.678 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.899 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 20.4 pttm -58.7 160.46 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.698 -1.137 . . . . 6.1900000000000004 110.958 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.4 tp -133.14 124.08 26.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.108 -0.637 . . . . 4.8499999999999996 112.312 -165.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.869 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.66 138.22 44.63 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.585 -0.734 . . . . 5.7199999999999998 111.006 169.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.615 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -134.39 63.76 1.62 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.671 -1.15 . . . . 4.4800000000000004 111.097 174.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 16.64 69.15 0.01 OUTLIER Glycine 0 N--CA 1.469 0.877 0 O-C-N 125.393 1.683 . . . . 3.7799999999999998 116.202 174.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 30.4 tt0 142.26 -25.04 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 104.218 -2.512 . . . . 6.8499999999999996 104.218 -169.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.663 ' HB3' HD13 ' A' ' 28' ' ' ILE . 8.0 m-80 -128.63 133.33 48.24 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 112.758 -2.019 . . . . 5.2300000000000004 110.961 -172.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.869 HD13 ' HD2' ' A' ' 22' ' ' ARG . 2.4 mm? -115.64 109.12 17.29 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 111.69 -2.504 . . . . 4.4500000000000002 105.24 165.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.899 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 10.3 mm -110.16 132.36 58.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.479 -0.489 . . . . 3.3599999999999999 110.83 -174.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' B' ' 168' ' ' VAL . 10.7 tp -86.23 -46.51 10.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.3 -1.37 . . . . 4.6699999999999999 107.3 164.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 65' ' ' PRO . . . 109.01 14.11 16.04 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.57 -1.195 . . . . 1.8200000000000001 115.165 166.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 -166.85 -178.42 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.466 1.133 . . . . 0.87 112.038 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.899 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.6699999999999999 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.669 ' O ' ' HB3' ' B' ' 165' ' ' GLU . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 1.54 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' B' ' 165' ' ' GLU . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.84999999999999998 111.197 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.848 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . -150.62 109.62 0.43 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.45 114.244 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' B' ' 163' ' ' ASN . . . 142.82 -23.24 2.31 Favored Glycine 0 CA--C 1.493 -1.31 0 C-N-CA 120.262 -0.97 . . . . 3.0 111.434 175.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.1 pt -56.99 -56.14 16.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.129 -1.536 . . . . 5.2199999999999998 113.952 -164.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.62 ' H ' HG13 ' A' ' 37' ' ' ILE . 22.3 t70 -119.02 13.97 13.09 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.066 0.936 . . . . 7.4900000000000002 109.204 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.757 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.37 -16.44 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.622 -1.172 . . . . 4.7999999999999998 112.469 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.57 123.18 82.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.177 -0.675 . . . . 5.1399999999999997 109.177 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.31 -23.53 70.36 Favored 'Trans proline' 0 C--N 1.327 -0.568 0 C-N-CA 124.32 3.347 . . . . 6.1200000000000001 113.142 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' B' ' 161' ' ' LYS . 19.1 t -77.1 -33.05 57.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.146 -0.479 . . . . 6.5499999999999998 110.801 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -99.43 -8.74 24.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.484 0.659 . . . . 5.9299999999999997 109.422 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -150.68 88.65 4.54 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.666 -1.152 . . . . 6.46 110.639 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.07 -1.06 11.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.789 2.326 . . . . 8.5199999999999996 111.412 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.92 -22.95 17.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 9.5399999999999991 111.008 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.5 m -122.78 156.9 33.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 120.888 0.375 . . . . 5.1299999999999999 110.144 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' SER . 10.3 pt-20 163.47 -23.6 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.349 -1.296 . . . . 7.4299999999999997 108.758 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -140.03 121.03 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.997 -1.001 . . . . 7.3899999999999997 109.752 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.8 mptt 68.13 -55.24 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.609 0.764 . . . . 8.0700000000000003 111.072 -173.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 p -77.21 -6.41 52.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.082 0.468 . . . . 5.5099999999999998 110.399 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -50.77 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.691 -1.141 . . . . 3.9700000000000002 112.035 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 76' ' ' LYS . 42.8 mmtm 60.69 29.13 18.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.819 -0.808 . . . . 6.6299999999999999 108.819 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.757 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -40.62 -67.48 0.71 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.392 -1.276 . . . . 1.3 115.235 -168.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.848 HD12 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 1.3600000000000001 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.8900000000000001 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 74' ' ' GLY . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 1.3700000000000001 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.45 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.6000000000000001 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 1.3799999999999999 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 2.1299999999999999 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.2799999999999998 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.598 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.546 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.76 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB1' HG12 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 1.0900000000000001 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 1.48 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 1.1200000000000001 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.48999999999999999 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.718 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 2.2200000000000002 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.718 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.3599999999999999 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 1.24 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG12 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.59999999999999998 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' OD1' HG21 ' A' ' 109' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.3500000000000001 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.6800000000000002 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 HG23 ' SD ' ' A' ' 85' ' ' MET . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 1.3200000000000001 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.579 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 1.1299999999999999 111.061 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 1.005 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.3 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.2599999999999998 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.647 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 1.45 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 17.4 m-80 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.8999999999999999 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1000000000000001 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.647 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 3.5099999999999998 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 1.005 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.6100000000000001 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.959 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.8400000000000001 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.75 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.623 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 2.1499999999999999 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.698 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.48 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.84 ' HB2' HD12 ' B' ' 164' ' ' LEU . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 3.1000000000000001 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.8100000000000001 110.488 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.698 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.7 mm100 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.9700000000000002 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 1.4299999999999999 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.777 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 4.5199999999999996 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.9300000000000002 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 4.3899999999999997 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.77 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.8300000000000001 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.741 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 2.25 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.7599999999999998 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.6699999999999999 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.741 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.1099999999999999 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.9399999999999999 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.73 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.71 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.5800000000000001 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.64 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 2.0299999999999998 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 2.1600000000000001 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.843 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.76 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.69 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 1.27 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 1.059 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.96 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.84 ' HB3' HG12 ' A' ' 9' ' ' VAL . 8.5 mm-40 -77.71 -58.65 3.15 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.8300000000000001 109.905 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 6.4 t 167.19 -30.66 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.253 -1.34 . . . . 4.7300000000000004 108.897 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.406 ' HA ' HD11 ' A' ' 114' ' ' LEU . 2.9 mm? -74.93 77.86 2.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.738 -1.574 . . . . 4.7699999999999996 109.954 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.15 -165.72 1.41 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 112.714 -2.039 . . . . 7.2400000000000002 111.023 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -120.64 176.33 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 9.4800000000000004 110.569 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.61 22.13 1.47 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.007 0.908 . . . . 11.58 109.196 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.77 91.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.08 -1.418 . . . . 12.380000000000001 110.34 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.23 89.82 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.483 -0.78 . . . . 14.960000000000001 109.449 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -83.88 -4.42 58.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.163 -0.471 . . . . 17.609999999999999 110.558 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.7 m -65.38 -79.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 19.469999999999999 111.584 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.8 -13.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.101 0.408 . . . . 21.969999999999999 112.101 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.8 mt 65.05 -166.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.494 0.496 . . . . 23.199999999999999 110.353 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.803 0.335 . . . . 23.960000000000001 110.787 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 42' ' ' SER . 11.5 mptt . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.061 0.393 . . . . 8.5899999999999999 112.061 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.33 82.85 0.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.912 0.863 . . . . 6.8700000000000001 110.86 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . 0.903 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 94.6 m-20 -91.03 -163.99 1.11 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.036 -0.983 . . . . 5.2400000000000002 109.905 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.84 HD12 ' HB2' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -178.42 -158.33 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.924 -0.398 . . . . 3.2200000000000002 109.924 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER 175.67 -156.72 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.256 0.973 . . . . 4.9199999999999999 112.099 168.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t -158.69 177.25 11.4 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 113.617 0.969 . . . . 1.3200000000000001 113.617 -161.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.6600000000000001 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 2.0699999999999998 110.829 -170.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.825 0.821 . . . . 0.97999999999999998 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.013 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.3500000000000001 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 1.8400000000000001 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.3100000000000001 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 3.5800000000000001 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 0.85999999999999999 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 66' ' ' ALA . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 0.93000000000000005 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 3.5299999999999998 114.192 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.997 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.869 -0.789 . . . . 0.72999999999999998 108.869 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.1599999999999999 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 0.89000000000000001 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.68999999999999995 112.316 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.4199999999999999 109.708 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.871 0 CA-C-O 120.696 0.053 . . . . 1.05 113.114 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.67000000000000004 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.6 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.48 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.906 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 0.66000000000000003 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.0 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.02 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.997 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 0.71999999999999997 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 1.77 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.2799999999999998 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.3200000000000001 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.747 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 0.37 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 0.89000000000000001 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 0.34000000000000002 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.48999999999999999 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 1.5800000000000001 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.599 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.3599999999999999 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 0.56999999999999995 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.6 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.59999999999999998 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.906 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.3500000000000001 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.1800000000000002 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 0.64000000000000001 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 0.47999999999999998 111.206 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.054 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.2599999999999998 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.751 HG21 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 0.77000000000000002 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.8999999999999999 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1000000000000001 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 2.75 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.981 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.6100000000000001 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.054 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.25 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.2200000000000002 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 1.73 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.3 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 2.4700000000000002 110.912 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.612 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.8100000000000001 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.78 ' HB2' HG12 ' A' ' 88' ' ' VAL . 23.5 mm-40 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.6600000000000001 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 0.80000000000000004 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.571 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 3.9500000000000002 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.48 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.631 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 3.7999999999999998 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 80' ' ' VAL . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.26 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.53 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 1.79 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.04 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.576 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.3100000000000001 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.1099999999999999 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.9399999999999999 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.1699999999999999 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 97' ' ' LEU . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.1600000000000001 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.1499999999999999 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.662 HD11 HD12 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 1.3500000000000001 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.939 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 1.53 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.1399999999999999 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 0.57999999999999996 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 1.013 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.4900000000000002 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.8300000000000001 111.521 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.504 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 21.1 m . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.729 0.27 . . . . 1.22 111.729 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.1899999999999999 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.509 HG13 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 1.54 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 121.638 0.732 . . . . 0.97999999999999998 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.3500000000000001 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 1.8400000000000001 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.3100000000000001 108.818 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 3.5800000000000001 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 0.85999999999999999 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 0.93000000000000005 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 104' ' ' VAL . 20.6 p80 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 3.5299999999999998 112.314 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 1.041 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.843 -0.428 . . . . 0.72999999999999998 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.695 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.1599999999999999 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.497 HG22 HG23 ' A' ' 57' ' ' VAL . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 0.89000000000000001 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.68999999999999995 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.4199999999999999 112.285 178.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.782 -0.127 . . . . 1.05 112.782 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 0.67000000000000004 110.154 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.48 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 0.66000000000000003 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.695 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.02 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.041 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 0.71999999999999997 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 1.77 107.113 162.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.2799999999999998 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.3200000000000001 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 0.37 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 0.89000000000000001 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 0.34000000000000002 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 1.5800000000000001 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.531 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.3599999999999999 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 0.56999999999999995 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.619 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.3500000000000001 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.1800000000000002 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 0.64000000000000001 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.404 ' C ' ' HG2' ' A' ' 79' ' ' GLN . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 0.47999999999999998 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.8 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.2599999999999998 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 0.77000000000000002 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.805 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 m120 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.8999999999999999 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1000000000000001 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.543 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 2.75 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.763 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.6100000000000001 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.8 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.25 111.892 -170.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.2200000000000002 110.942 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 1.73 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.858 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.3 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 2.4700000000000002 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG22 ' A' ' 89' ' ' THR . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.8100000000000001 110.118 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.858 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.6600000000000001 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 0.80000000000000004 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.614 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 3.9500000000000002 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.48 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 3.7999999999999998 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.26 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.53 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.79 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.04 111.188 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.3100000000000001 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.715 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.1099999999999999 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.9399999999999999 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.1699999999999999 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.1600000000000001 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.805 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.1499999999999999 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 1.3500000000000001 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 1.53 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.1399999999999999 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.662 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 0.57999999999999996 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.4900000000000002 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.8300000000000001 108.626 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.893 -0.41 . . . . 1.22 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.707 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.1899999999999999 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 31' ' ' PHE . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 1.54 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.855 0.36 . . . . 0.97999999999999998 110.475 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.3500000000000001 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 1.8400000000000001 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.3100000000000001 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.046 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 3.5800000000000001 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 0.85999999999999999 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.833 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 0.93000000000000005 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 3.5299999999999998 112.005 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 120.507 0.194 . . . . 0.72999999999999998 110.639 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.1599999999999999 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.672 HD11 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 0.89000000000000001 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.68999999999999995 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.4199999999999999 109.925 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.456 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.237 0.303 0 N-CA-C 112.838 -0.105 . . . . 1.05 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 0.67000000000000004 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.48 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 0.66000000000000003 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.02 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 0.71999999999999997 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 1.77 107.254 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.2799999999999998 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.644 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.3200000000000001 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.79 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 0.37 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 0.89000000000000001 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 0.34000000000000002 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.48999999999999999 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 1.5800000000000001 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.3599999999999999 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 0.56999999999999995 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.624 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.59999999999999998 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.3500000000000001 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.1800000000000002 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 0.64000000000000001 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 0.47999999999999998 110.518 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.997 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 0.77000000000000002 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.8999999999999999 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1000000000000001 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.662 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 2.75 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.893 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.6100000000000001 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.25 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.2200000000000002 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 1.73 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.672 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.672 ' HE1' HD11 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 2.4700000000000002 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.8100000000000001 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 36.4 mm-40 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.6600000000000001 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 0.80000000000000004 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 3.9500000000000002 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.48 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 3.7999999999999998 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD12 HG23 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.26 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.719 HG23 HD12 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.53 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.673 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.04 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.673 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.3100000000000001 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.1099999999999999 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.9399999999999999 107.369 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.1699999999999999 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.833 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.1600000000000001 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.1499999999999999 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 1.3500000000000001 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.046 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 1.53 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.1399999999999999 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.758 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 0.57999999999999996 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.623 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.4900000000000002 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.8300000000000001 110.324 174.286 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.69 -1.226 . . . . 1.22 107.69 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.1899999999999999 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 1.54 109.988 178.623 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 122.349 1.071 . . . . 0.97999999999999998 111.059 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.3500000000000001 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 1.8400000000000001 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.3100000000000001 109.765 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.656 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 3.5800000000000001 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 0.85999999999999999 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.879 HD12 HD22 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 0.93000000000000005 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 . . . . . 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 3.5299999999999998 114.335 -171.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 . . . . . 0 C--O 1.222 -0.371 0 N-CA-C 110.468 -0.197 . . . . 0.72999999999999998 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.1599999999999999 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 0.89000000000000001 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.68999999999999995 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.4199999999999999 110.729 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 115.014 0.766 . . . . 1.05 115.014 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 0.67000000000000004 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.48 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 0.66000000000000003 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.0 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.02 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 0.71999999999999997 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 1.77 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.2799999999999998 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 68' ' ' ILE . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.3200000000000001 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 0.37 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 0.89000000000000001 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 0.34000000000000002 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.48999999999999999 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.764 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 1.5800000000000001 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.3599999999999999 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 60' ' ' VAL . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.59999999999999998 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.3500000000000001 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 0.64000000000000001 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASP . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 0.47999999999999998 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 1.7 mt-30 -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.2599999999999998 111.246 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 0.77000000000000002 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.622 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.8999999999999999 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1000000000000001 112.928 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 2.75 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.6100000000000001 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.805 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.25 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.2200000000000002 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 1.73 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.919 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.3 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.664 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 2.4700000000000002 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.8100000000000001 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.919 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.6600000000000001 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 0.80000000000000004 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.664 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 3.9500000000000002 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.48 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 3.7999999999999998 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 HD12 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.53 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 1.79 109.213 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.04 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.3100000000000001 113.364 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.1099999999999999 111.418 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.9399999999999999 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.1699999999999999 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.622 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.1499999999999999 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 1.3500000000000001 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 1.53 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.1399999999999999 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.699 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 0.57999999999999996 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.4900000000000002 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.8300000000000001 110.95 -178.491 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.601 -0.518 . . . . 1.22 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.1899999999999999 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 97' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 1.54 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.51 -0.552 . . . . 0.97999999999999998 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.3500000000000001 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 1.8400000000000001 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.702 ' NE2' HH21 ' A' ' 111' ' ' ARG . 38.5 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.3100000000000001 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 3.5800000000000001 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 HD23 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 0.85999999999999999 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.851 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.909 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 0.93000000000000005 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HB2' HG23 ' A' ' 104' ' ' VAL . 10.5 t-160 . . . . . 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 3.5299999999999998 112.234 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.99 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.72999999999999998 108.302 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.1599999999999999 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 0.89000000000000001 110.247 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.68999999999999995 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.744 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . . . . . . 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.4199999999999999 112.091 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.05 115.042 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 0.67000000000000004 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.48 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 0.66000000000000003 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.0 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.02 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.99 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 0.71999999999999997 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 1.77 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.2799999999999998 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 68' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.3200000000000001 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.809 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 0.37 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 0.89000000000000001 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 0.34000000000000002 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.48999999999999999 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.809 HD23 ' HB1' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 1.5800000000000001 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.3599999999999999 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 0.56999999999999995 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.59999999999999998 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.3500000000000001 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.662 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.1800000000000002 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 0.64000000000000001 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.402 ' O ' ' HG3' ' A' ' 85' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 0.47999999999999998 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.051 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.2599999999999998 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 0.77000000000000002 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 80' ' ' VAL . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.8999999999999999 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1000000000000001 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.527 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 2.75 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.88 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.6100000000000001 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.25 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.2200000000000002 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 1.73 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.3 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.744 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 2.4700000000000002 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.8100000000000001 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.6600000000000001 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 0.80000000000000004 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 3.9500000000000002 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.48 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 3.7999999999999998 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG11 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.26 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.53 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 1.79 111.534 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.04 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.3100000000000001 110.089 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.1099999999999999 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.565 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.9399999999999999 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' HIS . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.1699999999999999 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.1600000000000001 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.851 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.1499999999999999 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.909 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 1.3500000000000001 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.051 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 1.53 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.662 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.1399999999999999 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 0.57999999999999996 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.702 HH21 ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.4900000000000002 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.8300000000000001 109.961 176.112 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.952 -0.388 . . . . 1.22 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.1899999999999999 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.432 HG11 HD11 ' A' ' 97' ' ' LEU . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 1.54 110.347 -172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.445 -0.708 0 CA-C-O 121.525 0.678 . . . . 0.97999999999999998 110.466 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.3500000000000001 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 1.8400000000000001 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 109.946 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 3.5800000000000001 108.806 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 0.85999999999999999 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.705 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 0.93000000000000005 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 104' ' ' VAL . 26.8 p80 . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 3.5299999999999998 112.25 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.894 0.378 . . . . 0.72999999999999998 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.1599999999999999 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 57' ' ' VAL . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 0.89000000000000001 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.68999999999999995 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.634 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.4199999999999999 110.14 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 N-CA-C 114.797 0.679 . . . . 1.05 114.797 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.634 HD13 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 0.67000000000000004 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.811 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.48 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.82 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 0.66000000000000003 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.0 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.02 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.752 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 0.71999999999999997 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 31' ' ' PHE . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 1.77 107.907 172.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.2799999999999998 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.3200000000000001 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 0.37 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 0.89000000000000001 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 0.34000000000000002 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.48999999999999999 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 1.5800000000000001 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.784 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 2.7 mp0 -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.3599999999999999 106.66 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 0.56999999999999995 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.811 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.59999999999999998 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.82 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.3500000000000001 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.1800000000000002 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG12 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.64000000000000001 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 0.47999999999999998 111.537 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.905 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.2599999999999998 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.598 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 0.77000000000000002 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.8999999999999999 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1000000000000001 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.598 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 2.75 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.6100000000000001 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.25 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.2200000000000002 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.62 HG13 ' OE1' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 1.73 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.562 ' HB ' ' HG3' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.3 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 2.4700000000000002 111.633 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.8100000000000001 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.883 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.6600000000000001 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 0.80000000000000004 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 3.9500000000000002 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.883 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.48 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 3.7999999999999998 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.26 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.664 HG22 HD12 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.53 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 1.79 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.04 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.713 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.3100000000000001 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.1099999999999999 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.9399999999999999 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.568 ' CB ' ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.1699999999999999 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 18' ' ' ILE . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.1600000000000001 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.1499999999999999 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 1.3500000000000001 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 1.53 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.1399999999999999 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.687 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 0.57999999999999996 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.4900000000000002 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 . . . . . 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.8300000000000001 112.612 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.22 114.081 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.1899999999999999 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.517 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 1.54 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.437 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.931 0.872 . . . . 0.97999999999999998 110.024 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.3500000000000001 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 1.8400000000000001 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 109.599 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.568 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 3.5800000000000001 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 69' ' ' ALA . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 0.85999999999999999 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 66' ' ' ALA . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 0.93000000000000005 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 . . . . . 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 3.5299999999999998 112.242 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 1.028 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.72999999999999998 108.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.1599999999999999 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 0.89000000000000001 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.68999999999999995 113.761 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.4199999999999999 112.538 174.055 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 114.19 0.436 . . . . 1.05 114.19 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 0.67000000000000004 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.48 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.984 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 0.66000000000000003 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.0 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.02 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.028 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 0.71999999999999997 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 1.77 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.2799999999999998 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.3200000000000001 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 0.37 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 0.89000000000000001 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 0.34000000000000002 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.48999999999999999 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 1.5800000000000001 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.59 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.3599999999999999 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 0.56999999999999995 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.59999999999999998 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.3500000000000001 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.673 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.1800000000000002 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.669 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 0.64000000000000001 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.609 ' CE ' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.47999999999999998 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.852 ' HG2' ' N ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.2599999999999998 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.852 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 0.77000000000000002 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.745 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.8999999999999999 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1000000000000001 113.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.671 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 2.75 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.6100000000000001 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.495 ' HG2' HG12 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.25 114.526 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.2200000000000002 110.936 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.561 ' HB ' ' CD ' ' A' ' 92' ' ' GLN . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 1.73 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 92' ' ' GLN . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.475 ' HE1' HD11 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 2.4700000000000002 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.8100000000000001 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.6600000000000001 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.718 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 0.80000000000000004 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 3.9500000000000002 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.48 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 3.7999999999999998 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.26 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.53 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.04 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.3100000000000001 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.1099999999999999 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.9399999999999999 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.839 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.1699999999999999 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.1600000000000001 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.1499999999999999 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.729 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 1.3500000000000001 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 1.53 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.1399999999999999 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 0.57999999999999996 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.574 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.4900000000000002 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.8300000000000001 111.879 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.22 114.071 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.1899999999999999 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 1.54 110.02 177.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 CA-C-O 121.417 0.627 . . . . 0.97999999999999998 110.298 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.3500000000000001 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 1.8400000000000001 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.3100000000000001 109.496 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HG3' HD22 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 3.5800000000000001 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG13 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 0.85999999999999999 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 HD21 ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 0.93000000000000005 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.643 ' HB2' HG23 ' A' ' 104' ' ' VAL . 6.0 t60 . . . . . 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 3.5299999999999998 110.505 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.756 -0.091 . . . . 0.72999999999999998 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.1599999999999999 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 HG22 HG22 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 0.89000000000000001 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.68999999999999995 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.4199999999999999 112.229 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.319 0.488 . . . . 1.05 114.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.586 HD13 ' HA2' ' A' ' 35' ' ' GLY . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 0.67000000000000004 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.48 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.658 HG21 HD21 ' A' ' 71' ' ' LEU . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 0.66000000000000003 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.0 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.02 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 0.71999999999999997 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 1.77 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.2799999999999998 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.3200000000000001 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 0.37 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 0.89000000000000001 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 0.34000000000000002 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.48999999999999999 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 1.5800000000000001 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.708 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.3599999999999999 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 60' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 0.56999999999999995 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.59999999999999998 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.3500000000000001 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.1800000000000002 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 0.64000000000000001 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 0.47999999999999998 109.538 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.045 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 73.9 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.2599999999999998 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 0.77000000000000002 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.904 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.8999999999999999 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1000000000000001 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 2.75 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 1.033 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.6100000000000001 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 80' ' ' VAL . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.25 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.2200000000000002 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.515 HG13 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 1.73 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.757 HG22 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.3 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 2.4700000000000002 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 89' ' ' THR . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.8100000000000001 110.544 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.757 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.6600000000000001 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 0.80000000000000004 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 3.9500000000000002 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.48 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.746 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 3.7999999999999998 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.26 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.53 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 1.79 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.04 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.3100000000000001 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.1099999999999999 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.9399999999999999 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.1699999999999999 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.1600000000000001 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.904 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.1499999999999999 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 1.3500000000000001 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.045 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 1.53 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.1399999999999999 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 0.57999999999999996 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.555 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.4900000000000002 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.8300000000000001 108.434 169.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.8 0.334 . . . . 1.22 110.216 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.1899999999999999 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 31' ' ' PHE . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 1.54 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.05 0 CA-C-O 121.76 0.791 . . . . 0.97999999999999998 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.3500000000000001 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 1.8400000000000001 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.514 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.752 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 3.5800000000000001 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 0.85999999999999999 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.887 HD13 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 0.93000000000000005 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.687 ' HA ' HG23 ' A' ' 104' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 3.5299999999999998 110.52 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 110.615 -0.143 . . . . 0.72999999999999998 110.615 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.953 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.1599999999999999 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 0.89000000000000001 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.68999999999999995 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.4199999999999999 111.854 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 114.331 0.493 . . . . 1.05 114.331 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 0.67000000000000004 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.48 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 0.66000000000000003 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.0 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.02 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 0.71999999999999997 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 1.77 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.2799999999999998 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.3200000000000001 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 0.37 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 0.34000000000000002 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.48999999999999999 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 1.5800000000000001 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.3599999999999999 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 0.56999999999999995 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.638 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.59999999999999998 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.826 ' H ' HG12 ' A' ' 57' ' ' VAL . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.3500000000000001 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.1800000000000002 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 0.64000000000000001 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.567 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 0.47999999999999998 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.812 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.2599999999999998 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 0.77000000000000002 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1000000000000001 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.578 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 2.75 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.812 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.6100000000000001 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.25 112.397 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.2200000000000002 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 1.73 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.662 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.3 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 2.4700000000000002 110.592 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.739 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.8100000000000001 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.662 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 39.4 mm-40 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.6600000000000001 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.739 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 3.9500000000000002 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.48 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 3.7999999999999998 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.26 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.706 HG23 HD12 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.53 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.757 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 1.79 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.04 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.757 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.9399999999999999 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.1699999999999999 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 18' ' ' ILE . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.1600000000000001 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.1499999999999999 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.887 HD22 HD13 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 1.3500000000000001 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 1.53 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.1399999999999999 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 0.57999999999999996 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.607 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.4900000000000002 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 . . . . . 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.8300000000000001 109.479 174.468 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.898 -0.038 . . . . 1.22 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.1899999999999999 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 1.54 108.584 178.231 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 CA-C-O 121.818 0.818 . . . . 0.97999999999999998 109.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.3500000000000001 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 1.8400000000000001 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.3100000000000001 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 3.5800000000000001 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 0.85999999999999999 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.841 HG21 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 0.93000000000000005 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 . . . . . 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 3.5299999999999998 111.425 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.874 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 . . . . . 0 C--O 1.242 0.659 0 CA-C-O 120.801 0.334 . . . . 0.72999999999999998 111.479 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.1599999999999999 111.381 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.961 HG22 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 0.89000000000000001 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.68999999999999995 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.4199999999999999 111.265 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.434 -1.472 0 CA-C-O 120.942 0.19 . . . . 1.05 113.356 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 0.67000000000000004 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.48 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.961 HG23 HG22 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 0.66000000000000003 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HG23 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.02 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 0.71999999999999997 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 1.77 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.787 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.2799999999999998 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.56 ' O ' HG13 ' A' ' 68' ' ' ILE . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.3200000000000001 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 0.37 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.787 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 0.89000000000000001 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 0.34000000000000002 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.48999999999999999 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.852 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 1.5800000000000001 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.852 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.589 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 0.56999999999999995 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.796 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.59999999999999998 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.824 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.3500000000000001 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.705 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.1800000000000002 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 0.64000000000000001 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 111.386 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.2599999999999998 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 0.77000000000000002 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.8999999999999999 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1000000000000001 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.656 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 2.75 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.569 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.6100000000000001 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.25 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.2200000000000002 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.882 HG13 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 1.73 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.967 HG22 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.3 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 2.4700000000000002 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.8100000000000001 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.967 ' HB2' HG22 ' A' ' 89' ' ' THR . 56.0 tp60 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.6600000000000001 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 0.80000000000000004 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.668 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 3.9500000000000002 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.48 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.656 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 3.7999999999999998 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.26 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.663 HG23 HD12 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.53 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.76 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 1.79 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.04 110.974 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.562 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.3100000000000001 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.1099999999999999 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.9399999999999999 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.1699999999999999 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.1600000000000001 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.1499999999999999 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 1.3500000000000001 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 1.53 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.1399999999999999 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 0.57999999999999996 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.699 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.4900000000000002 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.643 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.8300000000000001 109.298 -167.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 120.27 0.081 . . . . 1.22 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.66 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.1899999999999999 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 1.54 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.818 0.818 . . . . 0.97999999999999998 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.3500000000000001 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 1.8400000000000001 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.3100000000000001 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 3.5800000000000001 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 0.85999999999999999 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.914 ' HB3' HG23 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.897 HD12 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 0.93000000000000005 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 3.5299999999999998 110.949 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.979 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.813 -0.44 . . . . 0.72999999999999998 109.813 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.1599999999999999 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 0.89000000000000001 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.68999999999999995 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.4199999999999999 111.514 179.626 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.05 114.882 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.494 HG21 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 0.67000000000000004 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.48 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 0.66000000000000003 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.621 HG23 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.0 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.621 ' HG2' HG23 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.02 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.979 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 0.71999999999999997 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 1.77 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.2799999999999998 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.48 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.3200000000000001 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 0.37 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 0.89000000000000001 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 0.34000000000000002 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.48999999999999999 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 1.5800000000000001 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.611 ' O ' HG11 ' A' ' 57' ' ' VAL . 2.6 mt-30 -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.3599999999999999 108.73 -164.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 60' ' ' VAL . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 0.56999999999999995 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.64 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.59999999999999998 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.844 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.3500000000000001 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.733 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.1800000000000002 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG23 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 0.64000000000000001 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 0.47999999999999998 109.962 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.2599999999999998 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 0.77000000000000002 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.8999999999999999 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 112.465 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 2.75 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.889 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.6100000000000001 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.727 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.25 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.2200000000000002 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.727 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 1.73 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.3 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 2.4700000000000002 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.8100000000000001 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.6600000000000001 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 0.80000000000000004 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 3.9500000000000002 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 3.7999999999999998 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.748 HD12 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.26 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.748 HG23 HD12 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.53 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 1.79 107.196 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.04 107.751 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.3100000000000001 110.359 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.1099999999999999 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.9399999999999999 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.1699999999999999 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG23 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.1600000000000001 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.812 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.1499999999999999 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 1.3500000000000001 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.974 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.1399999999999999 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 0.57999999999999996 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.4900000000000002 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 . . . . . 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.8300000000000001 110.272 -175.886 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.023 0.379 . . . . 1.22 112.023 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.1899999999999999 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.506 ' CG1' HD13 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 1.54 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.545 0.688 . . . . 0.97999999999999998 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.3500000000000001 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 1.8400000000000001 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.3100000000000001 110.482 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.627 ' NE ' HD21 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 3.5800000000000001 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.686 HG13 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 0.85999999999999999 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.943 HG23 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 0.93000000000000005 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.587 ' HB3' HG23 ' A' ' 104' ' ' VAL . 7.4 p80 . . . . . 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 3.5299999999999998 111.965 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.987 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 110.115 -0.328 . . . . 0.72999999999999998 110.115 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.1599999999999999 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.682 HG22 HG23 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 0.89000000000000001 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.68999999999999995 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.4199999999999999 111.13 178.345 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 N-CA-C 115.477 0.951 . . . . 1.05 115.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.498 HG21 ' SD ' ' A' ' 85' ' ' MET . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 0.67000000000000004 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.48 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 0.66000000000000003 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.0 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.02 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.987 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 1.77 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.2799999999999998 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.3200000000000001 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.943 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 0.37 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 0.89000000000000001 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 0.34000000000000002 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.48999999999999999 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 1.5800000000000001 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.3599999999999999 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 0.56999999999999995 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.59999999999999998 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.726 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.1800000000000002 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.532 HG23 ' HB3' ' A' ' 107' ' ' LEU . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 0.64000000000000001 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.513 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 0.47999999999999998 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.934 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.2599999999999998 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 0.77000000000000002 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.705 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1000000000000001 112.626 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.599 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 2.75 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.888 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.6100000000000001 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.25 111.614 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.2200000000000002 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 85' ' ' MET . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 1.73 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.677 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.3 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 2.4700000000000002 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.8100000000000001 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.6600000000000001 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.693 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 3.9500000000000002 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.48 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 83' ' ' TRP . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 3.7999999999999998 112.327 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.778 ' HB2' HG21 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.26 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 HD12 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.53 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 101' ' ' SER . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 1.79 113.189 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.04 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.3100000000000001 111.234 -175.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.1099999999999999 110.464 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.9399999999999999 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.1699999999999999 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.1600000000000001 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.1499999999999999 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 1.3500000000000001 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.934 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 1.53 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.1399999999999999 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.745 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 0.57999999999999996 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.4900000000000002 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.8300000000000001 109.684 -179.183 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.775 -0.454 . . . . 1.22 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.1899999999999999 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 1.54 110.633 -176.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.925 0 CA-C-O 121.71 0.767 . . . . 0.97999999999999998 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.3500000000000001 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 1.8400000000000001 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.3100000000000001 110.412 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 3.5800000000000001 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.859 HG13 HD12 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 0.85999999999999999 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.807 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 0.93000000000000005 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.713 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.3 t60 . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 3.5299999999999998 112.339 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 1.05 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.141 0.496 . . . . 0.72999999999999998 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.1599999999999999 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 0.89000000000000001 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.68999999999999995 111.188 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.4199999999999999 110.444 177.554 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 115.026 0.771 . . . . 1.05 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.55 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 0.67000000000000004 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.48 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 0.66000000000000003 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.02 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.05 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 0.71999999999999997 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.576 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 1.77 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.2799999999999998 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.3200000000000001 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 0.37 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 0.89000000000000001 109.006 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 0.34000000000000002 107.423 171.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.48999999999999999 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 1.5800000000000001 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.3599999999999999 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 0.56999999999999995 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.59999999999999998 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.727 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.3500000000000001 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.748 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.1800000000000002 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 0.64000000000000001 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.47999999999999998 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.2599999999999998 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.557 HG11 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 0.77000000000000002 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.842 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 4.8 m120 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.8999999999999999 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1000000000000001 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 2.75 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.6100000000000001 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.25 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.2200000000000002 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.907 HG13 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 1.73 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.3 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' N ' HG23 ' A' ' 89' ' ' THR . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 2.4700000000000002 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.8100000000000001 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.907 ' HG3' HG13 ' A' ' 88' ' ' VAL . 42.7 tp60 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.6600000000000001 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 0.80000000000000004 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 3.9500000000000002 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.48 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 3.7999999999999998 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.26 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.543 HG23 HD12 ' A' ' 97' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.53 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 1.79 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.04 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.712 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.3100000000000001 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.1099999999999999 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.9399999999999999 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG23 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.1699999999999999 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.807 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.1600000000000001 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.1499999999999999 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.859 HD12 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 1.3500000000000001 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 1.53 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 0.57999999999999996 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.727 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.4900000000000002 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.8300000000000001 109.363 176.195 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.804 -0.443 . . . . 1.22 109.804 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.1899999999999999 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 1.54 108.084 173.614 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 1.007 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 121.647 0.737 . . . . 0.97999999999999998 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.3500000000000001 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 1.8400000000000001 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 3.5800000000000001 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 0.85999999999999999 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.847 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.898 HG21 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 0.93000000000000005 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.892 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 . . . . . 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 3.5299999999999998 112.401 -173.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.898 ' HE2' HG21 ' A' ' 18' ' ' ILE . 28.2 p90 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 120.685 0.279 . . . . 0.72999999999999998 111.577 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.1599999999999999 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG22 HG23 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 0.89000000000000001 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.68999999999999995 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.4199999999999999 111.37 177.453 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 114.446 0.538 . . . . 1.05 114.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 0.67000000000000004 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.48 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.768 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 0.66000000000000003 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.0 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.02 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 0.71999999999999997 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 1.77 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.2799999999999998 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.796 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.3200000000000001 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.916 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HA ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 0.89000000000000001 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 0.34000000000000002 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.48999999999999999 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.916 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 1.5800000000000001 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.47 ' N ' HD13 ' A' ' 71' ' ' LEU . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 0.56999999999999995 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.59999999999999998 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.768 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.3500000000000001 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 110' ' ' THR . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.1800000000000002 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 0.47999999999999998 110.003 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.2599999999999998 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 0.77000000000000002 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.67 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 5.9 m120 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.8999999999999999 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1000000000000001 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.584 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 2.75 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.798 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.6100000000000001 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.706 ' HB3' HG12 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.25 112.139 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.2200000000000002 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 1.73 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.781 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.3 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 2.4700000000000002 111.025 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.8100000000000001 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.781 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 18.8 mm-40 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.6600000000000001 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 0.80000000000000004 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.602 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 3.9500000000000002 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.48 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 3.7999999999999998 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.26 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 94' ' ' ARG . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.53 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 1.79 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.04 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.554 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.3100000000000001 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.1099999999999999 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.9399999999999999 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.1600000000000001 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.1499999999999999 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 1.3500000000000001 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 1.53 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.1399999999999999 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.007 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 0.57999999999999996 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.4900000000000002 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 1.3 mp0 . . . . . 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.8300000000000001 109.185 -157.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' SER . 39.6 m . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.818 -0.438 . . . . 1.22 109.818 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.1899999999999999 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.427 HG23 ' OXT' ' B' ' 168' ' ' VAL . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 1.54 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.878 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.51 -0.587 0 CA-C-O 121.025 0.44 . . . . 0.97999999999999998 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.3500000000000001 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 1.8400000000000001 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.3100000000000001 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HE ' HD21 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 3.5800000000000001 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 0.85999999999999999 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.939 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 0.93000000000000005 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG22 ' A' ' 18' ' ' ILE . 1.5 t60 . . . . . 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 3.5299999999999998 112.668 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.784 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 111.825 0.306 . . . . 0.72999999999999998 111.825 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.495 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.1599999999999999 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.592 HG22 HG23 ' A' ' 57' ' ' VAL . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 0.89000000000000001 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.68999999999999995 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.4199999999999999 112.021 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.699 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 112.335 -0.306 . . . . 1.05 112.335 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.697 HD13 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 0.67000000000000004 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.48 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 0.66000000000000003 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.02 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 0.71999999999999997 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 1.77 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.689 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.2799999999999998 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.755 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.689 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.3200000000000001 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 0.37 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 0.89000000000000001 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 0.34000000000000002 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.48999999999999999 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 1.5800000000000001 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.772 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 17.3 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.3599999999999999 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 0.56999999999999995 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.723 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.59999999999999998 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.796 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 -172.146 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.1800000000000002 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 0.64000000000000001 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.077 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.4 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.2599999999999998 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 0.77000000000000002 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.749 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.8999999999999999 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1000000000000001 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.691 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 2.75 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.932 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.6100000000000001 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.077 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.25 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.2200000000000002 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 1.73 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.827 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.3 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 2.4700000000000002 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.827 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 31.6 mm-40 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.6600000000000001 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 0.80000000000000004 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.517 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 3.9500000000000002 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.48 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.881 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 3.7999999999999998 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.823 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.26 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.53 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 101' ' ' SER . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 1.79 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.04 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.505 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.3100000000000001 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.1099999999999999 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.9399999999999999 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.1699999999999999 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.1600000000000001 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.939 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.1499999999999999 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 1.3500000000000001 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.891 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 1.53 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.1399999999999999 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.878 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 0.57999999999999996 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.4900000000000002 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.8300000000000001 108.072 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.416 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.9 m . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.04 -0.029 . . . . 1.22 110.945 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.1899999999999999 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 1.54 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.885 0.85 . . . . 0.97999999999999998 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.3500000000000001 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 1.8400000000000001 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.3100000000000001 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 3.5800000000000001 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.786 HG13 HD23 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 0.85999999999999999 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.051 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 0.93000000000000005 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.727 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 3.5299999999999998 111.254 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 120.507 0.194 . . . . 0.72999999999999998 110.947 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.1599999999999999 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.89000000000000001 109.788 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.68999999999999995 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.4199999999999999 109.164 169.346 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 114.323 0.489 . . . . 1.05 114.323 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 0.67000000000000004 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.48 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 0.66000000000000003 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.0 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.736 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.02 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 0.71999999999999997 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 1.77 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.2799999999999998 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' O ' HG13 ' A' ' 68' ' ' ILE . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.3200000000000001 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.051 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 0.37 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 0.89000000000000001 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 0.34000000000000002 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.48999999999999999 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HB1' ' A' ' 66' ' ' ALA . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 1.5800000000000001 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.3599999999999999 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 0.56999999999999995 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.59999999999999998 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.775 ' H ' HG12 ' A' ' 57' ' ' VAL . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.3500000000000001 109.208 -171.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.802 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.1800000000000002 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.64000000000000001 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.483 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 0.47999999999999998 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.729 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.2599999999999998 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 0.77000000000000002 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.8999999999999999 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1000000000000001 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.542 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 2.75 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.6100000000000001 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.729 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.25 110.745 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.2200000000000002 108.627 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 HH22 ' A' ' 96' ' ' ARG . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 1.73 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 2.4700000000000002 111.499 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.765 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.8100000000000001 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.582 ' OE1' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.6600000000000001 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 0.80000000000000004 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 3.9500000000000002 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.48 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.743 HH22 HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 3.7999999999999998 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.673 HD11 HG21 ' B' ' 168' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.26 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.53 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.04 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.3100000000000001 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.1099999999999999 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.9399999999999999 108.729 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.1699999999999999 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 18' ' ' ILE . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.1600000000000001 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.1499999999999999 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.786 HD23 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 1.3500000000000001 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 1.53 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.1399999999999999 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.802 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 0.57999999999999996 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.4900000000000002 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 . . . . . 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.8300000000000001 108.405 173.859 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 110.787 -0.079 . . . . 1.22 110.787 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.1899999999999999 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 1.54 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.502 -0.867 0 CA-C-O 122.055 0.931 . . . . 0.97999999999999998 111.759 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.3500000000000001 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 1.8400000000000001 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.3100000000000001 109.82 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HD22 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 3.5800000000000001 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 0.85999999999999999 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 0.93000000000000005 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 3.5299999999999998 111.484 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.897 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 109.717 -0.475 . . . . 0.72999999999999998 109.717 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.1599999999999999 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 0.89000000000000001 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.68999999999999995 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.4199999999999999 109.692 176.935 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.05 115.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 0.67000000000000004 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.48 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 0.66000000000000003 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.69 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.02 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.897 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 0.71999999999999997 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.49 ' HG ' ' N ' ' A' ' 31' ' ' PHE . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 1.77 109.042 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.2799999999999998 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.3200000000000001 114.951 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 0.37 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 0.89000000000000001 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 0.34000000000000002 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.48999999999999999 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.767 HD23 ' HB1' ' A' ' 66' ' ' ALA . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 1.5800000000000001 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.3599999999999999 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.507 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 0.56999999999999995 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.59999999999999998 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.795 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.3500000000000001 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.1800000000000002 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 0.64000000000000001 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 0.47999999999999998 110.296 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.2599999999999998 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.717 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 0.77000000000000002 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.8999999999999999 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1000000000000001 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 2.75 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.791 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.6100000000000001 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.25 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.2200000000000002 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 93' ' ' ALA . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 1.73 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.449 ' H ' ' CD ' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.3 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 2.4700000000000002 111.444 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.8100000000000001 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.782 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.6600000000000001 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.785 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 0.80000000000000004 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 3.9500000000000002 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.715 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.48 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 3.7999999999999998 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.26 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.53 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 1.79 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.566 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.04 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.655 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.3100000000000001 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.1099999999999999 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.9399999999999999 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.1699999999999999 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.1600000000000001 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.1499999999999999 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.559 HD22 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 1.3500000000000001 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 1.53 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.1399999999999999 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 0.57999999999999996 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.4900000000000002 111.441 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.8300000000000001 111.3 -178.778 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.22 112.615 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.1899999999999999 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 1.54 109.477 171.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.486 -1.512 0 CA-C-O 122.39 1.09 . . . . 0.97999999999999998 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.3500000000000001 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 1.8400000000000001 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.3100000000000001 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 3.5800000000000001 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.785 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 0.93000000000000005 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 104' ' ' VAL . 15.8 p80 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 3.5299999999999998 111.667 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.717 0.294 . . . . 0.72999999999999998 111.322 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.782 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.1599999999999999 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.897 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 0.89000000000000001 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.68999999999999995 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.4199999999999999 111.753 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 115.734 1.054 . . . . 1.05 115.734 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 0.67000000000000004 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.48 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.897 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 0.66000000000000003 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.0 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.02 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 0.71999999999999997 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 1.77 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.2799999999999998 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.3200000000000001 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.785 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 0.37 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 0.89000000000000001 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 0.34000000000000002 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.48999999999999999 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 1.5800000000000001 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.3599999999999999 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 0.56999999999999995 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.568 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.59999999999999998 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.771 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.3500000000000001 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.1800000000000002 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 0.64000000000000001 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.429 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 0.47999999999999998 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.104 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.2599999999999998 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.666 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 0.77000000000000002 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.8999999999999999 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1000000000000001 112.218 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.666 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 2.75 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 1.104 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.6100000000000001 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.547 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.25 111.936 -175.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.2200000000000002 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.906 HG12 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 1.73 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.918 HG22 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.3 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.918 ' H ' HG22 ' A' ' 89' ' ' THR . 18.0 t-160 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 2.4700000000000002 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.8100000000000001 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.906 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.6600000000000001 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.874 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 0.80000000000000004 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 3.9500000000000002 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.48 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.608 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 3.7999999999999998 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 HG21 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.26 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.529 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.53 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.79 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.04 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.3100000000000001 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.713 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.1099999999999999 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.9399999999999999 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.1699999999999999 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 18' ' ' ILE . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.1600000000000001 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' C ' HD13 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.1499999999999999 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 1.3500000000000001 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.817 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 1.53 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 110' ' ' THR . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.82 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 0.57999999999999996 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.4900000000000002 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.8300000000000001 109.692 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.22 113.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.782 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.1899999999999999 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 1.54 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.68 0.753 . . . . 0.97999999999999998 110.956 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.3500000000000001 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 1.8400000000000001 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 111' ' ' ARG . 17.3 mp0 -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.3100000000000001 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HE ' HD21 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 3.5800000000000001 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 0.85999999999999999 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.761 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 0.93000000000000005 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.64 ' HB3' HG23 ' A' ' 104' ' ' VAL . 25.2 p80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 3.5299999999999998 112.402 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.586 -1.264 . . . . 0.72999999999999998 107.586 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.1599999999999999 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.796 HG23 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 0.89000000000000001 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.68999999999999995 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.923 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.4199999999999999 107.299 162.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 113.916 0.326 . . . . 1.05 113.916 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.923 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 0.67000000000000004 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.48 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.872 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 0.66000000000000003 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.0 111.425 -173.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.583 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.02 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 0.71999999999999997 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 1.77 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.2799999999999998 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.3200000000000001 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.825 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 0.37 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 0.89000000000000001 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 0.34000000000000002 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.48999999999999999 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.662 HD22 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 1.5800000000000001 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 71' ' ' LEU . 12.7 mp0 -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.3599999999999999 107.426 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 0.56999999999999995 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.744 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.59999999999999998 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.872 ' H ' HG12 ' A' ' 57' ' ' VAL . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.3500000000000001 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.1800000000000002 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.686 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 0.64000000000000001 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 0.47999999999999998 110.237 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.0 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 45.2 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.2599999999999998 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.737 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 11.5 m120 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.8999999999999999 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1000000000000001 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.595 ' HB2' HG13 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 1.0 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.6100000000000001 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.737 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.25 112.605 -167.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.2200000000000002 111.564 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 1.73 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.069 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.3 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.446 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 2.4700000000000002 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.8100000000000001 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 1.069 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 2.7 mm-40 -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.6600000000000001 109.486 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.681 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 0.80000000000000004 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.796 HH22 HG23 ' A' ' 33' ' ' ILE . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 3.9500000000000002 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.48 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.532 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 3.7999999999999998 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.26 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.774 HG22 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.53 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 1.79 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.575 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.04 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.529 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.3100000000000001 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.601 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.1099999999999999 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.9399999999999999 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.1699999999999999 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.1600000000000001 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.815 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.1499999999999999 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 1.3500000000000001 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD21 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 1.53 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.1399999999999999 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 0.57999999999999996 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.67 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.4900000000000002 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.667 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.8300000000000001 109.566 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.931 -0.766 . . . . 1.22 108.931 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.1899999999999999 110.676 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.143 176.936 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.363 0.602 . . . . 0.97999999999999998 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.995 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 1.8400000000000001 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.692 ' H ' HG13 ' A' ' 13' ' ' VAL . 19.6 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.3100000000000001 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.501 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 3.5800000000000001 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.651 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 0.85999999999999999 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 0.93000000000000005 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.463 ' HB2' HG23 ' A' ' 104' ' ' VAL . 48.3 t-80 . . . . . 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 3.5299999999999998 110.678 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.973 0.416 . . . . 0.72999999999999998 112.038 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.895 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.1599999999999999 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.579 HG22 HG23 ' A' ' 57' ' ' VAL . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 0.89000000000000001 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.68999999999999995 111.197 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.978 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.4199999999999999 114.244 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 115.235 0.854 . . . . 1.05 115.235 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.978 HD13 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 0.67000000000000004 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.48 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 0.66000000000000003 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.0 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.02 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.66 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 0.71999999999999997 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 1.77 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.2799999999999998 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.624 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.3200000000000001 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 0.37 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 0.89000000000000001 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 0.34000000000000002 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.48999999999999999 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 1.5800000000000001 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.681 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.3599999999999999 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 0.56999999999999995 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.59999999999999998 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.3500000000000001 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.1800000000000002 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 33' ' ' ILE . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 0.64000000000000001 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 0.47999999999999998 111.061 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 1.028 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.1 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.2599999999999998 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 0.77000000000000002 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.8 m120 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.8999999999999999 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1000000000000001 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 2.75 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 1.028 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.6100000000000001 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.022 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.25 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.2200000000000002 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 1.73 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.755 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.3 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.441 ' NE2' ' HB2' ' B' ' 166' ' ' SER . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 2.4700000000000002 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.8100000000000001 110.488 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.755 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 30.7 mm-40 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.6600000000000001 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 0.80000000000000004 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.797 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 3.9500000000000002 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.48 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 3.7999999999999998 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.26 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.53 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.774 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.79 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.04 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.522 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.3100000000000001 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.774 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.1099999999999999 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.9399999999999999 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.1699999999999999 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.1600000000000001 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.1499999999999999 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.651 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 1.3500000000000001 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.682 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 1.53 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.856 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.1399999999999999 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.701 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 0.57999999999999996 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.995 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.4900000000000002 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 . . . . . 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.8300000000000001 109.905 -175.257 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 166' ' ' SER . . . . . 0.797 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.617 0.969 . . . . 1.22 113.617 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.1899999999999999 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 1.54 110.829 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.031 -0.359 . . . . 18.34 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 63.85 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.878 0.736 . . . . 15.06 112.2 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 72.73 117.99 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.316 -0.856 . . . . 14.539999999999999 111.693 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.6 mt -131.79 104.13 14.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.638 -0.71 . . . . 10.4 109.626 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -68.61 134.71 31.27 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.25 2.633 . . . . 10.74 112.081 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.04 -17.62 34.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.921 -0.657 . . . . 7.75 111.975 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -101.05 123.53 44.8 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-O 120.801 0.334 . . . . 6.8399999999999999 110.591 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.75 135.13 37.35 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.825 2.35 . . . . 4.8399999999999999 112.53 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.22 -1.08 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 122.289 1.042 . . . . 3.2599999999999998 109.606 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p 68.4 -65.38 0.27 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.749 -2.478 . . . . 2.1699999999999999 111.971 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.81 113.77 0.95 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.596 -1.184 . . . . 0.97999999999999998 111.085 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.013 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.3500000000000001 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 1.8400000000000001 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.3100000000000001 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 3.5800000000000001 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 0.85999999999999999 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 HD23 ' A' ' 29' ' ' LEU . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 0.93000000000000005 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 -109.4 126.75 53.77 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 3.5299999999999998 114.192 -172.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.697 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 20.8 pttp -47.27 155.38 0.32 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.306 -1.315 . . . . 5.6900000000000004 111.062 172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 42.6 tp -131.79 159.67 37.8 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.693 0.758 . . . . 4.5 110.823 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' HD21 ' A' ' 27' ' ' LEU . 13.9 tpt180 -72.54 118.48 15.5 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.509 -1.223 . . . . 5.2400000000000002 113.505 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -136.99 64.24 1.54 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.32 -1.309 . . . . 4.4800000000000004 109.116 167.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.5 -109.41 2.78 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.187 -1.37 . . . . 3.7799999999999998 112.0 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.43 -0.43 55.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.237 -1.024 . . . . 6.8499999999999996 108.237 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 19.5 m-80 -102.69 133.21 48.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 122.993 1.378 . . . . 4.8499999999999996 108.83 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' C ' ' HB2' ' A' ' 20' ' ' LYS . 4.5 mm? -119.58 105.32 11.09 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 112.394 -2.184 . . . . 3.6800000000000002 107.62 168.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -155.72 162.84 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 113.789 1.033 . . . . 2.8999999999999999 113.789 -174.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 HG22 ' A' ' 18' ' ' ILE . 1.1 mp -97.75 -49.25 4.9 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.06 -1.427 . . . . 4.1900000000000004 109.783 -165.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 95.14 6.75 59.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.656 -0.783 . . . . 1.6200000000000001 113.65 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.997 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 -98.51 167.37 10.86 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.869 -0.789 . . . . 0.72999999999999998 108.869 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.1599999999999999 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 0.89000000000000001 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.707 ' HA3' ' CG2' ' A' ' 37' ' ' ILE . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.68999999999999995 112.316 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -119.52 75.54 0.31 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.4199999999999999 109.708 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.643 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . 145.33 -9.54 1.71 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.698 -1.239 . . . . 3.0 111.213 -168.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.707 ' CG2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -38.35 -47.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.546 1.313 . . . . 4.71 114.546 -168.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -121.32 17.24 11.45 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.323 0.582 . . . . 7.4900000000000002 110.564 -175.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.643 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -119.73 -147.06 0.39 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.741 1.015 . . . . 4.5499999999999998 113.741 -176.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 1.061 ' HB3' HE22 ' A' ' 43' ' ' GLN . 8.3 t70 -179.22 172.03 0.62 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 107.027 -1.471 . . . . 5.1399999999999997 107.027 -153.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 74.4 Cg_endo -83.81 -14.51 7.56 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 121.825 1.684 . . . . 5.5800000000000001 112.43 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.3 m -78.34 -8.28 58.24 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.581 -1.191 . . . . 6.54 113.042 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 1.061 HE22 ' HB3' ' A' ' 40' ' ' ASP . 3.4 mp0 -91.31 -23.46 20.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.075 0.464 . . . . 5.9299999999999997 111.44 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.598 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 10.9 t30 -53.46 -32.87 11.7 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 115.116 1.524 . . . . 6.0599999999999996 115.116 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 44' ' ' ASN . 2.4 Cg_endo -45.0 -25.0 1.47 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.703 1.602 . . . . 8.0299999999999994 111.61 167.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 47' ' ' SER . 74.4 m-85 -120.4 -9.87 9.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.521 -0.763 . . . . 8.8699999999999992 112.188 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 24.1 m 69.04 30.39 4.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.253 -0.647 . . . . 5.1299999999999999 109.253 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 15.0 tp10 87.65 -60.06 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.29 -1.777 . . . . 7.4299999999999997 111.101 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.0 t70 -150.46 35.34 0.64 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.589 -0.893 . . . . 7.3899999999999997 108.589 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 26.8 mmtp 71.19 112.73 0.06 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 113.952 -1.476 . . . . 7.8200000000000003 111.285 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p 58.97 12.29 2.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.021 -0.99 . . . . 5.1200000000000001 111.728 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.856 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 4.0 t70 -67.52 -70.18 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.046 -0.979 . . . . 3.9700000000000002 111.117 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' B' ' 161' ' ' LYS . 29.2 mmtp 76.91 -21.17 0.34 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.109 -0.951 . . . . 6.0899999999999999 111.632 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.558 ' HA3' ' OE1' ' A' ' 39' ' ' GLN . . . 66.26 56.31 14.48 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.399 -0.819 . . . . 1.05 113.114 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.67000000000000004 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.6 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.48 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.906 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 0.66000000000000003 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.0 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.02 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.997 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 0.71999999999999997 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 1.77 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.2799999999999998 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.3200000000000001 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.747 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 0.37 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 0.89000000000000001 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 0.34000000000000002 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.48999999999999999 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 1.5800000000000001 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.599 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.3599999999999999 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 0.56999999999999995 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.6 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.59999999999999998 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.906 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.3500000000000001 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.1800000000000002 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 0.64000000000000001 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 0.47999999999999998 111.206 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.054 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.2599999999999998 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.751 HG21 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 0.77000000000000002 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.8999999999999999 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1000000000000001 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 2.75 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.981 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.6100000000000001 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.054 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.25 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.2200000000000002 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 1.73 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.3 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 2.4700000000000002 110.912 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.612 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.8100000000000001 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.78 ' HB2' HG12 ' A' ' 88' ' ' VAL . 23.5 mm-40 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.6600000000000001 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 0.80000000000000004 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.571 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 3.9500000000000002 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.48 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.631 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 3.7999999999999998 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 80' ' ' VAL . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.26 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.53 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 1.79 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.04 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.576 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.3100000000000001 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.1099999999999999 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.9399999999999999 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.1699999999999999 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 97' ' ' LEU . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.1600000000000001 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.1499999999999999 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.662 HD11 HD12 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 1.3500000000000001 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.939 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 1.53 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.1399999999999999 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 0.57999999999999996 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 1.013 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.4900000000000002 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 113' ' ' SER . 12.5 mm100 -100.2 -17.05 17.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.8300000000000001 111.521 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 64.2 m 88.49 -4.38 0.49 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 113.187 -1.824 . . . . 4.2999999999999998 110.438 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 114' ' ' LEU . 3.1 mm? -97.85 69.03 2.08 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.417 -1.72 . . . . 4.4800000000000004 109.184 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.96 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 112.258 -2.247 . . . . 6.5300000000000002 112.496 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.74 118.51 7.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 9.2799999999999994 111.355 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.87 20.99 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.253 -1.388 . . . . 11.58 107.253 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p 30.45 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.112 -2.313 . . . . 12.380000000000001 113.617 -168.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.11 113.0 26.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.172 -0.922 . . . . 14.960000000000001 109.486 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.41 81.41 6.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.944 0.402 . . . . 17.27 111.153 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 p -110.64 109.46 19.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.019 -0.537 . . . . 19.469999999999999 110.431 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 ttt -132.05 115.32 15.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.369 -0.378 . . . . 21.73 110.899 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.193 -0.458 . . . . 23.079999999999998 110.097 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.572 . . . . 23.960000000000001 111.283 -176.777 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 121.14 0.495 . . . . 8.2699999999999996 110.684 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.636 ' HB3' ' N ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -83.86 171.17 13.33 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.432 0.901 . . . . 6.8700000000000001 113.432 -164.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.633 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 28.3 t-20 -45.99 99.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.877 -1.51 . . . . 4.5499999999999998 113.756 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.437 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 2.3 pt? -153.04 120.39 5.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.527 0.679 . . . . 2.71 111.212 163.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -111.72 168.46 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.149 -0.685 . . . . 4.9199999999999999 109.149 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.504 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 21.1 m -164.74 141.31 6.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.729 0.27 . . . . 1.22 111.729 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.1899999999999999 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.551 ' OXT' ' HB2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 1.54 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.872 0.367 . . . . 18.34 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -122.99 -48.19 2.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.429 -0.582 . . . . 15.06 109.429 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -113.86 132.53 55.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.978 -0.749 . . . . 14.539999999999999 108.978 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.38 97.89 51.01 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.628 -0.26 . . . . 10.4 110.324 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.95 3.77 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.686 2.924 . . . . 10.74 111.305 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.01 40.49 2.06 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.334 -1.303 . . . . 7.75 111.269 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.7 pt20 -63.58 127.85 91.91 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.933 -0.395 . . . . 6.8399999999999999 109.933 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 40.4 Cg_endo -93.51 -166.85 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.087 2.525 . . . . 4.8399999999999999 113.72 -173.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 10' ' ' THR . 9.2 p 49.23 157.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.326 1.85 . . . . 3.2599999999999998 114.61 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 9' ' ' VAL . 34.0 p -107.67 -39.85 5.48 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.98 -1.463 . . . . 2.1699999999999999 110.759 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.53 115.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.202 -1.817 . . . . 0.97999999999999998 110.274 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.3500000000000001 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 1.8400000000000001 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.3100000000000001 108.818 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 3.5800000000000001 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 0.85999999999999999 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 0.93000000000000005 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 104' ' ' VAL . 20.6 p80 -107.89 79.71 1.3 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 3.5299999999999998 112.314 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.9 ' HD3' ' HD2' ' A' ' 31' ' ' PHE . 7.3 mtpm? -136.94 86.9 2.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.531 -1.213 . . . . 5.6900000000000004 109.197 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 28' ' ' ILE . 4.1 pp -152.51 161.61 42.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.403 -0.817 . . . . 4.5 109.328 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 100' ' ' ARG . 3.6 tmt_? -64.63 108.96 1.84 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.955 -0.387 . . . . 5.2400000000000002 109.955 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.084 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -127.88 64.28 1.38 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.981 0.895 . . . . 4.4800000000000004 110.543 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.76 -96.77 0.96 Allowed Glycine 0 CA--C 1.491 -1.428 0 CA-C-N 113.625 -1.625 . . . . 3.7799999999999998 112.584 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 25' ' ' GLU . 1.2 tp10 -83.65 -1.02 53.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.415 -0.957 . . . . 6.8499999999999996 108.415 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 1.084 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.2 m-80 -115.65 130.44 56.86 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-O 122.784 1.278 . . . . 4.8499999999999996 108.968 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' A' ' 22' ' ' ARG . 3.3 mm? -121.7 106.78 11.64 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 112.288 -2.233 . . . . 3.6800000000000002 107.841 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.735 HG12 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -112.26 127.16 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.892 -1.522 . . . . 2.8999999999999999 106.892 172.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' B' ' 168' ' ' VAL . 12.3 tp -168.98 58.62 0.05 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.376 -1.342 . . . . 4.1900000000000004 107.376 -160.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . -126.48 -54.13 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 116.52 1.368 . . . . 1.6200000000000001 116.52 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.041 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 -77.94 147.18 35.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.01 1.405 . . . . 0.72999999999999998 109.843 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.695 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.1599999999999999 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 0.89000000000000001 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.68999999999999995 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.96 122.32 2.68 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.4199999999999999 112.285 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.0 57.25 0.53 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.973 -0.451 . . . . 3.0 111.973 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -132.84 -37.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.791 0.329 . . . . 4.71 110.726 176.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -81.77 -4.87 57.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.942 -0.572 . . . . 7.4900000000000002 110.282 -177.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.705 ' HB2' HE22 ' A' ' 43' ' ' GLN . 3.2 mm100 -89.86 -79.76 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.745 -0.661 . . . . 4.5499999999999998 112.348 -162.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 13.0 t70 -148.78 140.61 14.51 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.704 -0.68 . . . . 5.1399999999999997 110.153 -168.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 37.5 Cg_endo -60.64 -20.49 65.25 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 123.475 2.783 . . . . 5.5800000000000001 113.116 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -62.28 -28.88 70.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.384 -0.371 . . . . 6.54 111.626 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.705 HE22 ' HB2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -89.14 -16.58 31.07 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 116.388 -0.369 . . . . 5.9299999999999997 110.862 -175.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -124.39 91.62 49.25 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.256 -0.577 . . . . 6.0599999999999996 112.302 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -95.38 17.55 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.292 2.662 . . . . 8.0299999999999994 110.61 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.626 ' HD1' ' HB2' ' A' ' 47' ' ' SER . 42.2 t80 179.13 -41.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.213 -0.903 . . . . 8.8699999999999992 109.96 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.661 ' OG ' ' HD2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -175.68 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.075 -1.083 . . . . 5.1299999999999999 108.075 -170.005 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 11.8 tp10 -172.87 -89.34 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.493 -1.685 . . . . 7.4299999999999997 108.505 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.46 61.05 0.7 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.548 -0.861 . . . . 7.3899999999999997 110.442 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 65.19 -72.21 0.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.136 . . . . 7.8200000000000003 112.06 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -88.23 15.86 7.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.821 -0.627 . . . . 5.1200000000000001 111.751 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.1 t70 -110.26 -170.27 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.581 -0.525 . . . . 3.9700000000000002 109.581 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.803 ' HG3' HG21 ' A' ' 86' ' ' THR . 15.6 tptm -135.85 -10.77 2.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.253 -0.885 . . . . 6.0899999999999999 108.977 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 -4.2 56.55 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.508 -0.769 . . . . 1.05 112.782 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 37' ' ' ILE . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 0.67000000000000004 110.154 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.48 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 0.66000000000000003 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.695 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.02 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.041 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 0.71999999999999997 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 1.77 107.113 162.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.2799999999999998 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.841 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.3200000000000001 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 0.37 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 0.89000000000000001 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 0.34000000000000002 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 1.5800000000000001 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.531 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.3599999999999999 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 0.56999999999999995 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.619 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.3500000000000001 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.1800000000000002 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 0.64000000000000001 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.404 ' C ' ' HG2' ' A' ' 79' ' ' GLN . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 0.47999999999999998 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.8 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.2599999999999998 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 0.77000000000000002 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.805 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 m120 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.8999999999999999 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1000000000000001 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.543 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 2.75 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.763 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.6100000000000001 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.8 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.803 HG21 ' HG3' ' A' ' 53' ' ' LYS . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.25 111.892 -170.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.2200000000000002 110.942 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 1.73 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.858 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.3 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 2.4700000000000002 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG22 ' A' ' 89' ' ' THR . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.8100000000000001 110.118 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.858 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.6600000000000001 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 0.80000000000000004 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.614 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 3.9500000000000002 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.48 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 3.7999999999999998 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.26 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.53 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.79 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.04 111.188 176.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.3100000000000001 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.715 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.1099999999999999 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.9399999999999999 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.1699999999999999 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.1600000000000001 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.805 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.1499999999999999 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 1.3500000000000001 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 1.53 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.1399999999999999 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.662 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 0.57999999999999996 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.4900000000000002 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -103.89 -30.76 10.14 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.8300000000000001 108.626 170.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 70.8 m 82.66 2.81 1.14 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 111.087 -2.779 . . . . 4.2999999999999998 111.617 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.1 mm? -123.13 41.85 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.341 -1.3 . . . . 4.4800000000000004 109.023 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.9 137.59 3.14 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.061 -2.336 . . . . 6.5300000000000002 112.71 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -149.89 154.21 37.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.625 -0.716 . . . . 9.2799999999999994 109.563 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -139.08 27.06 2.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.29 1.043 . . . . 11.58 108.824 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.1 t -123.06 84.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 113.634 -1.621 . . . . 12.380000000000001 109.709 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -133.18 107.33 8.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.463 -0.789 . . . . 14.960000000000001 110.637 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -110.52 -17.29 13.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 17.27 110.489 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.4 p -157.72 151.48 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.93 -0.577 . . . . 19.469999999999999 110.192 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.61 164.4 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.255 -0.429 . . . . 21.73 110.072 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.58 117.97 6.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.697 0.284 . . . . 23.079999999999998 110.723 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.123 -0.489 . . . . 23.960000000000001 110.442 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 29.9 mtmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.745 0.307 . . . . 8.2699999999999996 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.53 145.12 45.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.206 0.527 . . . . 6.8700000000000001 111.367 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -150.33 3.97 0.51 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.701 -0.681 . . . . 4.5499999999999998 112.678 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' B' ' 164' ' ' LEU . 3.0 mt -96.16 138.44 33.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.464 -0.773 . . . . 2.71 111.846 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.6 pt-20 -139.61 172.26 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.226 -1.028 . . . . 4.9199999999999999 108.226 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m -149.97 120.97 7.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.893 -0.41 . . . . 1.22 109.893 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.707 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.1899999999999999 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 1.54 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.24 -0.652 . . . . 18.34 109.24 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -132.95 143.22 49.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.985 0.422 . . . . 15.06 111.572 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -78.93 101.43 7.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.883 -0.598 . . . . 14.539999999999999 110.108 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -136.68 99.24 10.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.38 -0.827 . . . . 10.4 109.58 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.85 116.56 4.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.898 2.399 . . . . 10.74 111.287 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.97 -14.99 5.42 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.845 -0.693 . . . . 7.75 111.74 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.79 147.46 34.76 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 120.638 0.256 . . . . 6.8399999999999999 110.345 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.57 155.72 56.81 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.292 2.661 . . . . 4.8399999999999999 112.986 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 10' ' ' THR . 9.8 p -84.8 162.94 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.576 0.703 . . . . 3.2599999999999998 110.316 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 9' ' ' VAL . 82.5 p -98.34 -60.04 1.63 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.785 -1.098 . . . . 2.1699999999999999 109.977 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -171.67 121.7 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.124 -1.398 . . . . 0.97999999999999998 110.475 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.3500000000000001 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 1.8400000000000001 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.3100000000000001 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.046 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 3.5800000000000001 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 0.85999999999999999 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.833 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 0.93000000000000005 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 -152.74 90.24 1.46 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 3.5299999999999998 112.005 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HD2' ' HB ' ' B' ' 168' ' ' VAL . 7.6 ptmm? -61.5 152.56 29.8 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.849 -1.167 . . . . 5.6900000000000004 107.849 167.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 28' ' ' ILE . 2.8 tt -124.32 121.55 35.3 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.383 -1.327 . . . . 4.5 113.346 -155.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -87.13 124.14 32.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.785 0.802 . . . . 5.2400000000000002 110.143 167.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -130.77 63.63 1.58 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.597 -1.183 . . . . 4.4800000000000004 110.145 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 77.8 -97.73 1.38 Allowed Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 114.182 -1.372 . . . . 3.7799999999999998 112.26 169.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -77.93 -5.87 52.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.194 -1.039 . . . . 6.8499999999999996 108.194 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.682 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 27.7 m-80 -111.61 131.81 55.0 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-O 123.507 1.622 . . . . 4.8499999999999996 110.682 -175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.3 mm? -121.84 114.62 21.3 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 110.905 -2.861 . . . . 3.6800000000000002 105.156 165.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 21' ' ' LEU . 33.3 mm -100.82 117.52 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 118.915 -1.114 . . . . 2.8999999999999999 109.759 -173.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 7.9 tp -113.03 75.35 0.91 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 110.571 -3.013 . . . . 4.1900000000000004 105.751 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.55 1.12 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 113.884 -1.507 . . . . 1.6200000000000001 115.656 -162.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 -77.38 174.27 11.0 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.273 0.537 . . . . 0.72999999999999998 110.639 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.1599999999999999 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.672 HD11 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 0.89000000000000001 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.68999999999999995 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' B' ' 164' ' ' LEU . . . -127.01 131.86 7.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.4199999999999999 109.925 172.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.74 -26.37 0.94 Allowed Glycine 0 C--O 1.229 -0.208 0 C-N-CA 119.851 -1.166 . . . . 3.0 113.089 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -58.99 -36.84 64.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.557 0.577 . . . . 4.71 112.557 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' CG ' HG23 ' A' ' 89' ' ' THR . 29.3 t70 -105.16 13.79 30.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.49 -0.777 . . . . 7.4900000000000002 110.637 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -98.26 -83.04 0.41 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.286 -0.566 . . . . 4.5499999999999998 111.241 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 41' ' ' PRO . 26.2 t70 -156.29 125.31 3.04 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.051 -0.522 . . . . 5.1399999999999997 110.07 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 74.1 Cg_endo -66.78 -13.04 38.35 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.912 3.075 . . . . 5.5800000000000001 112.056 -175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.728 ' HB2' ' HG3' ' B' ' 161' ' ' LYS . 12.8 m -61.23 -45.05 96.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.14 -0.936 . . . . 6.54 110.141 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.682 ' OE1' ' HA ' ' B' ' 162' ' ' GLU . 7.0 pt20 -99.11 -36.78 9.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.001 0.429 . . . . 5.9299999999999997 110.327 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 44.3 m-80 -101.57 101.31 16.98 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.868 -0.606 . . . . 6.0599999999999996 109.636 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.35 -14.45 38.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.039 2.493 . . . . 8.0299999999999994 112.372 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -166.04 -40.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.194 -0.457 . . . . 8.8699999999999992 110.75 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.692 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.4 p -149.13 -63.92 0.23 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.558 0.694 . . . . 5.1299999999999999 109.87 -170.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -171.97 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.009 -1.45 . . . . 7.4299999999999997 108.554 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 7.1 t70 -142.7 -158.77 0.9 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.748 -1.114 . . . . 7.3899999999999997 108.63 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 4.9 mtpm? -64.92 -66.25 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.121 0.486 . . . . 7.8200000000000003 111.429 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -111.28 21.87 15.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.84 -0.618 . . . . 5.1200000000000001 110.966 -175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 25.6 t70 -70.07 -41.23 74.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.34 0.867 . . . . 3.9700000000000002 113.34 -174.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mptp? 90.25 -37.03 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.53 1.132 . . . . 6.0899999999999999 110.525 -175.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 97.46 0.81 59.32 Favored Glycine 0 C--O 1.237 0.303 0 C-N-CA 120.668 -0.777 . . . . 1.05 112.838 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 0.67000000000000004 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.48 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 0.66000000000000003 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.534 HG21 ' HG2' ' B' ' 165' ' ' GLU . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.02 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 0.71999999999999997 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 1.77 107.254 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.2799999999999998 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.644 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.3200000000000001 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.79 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 0.37 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 0.89000000000000001 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 0.34000000000000002 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.48999999999999999 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 1.5800000000000001 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.3599999999999999 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 0.56999999999999995 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.624 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.59999999999999998 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.3500000000000001 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.1800000000000002 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 0.64000000000000001 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' ' HE3' ' A' ' 53' ' ' LYS . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 0.47999999999999998 110.518 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.997 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 0.77000000000000002 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.8999999999999999 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1000000000000001 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.662 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 2.75 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.893 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.6100000000000001 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.25 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.2200000000000002 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 1.73 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.672 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.672 ' HE1' HD11 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 2.4700000000000002 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.8100000000000001 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 36.4 mm-40 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.6600000000000001 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 0.80000000000000004 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 3.9500000000000002 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.48 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 3.7999999999999998 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD12 HG23 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.26 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.719 HG23 HD12 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.53 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.673 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.04 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.673 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.3100000000000001 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.1099999999999999 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.9399999999999999 107.369 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.1699999999999999 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.833 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.1600000000000001 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.1499999999999999 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 1.3500000000000001 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.046 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 1.53 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.1399999999999999 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.758 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 0.57999999999999996 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.623 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.4900000000000002 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -88.64 -45.47 9.82 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.8300000000000001 110.324 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.543 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 9.1 t 91.17 -2.88 0.22 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.185 -2.28 . . . . 4.2999999999999998 109.344 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 113' ' ' SER . 1.7 mm? -120.35 18.27 12.19 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.097 -1.865 . . . . 4.4800000000000004 107.734 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HG3' ' H ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.27 140.28 40.02 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.324 -2.671 . . . . 6.5300000000000002 111.367 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.646 ' HB3' HG22 ' A' ' 118' ' ' VAL . 38.8 mmtm -147.38 161.28 41.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.313 -0.858 . . . . 9.2799999999999994 109.771 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.86 24.02 2.61 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.596 1.188 . . . . 11.58 108.645 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 116' ' ' LYS . 17.0 m -91.17 25.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 113.096 -1.865 . . . . 12.380000000000001 111.075 -174.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -105.34 141.54 36.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.912 -1.04 . . . . 14.960000000000001 110.09 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -71.73 171.93 10.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.36 0.6 . . . . 17.27 111.266 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 m -88.73 123.67 33.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 19.469999999999999 110.765 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.88 -14.42 54.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 21.73 109.727 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.7 mp -86.09 129.98 34.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.475 -0.784 . . . . 23.079999999999998 110.185 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.107 -0.497 . . . . 23.960000000000001 109.768 174.378 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.728 ' HG3' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.513 0.673 . . . . 8.2699999999999996 111.667 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.682 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.5 pt-20 -169.53 106.39 0.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 6.8700000000000001 110.142 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -111.45 -100.12 0.41 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.544 -1.207 . . . . 4.5499999999999998 110.716 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 75.6 mt 66.83 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.148 0.905 . . . . 2.71 111.522 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.534 ' HG2' HG21 ' A' ' 58' ' ' THR . 34.0 mt-10 -56.87 118.16 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.008 0.908 . . . . 4.9199999999999999 112.912 -171.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m -130.8 114.16 14.98 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.285 -1.325 . . . . 1.22 107.69 167.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.1899999999999999 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 1.54 109.988 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.566 0.222 . . . . 18.34 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' ILE . 11.5 p -100.33 20.78 14.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.332 -0.23 . . . . 15.06 111.347 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.9 -31.69 0.22 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.622 0.769 . . . . 14.539999999999999 112.32 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 2' ' ' SER . 49.7 mm 57.7 95.93 0.05 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 124.042 0.937 . . . . 10.4 112.111 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 135.01 67.43 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.936 2.424 . . . . 10.74 111.913 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.32 -38.72 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.588 -0.605 . . . . 7.75 111.588 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 79.5 mt-30 -91.71 147.57 35.4 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 6.8399999999999999 109.99 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.2 Cg_exo -71.73 -175.79 1.77 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.107 2.538 . . . . 4.8399999999999999 112.518 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.784 HG22 ' H ' ' A' ' 10' ' ' THR . 8.0 p -74.34 178.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 3.2599999999999998 110.314 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 9' ' ' VAL . 44.5 p -135.47 113.68 11.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.816 0.817 . . . . 2.1699999999999999 110.547 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.19 115.26 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.257 -1.792 . . . . 0.97999999999999998 111.059 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.3500000000000001 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 1.8400000000000001 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.3100000000000001 109.765 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.656 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 3.5800000000000001 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 0.85999999999999999 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.879 HD12 HD22 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 0.93000000000000005 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 -106.45 89.27 2.99 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 3.5299999999999998 114.335 -171.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.703 ' HE2' ' HG3' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -89.11 162.86 15.73 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.286 -1.325 . . . . 5.6900000000000004 107.457 160.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.517 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 42.6 tp -150.73 138.84 20.14 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 116.834 -1.947 . . . . 4.5 115.091 -153.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 1.6 tmm_? -81.38 112.49 18.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 5.2400000000000002 108.276 162.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -112.32 65.84 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.045 0.926 . . . . 4.4800000000000004 109.685 -173.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.66 -102.42 1.75 Allowed Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 113.954 -1.476 . . . . 3.7799999999999998 111.772 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.6 3.04 46.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 6.8499999999999996 109.908 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 36.5 m-80 -105.49 142.99 34.29 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 123.236 1.494 . . . . 4.8499999999999996 109.689 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.1 mm? -130.22 111.73 12.69 Favored 'General case' 0 C--N 1.256 -3.478 0 CA-C-N 111.238 -2.71 . . . . 3.6800000000000002 107.054 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 21' ' ' LEU . 7.6 mm -106.27 118.17 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 109.504 -0.554 . . . . 2.8999999999999999 109.504 -176.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 1.7 tp -123.73 80.1 1.77 Allowed 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 127.365 2.916 . . . . 4.1900000000000004 107.475 -173.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.66 -82.58 1.02 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 113.694 -1.594 . . . . 1.6200000000000001 115.97 -166.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 -81.44 165.75 20.98 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 117.266 0.533 . . . . 0.72999999999999998 110.468 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.1599999999999999 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 0.89000000000000001 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.68999999999999995 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -131.4 91.27 0.29 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.4199999999999999 110.729 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 39' ' ' GLN . . . 150.36 31.43 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.935 -1.126 . . . . 3.0 112.499 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' CD1' ' HA2' ' A' ' 54' ' ' GLY . 16.8 pt -52.58 -48.57 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.621 0.6 . . . . 4.71 112.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -125.67 -8.92 6.77 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.076 -0.713 . . . . 7.4900000000000002 109.076 176.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.415 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -139.69 -148.95 0.26 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.511 -1.222 . . . . 4.5499999999999998 110.913 -168.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' B' ' 163' ' ' ASN . 9.6 t70 -161.68 137.64 5.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.578 -0.897 . . . . 5.1399999999999997 108.578 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 71.6 Cg_endo -70.23 -18.57 34.72 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.324 2.683 . . . . 5.5800000000000001 113.707 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 m -70.31 -40.89 73.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.221 0.534 . . . . 6.54 109.794 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.15 -29.3 20.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.765 -0.652 . . . . 5.9299999999999997 110.559 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.676 HD21 ' HA ' ' A' ' 47' ' ' SER . 29.4 t30 -122.05 89.62 48.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.26 -0.882 . . . . 6.0599999999999996 110.533 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -86.49 33.61 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.212 2.608 . . . . 8.0299999999999994 111.626 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -154.33 -71.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 8.8699999999999992 111.557 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.676 ' HA ' HD21 ' A' ' 44' ' ' ASN . 3.6 m 150.25 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.413 -1.328 . . . . 5.1299999999999999 107.413 -162.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.97 -16.7 31.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.108 -0.637 . . . . 7.4299999999999997 110.409 -172.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.4 t70 -101.81 5.75 41.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.414 -0.812 . . . . 7.3899999999999997 109.876 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 21.3 mmtt 70.78 -66.23 0.3 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.202 -0.908 . . . . 7.8200000000000003 111.09 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -83.11 20.04 1.32 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.213 -0.903 . . . . 5.1200000000000001 109.735 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' LYS . 4.6 t70 -39.55 -71.11 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 113.654 -1.612 . . . . 3.9700000000000002 110.992 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG3' ' SD ' ' A' ' 78' ' ' MET . 5.1 mptp? 56.36 38.12 29.45 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.942 0.877 . . . . 6.0899999999999999 108.783 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 37' ' ' ILE . . . -56.54 -3.96 0.77 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.494 -1.685 . . . . 1.05 115.014 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 0.67000000000000004 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.48 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 0.66000000000000003 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.0 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.02 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 0.71999999999999997 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 1.77 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.2799999999999998 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.703 ' HG3' ' HE2' ' A' ' 20' ' ' LYS . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.3200000000000001 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 0.37 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 0.89000000000000001 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 0.34000000000000002 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.48999999999999999 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.764 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 1.5800000000000001 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.3599999999999999 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 60' ' ' VAL . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.59999999999999998 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.3500000000000001 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 0.64000000000000001 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.623 ' SD ' ' HG3' ' A' ' 53' ' ' LYS . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 0.47999999999999998 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 1.7 mt-30 -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.2599999999999998 111.246 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 0.77000000000000002 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.622 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.8999999999999999 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1000000000000001 112.928 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 2.75 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.6100000000000001 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.805 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.25 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.2200000000000002 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 1.73 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.919 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.3 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.664 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 2.4700000000000002 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.8100000000000001 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.919 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.6600000000000001 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 0.80000000000000004 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.664 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 3.9500000000000002 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.48 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 3.7999999999999998 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 HD12 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.53 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 1.79 109.213 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.04 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.3100000000000001 113.364 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.1099999999999999 111.418 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.9399999999999999 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.1699999999999999 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.622 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.1499999999999999 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 1.3500000000000001 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 1.53 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.1399999999999999 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.699 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 0.57999999999999996 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.4900000000000002 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -94.74 -17.6 22.04 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.8300000000000001 110.95 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.46 -5.35 0.62 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 111.728 -2.487 . . . . 4.2999999999999998 109.9 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.9 mm? -99.64 55.45 0.96 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.366 -1.743 . . . . 4.4800000000000004 109.3 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.36 142.62 55.41 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 112.231 -2.259 . . . . 6.5300000000000002 111.272 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 119' ' ' GLN . 2.8 mmmm -117.53 108.97 16.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.696 -0.683 . . . . 9.2799999999999994 109.912 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -116.84 15.77 15.27 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.747 1.261 . . . . 11.58 108.089 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.23 83.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.544 -2.116 . . . . 12.380000000000001 108.431 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 15.6 mm100 -120.76 165.37 15.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.477 -0.783 . . . . 14.960000000000001 111.114 -172.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -161.69 174.06 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.89 -0.782 . . . . 17.27 108.89 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.1 t 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.025 0.828 . . . . 19.469999999999999 111.131 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.4 mtt -140.98 111.44 6.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.968 -0.56 . . . . 21.73 109.519 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -118.91 141.1 48.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.407 . . . . 23.079999999999998 111.057 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 23.960000000000001 110.215 175.699 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' B' ' 161' ' ' LYS . 22.0 tptp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.668 -0.493 . . . . 8.2699999999999996 109.668 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.77 104.56 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.286 0.565 . . . . 6.8700000000000001 111.856 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.419 ' H ' ' HB2' ' A' ' 40' ' ' ASP . 57.2 t30 66.77 139.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.201 -1.363 . . . . 4.5499999999999998 112.514 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.11 150.58 27.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.479 -0.563 . . . . 2.71 109.479 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.95 -179.73 3.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.98 0.419 . . . . 4.9199999999999999 110.177 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -158.51 125.92 5.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.22 109.601 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.689 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.1899999999999999 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 1.54 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.651 0.263 . . . . 18.34 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -84.83 -30.13 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.597 -0.274 . . . . 15.06 110.688 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 51.64 70.42 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.673 0.608 . . . . 14.539999999999999 112.227 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.5 92.13 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.918 -1.037 . . . . 10.4 111.266 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.32 95.34 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.5 2.133 . . . . 10.74 110.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 171.48 -33.86 0.15 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.827 -0.701 . . . . 7.75 112.198 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.1 pt20 -90.03 106.5 14.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 6.8399999999999999 111.288 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 7.0 Cg_exo -73.36 141.44 31.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.853 2.368 . . . . 4.8399999999999999 111.336 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 10' ' ' THR . 7.7 p -73.98 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.475 0.655 . . . . 3.2599999999999998 109.793 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 9' ' ' VAL . 70.0 p -81.69 -56.38 4.04 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.808 -1.087 . . . . 2.1699999999999999 110.888 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.46 131.53 0.93 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.427 -1.26 . . . . 0.97999999999999998 109.51 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.3500000000000001 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 1.8400000000000001 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.702 ' NE2' HH21 ' A' ' 111' ' ' ARG . 38.5 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.3100000000000001 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 3.5800000000000001 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 HD23 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 0.85999999999999999 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.851 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.909 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 0.93000000000000005 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HB2' HG23 ' A' ' 104' ' ' VAL . 10.5 t-160 -121.08 96.66 5.19 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 3.5299999999999998 112.234 176.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HZ1' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -108.59 117.9 35.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.166 -1.379 . . . . 5.6900000000000004 109.516 174.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 22' ' ' ARG . 14.1 tp -153.76 158.6 41.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.401 -0.818 . . . . 4.5 109.973 -165.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 21' ' ' LEU . 3.9 tpp180 -62.45 108.32 1.1 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.446 -0.797 . . . . 5.2400000000000002 109.695 161.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -122.72 60.3 1.03 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.205 1.002 . . . . 4.4800000000000004 108.851 174.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.99 -100.42 1.36 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 113.563 -1.653 . . . . 3.7799999999999998 111.73 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -72.1 -10.29 59.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.846 0.832 . . . . 6.8499999999999996 109.486 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.629 ' HB3' HD11 ' A' ' 28' ' ' ILE . 26.7 m-80 -109.63 128.52 55.29 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 123.088 1.423 . . . . 4.8499999999999996 110.041 -172.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 26' ' ' ASN . 3.2 mm? -123.63 109.34 13.62 Favored 'General case' 0 C--N 1.254 -3.568 0 CA-C-N 111.648 -2.523 . . . . 3.6800000000000002 107.171 167.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -108.64 123.81 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 C-N-CA 119.691 -0.804 . . . . 2.8999999999999999 109.122 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.066 HD23 ' HA ' ' B' ' 168' ' ' VAL . 1.2 mt -177.56 61.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.067 -2.197 . . . . 4.1900000000000004 105.067 -166.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.63 -48.85 0.11 Allowed Glycine 0 C--N 1.314 -0.665 0 CA-C-N 113.709 -1.587 . . . . 1.6200000000000001 115.135 -161.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.99 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 -69.08 151.67 46.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.72999999999999998 108.302 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.1599999999999999 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 0.89000000000000001 110.247 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.68999999999999995 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.744 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . -138.2 140.19 10.94 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.4199999999999999 112.091 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.6 63.98 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.786 -0.721 . . . . 3.0 112.309 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.734 HG12 ' H ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -112.52 -66.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.813 0.34 . . . . 4.71 111.181 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.734 ' H ' HG12 ' A' ' 37' ' ' ILE . 34.3 t70 -92.24 7.6 41.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.147 0.975 . . . . 7.4900000000000002 109.224 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -82.62 -76.13 0.28 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.935 -1.029 . . . . 4.5499999999999998 111.287 -171.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.706 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 8.5 t70 -138.76 119.63 9.93 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.716 -0.675 . . . . 5.1399999999999997 110.491 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -91.8 -8.93 2.86 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 C-N-CA 123.571 2.847 . . . . 5.5800000000000001 112.037 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 m -63.24 -27.91 69.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.754 -1.112 . . . . 6.54 112.517 -166.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -98.42 2.55 47.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.491 0.662 . . . . 5.9299999999999997 111.016 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.754 ' HB3' ' HD2' ' B' ' 161' ' ' LYS . 1.3 t-20 -137.21 88.53 17.28 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 6.0599999999999996 110.041 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.44 0.05 9.62 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.74 2.294 . . . . 8.0299999999999994 111.274 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -94.17 -35.84 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.901 . . . . 8.8699999999999992 110.358 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 m -140.38 -168.25 2.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 120.85 -0.34 . . . . 5.1299999999999999 110.112 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.1 ' HA ' ' HE3' ' B' ' 161' ' ' LYS . 12.5 pt-20 179.2 -33.21 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 7.4299999999999997 108.966 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.06 -38.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.017 -0.992 . . . . 7.3899999999999997 110.649 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.4 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.32 -0.854 . . . . 7.8200000000000003 112.984 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 t -102.54 16.12 27.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.258 0.551 . . . . 5.1200000000000001 109.772 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -75.28 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.297 -0.865 . . . . 3.9700000000000002 111.534 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER 70.25 -48.1 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.629 -0.714 . . . . 6.0899999999999999 110.379 -174.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 57.41 21.93 42.99 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.05 115.042 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 0.67000000000000004 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.48 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 0.66000000000000003 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.0 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.02 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.99 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 0.71999999999999997 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 1.77 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.2799999999999998 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HG3' HG21 ' A' ' 28' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.3200000000000001 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.809 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 0.37 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 0.89000000000000001 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 0.34000000000000002 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.48999999999999999 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.809 HD23 ' HB1' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 1.5800000000000001 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.3599999999999999 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 0.56999999999999995 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.59999999999999998 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.3500000000000001 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.662 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.1800000000000002 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 0.64000000000000001 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.402 ' O ' ' HG3' ' A' ' 85' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 0.47999999999999998 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.051 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.2599999999999998 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 0.77000000000000002 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 80' ' ' VAL . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.8999999999999999 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1000000000000001 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.527 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 2.75 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.88 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.6100000000000001 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.25 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.2200000000000002 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 1.73 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.3 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.744 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 2.4700000000000002 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.8100000000000001 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.6600000000000001 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 0.80000000000000004 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 3.9500000000000002 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.48 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 3.7999999999999998 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG11 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.26 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.53 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 1.79 111.534 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.04 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.3100000000000001 110.089 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.1099999999999999 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.565 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.9399999999999999 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' HIS . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.1699999999999999 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.1600000000000001 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.851 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.1499999999999999 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.909 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 1.3500000000000001 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.051 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 1.53 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.662 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.1399999999999999 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 0.57999999999999996 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.702 HH21 ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.4900000000000002 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 113' ' ' SER . 13.3 mm100 -108.04 -58.91 1.92 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.8300000000000001 109.961 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.4 m 73.47 15.9 4.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.293 -1.776 . . . . 4.2999999999999998 111.618 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.1 mm? -123.69 36.99 4.51 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.913 1.34 . . . . 4.4800000000000004 109.478 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -71.02 159.43 34.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 111.923 -2.399 . . . . 6.5300000000000002 110.34 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.4 101.82 9.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 9.2799999999999994 110.417 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.53 7.58 35.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.625 1.678 . . . . 11.58 106.705 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.3 t -109.17 -15.37 9.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.861 -2.881 . . . . 12.380000000000001 108.613 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 56.45 -166.51 0.12 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.468 -2.151 . . . . 14.960000000000001 112.271 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -160.98 132.59 5.67 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.755 -0.657 . . . . 17.27 109.359 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.6 p -108.88 -21.88 12.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.879 0.325 . . . . 19.469999999999999 111.879 -175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -121.34 147.14 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.813 0.34 . . . . 21.73 110.68 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.85 86.99 2.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 23.079999999999998 109.721 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 23.960000000000001 111.092 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 1.1 ' HE3' ' HA ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.561 -0.163 . . . . 8.2699999999999996 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 10.0 tp10 75.04 145.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.463 0.705 . . . . 6.8700000000000001 110.619 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.43 99.7 6.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 4.5499999999999998 112.129 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' B' ' 164' ' ' LEU . 1.9 tp -114.84 104.29 11.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.26 -1.015 . . . . 2.71 108.26 168.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.3 pt-20 -102.96 156.28 17.77 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.209 -0.663 . . . . 4.9199999999999999 109.209 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m -145.73 126.49 14.36 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.233 -0.439 . . . . 1.22 109.952 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.1899999999999999 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.066 ' HA ' HD23 ' A' ' 29' ' ' LEU . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 1.54 110.347 -172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.928 0.394 . . . . 18.34 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -101.82 121.01 41.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.165 0.507 . . . . 15.06 111.213 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.79 152.79 30.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.335 -0.848 . . . . 14.539999999999999 109.304 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.96 103.04 15.77 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.731 0.3 . . . . 10.4 110.472 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.25 9.99 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.279 2.652 . . . . 10.74 112.005 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.8 54.14 0.6 Allowed Glycine 0 C--N 1.312 -0.765 0 CA-C-N 114.838 -1.074 . . . . 7.75 111.471 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.43 152.87 95.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.665 0.269 . . . . 6.8399999999999999 110.665 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -58.01 160.71 14.83 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.034 2.49 . . . . 4.8399999999999999 113.106 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 m -59.86 176.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 115.391 -0.822 . . . . 3.2599999999999998 112.274 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -113.42 100.09 8.27 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.08 1.419 . . . . 2.1699999999999999 110.949 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -70.97 110.68 5.82 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 111.964 -2.38 . . . . 0.97999999999999998 110.466 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.3500000000000001 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 1.8400000000000001 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 109.946 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 3.5800000000000001 108.806 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 0.85999999999999999 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.705 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 0.93000000000000005 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 104' ' ' VAL . 26.8 p80 -123.31 96.25 4.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 3.5299999999999998 112.25 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.655 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 47.7 tptt -77.23 -104.66 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.144 -0.688 . . . . 5.6900000000000004 109.144 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.45 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -151.2 116.52 5.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.772 -0.771 . . . . 4.5 112.199 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.521 ' HD3' ' H ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -81.05 108.92 15.13 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.089 -1.448 . . . . 5.2400000000000002 107.089 160.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.71 63.02 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.887 0.851 . . . . 4.4800000000000004 108.794 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.521 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 72.29 -98.53 0.82 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.016 -1.447 . . . . 3.7799999999999998 111.971 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.09 -2.9 39.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.715 -0.742 . . . . 6.8499999999999996 109.544 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.626 ' HB3' HD11 ' A' ' 28' ' ' ILE . 31.6 m-80 -110.39 138.84 46.24 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 123.109 1.433 . . . . 4.8499999999999996 110.51 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD13 ' HG2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.25 108.76 12.05 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 111.46 -2.609 . . . . 3.6800000000000002 106.854 170.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 26' ' ' ASN . 2.5 mm -121.82 131.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.66 -0.7 . . . . 2.8999999999999999 110.497 -176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.882 HD21 HG11 ' A' ' 105' ' ' VAL . 7.1 tp -111.19 -29.35 7.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.218 -1.03 . . . . 4.1900000000000004 108.218 167.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.28 -57.32 1.72 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.306 -0.861 . . . . 1.6200000000000001 113.502 167.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 -74.37 178.02 5.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.894 0.378 . . . . 0.72999999999999998 110.981 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.1599999999999999 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.888 HG13 ' HG3' ' B' ' 165' ' ' GLU . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 0.89000000000000001 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.68999999999999995 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.656 ' H ' ' HB2' ' B' ' 165' ' ' GLU . . . -117.97 85.74 0.39 Allowed Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.4199999999999999 110.14 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.07 -4.86 1.02 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 119.672 -1.251 . . . . 3.0 111.567 -166.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.591 HG13 ' CD1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -68.69 -46.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.362 0.875 . . . . 4.71 113.362 -170.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 37' ' ' ILE . 4.1 t0 -109.63 -1.14 18.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.777 0.799 . . . . 7.4900000000000002 110.35 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.836 ' NE2' ' HD3' ' B' ' 161' ' ' LYS . 0.0 OUTLIER -158.25 -173.08 4.15 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.586 -0.734 . . . . 4.5499999999999998 110.576 -173.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.967 ' OD1' ' HA ' ' B' ' 162' ' ' GLU . 0.2 OUTLIER 169.69 154.33 0.17 Allowed Pre-proline 0 C--N 1.316 -0.862 0 O-C-N 124.958 1.411 . . . . 5.1399999999999997 108.291 -172.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' B' ' 162' ' ' GLU . 90.8 Cg_endo -81.84 -26.67 2.91 Favored 'Trans proline' 0 CA--C 1.502 -1.098 0 C-N-CA 122.196 1.93 . . . . 5.5800000000000001 111.203 -167.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -95.34 -23.39 17.21 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.081 -1.418 . . . . 6.54 109.978 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.821 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -124.2 -4.21 7.93 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 120.021 -0.672 . . . . 5.9299999999999997 111.309 -172.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -143.31 74.42 17.38 Favored Pre-proline 0 C--O 1.233 0.225 0 C-N-CA 120.893 -0.323 . . . . 6.0599999999999996 110.803 166.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.47 7.59 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.23 1.954 . . . . 8.0299999999999994 110.031 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -88.47 -29.06 20.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.176 . . . . 8.8699999999999992 109.521 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 24.5 p -88.24 -159.64 0.56 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.067 -0.716 . . . . 5.1299999999999999 109.067 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 40.8 tt0 65.45 0.97 1.52 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.28 0.562 . . . . 7.4299999999999997 111.239 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -76.36 -55.45 5.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.33 -0.395 . . . . 7.3899999999999997 111.949 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -86.64 -95.61 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.125 -0.489 . . . . 7.8200000000000003 111.309 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -115.55 -4.03 12.3 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.222 -1.399 . . . . 5.1200000000000001 107.222 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 35.2 t0 58.4 168.55 0.05 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.657 -1.61 . . . . 3.9700000000000002 112.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.19 22.76 13.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.425 -1.261 . . . . 6.0899999999999999 108.461 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.712 ' HA2' ' NE2' ' A' ' 39' ' ' GLN . . . -46.22 -53.69 9.11 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 113.94 -1.482 . . . . 1.05 114.797 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.634 HD13 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 0.67000000000000004 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.811 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.48 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.82 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 0.66000000000000003 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.0 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.02 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.752 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 0.71999999999999997 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 1.77 107.907 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.2799999999999998 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.655 ' HA2' ' HD3' ' A' ' 20' ' ' LYS . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.3200000000000001 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 0.37 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 0.89000000000000001 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 0.34000000000000002 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.48999999999999999 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 1.5800000000000001 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.784 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 2.7 mp0 -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.3599999999999999 106.66 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 0.56999999999999995 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.811 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.59999999999999998 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.82 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.3500000000000001 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.1800000000000002 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG12 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.64000000000000001 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 0.47999999999999998 111.537 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.905 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.2599999999999998 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.598 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 0.77000000000000002 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.8999999999999999 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1000000000000001 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.598 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 2.75 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.6100000000000001 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.25 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.2200000000000002 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.62 HG13 ' OE1' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 1.73 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.562 ' HB ' ' HG3' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.3 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 1.095 ' HB2' HD13 ' B' ' 164' ' ' LEU . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 2.4700000000000002 111.633 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.8100000000000001 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.883 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.6600000000000001 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 0.80000000000000004 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 3.9500000000000002 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.883 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.48 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 3.7999999999999998 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.26 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.664 HG22 HD12 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.53 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 1.79 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.04 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.713 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.3100000000000001 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.1099999999999999 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.9399999999999999 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.568 ' CB ' ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.1699999999999999 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.882 HG11 HD21 ' A' ' 29' ' ' LEU . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.1600000000000001 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.1499999999999999 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 1.3500000000000001 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 1.53 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.1399999999999999 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.687 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 0.57999999999999996 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.4900000000000002 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 113' ' ' SER . 14.5 mm100 -104.8 -39.85 6.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.8300000000000001 112.612 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 72.0 m 75.66 13.43 2.92 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.676 1.235 . . . . 4.2999999999999998 109.499 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 56.91 26.15 11.36 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.504 -1.68 . . . . 4.4800000000000004 112.072 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -99.14 171.47 8.0 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.372 -1.74 . . . . 6.5300000000000002 111.424 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -136.95 135.84 38.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.52 -0.764 . . . . 9.2799999999999994 109.29 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.85 2.05 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.228 1.013 . . . . 11.58 109.291 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.37 77.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.78 -1.555 . . . . 12.380000000000001 109.721 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -124.2 24.84 7.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.972 -1.467 . . . . 14.960000000000001 110.533 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -82.24 131.69 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.299 -0.864 . . . . 17.27 109.199 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.7 m -148.42 114.2 5.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.211 -0.195 . . . . 19.469999999999999 111.392 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.7 ptt? 46.36 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.449 1.1 . . . . 21.73 113.3 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 123' ' ' LEU . 6.9 mp -75.04 116.62 15.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.853 -0.612 . . . . 23.079999999999998 110.661 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.014 -0.539 . . . . 23.960000000000001 110.718 178.904 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.836 ' HD3' ' NE2' ' A' ' 39' ' ' GLN . 7.4 tppt? . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.981 -0.748 . . . . 8.2699999999999996 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.967 ' HA ' ' OD1' ' A' ' 40' ' ' ASP . 1.6 pm0 -64.38 154.55 35.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 6.8700000000000001 110.397 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -47.38 105.95 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.343 0.497 . . . . 4.5499999999999998 112.343 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 1.095 HD13 ' HB2' ' A' ' 90' ' ' HIS . 3.5 pp -152.28 -179.53 7.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.749 -0.205 . . . . 2.71 111.461 175.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.888 ' HG3' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 113.57 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.184 1.794 . . . . 4.9199999999999999 112.161 172.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m -154.81 178.57 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.22 114.081 -154.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.1899999999999999 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' A' ' 29' ' ' LEU . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 1.54 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.562 0.22 . . . . 18.34 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -99.79 169.9 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.844 0.354 . . . . 15.06 111.275 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.89 148.1 23.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.819 -0.808 . . . . 14.539999999999999 108.819 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -119.95 96.75 49.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.111 0.482 . . . . 10.4 110.468 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.91 112.47 2.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.242 2.628 . . . . 10.74 111.17 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 50.98 5.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.576 -0.821 . . . . 7.75 111.715 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 16.6 pt20 -69.21 127.87 92.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 6.8399999999999999 110.753 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 24.1 Cg_exo -64.82 152.5 81.9 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 4.8399999999999999 113.191 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.733 HG22 ' H ' ' A' ' 10' ' ' THR . 9.8 p -82.94 174.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.491 -0.777 . . . . 3.2599999999999998 109.841 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.733 ' H ' HG22 ' A' ' 9' ' ' VAL . 34.2 p -128.88 110.1 11.83 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.8 1.286 . . . . 2.1699999999999999 111.225 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.437 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -84.32 113.54 21.21 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 112.938 -1.937 . . . . 0.97999999999999998 110.024 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.3500000000000001 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 1.8400000000000001 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 109.599 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.568 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 3.5800000000000001 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 69' ' ' ALA . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 0.85999999999999999 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 66' ' ' ALA . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 0.93000000000000005 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 -98.13 119.15 36.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 3.5299999999999998 112.242 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.667 ' HB3' ' C ' ' A' ' 27' ' ' LEU . 49.4 mtmt -54.77 163.66 0.92 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 112.746 -2.025 . . . . 5.6900000000000004 111.37 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.634 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 59.8 tp -130.54 156.75 44.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 122.044 0.926 . . . . 4.5 110.786 -165.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -74.56 116.03 14.79 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.577 -1.192 . . . . 5.2400000000000002 113.016 -168.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.484 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.78 70.4 1.38 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.156 0.979 . . . . 4.4800000000000004 109.584 167.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 -115.82 5.3 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 113.699 -1.591 . . . . 3.7799999999999998 110.767 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -81.09 -1.66 45.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.585 0.707 . . . . 6.8499999999999996 109.183 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -106.55 135.71 47.58 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-O 122.699 1.237 . . . . 4.8499999999999996 109.495 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.667 ' C ' ' HB3' ' A' ' 20' ' ' LYS . 4.6 mm? -118.3 103.54 9.91 Favored 'General case' 0 C--N 1.263 -3.164 0 CA-C-N 112.397 -2.183 . . . . 3.6800000000000002 107.792 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' OXT' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -161.72 171.0 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.78 1.232 . . . . 2.8999999999999999 109.23 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CD2' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -129.2 -31.39 2.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.568 -0.853 . . . . 4.1900000000000004 113.039 -175.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 105.19 18.62 11.79 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.999 -1.096 . . . . 1.6200000000000001 114.02 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.028 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 -87.72 152.98 21.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.72999999999999998 108.028 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.1599999999999999 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 0.89000000000000001 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' B' ' 165' ' ' GLU . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.68999999999999995 113.761 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.76 -115.6 1.45 Allowed Glycine 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.4199999999999999 112.538 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.84 -61.3 0.41 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.507 -1.037 . . . . 3.0 110.507 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.26 -58.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.346 -0.927 . . . . 4.71 110.249 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -149.98 -48.49 0.13 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.198 -1.365 . . . . 7.4900000000000002 109.044 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' B' ' 163' ' ' ASN . 7.0 mm100 53.04 -71.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.198 -1.364 . . . . 4.5499999999999998 114.287 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 9.8 t70 -143.25 134.48 12.67 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 114.659 -1.155 . . . . 5.1399999999999997 110.523 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.889 ' HA ' ' HB3' ' A' ' 44' ' ' ASN . 74.5 Cg_endo -67.42 -3.97 11.03 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.282 3.322 . . . . 5.5800000000000001 112.469 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.947 ' HB3' ' HG2' ' B' ' 161' ' ' LYS . 35.8 t -63.88 -45.29 90.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.357 -0.838 . . . . 6.54 109.694 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 14.8 pt20 -87.57 -28.97 21.62 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.448 -0.796 . . . . 5.9299999999999997 109.6 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.889 ' HB3' ' HA ' ' A' ' 41' ' ' PRO . 12.8 t-20 -73.41 104.72 1.23 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.766 -1.106 . . . . 6.0599999999999996 109.612 172.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.642 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -72.45 -30.38 12.5 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.969 2.446 . . . . 8.0299999999999994 112.501 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.69 11.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 113.039 0.755 . . . . 8.8699999999999992 113.039 -169.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 11.1 t -126.54 -137.19 0.26 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.81 -0.756 . . . . 5.1299999999999999 109.325 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' SER . 13.1 pt-20 166.44 -29.95 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.081 0 O-C-N 124.302 1.001 . . . . 7.4299999999999997 109.596 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 10.1 m-20 -146.69 155.32 42.33 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.637 -0.711 . . . . 7.3899999999999997 109.313 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 51.5 tptt 68.81 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.312 0.856 . . . . 7.8200000000000003 113.312 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -83.57 9.13 12.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.962 -0.563 . . . . 5.1200000000000001 112.231 -168.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.589 ' OD1' ' HD2' ' A' ' 45' ' ' PRO . 7.1 t70 -87.3 -161.81 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.026 -0.67 . . . . 3.9700000000000002 109.926 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.642 ' HD3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -109.99 22.9 15.05 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.021 -0.733 . . . . 6.0899999999999999 109.021 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.12 -37.14 7.61 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 114.655 -1.157 . . . . 1.05 114.19 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 0.67000000000000004 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.48 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.984 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 0.66000000000000003 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.0 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.02 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.028 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 0.71999999999999997 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 1.77 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.2799999999999998 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.3200000000000001 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 0.37 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 0.89000000000000001 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 0.34000000000000002 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.48999999999999999 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 1.5800000000000001 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.59 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.3599999999999999 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 0.56999999999999995 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.59999999999999998 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.3500000000000001 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.673 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.1800000000000002 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.669 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 0.64000000000000001 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.609 ' CE ' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.47999999999999998 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.852 ' HG2' ' N ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.2599999999999998 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.852 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 0.77000000000000002 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.745 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.8999999999999999 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1000000000000001 113.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.671 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 2.75 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.6100000000000001 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.495 ' HG2' HG12 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 50' ' ' LYS . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.25 114.526 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 49' ' ' ASP . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.2200000000000002 110.936 -174.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.561 ' HB ' ' CD ' ' A' ' 92' ' ' GLN . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 1.73 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 92' ' ' GLN . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.475 ' HE1' HD11 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 2.4700000000000002 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.8100000000000001 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.6600000000000001 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.718 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 0.80000000000000004 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 3.9500000000000002 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.48 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 3.7999999999999998 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.26 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.53 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.04 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.3100000000000001 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.1099999999999999 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.9399999999999999 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.839 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.1699999999999999 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.1600000000000001 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.1499999999999999 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.729 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 1.3500000000000001 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 1.53 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.1399999999999999 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 0.57999999999999996 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.574 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.4900000000000002 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.714 ' HB3' ' HG ' ' A' ' 114' ' ' LEU . 2.5 mp0 -83.5 -64.48 1.16 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.8300000000000001 111.879 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 73.7 m 80.97 17.39 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.398 -1.728 . . . . 4.2999999999999998 111.281 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 2.6 pp -123.55 9.54 9.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.052 1.406 . . . . 4.4800000000000004 111.216 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 114' ' ' LEU . 15.6 mm-40 -132.47 158.5 41.9 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.203 -2.271 . . . . 6.5300000000000002 110.894 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 10.3 mtmp? -88.0 131.81 34.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.504 -0.554 . . . . 9.2799999999999994 109.504 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.46 18.18 6.94 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.54 1.162 . . . . 11.58 108.473 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.22 80.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 113.124 -1.853 . . . . 12.380000000000001 109.472 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.52 20.38 7.95 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.457 -0.792 . . . . 14.960000000000001 109.307 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -90.61 133.25 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.252 -0.885 . . . . 17.27 111.391 -173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -132.86 103.6 6.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.691 -0.855 . . . . 19.469999999999999 108.691 171.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.4 mmm -96.83 161.98 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.293 0.568 . . . . 21.73 111.723 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -127.69 142.0 51.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 23.079999999999998 109.619 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.952 0.406 . . . . 23.960000000000001 110.408 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 16.8 tppt? . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.955 0.407 . . . . 8.2699999999999996 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' B' ' 162' ' ' GLU . 1.4 pm0 -64.86 140.98 58.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.881 0.372 . . . . 6.8700000000000001 110.419 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.407 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 8.5 t30 -102.53 -35.28 8.8 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.553 0.575 . . . . 4.5499999999999998 112.553 -169.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' B' ' 165' ' ' GLU . 1.9 pp -139.75 159.6 41.79 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.776 -0.453 . . . . 2.71 109.776 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.708 ' HB2' ' O ' ' B' ' 164' ' ' LEU . 0.3 OUTLIER 164.7 -151.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.45 1.094 . . . . 4.9199999999999999 111.239 166.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m -159.71 171.64 19.17 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.22 114.071 -165.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.1899999999999999 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.647 ' OXT' ' HB ' ' A' ' 28' ' ' ILE . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 1.54 110.02 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HG2' ' H ' ' A' ' 2' ' ' SER . 9.4 ttt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.453 -0.573 . . . . 18.34 109.453 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.546 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.9 m -67.97 -38.99 83.42 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.105 0.409 . . . . 15.06 112.105 -176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 2' ' ' SER . 63.4 m-85 71.03 164.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.563 0.539 . . . . 14.539999999999999 111.056 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.3 mt -117.7 91.82 39.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 10.4 109.737 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.11 133.26 14.79 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.043 2.495 . . . . 10.74 111.855 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.8 -29.65 5.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.818 -0.706 . . . . 7.75 112.273 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -114.01 95.81 39.49 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.66 0.267 . . . . 6.8399999999999999 110.73 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -94.88 -172.31 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.165 2.576 . . . . 4.8399999999999999 112.432 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.38 161.08 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 3.2599999999999998 110.057 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -89.56 -60.36 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 2.1699999999999999 111.428 -172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.76 125.65 2.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.698 -1.137 . . . . 0.97999999999999998 110.298 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.3500000000000001 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 1.8400000000000001 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.3100000000000001 109.496 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HG3' HD22 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 3.5800000000000001 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG13 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 0.85999999999999999 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 HD21 ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 0.93000000000000005 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.643 ' HB2' HG23 ' A' ' 104' ' ' VAL . 6.0 t60 -107.38 82.2 1.64 Allowed 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 3.5299999999999998 110.505 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HE2' HG22 ' A' ' 98' ' ' THR . 18.3 pttp -57.11 173.52 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.266 -1.334 . . . . 5.6900000000000004 109.771 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.639 HD12 ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -123.73 147.72 47.23 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 118.799 -1.16 . . . . 4.5 111.833 -166.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.73 110.25 15.71 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.768 -1.56 . . . . 5.2400000000000002 108.275 169.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -113.2 63.4 0.64 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.464 -0.335 . . . . 4.4800000000000004 111.513 -174.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 20.34 66.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.781 0 O-C-N 125.36 1.662 . . . . 3.7799999999999998 116.113 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 142.8 -26.22 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.1 -2.556 . . . . 6.8499999999999996 104.1 -171.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.2 m-80 -126.11 149.62 48.8 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 112.4 -2.182 . . . . 4.8499999999999996 110.681 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.2 mm? -128.81 125.99 38.95 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 110.408 -3.087 . . . . 3.6800000000000002 104.734 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG1' ' HB3' ' A' ' 21' ' ' LEU . 32.7 mm -104.87 119.51 53.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.318 0.58 . . . . 2.8999999999999999 109.778 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.753 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 3.0 tp -124.35 73.66 1.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 127.656 3.097 . . . . 4.1900000000000004 105.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.89 -87.78 0.67 Allowed Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.322 -1.308 . . . . 1.6200000000000001 115.355 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 -69.41 164.29 23.34 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.529 0.164 . . . . 0.72999999999999998 110.756 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.1599999999999999 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 HG22 HG22 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 0.89000000000000001 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.68999999999999995 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -137.99 122.96 2.56 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.4199999999999999 112.229 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.584 ' HA3' ' OE1' ' A' ' 48' ' ' GLU . . . -152.15 84.69 0.15 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.76 -0.733 . . . . 3.0 111.979 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.736 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -150.29 -65.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.218 0.532 . . . . 4.71 111.478 176.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' H ' HD12 ' A' ' 37' ' ' ILE . 37.7 t70 -107.58 19.61 19.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.873 1.321 . . . . 7.4900000000000002 108.004 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.736 ' HG2' ' H ' ' A' ' 37' ' ' ILE . 4.1 mm100 -81.7 -74.54 0.33 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.861 -1.518 . . . . 4.5499999999999998 111.34 -172.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.627 ' OD2' ' HB3' ' A' ' 42' ' ' SER . 38.7 t70 -149.35 125.17 5.06 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.321 -0.854 . . . . 5.1399999999999997 110.474 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.08 -16.99 40.85 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.682 2.921 . . . . 5.5800000000000001 112.512 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 22.9 t -68.6 -28.62 67.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.725 . . . . 6.54 109.989 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.706 ' HB3' ' HA ' ' B' ' 162' ' ' GLU . 39.6 mt-30 -90.05 -57.33 2.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.22 -0.9 . . . . 5.9299999999999997 109.575 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' OD1' ' HA ' ' A' ' 48' ' ' GLU . 14.3 m-80 -96.33 101.18 8.14 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-N 113.67 -1.605 . . . . 6.0599999999999996 111.017 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 43' ' ' GLN . 50.1 Cg_endo -70.12 -30.76 20.1 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.822 2.348 . . . . 8.0299999999999994 112.538 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.89 -47.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.394 -0.366 . . . . 8.8699999999999992 111.358 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 3.2 m -159.38 -63.98 0.08 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.944 -1.502 . . . . 5.1299999999999999 106.944 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.584 ' OE1' ' HA3' ' A' ' 36' ' ' GLY . 10.6 tp10 -139.93 -64.91 0.47 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.11 -1.859 . . . . 7.4299999999999997 106.494 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.71 -94.78 0.49 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.017 -1.447 . . . . 7.3899999999999997 107.929 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -127.51 -66.01 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.259 0.552 . . . . 7.8200000000000003 110.519 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -92.65 5.04 52.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.498 -0.774 . . . . 5.1200000000000001 111.814 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.9 t70 -83.78 172.61 12.03 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.752 0.787 . . . . 3.9700000000000002 109.96 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -117.81 -7.13 11.0 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.111 -1.404 . . . . 6.0899999999999999 109.589 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 86.5 -45.47 3.45 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.863 -0.608 . . . . 1.05 114.319 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.586 HD13 ' HA2' ' A' ' 35' ' ' GLY . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 0.67000000000000004 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.48 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.658 HG21 HD21 ' A' ' 71' ' ' LEU . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 0.66000000000000003 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.0 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.02 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 0.71999999999999997 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 1.77 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.2799999999999998 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.3200000000000001 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 0.37 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 0.89000000000000001 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 0.34000000000000002 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.48999999999999999 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 1.5800000000000001 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.708 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.3599999999999999 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 60' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 0.56999999999999995 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.59999999999999998 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.3500000000000001 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.1800000000000002 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 0.64000000000000001 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 0.47999999999999998 109.538 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.045 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 73.9 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.2599999999999998 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 0.77000000000000002 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.904 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.8999999999999999 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1000000000000001 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 2.75 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 1.033 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.6100000000000001 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 80' ' ' VAL . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.25 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.2200000000000002 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.515 HG13 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 1.73 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.757 HG22 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.3 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 2.4700000000000002 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 89' ' ' THR . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.8100000000000001 110.544 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.757 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.6600000000000001 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 0.80000000000000004 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 3.9500000000000002 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.48 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.746 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 3.7999999999999998 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.26 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.53 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 1.79 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.04 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.3100000000000001 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.1099999999999999 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.9399999999999999 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.1699999999999999 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.1600000000000001 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.904 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.1499999999999999 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 1.3500000000000001 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.045 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 1.53 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.1399999999999999 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 0.57999999999999996 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.555 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.4900000000000002 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 mp0 -86.56 -47.28 9.36 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.8300000000000001 108.434 169.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 t 95.77 17.15 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 112.301 -2.227 . . . . 4.2999999999999998 109.806 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 115' ' ' GLN . 1.2 pp -150.44 -30.05 0.21 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.406 -1.724 . . . . 4.4800000000000004 108.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HB2' ' HG2' ' A' ' 112' ' ' GLN . 41.2 mt-30 -97.31 120.97 38.64 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.976 -1.92 . . . . 6.5300000000000002 109.584 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -99.15 169.73 9.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.212 -0.449 . . . . 9.2799999999999994 110.318 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.08 26.39 4.9 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.134 0.968 . . . . 11.58 109.377 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.1 p -103.4 78.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.694 -1.594 . . . . 12.380000000000001 109.582 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -106.73 36.47 2.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.056 -1.429 . . . . 14.960000000000001 111.306 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -64.01 102.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.09 0.471 . . . . 17.27 110.096 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.6 m -88.67 -21.45 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 19.469999999999999 111.385 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.8 tpp -128.38 129.38 46.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 21.73 110.63 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -85.87 121.19 28.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 23.079999999999998 109.743 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 23.960000000000001 111.463 -177.079 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.686 ' HG3' ' HG2' ' A' ' 43' ' ' GLN . 10.1 tptp . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 119.452 -0.308 . . . . 8.2699999999999996 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.706 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 176.68 166.09 0.49 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.357 0.411 . . . . 6.8700000000000001 111.652 165.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 30.8 t30 57.32 99.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 124.537 1.148 . . . . 4.5499999999999998 113.432 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -90.71 125.96 35.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.165 -1.05 . . . . 2.71 108.165 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 158.85 22.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.401 -0.592 . . . . 4.9199999999999999 109.401 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m -152.85 105.48 2.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.309 -0.405 . . . . 1.22 110.216 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.75 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.1899999999999999 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 1.54 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.431 0.634 . . . . 18.34 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -77.11 109.12 10.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.678 -0.692 . . . . 15.06 110.826 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.09 167.68 21.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 14.539999999999999 111.133 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.61 98.62 31.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.414 -0.587 . . . . 10.4 109.414 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.71 122.72 8.0 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.122 2.548 . . . . 10.74 112.787 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.68 -15.97 56.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.77 -0.729 . . . . 7.75 113.005 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.3 94.49 42.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.968 0.384 . . . . 6.8399999999999999 111.149 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -98.67 -168.82 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.344 2.696 . . . . 4.8399999999999999 113.159 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.812 HG22 ' H ' ' A' ' 10' ' ' THR . 4.6 p -130.94 -166.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.966 -1.016 . . . . 3.2599999999999998 108.483 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.812 ' H ' HG22 ' A' ' 9' ' ' VAL . 70.6 p -104.07 -97.28 0.31 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.016 0.436 . . . . 2.1699999999999999 111.437 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.13 135.23 0.98 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.358 -0.837 . . . . 0.97999999999999998 111.02 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.3500000000000001 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 1.8400000000000001 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.514 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.752 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 3.5800000000000001 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 0.85999999999999999 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.887 HD13 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 0.93000000000000005 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.687 ' HA ' HG23 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -87.48 93.28 9.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 3.5299999999999998 110.52 -173.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.81 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -75.35 161.23 29.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.113 -1.403 . . . . 5.6900000000000004 110.38 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 tp -139.14 121.82 16.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.055 0.455 . . . . 4.5 111.589 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -76.49 132.29 39.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.64 0.733 . . . . 5.2400000000000002 110.304 170.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 64.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.19 0.995 . . . . 4.4800000000000004 110.172 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 78.75 -102.47 1.89 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.632 -1.622 . . . . 3.7799999999999998 111.572 174.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.84 -2.05 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.428 -0.582 . . . . 6.8499999999999996 109.428 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.633 ' HB3' HD11 ' A' ' 28' ' ' ILE . 32.7 m-80 -109.74 136.83 48.46 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 123.306 1.527 . . . . 4.8499999999999996 110.573 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.66 108.85 11.95 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.186 -2.733 . . . . 3.6800000000000002 106.567 170.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.81 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.0 mm -116.38 122.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 118.893 -0.575 . . . . 2.8999999999999999 111.95 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.71 ' HB2' HG23 ' B' ' 168' ' ' VAL . 6.7 mp -101.13 -24.81 14.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.479 -1.304 . . . . 4.1900000000000004 107.479 159.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.89 36.49 21.97 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 113.686 -1.597 . . . . 1.6200000000000001 114.451 161.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 -162.76 177.57 9.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.497 0.648 . . . . 0.72999999999999998 110.615 167.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.953 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.1599999999999999 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 0.89000000000000001 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.68999999999999995 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.3 121.38 4.05 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.4199999999999999 111.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' B' ' 162' ' ' GLU . . . -151.25 60.91 0.41 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.783 -0.722 . . . . 3.0 113.413 -175.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -119.78 -57.55 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.523 0.564 . . . . 4.71 112.523 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' H ' HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.99 20.33 3.47 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.136 -0.69 . . . . 7.4900000000000002 109.136 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.746 ' NE2' HD12 ' B' ' 164' ' ' LEU . 5.9 mm100 -58.39 -76.32 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.669 -1.15 . . . . 4.5499999999999998 111.794 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' B' ' 161' ' ' LYS . 2.8 t0 -147.8 115.79 4.12 Favored Pre-proline 0 C--N 1.315 -0.903 0 C-N-CA 120.234 -0.586 . . . . 5.1399999999999997 110.654 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.874 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 56.1 Cg_endo -61.74 -10.1 15.96 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.75 2.967 . . . . 5.5800000000000001 111.193 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.445 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 22.6 t -47.44 -55.56 8.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.052 -1.885 . . . . 6.54 111.84 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.484 HE22 ' N ' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -97.32 -21.46 17.21 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.774 -0.648 . . . . 5.9299999999999997 112.375 -161.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 7.3 t-20 -159.62 109.66 1.48 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.896 0.379 . . . . 6.0599999999999996 110.832 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.4 -13.42 15.11 Favored 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.837 2.358 . . . . 8.0299999999999994 113.649 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 11.4 t80 -141.0 -20.91 0.79 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.912 0.708 . . . . 8.8699999999999992 112.912 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 89.5 p 57.35 -88.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.85 1.26 . . . . 5.1299999999999999 110.519 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.668 ' HB2' ' HD2' ' A' ' 46' ' ' PHE . 41.0 tt0 62.06 15.39 7.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 7.4299999999999997 111.046 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.3 72.31 0.93 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.565 0.698 . . . . 7.3899999999999997 110.246 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 55.29 71.37 0.55 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.135 -1.393 . . . . 7.8200000000000003 111.897 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.2 t 50.64 35.62 12.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.619 -1.173 . . . . 5.1200000000000001 109.926 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -34.43 -58.21 0.49 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.684 -1.598 . . . . 3.9700000000000002 113.047 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HG3' HG21 ' A' ' 86' ' ' THR . 52.1 tptt 77.8 -25.97 0.19 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.071 0.857 . . . . 6.0899999999999999 110.553 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.675 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 97.87 -7.53 62.95 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.941 -0.572 . . . . 1.05 114.331 166.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 0.67000000000000004 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.48 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 0.66000000000000003 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.0 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.02 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 0.71999999999999997 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 1.77 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.2799999999999998 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.3200000000000001 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 0.37 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 0.34000000000000002 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.48999999999999999 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 1.5800000000000001 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.3599999999999999 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 0.56999999999999995 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.638 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.59999999999999998 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.826 ' H ' HG12 ' A' ' 57' ' ' VAL . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.3500000000000001 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.1800000000000002 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 0.64000000000000001 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.526 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 0.47999999999999998 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.812 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.2599999999999998 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 0.77000000000000002 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1000000000000001 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.578 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 2.75 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.812 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.6100000000000001 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 HG21 ' HG3' ' A' ' 53' ' ' LYS . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.25 112.397 -169.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.2200000000000002 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 1.73 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.662 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.3 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 2.4700000000000002 110.592 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.739 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.8100000000000001 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.662 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 39.4 mm-40 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.6600000000000001 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.739 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 3.9500000000000002 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.48 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 3.7999999999999998 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.26 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.706 HG23 HD12 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.53 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.757 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 1.79 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.04 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.3100000000000001 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.757 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.9399999999999999 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.1699999999999999 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 29' ' ' LEU . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.1600000000000001 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.1499999999999999 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.887 HD22 HD13 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 1.3500000000000001 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 1.53 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.1399999999999999 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 0.57999999999999996 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.607 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.4900000000000002 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.656 ' HB3' HD21 ' A' ' 114' ' ' LEU . 9.6 mm100 -96.12 -29.88 13.83 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.8300000000000001 109.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.6 t 80.81 18.96 0.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.027 -1.897 . . . . 4.2999999999999998 111.752 170.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 112' ' ' GLN . 1.3 pp -115.59 33.77 5.29 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.685 1.231 . . . . 4.4800000000000004 110.424 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.59 73.52 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.278 -2.237 . . . . 6.5300000000000002 112.911 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 73.44 146.87 0.08 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.938 0.895 . . . . 9.2799999999999994 112.155 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.48 37.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.789 0.804 . . . . 11.58 109.175 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.21 84.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.668 -1.151 . . . . 12.380000000000001 109.809 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -130.81 133.26 45.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.8 -1.091 . . . . 14.960000000000001 110.439 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 54.15 81.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.877 0.736 . . . . 17.27 112.673 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 m -82.88 -7.62 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 19.469999999999999 111.151 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -89.98 -38.36 13.69 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.921 0.391 . . . . 21.73 111.101 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.09 104.69 14.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.011 -0.54 . . . . 23.079999999999998 110.346 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.546 . . . . 23.960000000000001 110.643 178.667 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.874 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 1.9 mptt . . . . . 0 C--O 1.225 -0.218 0 CA-C-O 119.409 -0.329 . . . . 8.2699999999999996 110.451 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.631 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 16.5 tt0 -120.07 130.17 54.55 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 6.8700000000000001 114.25 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -166.7 15.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.97 -1.013 . . . . 4.5499999999999998 110.274 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.746 HD12 ' NE2' ' A' ' 39' ' ' GLN . 4.7 mt -110.68 133.17 53.56 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 113.302 0.853 . . . . 2.71 113.302 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.12 156.63 33.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.543 -1.208 . . . . 4.9199999999999999 108.842 164.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m -158.64 121.14 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.53 -0.305 . . . . 1.22 110.898 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.1899999999999999 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 29' ' ' LEU . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 1.54 108.584 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.0 mtm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.519 0.199 . . . . 18.34 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -84.33 -66.72 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.591 0.234 . . . . 15.06 110.606 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -111.98 -175.48 2.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.321 . . . . 14.539999999999999 110.536 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.05 98.75 26.41 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.232 -0.44 . . . . 10.4 110.141 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.58 141.4 22.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.836 2.357 . . . . 10.74 111.789 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.45 -36.13 3.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.268 -0.968 . . . . 7.75 112.624 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -116.87 85.12 16.9 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.384 0.512 . . . . 6.8399999999999999 112.384 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -100.9 152.16 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.168 2.579 . . . . 4.8399999999999999 111.707 168.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.89 152.2 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 3.2599999999999998 109.693 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 117' ' ' ALA . 76.2 p -88.58 -54.47 4.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.914 -1.039 . . . . 2.1699999999999999 110.9 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.51 145.79 3.26 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.863 -1.517 . . . . 0.97999999999999998 109.036 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.3500000000000001 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 1.8400000000000001 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.3100000000000001 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 3.5800000000000001 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 0.85999999999999999 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.841 HG21 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 0.93000000000000005 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 -142.98 116.01 8.86 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 3.5299999999999998 111.425 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.761 ' HA ' ' HB3' ' A' ' 65' ' ' PRO . 5.7 tmtm? -85.95 -81.18 0.21 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.034 -0.358 . . . . 5.6900000000000004 110.034 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 tp -151.24 120.23 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.055 -0.52 . . . . 4.5 111.952 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.431 ' HD2' ' C ' ' A' ' 22' ' ' ARG . 1.3 tmm_? -77.59 112.7 14.66 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.931 -0.766 . . . . 5.2400000000000002 108.931 166.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.945 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -123.04 68.31 0.98 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.225 1.012 . . . . 4.4800000000000004 110.703 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 73.34 -99.54 0.99 Allowed Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.555 -1.657 . . . . 3.7799999999999998 112.228 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.74 -8.13 56.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.757 -0.721 . . . . 6.8499999999999996 109.509 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.945 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 33.1 m-80 -112.51 134.78 53.85 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.362 1.553 . . . . 4.8499999999999996 110.69 -172.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' HD3' ' A' ' 100' ' ' ARG . 4.0 mm? -122.31 110.72 16.03 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 111.066 -2.788 . . . . 3.6800000000000002 106.006 167.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG13 ' OE1' ' A' ' 23' ' ' GLN . 42.0 mm -107.65 132.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.048 -0.523 . . . . 2.8999999999999999 111.555 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD21 HG11 ' A' ' 105' ' ' VAL . 5.7 mp -104.39 -31.87 9.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.584 -1.189 . . . . 4.1900000000000004 108.511 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -56.26 4.99 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 114.185 -1.371 . . . . 1.6200000000000001 114.574 172.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.874 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 -72.42 -174.88 1.44 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.684 0.394 . . . . 0.72999999999999998 111.479 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.649 ' HB3' ' HG3' ' B' ' 165' ' ' GLU . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.1599999999999999 111.381 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.961 HG22 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 0.89000000000000001 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.68999999999999995 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . -163.89 125.67 1.42 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.4199999999999999 111.265 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' B' ' 163' ' ' ASN . . . 144.35 -22.22 2.06 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.745 -1.217 . . . . 3.0 112.263 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.895 ' HA ' ' HB3' ' B' ' 163' ' ' ASN . 5.4 pt -46.95 -47.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.326 0.862 . . . . 4.71 113.326 -161.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -135.78 2.53 2.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.213 -1.032 . . . . 7.4900000000000002 108.213 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.785 ' OE1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -107.29 -15.54 14.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.078 1.14 . . . . 4.5499999999999998 114.078 -169.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER -54.04 128.6 56.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 121.203 0.525 . . . . 5.1399999999999997 110.138 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 38.8 Cg_endo -61.61 -17.35 53.83 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 124.205 3.27 . . . . 5.5800000000000001 111.929 -172.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 4.4 m -72.29 -40.3 67.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.41 -0.814 . . . . 6.54 110.019 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.465 ' HB3' ' HD2' ' B' ' 161' ' ' LYS . 15.0 pt20 -100.75 -18.15 16.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.858 0.837 . . . . 5.9299999999999997 110.636 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.0 t-20 -137.64 88.09 16.76 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.391 -1.277 . . . . 6.0599999999999996 109.777 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 36.8 Cg_endo -65.68 -7.95 17.96 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.903 2.402 . . . . 8.0299999999999994 111.804 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.599 ' O ' ' HB2' ' A' ' 47' ' ' SER . 88.2 m-85 -94.29 -66.73 0.9 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.667 -0.697 . . . . 8.8699999999999992 109.994 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 6.2 t 161.57 -72.75 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.338 -0.986 . . . . 5.1299999999999999 108.338 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' SER . 3.9 tm-20 174.08 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.648 -1.242 . . . . 7.4299999999999997 107.648 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 7.5 t70 -118.17 -78.36 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.718 -1.128 . . . . 7.3899999999999997 108.486 174.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD2' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -176.01 -38.1 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.393 -0.821 . . . . 7.8200000000000003 109.149 170.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -96.63 6.23 49.13 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.895 -1.048 . . . . 5.1200000000000001 108.857 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 38.6 t70 -76.2 -67.8 0.65 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.787 -0.642 . . . . 3.9700000000000002 111.064 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER 77.22 -45.93 0.48 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.937 0.895 . . . . 6.0899999999999999 108.813 -177.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.648 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 79.24 22.88 64.36 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.649 -1.16 . . . . 1.05 113.356 170.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 0.67000000000000004 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.48 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.961 HG23 HG22 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 0.66000000000000003 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HG23 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.02 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 0.71999999999999997 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 1.77 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.787 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.2799999999999998 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HA ' ' A' ' 20' ' ' LYS . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.3200000000000001 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 0.37 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.787 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 0.89000000000000001 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 0.34000000000000002 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.48999999999999999 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.852 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 1.5800000000000001 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.852 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.589 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 0.56999999999999995 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.796 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.59999999999999998 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.824 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.3500000000000001 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.705 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.1800000000000002 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 0.64000000000000001 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 111.386 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.2599999999999998 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 0.77000000000000002 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.8999999999999999 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1000000000000001 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.656 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 2.75 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.569 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.6100000000000001 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.25 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.2200000000000002 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.882 HG13 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 1.73 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.967 HG22 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.3 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.967 ' HB3' HD13 ' B' ' 164' ' ' LEU . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 2.4700000000000002 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.8100000000000001 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.967 ' HB2' HG22 ' A' ' 89' ' ' THR . 56.0 tp60 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.6600000000000001 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 0.80000000000000004 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.668 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 3.9500000000000002 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.48 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.656 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 3.7999999999999998 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.26 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.663 HG23 HD12 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.53 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.76 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 1.79 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' HD3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.04 110.974 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.562 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.3100000000000001 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.1099999999999999 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.9399999999999999 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.1699999999999999 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.603 HG11 HD21 ' A' ' 29' ' ' LEU . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.1600000000000001 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.1499999999999999 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 1.3500000000000001 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 1.53 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.1399999999999999 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 0.57999999999999996 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.699 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.4900000000000002 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.643 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER 54.54 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.8300000000000001 109.298 -167.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ARG . 44.0 t 53.69 29.28 9.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.659 -2.519 . . . . 4.2999999999999998 111.271 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 112' ' ' GLN . 2.7 pp -129.02 5.35 5.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 123.506 1.622 . . . . 4.4800000000000004 109.419 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -88.83 -176.08 5.09 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 111.478 -2.601 . . . . 6.5300000000000002 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 10' ' ' THR . 53.8 mtpt -65.51 125.99 26.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.603 -0.517 . . . . 9.2799999999999994 109.603 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -133.92 25.26 3.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.332 1.063 . . . . 11.58 109.063 -173.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.97 80.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.684 -1.598 . . . . 12.380000000000001 109.806 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -111.7 28.0 9.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.948 -1.478 . . . . 14.960000000000001 110.403 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -78.06 65.93 3.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.47 0.652 . . . . 17.27 110.342 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -105.81 -36.62 6.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.561 -0.745 . . . . 19.469999999999999 109.762 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -131.32 113.76 14.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 21.73 110.048 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.4 pt? -104.26 101.39 11.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.237 -0.438 . . . . 23.079999999999998 109.857 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 23.960000000000001 110.258 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 42' ' ' SER . 27.7 mtmm . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.958 0.409 . . . . 8.2699999999999996 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.518 ' H ' ' HB3' ' B' ' 161' ' ' LYS . 34.7 mt-10 73.04 -170.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.918 -1.037 . . . . 6.8700000000000001 112.839 173.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.895 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 8.4 p30 -123.58 154.86 38.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.873 -1.058 . . . . 4.5499999999999998 111.346 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.967 HD13 ' HB3' ' A' ' 90' ' ' HIS . 4.3 mp -139.88 162.73 34.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.938 0.399 . . . . 2.71 111.194 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.751 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.7 118.17 20.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.9199999999999999 108.56 166.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -157.11 150.35 23.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.694 . . . . 1.22 111.193 -167.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.66 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.1899999999999999 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 1.54 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.543 -0.54 . . . . 18.34 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -115.75 -7.92 12.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.794 0.331 . . . . 15.06 110.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -120.44 136.83 54.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.323 -0.399 . . . . 14.539999999999999 110.224 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mt -113.38 96.28 39.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.954 0.407 . . . . 10.4 110.055 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.1 20.95 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.606 2.871 . . . . 10.74 112.832 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.84 -11.67 10.98 Favored Glycine 0 C--N 1.315 -0.629 0 C-N-CA 120.71 -0.757 . . . . 7.75 112.736 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.18 147.22 33.21 Favored Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 110.002 -0.369 . . . . 6.8399999999999999 110.002 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.13 141.07 96.25 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.064 2.509 . . . . 4.8399999999999999 112.826 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.95 -2.32 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 122.92 1.343 . . . . 3.2599999999999998 108.936 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p 68.0 102.45 0.05 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.123 -2.762 . . . . 2.1699999999999999 112.008 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.29 109.76 19.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.768 -2.015 . . . . 0.97999999999999998 109.747 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.3500000000000001 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 1.8400000000000001 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.3100000000000001 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 3.5800000000000001 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 0.85999999999999999 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.914 ' HB3' HG23 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.897 HD12 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 0.93000000000000005 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -147.14 167.94 22.88 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 3.5299999999999998 110.949 164.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' HD22 ' A' ' 29' ' ' LEU . 66.6 mttm -28.13 144.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 125.497 1.748 . . . . 5.6900000000000004 114.358 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 57.8 tp -125.9 128.87 48.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.219 -0.9 . . . . 4.5 110.209 -168.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.945 ' HD3' ' HB3' ' A' ' 27' ' ' LEU . 2.9 tpp180 -60.86 120.77 10.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.864 -1.062 . . . . 5.2400000000000002 113.366 -173.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.41 71.17 1.43 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.136 -1.393 . . . . 4.4800000000000004 110.184 171.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.72 -107.81 2.37 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 113.469 -1.696 . . . . 3.7799999999999998 112.119 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.99 -2.17 54.53 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.883 -0.784 . . . . 6.8499999999999996 108.883 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 20.7 m-80 -115.67 153.27 31.62 Favored 'General case' 0 N--CA 1.405 -2.709 0 N-CA-C 108.186 -1.042 . . . . 4.8499999999999996 108.186 -173.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.945 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.21 111.09 5.03 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 112.834 -1.985 . . . . 3.6800000000000002 108.946 162.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.428 ' N ' ' H ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -154.14 157.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 112.812 -1.994 . . . . 2.8999999999999999 112.927 -170.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.867 ' HB3' ' HD1' ' A' ' 31' ' ' PHE . 3.5 mm? -75.68 -61.15 2.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.337 -0.847 . . . . 4.1900000000000004 109.848 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.89 -5.74 72.83 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.337 -0.847 . . . . 1.6200000000000001 112.449 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.979 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 -94.14 167.33 11.63 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.208 0.504 . . . . 0.72999999999999998 109.813 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.1599999999999999 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 0.89000000000000001 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.68999999999999995 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 39' ' ' GLN . . . -130.74 131.97 6.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.4199999999999999 111.514 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' B' ' 162' ' ' GLU . . . -132.13 13.08 5.25 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.873 -0.68 . . . . 3.0 112.752 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.838 HG13 ' H ' ' A' ' 38' ' ' ASP . 5.3 pt -54.1 -72.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.374 0.669 . . . . 4.71 112.797 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' H ' HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -101.66 10.35 40.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.152 0.501 . . . . 7.4900000000000002 109.836 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' B' ' 163' ' ' ASN . 28.4 mm-40 -78.57 -101.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.07 -0.968 . . . . 4.5499999999999998 113.329 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -125.5 102.43 29.66 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 120.48 -0.488 . . . . 5.1399999999999997 111.674 -168.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.538 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 55.7 Cg_endo -63.19 -10.9 22.67 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 123.47 2.78 . . . . 5.5800000000000001 109.468 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.8 m -52.74 -39.4 62.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.014 -1.903 . . . . 6.54 110.791 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.967 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 52.6 mt-30 -91.64 -12.77 33.24 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 120.495 -0.482 . . . . 5.9299999999999997 111.275 -170.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HB2' ' HB2' ' B' ' 161' ' ' LYS . 7.8 t-20 -152.58 97.77 2.9 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.572 -0.74 . . . . 6.0599999999999996 111.385 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.62 -12.07 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.703 2.269 . . . . 8.0299999999999994 111.645 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -89.58 -44.72 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 8.8699999999999992 111.301 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 p -135.29 -176.55 4.3 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.796 0.332 . . . . 5.1299999999999999 110.778 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.6 -34.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 7.4299999999999997 110.011 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 19.9 t70 -176.15 61.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.369 1.08 . . . . 7.3899999999999997 109.207 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 49' ' ' ASP . 12.0 mptt -128.75 -52.09 1.24 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.672 -1.149 . . . . 7.8200000000000003 108.306 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.2 p -116.42 8.37 14.08 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.732 -1.122 . . . . 5.1200000000000001 110.268 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 12.9 t70 -124.57 -60.33 1.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.109 1.152 . . . . 3.9700000000000002 114.109 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 4.5 mptp? 90.76 -16.52 0.2 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.444 1.09 . . . . 6.0899999999999999 111.938 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.35 -4.0 82.83 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.05 114.882 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.494 HG21 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 0.67000000000000004 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.48 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 0.66000000000000003 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.621 HG23 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.0 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.621 ' HG2' HG23 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.02 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.979 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 0.71999999999999997 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 1.77 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.2799999999999998 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.48 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.3200000000000001 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 0.37 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 0.89000000000000001 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 0.34000000000000002 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.48999999999999999 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 1.5800000000000001 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.611 ' O ' HG11 ' A' ' 57' ' ' VAL . 2.6 mt-30 -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.3599999999999999 108.73 -164.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 60' ' ' VAL . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 0.56999999999999995 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.64 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.59999999999999998 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.844 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.3500000000000001 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.733 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.1800000000000002 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG23 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 0.64000000000000001 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 0.47999999999999998 109.962 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.2599999999999998 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 0.77000000000000002 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.8999999999999999 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 112.465 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 2.75 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.889 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.6100000000000001 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.727 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.25 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.2200000000000002 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.727 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 1.73 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.3 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 2.4700000000000002 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.8100000000000001 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.6600000000000001 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 0.80000000000000004 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 3.9500000000000002 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 3.7999999999999998 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.748 HD12 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.26 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.748 HG23 HD12 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.53 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 1.79 107.196 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.04 107.751 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.3100000000000001 110.359 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.1099999999999999 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.9399999999999999 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.1699999999999999 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG23 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.1600000000000001 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.812 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.1499999999999999 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 1.3500000000000001 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.974 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.1399999999999999 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 0.57999999999999996 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.4900000000000002 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . 13.8 mm-40 -93.93 -46.02 7.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.8300000000000001 110.272 -175.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 38.9 m 79.18 9.38 1.72 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.453 -1.703 . . . . 4.2999999999999998 110.953 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.566 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.32 5.76 1.47 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 124.008 1.861 . . . . 4.4800000000000004 108.063 176.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 14.8 pt20 -63.6 166.01 7.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 110.206 -3.179 . . . . 6.5300000000000002 112.43 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -105.86 134.64 48.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.066 -0.97 . . . . 9.2799999999999994 109.228 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.11 19.96 7.61 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 122.357 1.075 . . . . 11.58 108.634 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.7 p -135.09 86.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.091 -1.868 . . . . 12.380000000000001 110.027 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.44 178.85 7.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.704 -0.68 . . . . 14.960000000000001 110.42 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.59 131.23 56.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.001 0.429 . . . . 17.27 110.709 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.9 p -145.28 103.76 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.823 -0.626 . . . . 19.469999999999999 110.425 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.78 132.06 34.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.163 -0.471 . . . . 21.73 110.229 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.76 157.34 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 23.079999999999998 110.563 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.94 -0.573 . . . . 23.960000000000001 110.214 178.323 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 42.0 tttm . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 122.043 0.925 . . . . 8.2699999999999996 109.817 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.517 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 8.6 pt-20 -98.82 133.12 43.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 115.097 1.517 . . . . 6.8700000000000001 115.097 -168.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 39' ' ' GLN . 46.4 t-20 -111.21 -30.87 7.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.604 0.716 . . . . 4.5499999999999998 109.198 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.78 123.09 42.79 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.875 -1.057 . . . . 2.71 113.097 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -112.27 159.41 18.65 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.608 -1.256 . . . . 4.9199999999999999 107.608 169.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m -152.74 122.47 6.9 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.171 -0.612 . . . . 1.22 112.023 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.1899999999999999 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.506 ' CG1' HD13 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 1.54 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.391 -0.596 . . . . 18.34 109.391 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -119.76 143.17 47.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.365 -0.38 . . . . 15.06 111.409 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 71.14 143.42 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.038 0.837 . . . . 14.539999999999999 111.992 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mm -122.16 95.67 47.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 10.4 110.827 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.67 124.18 6.8 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.024 2.483 . . . . 10.74 111.734 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.69 42.81 38.18 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.897 -0.668 . . . . 7.75 111.984 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 pt20 -62.62 125.97 87.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 6.8399999999999999 111.841 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 16.9 Cg_exo -67.57 167.81 19.88 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.011 2.474 . . . . 4.8399999999999999 112.542 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -97.33 6.5 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.188 0.994 . . . . 3.2599999999999998 110.485 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p 74.26 -54.66 0.67 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.482 -2.145 . . . . 2.1699999999999999 112.178 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -163.23 120.69 1.9 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.784 -1.098 . . . . 0.97999999999999998 111.042 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.3500000000000001 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 1.8400000000000001 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.3100000000000001 110.482 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.627 ' NE ' HD21 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 3.5800000000000001 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.686 HG13 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 0.85999999999999999 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.943 HG23 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 0.93000000000000005 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.587 ' HB3' HG23 ' A' ' 104' ' ' VAL . 7.4 p80 -94.42 82.22 4.03 Favored 'General case' 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 3.5299999999999998 111.965 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.946 ' HD3' ' HG2' ' A' ' 65' ' ' PRO . 3.0 mmmp? -127.88 99.28 5.46 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 112.845 -1.98 . . . . 5.6900000000000004 108.499 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 28' ' ' ILE . 55.3 tp -157.09 156.22 32.42 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.92 -0.582 . . . . 4.5 110.352 -162.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.924 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -80.67 109.89 15.63 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.879 0.847 . . . . 5.2400000000000002 109.866 160.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.998 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 1.4 pt20 -138.12 69.83 1.39 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.228 -1.351 . . . . 4.4800000000000004 111.492 -175.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.14 -100.46 0.86 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-N 114.07 -1.423 . . . . 3.7799999999999998 112.861 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.13 -13.11 60.2 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.513 -0.921 . . . . 6.8499999999999996 108.513 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.998 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.6 m-80 -108.01 120.85 43.48 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.791 1.281 . . . . 4.8499999999999996 110.02 -171.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -117.24 107.12 14.04 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 112.488 -2.142 . . . . 3.6800000000000002 107.565 169.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -127.23 121.08 56.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.833 -0.803 . . . . 2.8999999999999999 108.833 174.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.047 HD12 ' HA ' ' B' ' 168' ' ' VAL . 34.7 tp -162.03 73.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 125.929 2.018 . . . . 4.1900000000000004 107.256 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' H ' ' NZ ' ' A' ' 20' ' ' LYS . . . -131.7 -60.5 0.09 OUTLIER Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.968 1.147 . . . . 1.6200000000000001 115.968 -166.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.987 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 -69.67 156.86 38.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.471 1.135 . . . . 0.72999999999999998 110.115 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.1599999999999999 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.682 HG22 HG23 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 0.89000000000000001 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.68999999999999995 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 163' ' ' ASN . . . -136.06 131.16 5.59 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.4199999999999999 111.13 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.578 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -148.33 57.12 0.48 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.605 -0.807 . . . . 3.0 112.88 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.512 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -126.34 -43.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.559 0.218 . . . . 4.71 111.218 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -98.23 7.46 46.22 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.119 -0.696 . . . . 7.4900000000000002 109.119 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.578 ' HG2' ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -111.73 -67.3 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.011 -0.995 . . . . 4.5499999999999998 111.838 -175.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 13.3 t70 -128.73 128.07 23.5 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.697 -0.483 . . . . 5.1399999999999997 109.697 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.63 -16.02 11.95 Favored 'Trans proline' 0 CA--C 1.514 -0.509 0 C-N-CA 123.204 2.603 . . . . 5.5800000000000001 111.902 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' B' ' 161' ' ' LYS . 17.8 t -84.34 -9.61 58.3 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.592 -0.731 . . . . 6.54 110.107 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' OE1' ' HB3' ' B' ' 163' ' ' ASN . 34.7 mm-40 -54.63 -30.91 56.31 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.871 0.843 . . . . 5.9299999999999997 109.118 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -135.71 89.58 21.32 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.029 -1.442 . . . . 6.0599999999999996 111.584 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.93 8.51 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.756 2.304 . . . . 8.0299999999999994 111.733 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.42 -22.34 7.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 8.8699999999999992 111.112 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.4 t -148.97 -153.66 0.51 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.184 -1.043 . . . . 5.1299999999999999 108.184 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.39 -39.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.541 0.686 . . . . 7.4299999999999997 110.101 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -173.04 -177.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.776 -1.194 . . . . 7.3899999999999997 107.776 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mptt 68.56 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.198 0.599 . . . . 7.8200000000000003 110.478 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -83.03 -7.92 59.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 110.006 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.587 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 2.4 t0 -120.76 170.86 9.05 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.609 -0.886 . . . . 3.9700000000000002 108.609 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 3.3 mptp? -136.44 -21.74 1.33 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.66 -1.154 . . . . 6.0899999999999999 108.899 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 58.22 22.24 49.49 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.005 -0.998 . . . . 1.05 115.477 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.498 HG21 ' SD ' ' A' ' 85' ' ' MET . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 0.67000000000000004 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.48 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 0.66000000000000003 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.0 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.02 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.987 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 1.77 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.2799999999999998 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.946 ' HG2' ' HD3' ' A' ' 20' ' ' LYS . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.3200000000000001 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.943 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 0.37 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 0.89000000000000001 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 0.34000000000000002 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.48999999999999999 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 1.5800000000000001 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.3599999999999999 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 0.56999999999999995 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.59999999999999998 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.1800000000000002 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.532 HG23 ' HB3' ' A' ' 107' ' ' LEU . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 0.64000000000000001 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.497 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 0.47999999999999998 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.934 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.2599999999999998 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 0.77000000000000002 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.705 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1000000000000001 112.626 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.599 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 2.75 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.888 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.6100000000000001 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.25 111.614 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.2200000000000002 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 85' ' ' MET . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 1.73 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.677 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.3 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 2.4700000000000002 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.8100000000000001 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.6600000000000001 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.693 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 3.9500000000000002 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.48 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 83' ' ' TRP . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 3.7999999999999998 112.327 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.778 ' HB2' HG21 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.26 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 HD12 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.53 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 101' ' ' SER . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 1.79 113.189 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.04 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.3100000000000001 111.234 -175.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' HG2' HD22 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.1099999999999999 110.464 -177.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.9399999999999999 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.1699999999999999 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.1600000000000001 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.1499999999999999 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 1.3500000000000001 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.934 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 1.53 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.1399999999999999 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.745 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 0.57999999999999996 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.4900000000000002 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' SER . 8.8 mm100 -100.01 -35.59 9.66 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.8300000000000001 109.684 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.7 m 104.13 22.97 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 110.975 -2.829 . . . . 4.2999999999999998 109.589 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 54.72 71.8 0.51 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.512 -1.676 . . . . 4.4800000000000004 112.301 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 115' ' ' GLN . 3.2 pt20 -68.68 115.78 8.44 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.957 -1.474 . . . . 6.5300000000000002 109.408 172.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 68.89 125.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.227 -0.897 . . . . 9.2799999999999994 109.778 -168.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.52 26.59 4.08 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.239 1.019 . . . . 11.58 109.324 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' VAL . 22.1 m -79.94 26.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.51 -1.677 . . . . 12.380000000000001 112.174 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -110.78 94.48 5.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.547 -0.751 . . . . 14.960000000000001 110.107 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -89.86 -97.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.601 -0.272 . . . . 17.27 110.735 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.6 m -161.53 136.45 7.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.077 0.151 . . . . 19.469999999999999 110.621 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.2 mtt 66.96 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.463 0.705 . . . . 21.73 112.34 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 124' ' ' SER . 35.9 tp -135.52 166.62 22.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 23.079999999999998 109.865 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 123' ' ' LEU . 1.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.947 0.403 . . . . 23.960000000000001 110.514 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 12.6 ttpp . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.324 0.583 . . . . 8.2699999999999996 111.551 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.07 128.07 10.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 6.8700000000000001 111.199 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.649 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 10.1 p30 -99.18 -166.38 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.539 -0.755 . . . . 4.5499999999999998 110.55 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.464 HD21 ' ND1' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -128.02 136.51 51.35 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.415 -0.514 . . . . 2.71 110.249 175.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.1 157.5 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.571 -0.9 . . . . 4.9199999999999999 108.571 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t -137.11 118.82 15.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.775 -0.454 . . . . 1.22 109.775 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.1899999999999999 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.047 ' HA ' HD12 ' A' ' 29' ' ' LEU . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 1.54 110.633 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.026 -0.361 . . . . 18.34 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -72.32 78.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.288 0.477 . . . . 15.06 112.288 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -132.42 5.72 4.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.779 -0.646 . . . . 14.539999999999999 109.369 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.3 mt 57.5 81.36 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.796 -1.093 . . . . 10.4 111.488 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.57 105.62 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.687 2.258 . . . . 10.74 111.183 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 47.52 2.49 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.66 -0.781 . . . . 7.75 111.535 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.5 pt20 -63.58 126.68 90.14 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.9 0.381 . . . . 6.8399999999999999 111.234 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 28.1 Cg_exo -63.27 135.67 51.57 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.854 2.369 . . . . 4.8399999999999999 111.256 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -83.33 174.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.259 0.552 . . . . 3.2599999999999998 110.318 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 9' ' ' VAL . 76.4 p -96.22 -113.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.024 -0.989 . . . . 2.1699999999999999 111.602 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -171.99 143.63 1.6 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.681 -1.145 . . . . 0.97999999999999998 110.985 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.3500000000000001 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 1.8400000000000001 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.3100000000000001 110.412 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 3.5800000000000001 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.859 HG13 HD12 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 0.85999999999999999 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.807 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 0.93000000000000005 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.713 ' HB2' HG23 ' A' ' 104' ' ' VAL . 1.3 t60 -143.89 110.57 5.6 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 3.5299999999999998 112.339 -172.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 23.1 mmtp -129.52 -161.67 1.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.836 -1.542 . . . . 5.6900000000000004 106.836 161.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 25.9 tp -150.51 135.75 17.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 119.685 1.129 . . . . 4.5 112.04 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.943 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.64 136.31 43.86 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.006 -0.739 . . . . 5.2400000000000002 109.006 168.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 2.2 mt-30 -130.2 61.32 1.59 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.595 0.712 . . . . 4.4800000000000004 109.514 -175.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.58 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 71.18 -94.01 0.53 Allowed Glycine 0 CA--C 1.502 -0.72 0 CA-C-N 114.337 -1.301 . . . . 3.7799999999999998 112.216 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -71.42 -10.2 59.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.64 0.733 . . . . 6.8499999999999996 109.656 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.7 m-80 -113.99 143.9 43.97 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-O 123.21 1.481 . . . . 4.8499999999999996 110.39 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.6 mm? -126.7 107.81 10.5 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 111.346 -2.661 . . . . 3.6800000000000002 105.898 168.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 21' ' ' LEU . 13.5 mm -113.08 122.39 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 120.687 -0.405 . . . . 2.8999999999999999 111.25 -174.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.75 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 50.0 tp -143.3 -52.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.266 -1.383 . . . . 4.1900000000000004 107.266 165.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 102.51 -15.79 55.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 114.888 0.715 . . . . 1.6200000000000001 114.888 159.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.05 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 -96.26 162.92 13.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.522 1.161 . . . . 0.72999999999999998 110.973 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.1599999999999999 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 0.89000000000000001 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 165' ' ' GLU . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.68999999999999995 111.188 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' HD23 ' B' ' 164' ' ' LEU . . . -104.42 103.61 2.28 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.4199999999999999 110.444 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' CA ' ' HG3' ' A' ' 41' ' ' PRO . . . -156.57 67.74 0.29 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.717 -1.23 . . . . 3.0 113.221 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG13 ' H ' ' A' ' 38' ' ' ASP . 1.6 pt -99.79 -76.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.411 0.624 . . . . 4.71 110.792 176.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' H ' HG13 ' A' ' 37' ' ' ILE . 28.0 t70 -115.67 14.46 16.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.277 1.037 . . . . 7.4900000000000002 108.539 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 42.8 mm-40 -67.38 -72.1 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.952 -1.477 . . . . 4.5499999999999998 111.303 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.922 ' H ' ' HD2' ' A' ' 41' ' ' PRO . 47.7 m-20 -144.54 -39.92 0.01 OUTLIER Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 113.898 -1.501 . . . . 5.1399999999999997 109.522 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.922 ' HD2' ' H ' ' A' ' 40' ' ' ASP . 11.1 Cg_endo -47.71 -10.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.474 3.45 . . . . 5.5800000000000001 111.582 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 40' ' ' ASP . 41.0 t -46.92 -24.84 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.15 -1.841 . . . . 6.54 110.673 163.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.74 ' OE1' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.9 -18.74 58.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.213 0.53 . . . . 5.9299999999999997 111.255 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 2.4 t-20 -84.71 110.45 27.7 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.015 -0.993 . . . . 6.0599999999999996 111.353 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 47.3 Cg_endo -71.21 -8.61 23.84 Favored 'Trans proline' 0 C--N 1.334 -0.231 0 C-N-CA 123.251 2.634 . . . . 8.0299999999999994 111.526 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -84.28 -21.3 31.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.571 -0.74 . . . . 8.8699999999999992 110.244 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 44' ' ' ASN . 13.4 p -98.78 -167.79 1.54 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.574 -0.898 . . . . 5.1299999999999999 108.574 168.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 58.91 11.61 1.97 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.784 0.802 . . . . 7.4299999999999997 110.298 -171.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -138.75 120.09 14.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.965 -1.016 . . . . 7.3899999999999997 109.684 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm 52.49 90.2 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 124.484 1.115 . . . . 7.8200000000000003 111.751 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' LYS . 31.8 p 75.33 -16.16 0.61 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.506 -1.225 . . . . 5.1200000000000001 111.675 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.607 ' OD2' ' HA ' ' A' ' 37' ' ' ILE . 38.0 t70 69.45 -34.03 0.27 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.062 0.945 . . . . 3.9700000000000002 112.419 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 5.2 mptt 67.76 13.73 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.793 0.837 . . . . 6.0899999999999999 109.454 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 36' ' ' GLY . . . -62.6 -53.67 39.74 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.924 -1.035 . . . . 1.05 115.026 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.55 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 0.67000000000000004 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.48 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 0.66000000000000003 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.02 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.05 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 0.71999999999999997 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.576 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 1.77 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.2799999999999998 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.536 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.3200000000000001 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 0.37 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 0.89000000000000001 109.006 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 0.34000000000000002 107.423 171.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.48999999999999999 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 1.5800000000000001 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.3599999999999999 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 0.56999999999999995 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.59999999999999998 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.727 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.3500000000000001 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.748 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.1800000000000002 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 0.64000000000000001 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.47999999999999998 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.2599999999999998 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.557 HG11 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 0.77000000000000002 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.842 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 4.8 m120 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.8999999999999999 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1000000000000001 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 2.75 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.6100000000000001 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.25 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.2200000000000002 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.907 HG13 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 1.73 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.3 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' N ' HG23 ' A' ' 89' ' ' THR . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 2.4700000000000002 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.8100000000000001 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.907 ' HG3' HG13 ' A' ' 88' ' ' VAL . 42.7 tp60 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.6600000000000001 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 0.80000000000000004 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 3.9500000000000002 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.48 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 3.7999999999999998 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.26 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' HD12 ' A' ' 27' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.53 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 1.79 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.04 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.712 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.3100000000000001 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.1099999999999999 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.9399999999999999 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG23 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.1699999999999999 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.807 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.1600000000000001 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.1499999999999999 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.859 HD12 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 1.3500000000000001 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 1.53 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 0.57999999999999996 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.727 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.4900000000000002 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 113' ' ' SER . 1.7 mp0 -85.66 -44.11 12.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.8300000000000001 109.363 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 63.6 m 86.75 12.88 0.13 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.254 -2.248 . . . . 4.2999999999999998 109.956 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.49 32.79 5.84 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.622 -1.626 . . . . 4.4800000000000004 108.361 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 13.9 mm-40 -79.12 -177.5 5.67 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 111.781 -2.463 . . . . 6.5300000000000002 111.127 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 116' ' ' LYS . 3.3 ptpp? -113.5 129.85 56.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.091 0.472 . . . . 9.2799999999999994 111.415 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.13 23.28 3.02 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.607 1.194 . . . . 11.58 107.904 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.28 84.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 113.333 -1.758 . . . . 12.380000000000001 109.564 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -118.6 158.76 24.83 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.06 -1.427 . . . . 14.960000000000001 110.138 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -86.34 80.63 8.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.554 -0.535 . . . . 17.27 109.554 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.1 p -76.09 102.03 5.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 19.469999999999999 110.028 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -77.76 46.0 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.679 -0.691 . . . . 21.73 111.213 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -172.1 -51.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.809 -0.811 . . . . 23.079999999999998 108.809 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 115.381 -0.827 . . . . 23.960000000000001 110.682 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.845 ' HE3' ' HA ' ' A' ' 40' ' ' ASP . 23.2 tptt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.333 -0.617 . . . . 8.2699999999999996 109.333 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.481 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 39.9 tt0 -166.03 156.66 12.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.849 0.357 . . . . 6.8700000000000001 110.998 174.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.02 158.71 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.637 -0.711 . . . . 4.5499999999999998 112.73 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.602 HD23 ' H ' ' B' ' 164' ' ' LEU . 2.2 pt? -113.18 125.83 54.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.531 -0.759 . . . . 2.71 111.046 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.417 ' HG3' ' HA2' ' A' ' 34' ' ' GLY . 3.0 mp0 -104.65 161.56 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.642 -0.708 . . . . 4.9199999999999999 110.843 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m -159.32 162.39 35.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.702 -0.681 . . . . 1.22 109.804 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.1899999999999999 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.656 ' OXT' ' HB3' ' A' ' 29' ' ' LEU . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 1.54 108.084 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.72 0.295 . . . . 18.34 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -108.04 98.81 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.766 0.317 . . . . 15.06 110.647 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.05 142.86 30.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.097 0.475 . . . . 14.539999999999999 110.867 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.4 mt -137.27 97.33 10.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.242 -0.651 . . . . 10.4 109.242 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.38 104.95 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.618 2.212 . . . . 10.74 112.161 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.36 -47.14 0.81 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.792 -0.718 . . . . 7.75 112.017 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -128.81 83.33 66.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.717 0.294 . . . . 6.8399999999999999 111.008 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.38 128.28 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.181 2.588 . . . . 4.8399999999999999 111.724 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.88 126.47 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.694 0.759 . . . . 3.2599999999999998 111.434 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 63.6 p -91.56 -46.17 8.1 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.487 -1.233 . . . . 2.1699999999999999 111.083 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 1.007 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -157.68 130.62 7.52 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.302 -1.317 . . . . 0.97999999999999998 111.248 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.3500000000000001 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 1.8400000000000001 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 3.5800000000000001 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 0.85999999999999999 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.847 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.898 HG21 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 0.93000000000000005 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.892 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 -94.07 96.36 9.61 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 3.5299999999999998 112.401 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -61.25 177.52 0.35 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.345 -1.298 . . . . 5.6900000000000004 111.122 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.753 HD13 ' HG2' ' A' ' 23' ' ' GLN . 0.7 OUTLIER -148.9 118.89 7.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.215 -0.594 . . . . 4.5 111.087 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.2 ttt180 -69.85 145.57 51.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.255 -0.884 . . . . 5.2400000000000002 110.472 167.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.933 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 9.2 mt-30 -139.09 61.71 1.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.519 -0.764 . . . . 4.4800000000000004 109.627 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.93 -97.32 0.25 Allowed Glycine 0 CA--C 1.495 -1.209 0 CA-C-N 113.91 -1.495 . . . . 3.7799999999999998 112.146 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -79.95 1.75 26.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.569 -0.816 . . . . 6.8499999999999996 109.871 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.933 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 47.6 m-80 -117.26 147.73 42.29 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 122.664 1.221 . . . . 4.8499999999999996 109.869 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.0 mm? -133.49 109.92 9.61 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 111.8 -2.454 . . . . 3.6800000000000002 106.691 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.796 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.9 mm -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.612 -0.884 . . . . 2.8999999999999999 108.612 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.628 ' HB2' ' C ' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -95.85 -33.57 12.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.479 -0.934 . . . . 4.1900000000000004 108.479 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.7 -63.95 0.35 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.023 -1.084 . . . . 1.6200000000000001 115.786 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.898 ' HE2' HG21 ' A' ' 18' ' ' ILE . 28.2 p90 -160.16 -177.35 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.38 0.59 . . . . 0.72999999999999998 111.577 -162.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.1599999999999999 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG22 HG23 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 0.89000000000000001 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.68999999999999995 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . -108.75 134.84 12.48 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.4199999999999999 111.37 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -143.24 60.61 0.52 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.313 -1.115 . . . . 3.0 110.313 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -124.02 -37.3 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.449 0.642 . . . . 4.71 110.746 -172.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 37' ' ' ILE . 1.2 p30 -119.89 25.07 10.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.298 -0.864 . . . . 7.4900000000000002 109.755 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.528 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 18.6 mm100 -91.23 -83.61 0.27 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.727 0.775 . . . . 4.5499999999999998 112.45 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -150.17 144.57 17.68 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 114.639 -1.164 . . . . 5.1399999999999997 111.097 -165.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.81 -12.15 13.62 Favored 'Trans proline' 0 C--N 1.336 -0.127 0 C-N-CA 123.389 2.726 . . . . 5.5800000000000001 112.079 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 4.5 t -73.04 -21.0 60.87 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.572 -0.74 . . . . 6.54 111.022 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' B' ' 161' ' ' LYS . 4.5 pt20 -82.9 -8.88 59.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.526 0.679 . . . . 5.9299999999999997 110.059 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -177.3 108.54 0.23 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 114.545 -1.207 . . . . 6.0599999999999996 109.611 176.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 9.8 Cg_endo -53.91 -17.01 9.82 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.063 2.509 . . . . 8.0299999999999994 112.571 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -166.16 -46.14 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.07 -0.514 . . . . 8.8699999999999992 111.018 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 117' ' ' ALA . 26.7 t 159.19 147.85 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 109.185 -0.672 . . . . 5.1299999999999999 109.185 -157.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -138.32 4.69 2.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.887 -0.597 . . . . 7.4299999999999997 110.62 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -153.17 23.29 0.55 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.75 0.786 . . . . 7.3899999999999997 109.786 173.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.4 mmtm 74.94 -88.1 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.209 1.189 . . . . 7.8200000000000003 114.209 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.0 p -99.69 36.84 1.71 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.669 -0.696 . . . . 5.1200000000000001 111.574 -165.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.899 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 43.0 t0 -74.32 155.38 38.26 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.538 1.161 . . . . 3.9700000000000002 110.125 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 32.0 mmtp -94.89 -37.0 11.39 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.899 -1.955 . . . . 6.0899999999999999 108.86 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 32.05 20.17 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 114.789 -1.096 . . . . 1.05 114.446 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 0.67000000000000004 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.48 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.768 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 0.66000000000000003 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.0 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.02 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 0.71999999999999997 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 1.77 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.2799999999999998 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.796 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.3200000000000001 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.916 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HA ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 0.89000000000000001 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 0.34000000000000002 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.48999999999999999 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.916 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 1.5800000000000001 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.47 ' N ' HD13 ' A' ' 71' ' ' LEU . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 0.56999999999999995 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.59999999999999998 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.768 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.3500000000000001 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HE2' ' HG3' ' A' ' 115' ' ' GLN . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.1800000000000002 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 0.47999999999999998 110.003 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.2599999999999998 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 0.77000000000000002 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.67 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 5.9 m120 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.8999999999999999 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1000000000000001 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.584 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 2.75 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.798 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.6100000000000001 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.706 ' HB3' HG12 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LYS . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.25 112.139 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.2200000000000002 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 1.73 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.781 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.3 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.695 ' HB2' HD21 ' B' ' 164' ' ' LEU . 57.4 t60 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 2.4700000000000002 111.025 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.8100000000000001 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.781 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 18.8 mm-40 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.6600000000000001 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 0.80000000000000004 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.602 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 3.9500000000000002 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.48 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 3.7999999999999998 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.26 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 29' ' ' LEU . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.53 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 1.79 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.04 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.554 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.3100000000000001 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.1099999999999999 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.9399999999999999 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.1600000000000001 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.1499999999999999 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 1.3500000000000001 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 1.53 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.1399999999999999 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.007 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 0.57999999999999996 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.4900000000000002 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 1.3 mp0 70.13 -62.53 0.43 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.8300000000000001 109.185 -157.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.486 ' OG ' ' HG3' ' A' ' 76' ' ' LYS . 33.2 t 68.73 19.56 8.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.27 -2.241 . . . . 4.2999999999999998 111.391 170.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.76 26.42 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.533 -1.212 . . . . 4.4800000000000004 112.268 -167.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.718 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 6.7 pt20 -112.2 144.72 41.13 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.025 -1.898 . . . . 6.5300000000000002 109.721 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 52' ' ' ASP . 26.4 mtpp -141.5 160.91 39.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.458 0.171 . . . . 9.2799999999999994 111.451 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . . . 168.1 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.179 0.992 . . . . 11.58 108.726 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 118' ' ' VAL . 12.2 p -77.06 33.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.563 1.173 . . . . 12.380000000000001 110.278 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 117' ' ' ALA . 86.0 mm-40 -109.12 91.11 3.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.228 -0.896 . . . . 14.960000000000001 112.206 -172.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -118.15 166.05 13.04 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.04 -0.527 . . . . 17.27 110.12 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -85.14 142.24 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.053 -0.351 . . . . 19.469999999999999 110.053 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -97.78 118.68 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.235 -0.438 . . . . 21.73 110.66 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 123' ' ' LEU . 3.5 pp -90.82 167.66 12.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.092 -0.504 . . . . 23.079999999999998 110.273 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.096 0.474 . . . . 23.960000000000001 110.752 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 14.1 mptt . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.604 -0.236 . . . . 8.2699999999999996 110.582 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.36 112.07 12.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.859 -0.737 . . . . 6.8700000000000001 111.04 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.47 27.26 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.938 -1.028 . . . . 4.5499999999999998 113.047 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 90' ' ' HIS . 2.8 tp -100.31 86.07 3.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.584 -0.697 . . . . 2.71 109.459 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.7 mt-10 -109.27 162.75 14.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.447 0.641 . . . . 4.9199999999999999 111.759 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' SER . 39.6 m -156.93 125.78 5.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.785 -1.098 . . . . 1.22 109.818 171.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.1899999999999999 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.628 ' C ' ' HB2' ' A' ' 29' ' ' LEU . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 1.54 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.074 -0.343 . . . . 18.34 110.074 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 72.03 176.09 0.28 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.801 0.688 . . . . 15.06 111.727 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -123.45 141.64 51.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.997 -0.742 . . . . 14.539999999999999 108.997 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.84 94.03 45.27 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.399 . . . . 10.4 110.509 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.94 96.73 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.887 2.392 . . . . 10.74 111.571 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.01 -41.15 0.29 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.028 -0.987 . . . . 7.75 110.722 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 pp0? -93.38 127.36 46.83 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 115.403 -0.398 . . . . 6.8399999999999999 110.266 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 3.0 Cg_exo -76.05 144.39 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.761 2.307 . . . . 4.8399999999999999 111.887 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -80.31 177.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.32 -0.622 . . . . 3.2599999999999998 109.32 175.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.593 ' H ' HG22 ' A' ' 9' ' ' VAL . 78.4 p -92.76 -119.05 0.09 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.249 -0.887 . . . . 2.1699999999999999 110.397 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.878 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -171.74 125.36 0.58 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.828 -1.078 . . . . 0.97999999999999998 110.559 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.3500000000000001 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 1.8400000000000001 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.3100000000000001 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HE ' HD21 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 3.5800000000000001 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 0.85999999999999999 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.939 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 0.93000000000000005 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG22 ' A' ' 18' ' ' ILE . 1.5 t60 -131.95 123.49 27.48 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 3.5299999999999998 112.668 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.915 ' HD3' HG13 ' A' ' 105' ' ' VAL . 11.7 mmmm -46.01 160.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.523 -1.672 . . . . 5.6900000000000004 110.989 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' H ' ' N ' ' A' ' 28' ' ' ILE . 42.3 tp -126.12 136.81 53.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.947 0.879 . . . . 4.5 111.665 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.574 HH11 HD21 ' A' ' 27' ' ' LEU . 3.7 tpt180 -59.41 118.6 6.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.801 -1.545 . . . . 5.2400000000000002 113.332 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.641 HE22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -139.69 69.79 1.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.361 -1.291 . . . . 4.4800000000000004 110.393 167.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 46.81 78.42 0.09 OUTLIER Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 114.319 -1.31 . . . . 3.7799999999999998 113.915 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.5 mm-40 89.21 -3.85 0.41 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.122 1.369 . . . . 6.8499999999999996 107.743 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' C ' HD22 ' A' ' 27' ' ' LEU . 16.8 m-80 -117.35 140.89 48.99 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 114.952 -1.022 . . . . 4.8499999999999996 109.473 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 4.6 mm? -123.32 102.87 8.16 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.118 -1.855 . . . . 3.6800000000000002 107.655 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.692 ' HB ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 pt -163.56 177.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 115.348 1.61 . . . . 2.8999999999999999 115.348 -174.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.692 ' HG ' ' HB ' ' A' ' 28' ' ' ILE . 69.9 mt 74.48 77.6 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 112.119 -2.31 . . . . 4.1900000000000004 112.481 156.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.32 -50.48 0.66 Allowed Glycine 0 C--N 1.298 -1.538 0 CA-C-N 111.093 -2.776 . . . . 1.6200000000000001 113.102 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.784 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 -158.42 -179.13 7.81 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.856 -0.791 . . . . 0.72999999999999998 111.825 -169.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.495 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.1599999999999999 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 0.89000000000000001 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.68999999999999995 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -151.17 120.21 1.08 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.4199999999999999 112.021 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.05 -4.31 1.16 Allowed Glycine 0 C--O 1.224 -0.511 0 C-N-CA 119.498 -1.334 . . . . 3.0 112.544 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.626 HG13 ' H ' ' A' ' 38' ' ' ASP . 11.1 pt -41.03 -65.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 115.759 1.763 . . . . 4.71 115.759 -164.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' H ' HG13 ' A' ' 37' ' ' ILE . 23.5 t70 -131.8 -8.38 3.56 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.686 0.755 . . . . 7.4900000000000002 109.958 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.637 ' NE2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -117.96 -16.21 9.9 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.211 1.189 . . . . 4.5499999999999998 114.211 -163.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 13.3 t70 -53.94 137.87 55.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.505 -0.771 . . . . 5.1399999999999997 110.647 -175.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 58.8 Cg_endo -59.48 -16.31 35.0 Favored 'Trans proline' 0 N--CA 1.475 0.406 0 C-N-CA 124.345 3.363 . . . . 5.5800000000000001 113.014 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -75.23 -34.7 61.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.078 -0.712 . . . . 6.54 109.078 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -106.33 -48.36 3.59 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.722 0.772 . . . . 5.9299999999999997 110.636 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' H ' ' HG2' ' A' ' 43' ' ' GLN . 9.2 t-20 -122.46 81.55 46.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.182 -1.372 . . . . 6.0599999999999996 111.758 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.59 -3.78 14.11 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.049 1.833 . . . . 8.0299999999999994 111.464 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -83.74 -22.88 31.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.915 -0.772 . . . . 8.8699999999999992 108.915 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' ASP . 74.6 m -96.51 -161.37 0.86 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.668 -0.696 . . . . 5.1299999999999999 109.145 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 47' ' ' SER . 44.3 tt0 69.52 -20.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.176 0.513 . . . . 7.4299999999999997 110.856 -175.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . 16.1 t70 -64.95 -28.94 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 7.3899999999999997 110.446 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' H ' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.82 0.67 17.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.033 -0.985 . . . . 7.8200000000000003 110.318 179.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 p 62.45 27.58 16.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.335 1.022 . . . . 5.1200000000000001 108.34 -164.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -51.5 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.043 -1.435 . . . . 3.9700000000000002 111.33 -178.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HA ' ' NE2' ' A' ' 39' ' ' GLN . 13.0 tptt 69.39 -23.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.783 1.233 . . . . 6.0899999999999999 112.468 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.699 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 58.38 50.23 68.72 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 1.05 112.335 170.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.697 HD13 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 0.67000000000000004 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.48 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 0.66000000000000003 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.02 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 0.71999999999999997 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 1.77 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.689 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.2799999999999998 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.755 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.689 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.3200000000000001 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 0.37 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 0.89000000000000001 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 0.34000000000000002 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.48999999999999999 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 1.5800000000000001 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.772 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 17.3 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.3599999999999999 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 0.56999999999999995 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.723 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.59999999999999998 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.796 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 -172.146 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.1800000000000002 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 0.64000000000000001 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.077 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.4 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.2599999999999998 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 0.77000000000000002 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.749 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.8999999999999999 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1000000000000001 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.691 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 2.75 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.932 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.6100000000000001 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.077 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.25 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.2200000000000002 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 1.73 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.827 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.3 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 2.4700000000000002 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.827 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 31.6 mm-40 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.6600000000000001 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 0.80000000000000004 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.517 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 3.9500000000000002 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.48 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.881 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 3.7999999999999998 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.823 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.26 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.53 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 101' ' ' SER . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 1.79 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.04 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.505 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.3100000000000001 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.1099999999999999 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.9399999999999999 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.1699999999999999 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.915 HG13 ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.1600000000000001 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.939 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.1499999999999999 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 1.3500000000000001 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.891 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 1.53 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.1399999999999999 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.878 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 0.57999999999999996 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.4900000000000002 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -92.99 -45.73 7.8 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.8300000000000001 108.072 171.028 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 56.7 m 69.08 6.25 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.817 -1.992 . . . . 4.2999999999999998 110.428 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.7 mm? -133.73 29.8 3.81 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.699 -2.046 . . . . 4.4800000000000004 107.396 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -53.27 114.79 1.6 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 111.197 -2.729 . . . . 6.5300000000000002 110.347 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -87.11 132.06 33.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 9.2799999999999994 112.143 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.41 24.03 0.24 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.509 -1.223 . . . . 11.58 109.238 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.41 81.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.152 -1.385 . . . . 12.380000000000001 110.209 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -103.66 97.8 7.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.435 -1.257 . . . . 14.960000000000001 109.208 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -104.64 -0.76 27.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.861 0.319 . . . . 17.27 111.861 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.2 m 57.97 41.02 25.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.3 0.571 . . . . 19.469999999999999 111.223 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 62.9 mtm -76.51 92.23 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 21.73 110.67 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -62.28 -45.01 95.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.685 -0.688 . . . . 23.079999999999998 111.129 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.533 0.322 0 O-C-N 123.803 0.689 . . . . 23.960000000000001 111.341 -179.455 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.852 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 10.3 mmpt? . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 110.198 -0.297 . . . . 8.2699999999999996 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.456 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 32.3 tt0 -173.96 -116.35 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 112.11 0.411 . . . . 6.8700000000000001 112.11 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -176.47 157.91 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 4.5499999999999998 109.412 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.34 123.38 48.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.917 0.389 . . . . 2.71 111.552 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 22.7 mt-10 -113.29 148.5 35.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 4.9199999999999999 109.992 172.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.416 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.9 m -159.78 141.97 13.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.088 -0.505 . . . . 1.22 110.945 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.1899999999999999 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 1.54 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.301 . . . . 18.34 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -101.45 117.05 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 15.06 110.066 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 4' ' ' ILE . 36.8 p90 -116.5 30.43 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 14.539999999999999 109.439 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 80.1 mt 73.36 88.92 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.083 -1.417 . . . . 10.4 110.149 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.77 95.47 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.672 2.248 . . . . 10.74 112.247 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.75 -46.2 0.45 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.046 -0.979 . . . . 7.75 110.666 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.5 mt-30 -135.57 99.0 11.92 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.804 -0.443 . . . . 6.8399999999999999 109.804 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' GLN . 16.7 Cg_endo -57.84 130.19 37.19 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.053 2.502 . . . . 4.8399999999999999 113.184 -176.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 10' ' ' THR . 4.2 p -147.23 178.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.691 -0.686 . . . . 3.2599999999999998 109.411 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.708 ' H ' HG22 ' A' ' 9' ' ' VAL . 48.2 p -131.77 103.86 6.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.224 1.012 . . . . 2.1699999999999999 110.558 -172.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.17 99.22 8.43 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.101 -1.863 . . . . 0.97999999999999998 110.39 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.3500000000000001 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 1.8400000000000001 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.3100000000000001 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 3.5800000000000001 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.786 HG13 HD23 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 0.85999999999999999 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.051 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 0.93000000000000005 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.727 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -121.69 112.69 18.73 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 3.5299999999999998 111.254 174.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.978 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 1.8 tmtt? -91.77 -99.01 0.12 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.505 -0.77 . . . . 5.6900000000000004 109.44 173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 24.5 tp -153.89 123.65 6.75 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.192 0.812 . . . . 4.5 113.192 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.987 ' HB2' ' HB3' ' A' ' 103' ' ' GLU . 5.7 tmm_? -79.27 107.16 11.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.549 -0.908 . . . . 5.2400000000000002 108.549 164.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -112.82 65.87 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.208 1.004 . . . . 4.4800000000000004 109.868 -176.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 80.33 -104.22 2.24 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.584 -1.644 . . . . 3.7799999999999998 111.481 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.69 -7.19 56.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.864 -0.791 . . . . 6.8499999999999996 108.864 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' C ' HD22 ' A' ' 27' ' ' LEU . 34.3 m-80 -101.72 134.82 44.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.179 1.466 . . . . 4.8499999999999996 110.365 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD22 ' C ' ' A' ' 26' ' ' ASN . 4.3 mm? -122.88 109.89 14.73 Favored 'General case' 0 C--N 1.256 -3.467 0 CA-C-N 111.256 -2.702 . . . . 3.6800000000000002 105.767 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 21' ' ' LEU . 35.6 mm -109.17 124.13 65.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.996 -0.547 . . . . 2.8999999999999999 110.95 -172.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD12 HG11 ' A' ' 105' ' ' VAL . 1.2 tt -100.51 -28.05 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 124.607 1.192 . . . . 4.1900000000000004 109.369 172.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -57.17 4.03 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.989 -0.624 . . . . 1.6200000000000001 114.426 169.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 -81.72 177.98 8.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 117.423 0.612 . . . . 0.72999999999999998 110.947 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.1599999999999999 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.89000000000000001 109.788 -173.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.68999999999999995 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' B' ' 164' ' ' LEU . . . -83.53 100.61 2.28 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.4199999999999999 109.164 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.634 ' HA3' ' HE1' ' A' ' 56' ' ' TYR . . . -121.81 38.07 2.72 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.993 -0.843 . . . . 3.0 110.993 -167.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.8 ' HB ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -55.89 -47.94 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 CA-C-N 114.652 -0.774 . . . . 4.71 111.092 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' ILE . 30.4 t70 163.55 -23.75 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.916 -1.493 . . . . 7.4900000000000002 107.448 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.587 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mp0 69.48 160.23 0.19 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 113.769 -1.559 . . . . 4.5499999999999998 112.751 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.609 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 22.2 t70 74.76 162.37 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.062 -1.881 . . . . 5.1399999999999997 108.802 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.909 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 1.0 OUTLIER -42.76 -24.23 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.917 3.078 . . . . 5.5800000000000001 111.938 175.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 39' ' ' GLN . 40.5 t -44.98 -38.91 5.08 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.006 -2.361 . . . . 6.54 112.328 172.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.8 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.8 pt20 -80.13 -20.9 43.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.887 -0.597 . . . . 5.9299999999999997 110.526 -167.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.5 t30 52.72 92.16 0.06 OUTLIER Pre-proline 0 C--O 1.216 -0.668 0 O-C-N 124.642 1.213 . . . . 6.0599999999999996 113.423 174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.573 ' CG ' ' HD2' ' B' ' 161' ' ' LYS . 71.9 Cg_endo -76.13 11.96 1.63 Allowed 'Trans proline' 0 CA--C 1.521 -0.162 0 C-N-CA 122.534 2.156 . . . . 8.0299999999999994 110.708 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -98.6 -15.47 19.46 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.846 -1.07 . . . . 8.8699999999999992 109.151 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -84.28 -91.82 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.029 -0.668 . . . . 5.1299999999999999 109.216 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 89' ' ' THR . 47.2 mt-10 47.1 34.18 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.771 0.796 . . . . 7.4299999999999997 109.355 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -98.01 -30.95 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.728 -1.124 . . . . 7.3899999999999997 113.31 -166.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER 175.15 -64.15 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.568 0.699 . . . . 7.8200000000000003 112.24 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -68.43 -15.08 63.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.425 -1.261 . . . . 5.1200000000000001 110.464 -170.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.28 -61.62 2.18 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.366 -1.288 . . . . 3.9700000000000002 110.636 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tptm 59.86 22.67 11.64 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.541 -0.754 . . . . 6.0899999999999999 109.635 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 37' ' ' ILE . . . -89.59 30.04 5.92 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.821 -1.081 . . . . 1.05 114.323 -169.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 0.67000000000000004 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.48 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 0.66000000000000003 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.0 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.736 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.02 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 0.71999999999999997 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 1.77 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.2799999999999998 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.978 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.3200000000000001 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.051 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 0.37 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 0.89000000000000001 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 0.34000000000000002 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.48999999999999999 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HB1' ' A' ' 66' ' ' ALA . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 1.5800000000000001 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.3599999999999999 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 0.56999999999999995 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.59999999999999998 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.775 ' H ' HG12 ' A' ' 57' ' ' VAL . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.3500000000000001 109.208 -171.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.802 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.1800000000000002 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.64000000000000001 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.483 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 0.47999999999999998 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.729 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.2599999999999998 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 0.77000000000000002 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.8999999999999999 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1000000000000001 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.542 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 2.75 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.6100000000000001 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.729 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.445 ' OG1' ' HE2' ' A' ' 50' ' ' LYS . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.25 110.745 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.2200000000000002 108.627 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 HH22 ' A' ' 96' ' ' ARG . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 1.73 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.749 ' HD1' HD13 ' B' ' 164' ' ' LEU . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 2.4700000000000002 111.499 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.765 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.8100000000000001 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.582 ' OE1' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.6600000000000001 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 0.80000000000000004 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 3.9500000000000002 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.48 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.743 HH22 HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 3.7999999999999998 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.673 HD11 HG21 ' B' ' 168' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.26 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.53 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.04 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.3100000000000001 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.1099999999999999 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.987 ' HB3' ' HB2' ' A' ' 22' ' ' ARG . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.9399999999999999 108.729 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.1699999999999999 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.643 HG11 HD12 ' A' ' 29' ' ' LEU . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.1600000000000001 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.1499999999999999 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.786 HD23 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 1.3500000000000001 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 1.53 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.1399999999999999 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.802 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 0.57999999999999996 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.4900000000000002 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 8.5 mm100 -101.84 -34.35 9.44 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.8300000000000001 108.405 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 12' ' ' VAL . 28.9 m 67.42 19.3 10.08 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.417 -2.174 . . . . 4.2999999999999998 112.22 175.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.612 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.03 3.16 1.04 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.75 1.262 . . . . 4.4800000000000004 108.536 177.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 112' ' ' GLN . 9.4 mm100 4.43 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.082 -3.235 . . . . 6.5300000000000002 114.17 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -106.8 149.83 26.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.006 -0.543 . . . . 9.2799999999999994 109.802 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.07 19.0 1.77 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.185 -1.042 . . . . 11.58 108.185 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 11.6 p 31.85 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 112.049 -2.341 . . . . 12.380000000000001 114.337 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -113.54 33.64 5.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.736 -1.12 . . . . 14.960000000000001 109.874 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.99 140.61 52.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.228 -0.896 . . . . 17.27 109.252 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t 62.58 79.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.842 0.714 . . . . 19.469999999999999 109.235 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.4 mmt 67.14 -166.31 0.21 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.105 -0.952 . . . . 21.73 109.301 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.24 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.407 0.622 . . . . 23.079999999999998 111.818 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.524 . . . . 23.960000000000001 110.704 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.909 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.996 0.369 . . . . 8.2699999999999996 111.996 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.454 ' HA ' ' H ' ' A' ' 40' ' ' ASP . 11.0 pt-20 -173.7 -176.92 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 6.8700000000000001 110.961 172.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -55.42 125.9 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 4.5499999999999998 110.491 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.749 HD13 ' HD1' ' A' ' 90' ' ' HIS . 7.9 mt -113.48 148.9 35.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.25 0.548 . . . . 2.71 112.321 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 15.0 mt-10 -144.56 155.04 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.151 -0.931 . . . . 4.9199999999999999 109.855 169.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -158.35 101.09 1.7 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.997 -0.547 . . . . 1.22 110.787 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.1899999999999999 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 1.54 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.148 -0.316 . . . . 18.34 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 67.02 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.729 0.643 . . . . 15.06 110.935 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -133.5 141.49 47.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 14.539999999999999 109.603 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm 49.82 85.48 0.18 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.87 0.731 . . . . 10.4 112.105 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.9 109.17 0.39 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.841 2.361 . . . . 10.74 112.11 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.18 -28.11 3.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.022 -0.609 . . . . 7.75 112.167 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -121.9 102.03 41.56 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-O 120.939 0.4 . . . . 6.8399999999999999 111.624 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -91.91 -167.53 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.089 2.526 . . . . 4.8399999999999999 112.619 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 10' ' ' THR . 2.9 p -128.68 -176.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.259 -0.645 . . . . 3.2599999999999998 109.259 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.741 ' H ' HG22 ' A' ' 9' ' ' VAL . 57.1 p -111.17 -88.56 0.51 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.107 0.479 . . . . 2.1699999999999999 111.424 -175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -170.8 142.04 1.87 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.055 0.931 . . . . 0.97999999999999998 111.759 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.3500000000000001 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 1.8400000000000001 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.3100000000000001 109.82 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HD22 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 3.5800000000000001 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 0.85999999999999999 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 0.93000000000000005 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 -146.67 119.01 8.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 3.5299999999999998 111.484 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.935 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 27.5 tptp -95.22 -80.06 0.42 Allowed 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 121.997 -0.439 . . . . 5.6900000000000004 110.504 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.478 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 22.6 tp -149.9 117.26 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.148 0.499 . . . . 4.5 111.618 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.587 ' HD3' ' H ' ' A' ' 24' ' ' GLY . 2.3 tmt_? -79.71 112.03 16.58 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.772 -0.825 . . . . 5.2400000000000002 108.772 167.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.94 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -120.6 64.84 0.84 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.858 0.837 . . . . 4.4800000000000004 110.232 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 75.9 -98.24 1.18 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 113.799 -1.546 . . . . 3.7799999999999998 112.114 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.12 0.92 38.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.802 -0.699 . . . . 6.8499999999999996 109.569 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.94 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 24.3 m-80 -115.47 132.98 56.45 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-O 123.076 1.417 . . . . 4.8499999999999996 110.515 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 101' ' ' SER . 3.8 mm? -120.58 110.94 17.04 Favored 'General case' 0 C--N 1.261 -3.254 0 CA-C-N 111.524 -2.58 . . . . 3.6800000000000002 105.881 166.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 51.9 mm -107.25 128.32 62.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.7 -0.682 . . . . 2.8999999999999999 112.087 -169.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' HG23 ' B' ' 168' ' ' VAL . 2.9 mm? -114.76 -49.53 2.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.793 -1.094 . . . . 4.1900000000000004 108.511 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 91.11 -40.33 2.99 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.599 -0.728 . . . . 1.6200000000000001 113.366 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.897 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 -70.05 167.9 16.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.717 -0.475 . . . . 0.72999999999999998 109.717 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.1599999999999999 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.523 HD11 ' HG2' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 0.89000000000000001 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.68999999999999995 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' H ' ' H ' ' B' ' 164' ' ' LEU . . . 140.61 170.85 12.23 Favored Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.4199999999999999 109.692 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.821 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . 149.4 -124.38 1.79 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.313 -1.422 . . . . 3.0 113.973 169.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HD22 ' B' ' 164' ' ' LEU . 0.4 OUTLIER 17.44 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 127.353 2.261 . . . . 4.71 115.837 -178.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' H ' HG13 ' A' ' 37' ' ' ILE . 12.1 t70 166.4 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.969 -1.123 . . . . 7.4900000000000002 107.969 -170.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 1.08 ' HG2' ' HB3' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -2.5 -104.23 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 N-CA-C 116.032 1.864 . . . . 4.5499999999999998 116.032 -168.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 161' ' ' LYS . 1.3 t70 -138.67 132.98 16.52 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 112.492 0.553 . . . . 5.1399999999999997 112.492 -169.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' B' ' 161' ' ' LYS . 56.7 Cg_endo -80.5 -12.8 12.44 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 124.034 3.156 . . . . 5.5800000000000001 112.639 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 36.2 t -44.84 -43.09 8.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.016 0.926 . . . . 6.54 112.694 -172.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' OE1' ' HB2' ' B' ' 162' ' ' GLU . 14.1 pt20 -90.08 -0.03 57.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.755 -0.657 . . . . 5.9299999999999997 112.304 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.628 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -33.8 109.61 0.35 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 114.33 1.233 . . . . 6.0599999999999996 114.33 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.4 -8.86 12.65 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.883 2.389 . . . . 8.0299999999999994 111.446 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 48' ' ' GLU . 19.9 t80 -155.74 -54.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.754 -0.657 . . . . 8.8699999999999992 110.587 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.815 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 3.8 t 69.09 11.43 8.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.465 0.706 . . . . 5.1299999999999999 110.651 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.806 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 7.2 mm-40 70.32 -59.64 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.955 0.785 . . . . 7.4299999999999997 112.023 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t70 161.77 -38.82 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.64 -1.615 . . . . 7.3899999999999997 106.64 -169.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.806 ' HE3' ' HB3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -98.27 -97.75 0.21 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.131 -1.85 . . . . 7.8200000000000003 110.061 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -137.18 12.89 3.06 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.894 -1.15 . . . . 5.1200000000000001 107.894 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.754 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 20.9 t0 66.26 165.82 0.2 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.114 -1.403 . . . . 3.9700000000000002 110.912 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HG2' ' SD ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -81.06 -23.33 38.61 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.909 -1.042 . . . . 6.0899999999999999 110.491 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.27 10.05 86.4 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.05 115.712 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 0.67000000000000004 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.48 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 0.66000000000000003 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.69 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.02 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.897 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 0.71999999999999997 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 1.77 109.042 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.2799999999999998 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.935 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.3200000000000001 114.951 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 0.37 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 0.89000000000000001 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 0.34000000000000002 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.48999999999999999 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.767 HD23 ' HB1' ' A' ' 66' ' ' ALA . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 1.5800000000000001 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.3599999999999999 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.507 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 0.56999999999999995 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.59999999999999998 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.795 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.3500000000000001 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.1800000000000002 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 0.64000000000000001 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.591 ' SD ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 0.47999999999999998 110.296 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.2599999999999998 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.717 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 0.77000000000000002 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.8999999999999999 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1000000000000001 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 2.75 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.791 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.6100000000000001 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.25 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.2200000000000002 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 93' ' ' ALA . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 1.73 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.449 ' H ' ' CD ' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.3 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.95 ' HB2' HD11 ' B' ' 164' ' ' LEU . 0.6 OUTLIER -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 2.4700000000000002 111.444 -177.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.8100000000000001 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.782 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.6600000000000001 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.785 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 0.80000000000000004 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 3.9500000000000002 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.715 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.48 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 3.7999999999999998 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.26 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.53 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 1.79 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.566 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.04 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.655 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.3100000000000001 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.1099999999999999 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.9399999999999999 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.1699999999999999 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.1600000000000001 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.1499999999999999 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.559 HD22 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 1.3500000000000001 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 1.53 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.1399999999999999 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 0.57999999999999996 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.4900000000000002 111.441 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -99.24 9.73 42.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.8300000000000001 111.3 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t 80.2 26.06 0.33 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.692 -2.049 . . . . 4.2999999999999998 110.157 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 114' ' ' LEU . 2.7 mm? 60.63 57.84 2.61 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.195 -1.366 . . . . 4.4800000000000004 110.495 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 9' ' ' VAL . 53.5 mm-40 -39.7 105.76 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.528 -2.123 . . . . 6.5300000000000002 114.043 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.69 142.85 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.508 -1.224 . . . . 9.2799999999999994 108.165 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.23 20.29 7.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.428 1.109 . . . . 11.58 108.872 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.68 82.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 113.299 -1.773 . . . . 12.380000000000001 108.578 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -115.12 177.77 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.694 -1.139 . . . . 14.960000000000001 110.543 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -106.58 130.2 54.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.632 -0.713 . . . . 17.27 109.217 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -84.48 170.1 13.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.514 -0.312 . . . . 19.469999999999999 110.181 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 5.2 mpp? 72.27 105.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.932 0.77 . . . . 21.73 111.401 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.7 -171.55 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.077 -0.965 . . . . 23.079999999999998 111.369 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.607 -0.724 . . . . 23.960000000000001 110.445 -178.231 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 47' ' ' SER . 11.8 mmtp . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.525 0.202 . . . . 8.2699999999999996 110.985 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 1.08 ' HB3' ' HG2' ' A' ' 39' ' ' GLN . 27.7 tt0 -79.8 156.23 27.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.179 0.514 . . . . 6.8700000000000001 110.013 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.414 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 7.3 p30 -87.7 128.48 35.3 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.134 -0.939 . . . . 4.5499999999999998 113.17 -168.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -120.69 163.65 17.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.511 -1.292 . . . . 2.71 107.511 168.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.653 ' OE1' ' HA ' ' A' ' 90' ' ' HIS . 4.9 tp10 89.49 -145.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.107 0.963 . . . . 4.9199999999999999 112.132 172.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.477 ' H ' ' HG3' ' B' ' 165' ' ' GLU . 63.7 m -173.35 -169.03 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.22 112.615 -148.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.1899999999999999 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 1.54 109.477 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.307 0.099 . . . . 18.34 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t 67.91 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.39 0.614 . . . . 15.06 111.093 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -137.46 103.82 5.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.941 -0.572 . . . . 14.539999999999999 110.073 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.58 103.43 6.46 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.691 . . . . 10.4 110.754 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.82 -154.03 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.249 2.632 . . . . 10.74 111.417 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.0 50.12 1.87 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.032 -0.604 . . . . 7.75 112.37 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 20.92 86.81 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.49 1.516 . . . . 6.8399999999999999 114.998 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -91.29 -169.05 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.479 2.786 . . . . 4.8399999999999999 112.312 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 p -85.68 -10.37 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 122.567 1.175 . . . . 3.2599999999999998 109.412 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p 69.08 109.55 0.05 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 111.693 -2.503 . . . . 2.1699999999999999 112.439 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -55.92 137.22 50.96 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 113.008 -1.906 . . . . 0.97999999999999998 110.814 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.3500000000000001 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 1.8400000000000001 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.3100000000000001 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 3.5800000000000001 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.785 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 0.93000000000000005 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 104' ' ' VAL . 15.8 p80 -130.29 104.63 7.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 3.5299999999999998 111.667 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.742 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 5.4 tmtt? -79.64 -100.77 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.561 -0.533 . . . . 5.6900000000000004 109.561 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 21.9 tp -154.47 134.07 12.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.533 -0.467 . . . . 4.5 111.524 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -76.62 132.78 39.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.109 -0.7 . . . . 5.2400000000000002 109.109 167.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.9 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 2.3 mt-30 -128.92 62.4 1.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.014 0.911 . . . . 4.4800000000000004 109.91 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.69 -99.6 0.85 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 113.581 -1.645 . . . . 3.7799999999999998 111.91 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.64 -5.06 43.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.777 0.799 . . . . 6.8499999999999996 109.697 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.9 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 39.6 m-80 -109.57 146.42 34.71 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 123.228 1.49 . . . . 4.8499999999999996 110.308 -175.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 26' ' ' ASN . 3.9 mm? -135.43 110.24 8.71 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 110.815 -2.902 . . . . 3.6800000000000002 104.98 172.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.557 HG13 ' OE1' ' A' ' 23' ' ' GLN . 43.1 mm -107.49 129.51 61.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.359 0.6 . . . . 2.8999999999999999 111.815 -168.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 105' ' ' VAL . 7.6 tp -93.47 -41.05 10.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.413 -1.721 . . . . 4.1900000000000004 108.849 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.52 -48.73 1.36 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.618 -0.801 . . . . 1.6200000000000001 114.036 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 -88.03 173.81 8.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.6 0.7 . . . . 0.72999999999999998 111.322 -173.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.782 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.1599999999999999 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.944 HD11 ' HG3' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 0.89000000000000001 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.68999999999999995 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -134.01 155.5 21.86 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.4199999999999999 111.753 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.88 60.64 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.292 -0.48 . . . . 3.0 112.492 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.793 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -124.21 -58.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 4.71 111.272 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 37' ' ' ILE . 19.9 t70 -109.26 16.63 22.28 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.434 -0.95 . . . . 7.4900000000000002 108.434 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.673 ' HB3' HD21 ' B' ' 164' ' ' LEU . 33.3 mm-40 -85.14 -75.26 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.485 -1.234 . . . . 4.5499999999999998 111.222 -174.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 1.5 t70 -130.78 127.17 22.13 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.809 -1.087 . . . . 5.1399999999999997 109.557 -176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.53 -17.99 26.16 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 123.197 2.598 . . . . 5.5800000000000001 111.747 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.452 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 3.6 m -67.16 -37.32 83.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.109 -0.951 . . . . 6.54 110.77 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' B' ' 162' ' ' GLU . 0.6 OUTLIER -86.66 -33.93 19.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.428 0.632 . . . . 5.9299999999999997 110.543 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.976 HD21 ' HA ' ' A' ' 48' ' ' GLU . 2.3 t-20 -162.66 97.95 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 114.867 -1.061 . . . . 6.0599999999999996 111.098 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.97 6.87 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.707 2.271 . . . . 8.0299999999999994 111.326 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -119.51 -73.14 0.66 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.565 -0.743 . . . . 8.8699999999999992 110.66 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HG22 ' A' ' 37' ' ' ILE . 1.6 m 171.33 -47.95 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.309 -0.997 . . . . 5.1299999999999999 108.309 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.976 ' HA ' HD21 ' A' ' 44' ' ' ASN . 0.0 OUTLIER 170.61 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.069 -1.878 . . . . 7.4299999999999997 108.53 178.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -111.37 37.31 2.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.401 -0.963 . . . . 7.3899999999999997 108.401 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tptm 72.3 -65.58 0.34 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.36 -1.291 . . . . 7.8200000000000003 111.219 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 10.16 8.0 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.719 -1.128 . . . . 5.1200000000000001 112.199 -172.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.27 -174.31 4.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.69 -0.856 . . . . 3.9700000000000002 108.69 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HD2' ' HB ' ' A' ' 86' ' ' THR . 69.9 mmtt -127.33 -16.17 4.99 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.282 -0.872 . . . . 6.0899999999999999 110.088 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.793 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 70.92 -5.29 8.08 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.795 -1.093 . . . . 1.05 115.734 171.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 0.67000000000000004 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.48 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.897 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 0.66000000000000003 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.0 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.02 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 0.71999999999999997 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 1.77 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.2799999999999998 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.742 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.3200000000000001 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.785 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 0.37 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 0.89000000000000001 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 0.34000000000000002 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.48999999999999999 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 1.5800000000000001 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.3599999999999999 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 0.56999999999999995 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.731 ' O ' ' HB3' ' A' ' 114' ' ' LEU . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.59999999999999998 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.771 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.3500000000000001 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.1800000000000002 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 0.64000000000000001 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.518 ' SD ' ' HG3' ' A' ' 53' ' ' LYS . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 0.47999999999999998 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.104 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.2599999999999998 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.666 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 0.77000000000000002 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.8999999999999999 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1000000000000001 112.218 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.666 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 2.75 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 1.104 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.6100000000000001 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.547 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.712 ' HB ' ' HD2' ' A' ' 53' ' ' LYS . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.25 111.936 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.2200000000000002 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.906 HG12 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 1.73 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.918 HG22 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.3 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.918 ' H ' HG22 ' A' ' 89' ' ' THR . 4.5 t60 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 2.4700000000000002 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.8100000000000001 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.906 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.6600000000000001 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.874 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 0.80000000000000004 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.698 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 3.9500000000000002 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.48 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.608 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 3.7999999999999998 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 HG21 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.26 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.529 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.53 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.79 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.04 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.3100000000000001 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.713 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.1099999999999999 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.9399999999999999 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.1699999999999999 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG21 HD13 ' A' ' 29' ' ' LEU . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.1600000000000001 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' C ' HD13 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.1499999999999999 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 1.3500000000000001 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.817 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 1.53 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 110' ' ' THR . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.82 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 0.57999999999999996 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.4900000000000002 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER 61.64 11.51 3.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.8300000000000001 109.692 -173.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 111' ' ' ARG . 8.5 t -102.17 14.31 32.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 111.388 -2.642 . . . . 4.2999999999999998 109.137 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.731 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -110.69 17.73 20.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.708 -1.587 . . . . 4.4800000000000004 110.386 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -73.9 90.22 1.91 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 112.804 -1.998 . . . . 6.5300000000000002 111.814 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -112.13 128.49 56.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.566 -0.743 . . . . 9.2799999999999994 109.604 172.34 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.22 22.57 3.77 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.447 1.118 . . . . 11.58 108.893 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 118' ' ' VAL . 5.7 p -128.51 90.15 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 113.311 -1.768 . . . . 12.380000000000001 110.049 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -116.55 125.25 51.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.017 -0.992 . . . . 14.960000000000001 109.257 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -88.36 99.35 12.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 17.27 110.275 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 52.6 m 71.62 134.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.054 0.846 . . . . 19.469999999999999 111.258 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 84.3 mtp -104.27 119.48 39.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 21.73 111.672 -173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.4 mt 56.73 42.71 26.41 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.977 -0.556 . . . . 23.079999999999998 111.777 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.466 0.374 0 O-C-N 123.725 0.64 . . . . 23.960000000000001 110.946 -179.324 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 14.0 tppt? . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.324 -0.991 . . . . 8.2699999999999996 108.324 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' GLU . . . . . 0.533 ' HA ' ' NE2' ' A' ' 43' ' ' GLN . 2.3 pt-20 -84.47 111.96 19.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.409 -1.268 . . . . 6.8700000000000001 111.67 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 175.78 89.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.448 -0.796 . . . . 4.5499999999999998 110.928 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -163.93 138.42 5.82 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.796 -0.446 . . . . 2.71 109.796 164.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.944 ' HG3' HD11 ' A' ' 33' ' ' ILE . 6.8 tp10 167.52 -37.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.618 1.198 . . . . 4.9199999999999999 108.039 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m 80.05 -175.34 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.22 113.436 159.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.782 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.1899999999999999 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.648 HG23 ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 1.54 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.68 0.276 . . . . 18.34 110.603 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -133.38 -70.35 0.53 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.086 -0.709 . . . . 15.06 109.086 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 61.47 122.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.106 0.879 . . . . 14.539999999999999 111.941 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.0 mt 64.94 103.86 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.181 -0.918 . . . . 10.4 110.563 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.94 -135.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.863 2.375 . . . . 10.74 111.589 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.728 -0.749 . . . . 7.75 111.335 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -16.46 100.86 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 125.141 1.377 . . . . 6.8399999999999999 113.738 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -92.03 -171.92 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.161 2.574 . . . . 4.8399999999999999 112.328 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -93.84 179.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.468 -0.567 . . . . 3.2599999999999998 109.468 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.621 ' H ' HG22 ' A' ' 9' ' ' VAL . 75.1 p -90.26 -113.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.6 0.714 . . . . 2.1699999999999999 111.561 -174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -170.88 130.44 0.8 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.719 -1.128 . . . . 0.97999999999999998 110.956 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.3500000000000001 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 1.8400000000000001 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 115' ' ' GLN . 17.3 mp0 -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.3100000000000001 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HE ' HD21 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 3.5800000000000001 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 0.85999999999999999 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.761 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 0.93000000000000005 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.64 ' HB3' HG23 ' A' ' 104' ' ' VAL . 25.2 p80 -104.88 72.36 1.01 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 3.5299999999999998 112.402 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.914 ' HG3' ' HD2' ' A' ' 31' ' ' PHE . 17.2 mmtt -106.68 95.83 6.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 113.913 -1.494 . . . . 5.6900000000000004 109.219 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.0 tp -158.4 146.58 18.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.235 -0.893 . . . . 4.5 111.308 -161.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.647 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.34 116.7 6.93 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.729 0.776 . . . . 5.2400000000000002 108.915 159.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.115 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 2.0 pt20 -143.61 60.65 1.38 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.697 0.761 . . . . 4.4800000000000004 110.487 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.46 -91.66 0.21 Allowed Glycine 0 CA--C 1.497 -1.042 0 CA-C-N 113.733 -1.576 . . . . 3.7799999999999998 113.291 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -71.15 -12.73 61.65 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.49 -0.93 . . . . 6.8499999999999996 108.49 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 1.115 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 13.1 m-80 -125.84 136.4 53.05 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.331 -1.304 . . . . 4.8499999999999996 108.215 -174.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.509 HD22 ' O ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -135.03 108.37 7.8 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 113.493 -1.685 . . . . 3.6800000000000002 108.174 167.03 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.844 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -117.69 119.86 62.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.119 -1.4 . . . . 2.8999999999999999 107.445 176.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' B' ' 168' ' ' VAL . 56.5 tp -162.15 75.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 125.782 1.926 . . . . 4.1900000000000004 109.081 -169.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' B' ' 167' ' ' MET . . . 177.08 31.22 0.05 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 118.705 -1.712 . . . . 1.6200000000000001 116.576 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.914 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -109.65 139.63 44.45 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.586 -1.264 . . . . 0.72999999999999998 107.586 168.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.1599999999999999 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.796 HG23 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 0.89000000000000001 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' B' ' 165' ' ' GLU . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.68999999999999995 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.923 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -71.5 133.47 21.57 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.4199999999999999 107.299 162.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.45 -25.3 71.32 Favored Glycine 0 CA--C 1.489 -1.582 0 O-C-N 124.992 1.054 . . . . 3.0 112.12 -157.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -141.35 -137.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 121.793 0.806 . . . . 4.71 112.255 -172.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 37' ' ' ILE . 12.0 p-10 -131.46 21.52 4.74 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.257 -1.338 . . . . 7.4900000000000002 108.111 -170.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.862 HE22 ' HB2' ' B' ' 163' ' ' ASN . 0.0 OUTLIER -60.37 -138.16 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.23 -2.259 . . . . 4.5499999999999998 111.319 171.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' B' ' 161' ' ' LYS . 33.0 t70 163.15 -67.58 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.852 -0.613 . . . . 5.1399999999999997 111.869 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 93.8 Cg_endo -71.2 -6.83 20.05 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.088 1.859 . . . . 5.5800000000000001 109.096 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 t -69.58 -39.73 77.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.125 -2.307 . . . . 6.54 110.927 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.581 ' OE1' ' HB3' ' B' ' 161' ' ' LYS . 9.9 pt20 -82.5 3.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.322 -0.854 . . . . 5.9299999999999997 111.146 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 9.1 t-20 -23.41 138.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 125.571 1.548 . . . . 6.0599999999999996 114.151 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.674 ' HA ' ' OG1' ' A' ' 86' ' ' THR . 11.9 Cg_endo -60.1 -19.69 57.6 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 124.209 3.273 . . . . 8.0299999999999994 112.8 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -92.86 -22.68 19.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.798 -0.816 . . . . 8.8699999999999992 108.798 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t 74.37 142.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.335 -1.302 . . . . 5.1299999999999999 110.717 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -54.82 -35.08 63.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.213 -0.903 . . . . 7.4299999999999997 111.587 -176.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.41 41.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.094 -0.706 . . . . 7.3899999999999997 109.094 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.69 -80.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.808 -1.087 . . . . 7.8200000000000003 110.414 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.637 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 13.4 t -91.97 40.32 1.04 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.837 0.827 . . . . 5.1200000000000001 109.236 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.477 ' CG ' ' HB3' ' A' ' 48' ' ' GLU . 14.4 t70 -77.15 7.92 4.54 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.061 0.934 . . . . 3.9700000000000002 111.898 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HD3' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 70.4 10.5 7.24 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.253 -1.339 . . . . 6.0899999999999999 111.014 172.555 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -42.42 -49.19 5.74 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 124.096 0.872 . . . . 1.05 113.916 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.923 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 0.67000000000000004 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.48 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.872 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 0.66000000000000003 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.693 HG21 ' HG2' ' B' ' 165' ' ' GLU . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.0 111.425 -173.322 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.583 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.02 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 0.71999999999999997 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 1.77 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.2799999999999998 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.901 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.3200000000000001 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.825 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 0.37 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 0.89000000000000001 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 0.34000000000000002 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.48999999999999999 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.662 HD22 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 1.5800000000000001 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 71' ' ' LEU . 12.7 mp0 -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.3599999999999999 107.426 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 0.56999999999999995 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.744 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.59999999999999998 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.872 ' H ' HG12 ' A' ' 57' ' ' VAL . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.3500000000000001 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.1800000000000002 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.686 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 0.64000000000000001 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 0.47999999999999998 110.237 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.0 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 45.2 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.2599999999999998 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.737 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 11.5 m120 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.8999999999999999 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1000000000000001 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.595 ' HB2' HG13 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 1.0 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.6100000000000001 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.737 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 45' ' ' PRO . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.25 112.605 -167.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' PRO . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.2200000000000002 111.564 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 1.73 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.069 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.3 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.446 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 2.4700000000000002 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.8100000000000001 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 1.069 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 2.7 mm-40 -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.6600000000000001 109.486 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.681 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 0.80000000000000004 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.796 HH22 HG23 ' A' ' 33' ' ' ILE . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 3.9500000000000002 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.48 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.532 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 3.7999999999999998 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.26 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.774 HG22 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.53 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 1.79 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.04 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.529 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.3100000000000001 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.601 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.1099999999999999 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.9399999999999999 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.1699999999999999 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.1600000000000001 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.815 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.1499999999999999 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 1.3500000000000001 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD21 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 1.53 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.1399999999999999 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 0.57999999999999996 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.67 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.4900000000000002 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.667 ' CA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -90.44 -37.33 14.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.8300000000000001 109.566 173.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -171.82 19.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.557 -1.656 . . . . 4.2999999999999998 110.731 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' H ' ' HB3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -96.6 42.13 1.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.413 1.101 . . . . 4.4800000000000004 109.81 -174.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.592 ' HB3' HG11 ' A' ' 12' ' ' VAL . 29.3 pt20 -84.27 161.51 20.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.362 -1.745 . . . . 6.5300000000000002 111.141 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -115.93 138.89 50.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.985 -0.552 . . . . 9.2799999999999994 110.56 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -142.33 27.41 1.74 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.327 1.061 . . . . 11.58 108.499 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.2 t -131.61 90.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.49 -1.687 . . . . 12.380000000000001 109.161 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.97 130.16 46.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.519 -0.764 . . . . 14.960000000000001 110.617 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.01 -11.4 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.938 -0.574 . . . . 17.27 109.69 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 p 51.1 70.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.002 -0.999 . . . . 19.469999999999999 112.159 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.4 mmt -104.63 161.58 14.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.32 -0.855 . . . . 21.73 109.242 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.57 12.54 1.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.615 -0.266 . . . . 23.079999999999998 111.645 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.196 0.522 . . . . 23.960000000000001 110.311 175.598 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 110.25 -0.278 . . . . 8.2699999999999996 110.25 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 63.84 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.091 1.145 . . . . 6.8700000000000001 114.091 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.862 ' HB2' HE22 ' A' ' 39' ' ' GLN . 29.9 m-20 -147.33 -178.39 6.2 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.933 0.716 . . . . 4.5499999999999998 112.933 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' B' ' 163' ' ' ASN . 1.7 pt? 160.74 162.66 0.01 OUTLIER 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.225 -1.028 . . . . 2.71 108.225 -165.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 58' ' ' THR . 22.1 mt-10 -87.51 157.21 19.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.296 -0.561 . . . . 4.9199999999999999 109.958 170.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m -153.75 155.21 35.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.931 -0.766 . . . . 1.22 108.931 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.472 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.1899999999999999 110.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.01 ' HA ' HD12 ' A' ' 29' ' ' LEU . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.143 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.665 0.269 . . . . 18.34 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -164.64 143.25 6.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 15.06 110.091 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.57 141.58 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.821 -0.437 . . . . 14.539999999999999 109.821 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -116.15 99.48 52.7 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 10.4 109.83 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.73 111.95 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.041 2.494 . . . . 10.74 111.453 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.56 2.71 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 7.75 112.078 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.3 pt20 -81.7 120.49 77.95 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.365 . . . . 6.8399999999999999 110.377 173.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 81.2 Cg_endo -91.48 -167.84 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.777 2.318 . . . . 4.8399999999999999 113.291 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 112' ' ' GLN . 1.0 OUTLIER -149.47 -179.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.306 -0.861 . . . . 3.2599999999999998 108.995 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.587 ' H ' HG22 ' A' ' 9' ' ' VAL . 59.3 p -92.84 -123.84 0.09 Allowed 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.27 -0.877 . . . . 2.1699999999999999 110.119 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . -171.89 119.75 0.44 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.299 -0.864 . . . . 0.97999999999999998 111.583 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.995 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 1.8400000000000001 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.692 ' H ' HG13 ' A' ' 13' ' ' VAL . 19.6 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.3100000000000001 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.501 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 3.5800000000000001 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 0.85999999999999999 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 0.93000000000000005 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.463 ' HB2' HG23 ' A' ' 104' ' ' VAL . 48.3 t-80 -78.4 83.26 4.63 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 3.5299999999999998 110.678 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.908 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 20.4 pttm -58.7 160.46 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.698 -1.137 . . . . 5.6900000000000004 110.958 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.4 tp -133.14 124.08 26.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.108 -0.637 . . . . 4.5 112.312 -165.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.878 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.66 138.22 44.63 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.585 -0.734 . . . . 5.2400000000000002 111.006 169.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.63 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -134.39 63.76 1.62 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.671 -1.15 . . . . 4.4800000000000004 111.097 174.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 16.64 69.15 0.01 OUTLIER Glycine 0 N--CA 1.469 0.877 0 O-C-N 125.393 1.683 . . . . 3.7799999999999998 116.202 174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 30.4 tt0 142.26 -25.04 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 104.218 -2.512 . . . . 6.8499999999999996 104.218 -169.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.656 ' HB3' HD11 ' A' ' 28' ' ' ILE . 10.2 m120 -128.63 133.33 48.24 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 112.758 -2.019 . . . . 4.8499999999999996 110.961 -172.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.878 HD13 ' HD2' ' A' ' 22' ' ' ARG . 2.4 mm? -115.64 109.12 17.29 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 111.69 -2.504 . . . . 3.6800000000000002 105.24 165.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.908 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 10.3 mm -110.16 132.36 58.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.479 -0.489 . . . . 2.8999999999999999 110.83 -174.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.789 ' HB3' ' HB ' ' B' ' 168' ' ' VAL . 10.7 tp -86.23 -46.51 10.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.3 -1.37 . . . . 4.1900000000000004 107.3 164.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' HG2' ' A' ' 65' ' ' PRO . . . 109.01 14.11 16.04 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.57 -1.195 . . . . 1.6200000000000001 115.165 166.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 -166.85 -178.42 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.466 1.133 . . . . 0.72999999999999998 112.038 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.895 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.1599999999999999 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' B' ' 165' ' ' GLU . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 0.89000000000000001 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' B' ' 165' ' ' GLU . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.68999999999999995 111.197 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.978 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . -150.62 109.62 0.43 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.4199999999999999 114.244 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.939 ' HA3' ' HB2' ' B' ' 163' ' ' ASN . . . 142.82 -23.24 2.31 Favored Glycine 0 CA--C 1.493 -1.31 0 C-N-CA 120.262 -0.97 . . . . 3.0 111.434 175.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.1 pt -56.99 -56.14 16.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.129 -1.536 . . . . 4.71 113.952 -164.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' H ' HG13 ' A' ' 37' ' ' ILE . 22.3 t70 -119.02 13.97 13.09 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.066 0.936 . . . . 7.4900000000000002 109.204 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.778 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.37 -16.44 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.622 -1.172 . . . . 4.5499999999999998 112.469 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.57 123.18 82.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.177 -0.675 . . . . 5.1399999999999997 109.177 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 30.8 Cg_endo -59.31 -23.53 70.36 Favored 'Trans proline' 0 C--N 1.327 -0.568 0 C-N-CA 124.32 3.347 . . . . 5.5800000000000001 113.142 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.456 ' H ' ' HG2' ' B' ' 161' ' ' LYS . 19.1 t -77.1 -33.05 57.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.146 -0.479 . . . . 6.54 110.801 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.43 -8.74 24.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.484 0.659 . . . . 5.9299999999999997 109.422 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 23.0 t-20 -150.68 88.65 4.54 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.666 -1.152 . . . . 6.0599999999999996 110.639 173.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.07 -1.06 11.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.789 2.326 . . . . 8.0299999999999994 111.412 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.92 -22.95 17.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 8.8699999999999992 111.008 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.5 m -122.78 156.9 33.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 120.888 0.375 . . . . 5.1299999999999999 110.144 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 47' ' ' SER . 10.3 pt-20 163.47 -23.6 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.349 -1.296 . . . . 7.4299999999999997 108.758 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -140.03 121.03 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.997 -1.001 . . . . 7.3899999999999997 109.752 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.8 mptt 68.13 -55.24 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.609 0.764 . . . . 7.8200000000000003 111.072 -173.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 p -77.21 -6.41 52.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.082 0.468 . . . . 5.1200000000000001 110.399 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -50.77 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.691 -1.141 . . . . 3.9700000000000002 112.035 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm 60.69 29.13 18.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.819 -0.808 . . . . 6.0899999999999999 108.819 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.778 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -40.62 -67.48 0.71 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.392 -1.276 . . . . 1.05 115.235 -168.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.978 HD13 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 0.67000000000000004 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.48 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 0.66000000000000003 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.0 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.02 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.66 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 0.71999999999999997 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 1.77 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.2799999999999998 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.624 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.3200000000000001 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 0.37 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 0.89000000000000001 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 0.34000000000000002 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.48999999999999999 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 1.5800000000000001 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.681 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.3599999999999999 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 0.56999999999999995 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.59999999999999998 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.3500000000000001 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.1800000000000002 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 33' ' ' ILE . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 0.64000000000000001 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 0.47999999999999998 111.061 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 1.028 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.1 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.2599999999999998 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 0.77000000000000002 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.8 m120 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.8999999999999999 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1000000000000001 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 2.75 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 1.028 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.6100000000000001 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.022 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.25 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.2200000000000002 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 1.73 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.755 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.3 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.813 ' HB2' HD11 ' B' ' 164' ' ' LEU . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 2.4700000000000002 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.8100000000000001 110.488 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.755 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 30.7 mm-40 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.6600000000000001 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 0.80000000000000004 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.797 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 3.9500000000000002 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.48 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 3.7999999999999998 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.26 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.53 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.774 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.79 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.04 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.522 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.3100000000000001 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.774 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.1099999999999999 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.9399999999999999 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.1699999999999999 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.1600000000000001 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.1499999999999999 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.651 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 1.3500000000000001 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.682 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 1.53 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.856 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.1399999999999999 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.701 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 0.57999999999999996 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.995 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.4900000000000002 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.867 ' HB3' HG11 ' A' ' 9' ' ' VAL . 5.1 mm100 -77.71 -58.65 3.15 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.8300000000000001 109.905 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 6.4 t 167.19 -30.66 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.253 -1.34 . . . . 4.2999999999999998 108.897 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.93 77.86 2.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.738 -1.574 . . . . 4.4800000000000004 109.954 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -89.15 -165.72 1.41 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 112.714 -2.039 . . . . 6.5300000000000002 111.023 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -120.64 176.33 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 9.2799999999999994 110.569 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.61 22.13 1.47 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.007 0.908 . . . . 11.58 109.196 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.77 91.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.08 -1.418 . . . . 12.380000000000001 110.34 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.23 89.82 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.483 -0.78 . . . . 14.960000000000001 109.449 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -83.88 -4.42 58.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.163 -0.471 . . . . 17.27 110.558 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.7 m -65.38 -79.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 19.469999999999999 111.584 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.8 -13.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.101 0.408 . . . . 21.73 112.101 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.8 mt 65.05 -166.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.494 0.496 . . . . 23.079999999999998 110.353 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.803 0.335 . . . . 23.960000000000001 110.787 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 42' ' ' SER . 11.5 mptt . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.061 0.393 . . . . 8.2699999999999996 112.061 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.33 82.85 0.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.912 0.863 . . . . 6.8700000000000001 110.86 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' ASN . . . . . 0.939 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 94.6 m-20 -91.03 -163.99 1.11 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.036 -0.983 . . . . 4.5499999999999998 109.905 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -178.42 -158.33 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.924 -0.398 . . . . 2.71 109.924 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 165' ' ' GLU . . . . . 0.681 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER 175.67 -156.72 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.256 0.973 . . . . 4.9199999999999999 112.099 168.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 166' ' ' SER . . . . . 0.797 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t -158.69 177.25 11.4 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 113.617 0.969 . . . . 1.22 113.617 -161.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.1899999999999999 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.789 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 1.54 110.829 -170.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.825 0.821 . . . . 0.98 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.013 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.35 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 1.84 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.31 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 3.58 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 0.86 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 66' ' ' ALA . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 0.93 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 3.53 114.192 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.997 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.869 -0.789 . . . . 0.73 108.869 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.16 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 0.89 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.69 112.316 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.42 109.708 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.871 0 CA-C-O 120.696 0.053 . . . . 1.05 113.114 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.67 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.6 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.48 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.906 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 0.66 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.0 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.02 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.997 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 0.72 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 1.77 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.28 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.32 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.747 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 0.37 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 0.89 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 0.34 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.49 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 1.58 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.599 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.36 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 0.57 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.6 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.6 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.906 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.35 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.18 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 0.64 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 0.48 111.206 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.054 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.26 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.751 HG21 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 0.77 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.9 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 2.75 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.981 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.61 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.054 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.25 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.22 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 1.73 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.3 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 59.8 t-80 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 2.47 110.912 -174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.612 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.81 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.78 ' HB2' HG12 ' A' ' 88' ' ' VAL . 4.9 mm100 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.66 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 0.8 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.571 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 3.95 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.48 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.631 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 3.8 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 80' ' ' VAL . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.26 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.53 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 1.79 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.04 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.576 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.31 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.11 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.94 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.17 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 97' ' ' LEU . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.16 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.15 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.662 HD11 HD12 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 1.35 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.939 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 1.53 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.14 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 0.58 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 1.013 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.49 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.83 111.521 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.504 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 21.1 m . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.729 0.27 . . . . 1.22 111.729 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.19 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.509 HG13 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 1.54 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 121.638 0.732 . . . . 0.98 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.35 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 1.84 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.545 HE22 ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.31 108.818 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 3.58 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 0.86 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 0.93 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 104' ' ' VAL . 20.6 p80 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 3.53 112.314 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 1.041 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.843 -0.428 . . . . 0.73 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.695 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.16 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.497 HG22 HG23 ' A' ' 57' ' ' VAL . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 0.89 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.69 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.42 112.285 178.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.782 -0.127 . . . . 1.05 112.782 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 0.67 110.154 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.48 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 0.66 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.695 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.02 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.041 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 0.72 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 1.77 107.113 162.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.28 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.32 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 0.37 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 0.89 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 0.34 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.49 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 1.58 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.531 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.36 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 0.57 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.6 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.619 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.35 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.18 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 0.64 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.404 ' C ' ' HG2' ' A' ' 79' ' ' GLN . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 0.48 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.8 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.26 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 0.77 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.805 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 31.4 m-80 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.9 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.543 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 2.75 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.763 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.61 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.8 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.25 111.892 -170.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.22 110.942 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 1.73 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.858 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.3 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 2.47 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG22 ' A' ' 89' ' ' THR . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.81 110.118 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.858 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.66 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 0.8 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.614 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 3.95 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.48 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 3.8 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.26 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.53 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.79 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.04 111.188 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.31 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.715 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.11 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.94 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.17 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.16 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.805 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.15 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 1.35 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 1.53 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.14 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.662 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 0.58 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HB2' HE22 ' A' ' 14' ' ' GLN . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.49 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.649 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.83 108.626 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.893 -0.41 . . . . 1.22 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.707 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.19 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 31' ' ' PHE . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 1.54 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.855 0.36 . . . . 0.98 110.475 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.35 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 1.84 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.31 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.046 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 3.58 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 0.86 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.833 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 0.93 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 3.53 112.005 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 120.507 0.194 . . . . 0.73 110.639 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.16 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.672 HD11 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 0.89 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.69 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.42 109.925 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.456 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.237 0.303 0 N-CA-C 112.838 -0.105 . . . . 1.05 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 0.67 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.48 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 0.66 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.02 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 0.72 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 1.77 107.254 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.28 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.644 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.32 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.79 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 0.37 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 0.89 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 0.34 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.49 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 1.58 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.36 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 0.57 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.624 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.6 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.35 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.18 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 0.64 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 0.48 110.518 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.997 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.26 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 0.77 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.9 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.662 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 2.75 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.893 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.61 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.25 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.22 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 1.73 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.672 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.672 ' HE1' HD11 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 2.47 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.81 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 6.5 mm100 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.66 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 0.8 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 3.95 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.48 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 3.8 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD12 HG23 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.26 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.719 HG23 HD12 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.53 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.673 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.04 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.673 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.31 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.11 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.94 107.369 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.17 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.833 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.16 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.15 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 1.35 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.046 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 1.53 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.14 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.758 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 0.58 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.623 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.49 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.83 110.324 174.286 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.69 -1.226 . . . . 1.22 107.69 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.19 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 1.54 109.988 178.623 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 122.349 1.071 . . . . 0.98 111.059 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.35 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 1.84 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.478 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.31 109.765 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.656 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 3.58 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 0.86 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.879 HD12 HD22 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 0.93 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 . . . . . 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 3.53 114.335 -171.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 . . . . . 0 C--O 1.222 -0.371 0 N-CA-C 110.468 -0.197 . . . . 0.73 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.16 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 0.89 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.69 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.42 110.729 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 115.014 0.766 . . . . 1.05 115.014 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 0.67 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.48 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 0.66 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.0 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.02 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 0.72 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 1.77 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.28 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 68' ' ' ILE . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.32 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 0.37 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 0.89 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 0.34 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.49 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.764 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 1.58 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.36 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 60' ' ' VAL . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 0.57 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.6 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.35 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.18 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 0.64 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASP . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 0.48 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.26 111.246 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 0.77 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.622 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.9 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1 112.928 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 2.75 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.61 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.805 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.25 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.22 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 1.73 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.919 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.3 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.664 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 2.47 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.81 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.919 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.66 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 0.8 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.664 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 3.95 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.48 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 3.8 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 HD12 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.53 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 1.79 109.213 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.04 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.31 113.364 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.11 111.418 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.94 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.17 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.16 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.622 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.15 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 1.35 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 1.53 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.14 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.699 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 0.58 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.49 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.511 HE22 ' HA ' ' A' ' 11' ' ' ALA . 17.1 mm-40 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.83 110.95 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.601 -0.518 . . . . 1.22 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.19 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 97' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 1.54 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.709 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.51 -0.552 . . . . 0.98 109.51 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.35 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 1.84 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 5.2 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.31 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 3.58 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 HD23 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 0.86 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.851 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.909 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 0.93 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HB2' HG23 ' A' ' 104' ' ' VAL . 10.5 t-160 . . . . . 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 3.53 112.234 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.99 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.73 108.302 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.16 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 0.89 110.247 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.69 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.744 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . . . . . . 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.42 112.091 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.05 115.042 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 0.67 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.48 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 0.66 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.0 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.02 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.99 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 0.72 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 1.77 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.28 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 68' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.32 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.809 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 0.37 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 0.89 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 0.34 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.49 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.809 HD23 ' HB1' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 1.58 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.36 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 0.57 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.6 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.35 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.662 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.18 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 0.64 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.402 ' O ' ' HG3' ' A' ' 85' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 0.48 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.051 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.26 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 0.77 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 80' ' ' VAL . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.9 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.527 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 2.75 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.88 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.61 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.25 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.22 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 1.73 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.3 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.744 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 2.47 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.81 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.66 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 0.8 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 3.95 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.48 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 3.8 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG11 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.26 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.53 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 1.79 111.534 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.04 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.31 110.089 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.11 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.565 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.94 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' HIS . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.17 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.16 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.851 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.15 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.909 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 1.35 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.051 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 1.53 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.662 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.14 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 0.58 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.668 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.49 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.709 HE22 ' HA ' ' A' ' 11' ' ' ALA . 24.5 mm-40 . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.83 109.961 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.952 -0.388 . . . . 1.22 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.19 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.432 HG11 HD11 ' A' ' 97' ' ' LEU . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 1.54 110.347 -172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . . . . . . 0 N--CA 1.445 -0.708 0 CA-C-O 121.525 0.678 . . . . 0.98 110.466 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.35 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 1.84 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 9.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.31 109.946 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 3.58 108.806 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 0.86 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.705 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 0.93 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 104' ' ' VAL . 26.8 p80 . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 3.53 112.25 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.894 0.378 . . . . 0.73 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.16 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 57' ' ' VAL . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 0.89 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.69 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.634 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.42 110.14 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 N-CA-C 114.797 0.679 . . . . 1.05 114.797 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.634 HD13 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 0.67 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.811 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.48 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.82 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 0.66 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.0 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.02 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.752 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 0.72 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 31' ' ' PHE . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 1.77 107.907 172.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.28 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.32 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 0.37 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 0.89 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 0.34 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.49 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 1.58 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.784 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.36 106.66 -175.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 0.57 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.811 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.6 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.82 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.35 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.18 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG12 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.64 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 0.48 111.537 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.905 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.26 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.598 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 0.77 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.9 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.598 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 2.75 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.61 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.25 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.22 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.776 HG13 ' NE2' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 1.73 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.562 ' HB ' ' HG3' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.3 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 2.47 111.633 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.81 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.883 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.66 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 0.8 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 3.95 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.883 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.48 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 3.8 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.26 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.664 HG22 HD12 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.53 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 1.79 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.04 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.713 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.31 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.11 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.94 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.568 ' CB ' ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.17 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 18' ' ' ILE . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.16 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.15 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 1.35 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 1.53 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.14 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.687 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 0.58 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.49 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.616 HE22 ' HA ' ' A' ' 11' ' ' ALA . 28.6 mm-40 . . . . . 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.83 112.612 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.22 114.081 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.19 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.517 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 1.54 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.437 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.931 0.872 . . . . 0.98 110.024 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.35 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 1.84 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.31 109.599 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 3.58 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 69' ' ' ALA . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 0.86 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 66' ' ' ALA . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 0.93 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 . . . . . 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 3.53 112.242 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 1.028 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.73 108.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.16 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 0.89 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.69 113.761 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.42 112.538 174.055 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 114.19 0.436 . . . . 1.05 114.19 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 0.67 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.48 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.984 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.0 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.02 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.028 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 0.72 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 1.77 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.28 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.32 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 0.37 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 0.89 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 0.34 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.49 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 1.58 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.658 HE22 ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.36 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 0.57 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.6 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' HE22 ' A' ' 72' ' ' GLN . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.35 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.673 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.18 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.669 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 0.64 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.609 ' CE ' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.48 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.852 ' HG2' ' N ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.26 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.852 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 0.77 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.745 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.9 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1 113.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.671 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 2.75 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.61 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.495 ' HG2' HG12 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.25 114.526 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.22 110.936 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.561 ' HB ' ' CD ' ' A' ' 92' ' ' GLN . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 1.73 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 92' ' ' GLN . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.475 ' HE1' HD11 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 2.47 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.81 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.66 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.718 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 0.8 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 3.95 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.48 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 3.8 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.26 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.53 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.04 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.31 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.11 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.94 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.839 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.17 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.16 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.15 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.729 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 1.35 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 1.53 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.14 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 0.58 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.574 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.49 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.83 111.879 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.22 114.071 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.19 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 1.54 110.02 177.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 CA-C-O 121.417 0.627 . . . . 0.98 110.298 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.35 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 1.84 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.521 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.31 109.496 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HG3' HD22 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 3.58 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG13 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 0.86 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 HD21 ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 0.93 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.643 ' HB2' HG23 ' A' ' 104' ' ' VAL . 8.4 t-160 . . . . . 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 3.53 110.505 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.756 -0.091 . . . . 0.73 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.16 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 HG22 HG22 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 0.89 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.69 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.42 112.229 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.319 0.488 . . . . 1.05 114.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.586 HD13 ' HA2' ' A' ' 35' ' ' GLY . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 0.67 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.48 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.658 HG21 HD21 ' A' ' 71' ' ' LEU . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 0.66 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.0 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.02 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 0.72 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 1.77 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.28 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.32 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 0.37 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 0.89 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 0.34 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.49 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 1.58 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.708 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.36 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 60' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 0.57 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.6 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.35 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.18 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 0.64 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 0.48 109.538 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.045 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 22.2 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.26 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 0.77 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.904 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.9 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 2.75 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 1.033 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.61 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 80' ' ' VAL . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.25 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.22 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.515 HG13 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 1.73 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.757 HG22 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.3 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 2.47 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 89' ' ' THR . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.81 110.544 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.757 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.66 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 0.8 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 3.95 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.48 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.746 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 3.8 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.26 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.53 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 1.79 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.04 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.31 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.11 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.94 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.17 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.16 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.904 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.15 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 1.35 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.045 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 1.53 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.14 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 0.58 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.555 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.49 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.83 108.434 169.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.8 0.334 . . . . 1.22 110.216 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.19 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 31' ' ' PHE . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 1.54 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.05 0 CA-C-O 121.76 0.791 . . . . 0.98 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.35 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 1.84 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.514 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.31 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.752 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 3.58 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 0.86 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.887 HD13 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 0.93 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.687 ' HA ' HG23 ' A' ' 104' ' ' VAL . 14.0 t-160 . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 3.53 110.52 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 110.615 -0.143 . . . . 0.73 110.615 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.953 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.16 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 0.89 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.69 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.42 111.854 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 114.331 0.493 . . . . 1.05 114.331 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 0.67 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.48 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 0.66 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.0 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.02 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 0.72 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 1.77 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.28 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.32 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 0.37 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 0.89 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 0.34 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.49 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 1.58 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.36 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 0.57 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.638 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.6 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.826 ' H ' HG12 ' A' ' 57' ' ' VAL . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.35 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.18 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 0.64 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.567 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 0.48 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.812 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.26 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 0.77 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.9 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.578 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 2.75 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.812 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.61 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.25 112.397 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.22 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 1.73 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.662 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.3 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 2.47 110.592 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.739 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.81 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.662 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 7.5 mm100 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.66 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 0.8 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.739 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 3.95 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.48 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 3.8 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.26 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.706 HG23 HD12 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.53 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.757 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 1.79 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.04 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.31 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.757 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.11 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.94 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.17 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 18' ' ' ILE . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.16 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.15 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.887 HD22 HD13 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 1.35 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 1.53 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.14 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 0.58 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.607 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.49 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.83 109.479 174.468 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.898 -0.038 . . . . 1.22 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.19 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 1.54 108.584 178.231 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.113 0 CA-C-O 121.818 0.818 . . . . 0.98 109.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.35 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 1.84 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.31 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 3.58 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 0.86 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.841 HG21 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 0.93 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 . . . . . 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 3.53 111.425 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.874 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 . . . . . 0 C--O 1.242 0.659 0 CA-C-O 120.801 0.334 . . . . 0.73 111.479 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.16 111.381 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.961 HG22 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 0.89 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.69 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.42 111.265 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.434 -1.472 0 CA-C-O 120.942 0.19 . . . . 1.05 113.356 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 0.67 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.48 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.961 HG23 HG22 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 0.66 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HG23 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.02 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 0.72 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 1.77 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.787 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.28 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.56 ' O ' HG13 ' A' ' 68' ' ' ILE . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.32 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 0.37 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.787 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 0.89 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 0.34 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.49 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.852 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 1.58 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.852 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.36 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.589 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 0.57 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.796 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.6 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.824 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.35 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.705 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.18 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 0.64 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.386 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.26 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 0.77 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.9 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.656 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 2.75 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.569 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.61 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.25 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.22 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.882 HG13 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 1.73 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.967 HG22 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.3 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 2.47 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.81 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.967 ' HB2' HG22 ' A' ' 89' ' ' THR . 8.6 tp-100 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.66 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 0.8 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.668 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 3.95 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.48 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.656 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 3.8 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.26 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.663 HG23 HD12 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.53 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.76 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 1.79 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.04 110.974 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.562 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.31 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.11 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.94 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.17 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.16 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.15 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 1.35 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 1.53 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.14 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 0.58 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.699 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.49 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.643 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.83 109.298 -167.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 120.27 0.081 . . . . 1.22 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.66 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.19 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 1.54 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.818 0.818 . . . . 0.98 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.35 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 1.84 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.31 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 3.58 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 0.86 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.914 ' HB3' HG23 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.897 HD12 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 0.93 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 3.53 110.949 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.979 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.813 -0.44 . . . . 0.73 109.813 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.16 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 0.89 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.69 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.42 111.514 179.626 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.05 114.882 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.494 HG21 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 0.67 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.48 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 0.66 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.621 HG23 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.0 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.621 ' HG2' HG23 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.02 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.979 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 0.72 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 1.77 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.28 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.48 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.32 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 0.37 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 0.89 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 0.34 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.49 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 1.58 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.611 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.36 108.73 -164.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 60' ' ' VAL . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 0.57 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.64 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.6 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.844 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.35 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.733 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.18 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG23 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 0.64 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 0.48 109.962 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.26 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 0.77 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.9 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1 112.465 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 2.75 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.889 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.61 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.727 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.25 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.22 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.727 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 1.73 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.3 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 2.47 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.81 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.66 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 0.8 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 3.95 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 3.8 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.748 HD12 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.26 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.748 HG23 HD12 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.53 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 1.79 107.196 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.04 107.751 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.31 110.359 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.11 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.94 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.17 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG23 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.16 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.812 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.15 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 1.35 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.974 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.14 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 0.58 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.49 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.83 110.272 -175.886 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.023 0.379 . . . . 1.22 112.023 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.19 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.506 ' CG1' HD13 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 1.54 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.545 0.688 . . . . 0.98 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.35 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 1.84 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.31 110.482 178.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.627 ' NE ' HD21 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 3.58 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.686 HG13 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 0.86 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.943 HG23 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 0.93 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.587 ' HB3' HG23 ' A' ' 104' ' ' VAL . 7.4 p80 . . . . . 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 3.53 111.965 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.987 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 110.115 -0.328 . . . . 0.73 110.115 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.16 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.682 HG22 HG23 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 0.89 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.69 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.42 111.13 178.345 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 N-CA-C 115.477 0.951 . . . . 1.05 115.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.498 HG21 ' SD ' ' A' ' 85' ' ' MET . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 0.67 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.48 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 0.66 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.0 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.02 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.987 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 0.72 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 1.77 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.28 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.32 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.943 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 0.37 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 0.89 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 0.34 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.49 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 1.58 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.36 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 0.57 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.6 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.726 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.35 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.18 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.532 HG23 ' HB3' ' A' ' 107' ' ' LEU . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 0.64 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.513 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 0.48 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.934 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.26 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 0.77 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.705 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.9 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1 112.626 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.599 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 2.75 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.888 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.61 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.25 111.614 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.22 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.573 HG13 ' NE2' ' A' ' 92' ' ' GLN . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 1.73 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.677 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.3 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 2.47 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.81 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.751 HE21 ' N ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.66 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 0.8 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.693 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 3.95 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.48 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 83' ' ' TRP . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 3.8 112.327 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.778 ' HB2' HG21 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.26 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 HD12 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.53 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 101' ' ' SER . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 1.79 113.189 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.04 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.31 111.234 -175.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.11 110.464 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.94 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.17 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.16 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.15 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 1.35 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.934 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 1.53 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.14 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.745 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 0.58 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.49 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.83 109.684 -179.183 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.775 -0.454 . . . . 1.22 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.19 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 1.54 110.633 -176.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.925 0 CA-C-O 121.71 0.767 . . . . 0.98 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.35 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 1.84 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.499 HE22 ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.31 110.412 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 3.58 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.859 HG13 HD12 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 0.86 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.807 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 0.93 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.713 ' HB2' HG23 ' A' ' 104' ' ' VAL . 19.7 t-160 . . . . . 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 3.53 112.339 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 1.05 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.141 0.496 . . . . 0.73 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.16 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 0.89 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.69 111.188 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.42 110.444 177.554 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 115.026 0.771 . . . . 1.05 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.55 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 0.67 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.48 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 0.66 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.02 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.05 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 0.72 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.576 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 1.77 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.28 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.32 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 0.37 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 0.89 109.006 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 0.34 107.423 171.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.49 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 1.58 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.36 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 0.57 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.6 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.727 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.35 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.748 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.18 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 0.64 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.402 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.48 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.26 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.557 HG11 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 0.77 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.842 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 15.3 m-80 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.9 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 2.75 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.61 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.25 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.22 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.907 HG13 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 1.73 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.3 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' N ' HG23 ' A' ' 89' ' ' THR . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 2.47 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.81 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.907 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.5 tp-100 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.66 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 0.8 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 3.95 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.48 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 3.8 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.26 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.543 HG23 HD12 ' A' ' 97' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.53 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 1.79 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.04 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.712 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.31 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.11 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.94 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG23 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.17 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.807 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.16 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.15 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.859 HD12 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 1.35 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 1.53 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.14 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 0.58 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.727 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.49 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.83 109.363 176.195 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.804 -0.443 . . . . 1.22 109.804 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.19 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 1.54 108.084 173.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 1.007 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 121.647 0.737 . . . . 0.98 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.35 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 1.84 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.31 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 3.58 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 0.86 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.847 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.898 HG21 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 0.93 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.892 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 . . . . . 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 3.53 112.401 -173.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.898 ' HE2' HG21 ' A' ' 18' ' ' ILE . 28.2 p90 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 120.685 0.279 . . . . 0.73 111.577 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.16 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG22 HG23 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 0.89 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.69 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.42 111.37 177.453 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 114.446 0.538 . . . . 1.05 114.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 0.67 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.48 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.768 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 0.66 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.0 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.02 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 0.72 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 1.77 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.28 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.796 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.32 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.916 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HA ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 0.89 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 0.34 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.49 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.916 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 1.58 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.47 ' N ' HD13 ' A' ' 71' ' ' LEU . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.36 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 0.57 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.6 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.768 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.35 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 110' ' ' THR . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.18 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 0.64 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 0.48 110.003 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.26 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 0.77 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.67 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 18.2 m-80 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.9 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.584 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 2.75 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.798 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.61 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.706 ' HB3' HG12 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.25 112.139 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.22 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 1.73 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.781 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.3 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.511 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 38.6 t-80 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 2.47 111.025 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.81 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.781 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 4.4 mm100 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.66 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 0.8 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.602 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 3.95 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.48 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 3.8 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.26 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 94' ' ' ARG . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.53 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 1.79 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.04 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.554 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.31 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.11 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.94 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.17 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.16 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.15 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 1.35 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 1.53 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.14 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.007 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 0.58 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.49 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.83 109.185 -157.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.511 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 39.6 m . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.818 -0.438 . . . . 1.22 109.818 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.19 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.427 HG23 ' OXT' ' B' ' 168' ' ' VAL . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 1.54 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.878 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.51 -0.587 0 CA-C-O 121.025 0.44 . . . . 0.98 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.35 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 1.84 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.31 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HE ' HD21 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 3.58 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 0.86 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.939 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 0.93 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG22 ' A' ' 18' ' ' ILE . 11.3 t-160 . . . . . 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 3.53 112.668 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.784 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 111.825 0.306 . . . . 0.73 111.825 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.495 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.16 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.592 HG22 HG23 ' A' ' 57' ' ' VAL . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 0.89 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.69 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.42 112.021 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.699 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 112.335 -0.306 . . . . 1.05 112.335 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.697 HD13 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 0.67 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.48 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 0.66 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.02 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 0.72 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 1.77 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.689 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.28 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.755 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.689 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.32 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 0.37 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 0.89 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 0.34 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.49 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 1.58 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.772 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 5.4 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.36 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 0.57 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.723 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.6 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.796 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.35 108.394 -172.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.18 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 0.64 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 0.48 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.077 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.7 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.26 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 0.77 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.749 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.9 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.691 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 2.75 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.932 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.61 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.077 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.25 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.22 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 1.73 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.827 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.3 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 2.47 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.81 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.827 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 5.8 mm100 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.66 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 0.8 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.517 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 3.95 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.48 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.881 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 3.8 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.823 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.26 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.53 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 101' ' ' SER . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 1.79 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.04 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.505 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.31 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.11 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.94 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.17 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.16 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.939 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.15 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 1.35 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.891 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 1.53 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.14 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.878 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 0.58 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.49 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.62 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.83 108.072 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.416 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.9 m . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.04 -0.029 . . . . 1.22 110.945 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.19 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 1.54 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.885 0.85 . . . . 0.98 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.35 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 1.84 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.31 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 3.58 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.786 HG13 HD23 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 0.86 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.051 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 0.93 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.727 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 3.53 111.254 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 120.507 0.194 . . . . 0.73 110.947 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.16 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.89 109.788 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.69 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.42 109.164 169.346 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 114.323 0.489 . . . . 1.05 114.323 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 0.67 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.48 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 0.66 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.0 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.736 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.02 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 0.72 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 1.77 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.28 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' O ' HG13 ' A' ' 68' ' ' ILE . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.32 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.051 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 0.37 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 0.89 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 0.34 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.49 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HB1' ' A' ' 66' ' ' ALA . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 1.58 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.36 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 0.57 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.6 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.775 ' H ' HG12 ' A' ' 57' ' ' VAL . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.35 109.208 -171.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.802 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.18 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.64 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.483 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 0.48 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.729 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.26 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 0.77 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.9 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.542 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 2.75 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.61 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.729 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.25 110.745 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.22 108.627 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 HH22 ' A' ' 96' ' ' ARG . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 1.73 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 2.47 111.499 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.765 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.81 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.732 ' NE2' HG13 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.66 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 0.8 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 3.95 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.48 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.743 HH22 HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 3.8 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.673 HD11 HG21 ' B' ' 168' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.26 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.53 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.04 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.31 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.11 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.94 108.729 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.17 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 18' ' ' ILE . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.16 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.15 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.786 HD23 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 1.35 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 1.53 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.14 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.802 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 0.58 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.49 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 . . . . . 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.83 108.405 173.859 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 110.787 -0.079 . . . . 1.22 110.787 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.19 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 1.54 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.502 -0.867 0 CA-C-O 122.055 0.931 . . . . 0.98 111.759 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.35 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 1.84 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.31 109.82 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HD22 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 3.58 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 0.86 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 0.93 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 3.53 111.484 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.897 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 109.717 -0.475 . . . . 0.73 109.717 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.16 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 0.89 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.69 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.42 109.692 176.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.05 115.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 0.67 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.48 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 0.66 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.69 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.02 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.897 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 0.72 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.49 ' HG ' ' N ' ' A' ' 31' ' ' PHE . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 1.77 109.042 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.28 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.32 114.951 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 0.37 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 0.89 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 0.34 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.49 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.767 HD23 ' HB1' ' A' ' 66' ' ' ALA . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 1.58 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.36 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.507 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 0.57 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.6 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.795 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.35 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.18 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 0.64 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 0.48 110.296 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.26 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.717 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 0.77 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.9 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 2.75 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.791 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.61 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.25 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.22 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.772 HG22 HE22 ' A' ' 92' ' ' GLN . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 1.73 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.573 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.3 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 2.47 111.444 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.81 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.782 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.66 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.785 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 0.8 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 3.95 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.715 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.48 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 3.8 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.26 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.53 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 1.79 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.566 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.04 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.655 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.31 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.11 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.94 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.17 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.16 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.15 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.559 HD22 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 1.35 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 1.53 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.14 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 0.58 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.49 111.441 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.83 111.3 -178.778 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.22 112.615 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.19 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 1.54 109.477 171.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.486 -1.512 0 CA-C-O 122.39 1.09 . . . . 0.98 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.35 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 1.84 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.31 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 3.58 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 0.86 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.785 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 0.93 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 104' ' ' VAL . 15.8 p80 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 3.53 111.667 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.717 0.294 . . . . 0.73 111.322 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.782 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.16 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.897 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 0.89 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.69 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.42 111.753 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 115.734 1.054 . . . . 1.05 115.734 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 0.67 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.48 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.897 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 0.66 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.0 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.02 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 0.72 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 1.77 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.28 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.32 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.785 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 0.37 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 0.89 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 0.34 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.49 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 1.58 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.36 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 0.57 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.568 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.6 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.771 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.35 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.18 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 0.64 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.429 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 0.48 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.104 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.26 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.666 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 0.77 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.9 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1 112.218 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.666 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 2.75 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 1.104 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.61 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.547 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.25 111.936 -175.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.22 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.906 HG12 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 1.73 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.918 HG22 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.3 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.918 ' H ' HG22 ' A' ' 89' ' ' THR . 18.0 t-160 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 2.47 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.81 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.906 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.66 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.874 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 0.8 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 3.95 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.48 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.608 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 3.8 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 HG21 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.26 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.529 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.53 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.79 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.04 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.31 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.713 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.11 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.94 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.17 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 18' ' ' ILE . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.16 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' C ' HD13 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.15 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 1.35 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.817 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 1.53 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 110' ' ' THR . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.14 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.82 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 0.58 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.49 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.83 109.692 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.22 113.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.782 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.19 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 97' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 1.54 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.68 0.753 . . . . 0.98 110.956 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.35 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 1.84 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.574 ' NE2' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.31 110.223 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HE ' HD21 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 3.58 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 0.86 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.761 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 0.93 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.64 ' HB3' HG23 ' A' ' 104' ' ' VAL . 25.2 p80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 3.53 112.402 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.586 -1.264 . . . . 0.73 107.586 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.16 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.796 HG23 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 0.89 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.69 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.923 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.42 107.299 162.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 113.916 0.326 . . . . 1.05 113.916 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.923 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 0.67 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.48 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.872 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 0.66 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.0 111.425 -173.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.583 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.02 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 0.72 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 1.77 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.28 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.32 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.825 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 0.37 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 0.89 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 0.34 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.49 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.662 HD22 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 1.58 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.36 107.426 -173.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 0.57 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.744 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.6 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.872 ' H ' HG12 ' A' ' 57' ' ' VAL . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.35 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.18 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.686 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 0.64 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 0.48 110.237 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.0 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 9.9 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.26 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.737 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 0.77 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 38.7 m-80 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.9 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.595 ' HB2' HG13 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 1.0 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.61 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.737 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.25 112.605 -167.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.22 111.564 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 1.73 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.069 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.3 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.446 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 2.47 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.81 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 1.069 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.66 109.486 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.681 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 0.8 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.796 HH22 HG23 ' A' ' 33' ' ' ILE . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 3.95 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.48 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.532 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 3.8 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.26 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.774 HG22 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.53 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 1.79 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.575 ' HA ' ' HE ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.04 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.529 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.31 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.601 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.11 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.94 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.17 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.16 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.815 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.15 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 1.35 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD21 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 1.53 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.14 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 0.58 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.67 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.49 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.667 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.83 109.566 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.931 -0.766 . . . . 1.22 108.931 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.19 110.676 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.143 176.936 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.363 0.602 . . . . 0.98 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.35 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.995 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 1.84 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.692 ' H ' HG13 ' A' ' 13' ' ' VAL . 1.5 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.31 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.501 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 3.58 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.651 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 0.86 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 0.93 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.463 ' HB2' HG23 ' A' ' 104' ' ' VAL . 48.3 t-80 . . . . . 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 3.53 110.678 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.973 0.416 . . . . 0.73 112.038 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.895 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.16 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.579 HG22 HG23 ' A' ' 57' ' ' VAL . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 0.89 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.69 111.197 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.978 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.42 114.244 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 115.235 0.854 . . . . 1.05 115.235 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.978 HD13 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 0.67 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.48 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 0.66 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.0 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.02 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.66 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 0.72 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 1.77 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.28 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.624 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.32 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 0.37 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 0.89 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 0.34 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.49 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 1.58 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.681 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.36 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 0.57 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.6 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.35 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.18 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 33' ' ' ILE . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 0.64 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 0.48 111.061 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 1.028 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.3 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.26 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 0.77 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 17.4 m-80 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.9 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 2.75 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 1.028 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.61 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.022 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.25 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.22 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 1.73 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.755 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.3 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.441 ' NE2' ' HB2' ' B' ' 166' ' ' SER . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 2.47 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.81 110.488 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.755 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 5.7 mm100 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.66 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 0.8 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.797 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 3.95 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.48 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 3.8 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.26 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.53 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.774 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.79 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.04 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.522 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.31 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.774 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.11 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.94 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.17 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.16 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.15 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.651 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 1.35 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.682 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 1.53 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.856 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.14 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.701 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 0.58 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.995 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.49 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.461 ' N ' HE21 ' A' ' 112' ' ' GLN . 8.5 mm-40 . . . . . 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.83 109.905 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' SER . . . . . 0.797 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.617 0.969 . . . . 1.22 113.617 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.19 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 1.54 110.829 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.031 -0.359 . . . . 18.34 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 63.85 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 123.878 0.736 . . . . 15.06 112.2 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 72.73 117.99 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.316 -0.856 . . . . 14.54 111.693 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.6 mt -131.79 104.13 14.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.638 -0.71 . . . . 10.4 109.626 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -68.61 134.71 31.27 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.25 2.633 . . . . 10.74 112.081 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.04 -17.62 34.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.921 -0.657 . . . . 7.75 111.975 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -101.05 123.53 44.8 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-O 120.801 0.334 . . . . 6.84 110.591 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.75 135.13 37.35 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.825 2.35 . . . . 4.84 112.53 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.22 -1.08 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 122.289 1.042 . . . . 3.26 109.606 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p 68.4 -65.38 0.27 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.749 -2.478 . . . . 2.17 111.971 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.81 113.77 0.95 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.596 -1.184 . . . . 0.98 111.085 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.013 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 25.2 t -84.93 117.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.622 -1.172 . . . . 1.35 109.311 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.41 109.31 21.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.517 0.675 . . . . 1.84 109.311 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.92 147.14 44.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.89 -1.05 . . . . 2.31 108.589 -172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 78.0 mtm-85 -106.61 131.56 53.62 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-O 122.031 0.92 . . . . 3.58 109.859 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 HG13 ' A' ' 18' ' ' ILE . 2.1 p -138.65 127.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 113.976 -1.465 . . . . 0.86 109.421 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 2.4 pt-20 -103.3 108.33 19.51 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.832 0.825 . . . . 1.75 109.521 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 HD23 ' A' ' 29' ' ' LEU . 87.7 mt -105.53 121.19 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 114.328 -1.306 . . . . 0.93 109.87 -174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 25.8 p80 -109.4 126.75 53.77 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 114.192 1.182 . . . . 3.53 114.192 -172.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.697 ' HA ' ' HG ' ' A' ' 29' ' ' LEU . 20.8 pttp -47.27 155.38 0.32 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.306 -1.315 . . . . 5.69 111.062 172.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 42.6 tp -131.79 159.67 37.8 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.693 0.758 . . . . 4.5 110.823 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' NH1' HD21 ' A' ' 27' ' ' LEU . 13.9 tpt180 -72.54 118.48 15.5 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.509 -1.223 . . . . 5.24 113.505 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -136.99 64.24 1.54 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.32 -1.309 . . . . 4.48 109.116 167.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.5 -109.41 2.78 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.187 -1.37 . . . . 3.78 112.0 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.43 -0.43 55.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.237 -1.024 . . . . 6.85 108.237 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 19.5 m-80 -102.69 133.21 48.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 122.993 1.378 . . . . 4.85 108.83 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' C ' ' HB2' ' A' ' 20' ' ' LYS . 4.5 mm? -119.58 105.32 11.09 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 112.394 -2.184 . . . . 3.68 107.62 168.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -155.72 162.84 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 113.789 1.033 . . . . 2.9 113.789 -174.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 HG22 ' A' ' 18' ' ' ILE . 1.1 mp -97.75 -49.25 4.9 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.06 -1.427 . . . . 4.19 109.783 -165.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 95.14 6.75 59.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.656 -0.783 . . . . 1.62 113.65 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.997 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 16.6 p90 -98.51 167.37 10.86 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.869 -0.789 . . . . 0.73 108.869 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 16.3 t -124.26 140.58 52.82 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.049 -0.66 . . . . 1.16 110.894 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 57' ' ' VAL . 2.0 pp -130.85 144.18 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 109.352 -0.61 . . . . 0.89 109.352 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.707 ' HA3' ' CG2' ' A' ' 37' ' ' ILE . . . -111.34 121.08 5.66 Favored Glycine 0 N--CA 1.425 -2.092 0 C-N-CA 119.599 -1.286 . . . . 0.69 112.316 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -119.52 75.54 0.31 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 109.708 -1.357 . . . . 1.42 109.708 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.643 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . 145.33 -9.54 1.71 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.698 -1.239 . . . . 3.0 111.213 -168.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.707 ' CG2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -38.35 -47.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.546 1.313 . . . . 4.71 114.546 -168.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -121.32 17.24 11.45 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.323 0.582 . . . . 7.49 110.564 -175.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.643 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -119.73 -147.06 0.39 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.741 1.015 . . . . 4.55 113.741 -176.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.761 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 8.3 t70 -179.22 172.03 0.62 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 107.027 -1.471 . . . . 5.14 107.027 -153.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 74.4 Cg_endo -83.81 -14.51 7.56 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 121.825 1.684 . . . . 5.58 112.43 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.3 m -78.34 -8.28 58.24 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.581 -1.191 . . . . 6.54 113.042 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.761 ' OE1' ' HB3' ' A' ' 40' ' ' ASP . 1.3 mp0 -91.31 -23.46 20.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.075 0.464 . . . . 5.93 111.44 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.598 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 10.9 t30 -53.46 -32.87 11.7 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 115.116 1.524 . . . . 6.06 115.116 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 44' ' ' ASN . 2.4 Cg_endo -45.0 -25.0 1.47 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.703 1.602 . . . . 8.03 111.61 167.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 47' ' ' SER . 74.4 m-85 -120.4 -9.87 9.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.521 -0.763 . . . . 8.87 112.188 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 24.1 m 69.04 30.39 4.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.253 -0.647 . . . . 5.13 109.253 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 15.0 tp10 87.65 -60.06 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.29 -1.777 . . . . 7.43 111.101 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.0 t70 -150.46 35.34 0.64 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.589 -0.893 . . . . 7.39 108.589 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 26.8 mmtp 71.19 112.73 0.06 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 113.952 -1.476 . . . . 7.82 111.285 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p 58.97 12.29 2.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.021 -0.99 . . . . 5.12 111.728 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.856 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 4.0 t70 -67.52 -70.18 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.046 -0.979 . . . . 3.97 111.117 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' B' ' 161' ' ' LYS . 29.2 mmtp 76.91 -21.17 0.34 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.109 -0.951 . . . . 6.09 111.632 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.558 ' HA3' ' OE1' ' A' ' 39' ' ' GLN . . . 66.26 56.31 14.48 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.399 -0.819 . . . . 1.05 113.114 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.6 mm -106.5 121.6 59.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.67 110.186 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.6 ' CZ ' ' HA2' ' A' ' 74' ' ' GLY . 15.8 t80 -159.7 130.76 5.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.949 -0.569 . . . . 2.48 111.185 -168.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.906 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -73.11 129.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.65 -0.5 . . . . 0.66 109.65 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -115.64 -1.68 12.66 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.605 1.191 . . . . 1.0 111.054 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -169.18 171.68 7.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.382 0.611 . . . . 3.02 110.757 174.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.997 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 78.5 t -148.48 138.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 114.408 -1.269 . . . . 0.72 109.591 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.5 p -71.14 100.74 2.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.403 -0.962 . . . . 1.77 108.403 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.47 146.18 43.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 122.868 1.318 . . . . 3.28 112.127 -169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 61.66 28.54 70.03 Favored Glycine 0 C--N 1.293 -1.827 0 CA-C-N 111.736 -2.484 . . . . 1.03 111.047 -171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.85 -122.13 3.93 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.2 -1.0 . . . . 1.27 112.269 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.77 -39.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.469 2.779 . . . . 1.32 115.655 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.747 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -75.51 -41.64 54.7 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.24 1.019 . . . . 0.37 108.688 -166.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -85.7 -22.0 28.04 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.074 -1.421 . . . . 1.45 108.412 -163.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 69' ' ' ALA . 27.4 pt -79.42 -31.83 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-O 122.299 1.047 . . . . 0.89 108.407 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -64.45 -28.01 69.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.215 -1.811 . . . . 0.34 108.409 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.97 44.8 0.48 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.636 -1.165 . . . . 0.49 112.096 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.6 tm? -124.66 161.18 26.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.631 . . . . 1.58 106.595 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.599 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -164.72 -178.29 5.22 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.719 -0.845 . . . . 2.36 108.719 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.86 113.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 121.172 -0.211 . . . . 0.57 110.877 -171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.6 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.84 52.0 0.47 Allowed Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 119.558 -1.306 . . . . 0.6 111.268 172.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.906 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -130.02 133.96 47.09 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.556 -0.535 . . . . 1.35 109.556 -168.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 1.9 mptp? -99.69 106.94 18.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.763 -0.775 . . . . 2.18 109.505 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 mt -84.42 117.08 29.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.755 -1.112 . . . . 0.64 110.441 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.3 mmt -99.15 -24.62 14.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.031 -0.531 . . . . 0.48 111.206 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.054 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 3.2 pt20 -165.12 158.01 16.25 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 122.255 1.026 . . . . 2.26 112.853 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.751 HG21 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -133.87 131.76 56.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 112.528 -2.124 . . . . 0.77 111.285 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' ARG . 84.3 m-20 58.11 19.26 5.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 122.199 1.0 . . . . 1.9 109.877 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.66 8.85 65.13 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.58 -1.645 . . . . 1.1 113.433 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -100.27 86.05 3.12 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 117.587 0.693 . . . . 2.75 109.478 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.981 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 6.8 t70 -26.29 108.53 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.113 0.883 . . . . 1.61 111.858 167.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.054 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 37.3 mtp -77.95 -9.67 59.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.346 -0.843 . . . . 1.72 112.776 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 p -72.58 -35.54 67.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.043 0.386 . . . . 1.25 112.043 -170.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.4 mtp -94.54 0.5 55.29 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.029 -0.419 . . . . 3.22 111.515 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.5 t -109.93 174.74 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.235 -0.654 . . . . 1.73 109.235 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -103.39 164.46 11.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.861 0.755 . . . . 1.3 109.984 -173.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' HE1' ' OG ' ' B' ' 166' ' ' SER . 59.8 t-80 -61.77 -38.75 89.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.87 0.367 . . . . 2.47 110.912 -174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.612 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.9 t70 -69.86 -40.48 75.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.81 109.68 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.78 ' HB2' HG12 ' A' ' 88' ' ' VAL . 4.9 mm100 -59.36 -41.19 88.69 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.205 1.002 . . . . 2.66 109.122 175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.2 -44.21 89.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.29 -1.323 . . . . 0.8 108.286 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.571 HH22 HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -54.57 -40.48 68.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.854 -1.066 . . . . 3.95 110.769 178.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 62.2 mttm -58.27 -50.92 71.9 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.682 -0.69 . . . . 2.48 111.776 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.631 ' NH2' ' HA ' ' A' ' 85' ' ' MET . 7.1 ptt-85 -87.34 -9.33 55.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.16 0.8 . . . . 3.8 113.16 -169.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 80' ' ' VAL . 56.4 mt -81.21 -37.83 28.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.472 0.653 . . . . 1.26 111.452 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.0 p -134.25 55.95 1.87 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.046 -0.979 . . . . 1.53 112.736 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 101' ' ' SER . 18.3 ptmt -97.49 -152.36 0.39 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.355 -0.538 . . . . 1.79 109.596 169.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 100' ' ' ARG . 8.9 mmt85 -127.8 29.71 5.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.244 0.545 . . . . 5.04 110.494 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.576 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 31.9 m -112.77 -10.1 13.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.363 -0.835 . . . . 2.31 111.006 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -124.13 179.66 4.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.145 -1.057 . . . . 2.11 108.145 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' HIS . 72.1 mm-40 -136.5 10.43 3.19 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 106.639 -1.615 . . . . 3.94 106.639 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 14.9 p -177.33 144.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 112.681 -2.054 . . . . 1.17 111.179 -163.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 97' ' ' LEU . 16.9 m -114.5 118.0 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.138 0.494 . . . . 2.16 110.329 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 9.3 ttt180 -87.11 116.2 25.01 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 121.671 0.748 . . . . 3.15 111.087 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.662 HD11 HD12 ' A' ' 18' ' ' ILE . 12.1 mt -106.32 146.09 30.83 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 1.35 112.54 -167.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.939 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 4.4 mm? -106.14 107.8 18.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.003 -1.48 . . . . 1.53 107.003 162.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 110' ' ' THR . 6.1 p -123.38 169.34 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 108.849 -0.797 . . . . 1.14 108.849 -172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 5.2 p -127.18 110.09 12.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.385 -1.28 . . . . 0.58 111.609 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 1.013 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 15.8 mmt85 -91.16 151.95 20.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.019 -0.991 . . . . 3.49 111.211 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 113' ' ' SER . 24.4 mm-40 -100.2 -17.05 17.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.322 -0.854 . . . . 2.83 111.521 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 64.2 m 88.49 -4.38 0.49 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 113.187 -1.824 . . . . 4.3 110.438 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 114' ' ' LEU . 3.1 mm? -97.85 69.03 2.08 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.417 -1.72 . . . . 4.48 109.184 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.96 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 112.258 -2.247 . . . . 6.53 112.496 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.74 118.51 7.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 9.28 111.355 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.87 20.99 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.253 -1.388 . . . . 11.58 107.253 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p 30.45 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.112 -2.313 . . . . 12.38 113.617 -168.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.11 113.0 26.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.172 -0.922 . . . . 14.96 109.486 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.41 81.41 6.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.944 0.402 . . . . 17.27 111.153 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 p -110.64 109.46 19.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.019 -0.537 . . . . 19.47 110.431 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 ttt -132.05 115.32 15.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.369 -0.378 . . . . 21.73 110.899 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.193 -0.458 . . . . 23.08 110.097 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.572 . . . . 23.96 111.283 -176.777 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' B' ' 161' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 121.14 0.495 . . . . 8.27 110.684 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.636 ' HB3' ' N ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -83.86 171.17 13.33 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.432 0.901 . . . . 6.87 113.432 -164.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.633 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 28.3 t-20 -45.99 99.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.877 -1.51 . . . . 4.55 113.756 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.437 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 2.3 pt? -153.04 120.39 5.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.527 0.679 . . . . 2.71 111.212 163.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -111.72 168.46 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.149 -0.685 . . . . 4.92 109.149 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.504 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 21.1 m -164.74 141.31 6.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.729 0.27 . . . . 1.22 111.729 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 23.3 ptp -91.26 150.42 21.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.731 -0.47 . . . . 3.19 109.731 167.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.551 ' OXT' ' HB2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 107.902 -1.147 . . . . 1.54 107.902 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.872 0.367 . . . . 18.34 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -122.99 -48.19 2.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.429 -0.582 . . . . 15.06 109.429 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -113.86 132.53 55.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.978 -0.749 . . . . 14.54 108.978 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.38 97.89 51.01 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.628 -0.26 . . . . 10.4 110.324 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.95 3.77 7.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.686 2.924 . . . . 10.74 111.305 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.01 40.49 2.06 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.334 -1.303 . . . . 7.75 111.269 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 23.7 pt20 -63.58 127.85 91.91 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.933 -0.395 . . . . 6.84 109.933 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 40.4 Cg_endo -93.51 -166.85 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.087 2.525 . . . . 4.84 113.72 -173.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 10' ' ' THR . 9.2 p 49.23 157.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.326 1.85 . . . . 3.26 114.61 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 9' ' ' VAL . 34.0 p -107.67 -39.85 5.48 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.98 -1.463 . . . . 2.17 110.759 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.53 115.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.202 -1.817 . . . . 0.98 110.274 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -86.32 134.74 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 108.082 -1.081 . . . . 1.35 108.082 170.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.92 122.58 49.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.514 -0.766 . . . . 1.84 110.196 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.545 HE22 ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -139.58 163.74 31.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.818 -0.808 . . . . 2.31 108.818 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 83.8 mtt180 -126.06 136.09 52.52 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.239 -0.891 . . . . 3.58 109.571 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 2.4 p -139.12 127.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.67 -0.863 . . . . 0.86 108.67 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 30.1 mt-10 -105.14 107.08 17.87 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.248 -1.019 . . . . 1.75 108.248 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 71' ' ' LEU . 82.9 mt -107.43 129.25 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 123.293 0.637 . . . . 0.93 109.454 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 104' ' ' VAL . 20.6 p80 -107.89 79.71 1.3 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.838 0.828 . . . . 3.53 112.314 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.9 ' HD3' ' HD2' ' A' ' 31' ' ' PHE . 7.3 mtpm? -136.94 86.9 2.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.531 -1.213 . . . . 5.69 109.197 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 28' ' ' ILE . 4.1 pp -152.51 161.61 42.35 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.403 -0.817 . . . . 4.5 109.328 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 100' ' ' ARG . 3.6 tmt_? -64.63 108.96 1.84 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.955 -0.387 . . . . 5.24 109.955 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.084 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -127.88 64.28 1.38 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.981 0.895 . . . . 4.48 110.543 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.76 -96.77 0.96 Allowed Glycine 0 CA--C 1.491 -1.428 0 CA-C-N 113.625 -1.625 . . . . 3.78 112.584 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 25' ' ' GLU . 1.2 tp10 -83.65 -1.02 53.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.415 -0.957 . . . . 6.85 108.415 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.084 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.2 m-80 -115.65 130.44 56.86 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-O 122.784 1.278 . . . . 4.85 108.968 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' A' ' 22' ' ' ARG . 3.3 mm? -121.7 106.78 11.64 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 112.288 -2.233 . . . . 3.68 107.841 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.735 HG12 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -112.26 127.16 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.892 -1.522 . . . . 2.9 106.892 172.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' B' ' 168' ' ' VAL . 12.3 tp -168.98 58.62 0.05 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.376 -1.342 . . . . 4.19 107.376 -160.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . -126.48 -54.13 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 116.52 1.368 . . . . 1.62 116.52 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.041 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p90 -77.94 147.18 35.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.01 1.405 . . . . 0.73 109.843 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.695 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 43.1 t -113.38 138.97 49.3 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.893 -0.594 . . . . 1.16 111.165 -163.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 38.4 pt -128.63 147.34 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.579 -0.737 . . . . 0.89 109.077 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.87 142.01 15.81 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.093 -1.051 . . . . 0.69 112.117 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.96 122.32 2.68 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 112.285 -0.326 . . . . 1.42 112.285 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.0 57.25 0.53 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.973 -0.451 . . . . 3.0 111.973 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -132.84 -37.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.791 0.329 . . . . 4.71 110.726 176.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -81.77 -4.87 57.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.942 -0.572 . . . . 7.49 110.282 -177.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.89 HE22 HD12 ' B' ' 164' ' ' LEU . 12.0 mm-40 -89.86 -79.76 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.745 -0.661 . . . . 4.55 112.348 -162.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 13.0 t70 -148.78 140.61 14.51 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.704 -0.68 . . . . 5.14 110.153 -168.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 37.5 Cg_endo -60.64 -20.49 65.25 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 123.475 2.783 . . . . 5.58 113.116 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -62.28 -28.88 70.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.384 -0.371 . . . . 6.54 111.626 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.705 HE22 ' HB2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -89.14 -16.58 31.07 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 116.388 -0.369 . . . . 5.93 110.862 -175.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -124.39 91.62 49.25 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.256 -0.577 . . . . 6.06 112.302 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -95.38 17.55 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.292 2.662 . . . . 8.03 110.61 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.626 ' HD1' ' HB2' ' A' ' 47' ' ' SER . 42.2 t80 179.13 -41.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.213 -0.903 . . . . 8.87 109.96 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.661 ' OG ' ' HD2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -175.68 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.075 -1.083 . . . . 5.13 108.075 -170.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 11.8 tp10 -172.87 -89.34 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.493 -1.685 . . . . 7.43 108.505 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.46 61.05 0.7 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.548 -0.861 . . . . 7.39 110.442 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 65.19 -72.21 0.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.136 . . . . 7.82 112.06 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -88.23 15.86 7.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.821 -0.627 . . . . 5.12 111.751 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.1 t70 -110.26 -170.27 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.581 -0.525 . . . . 3.97 109.581 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.803 ' HG3' HG21 ' A' ' 86' ' ' THR . 15.6 tptm -135.85 -10.77 2.05 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.253 -0.885 . . . . 6.09 108.977 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 -4.2 56.55 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.508 -0.769 . . . . 1.05 112.782 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 37' ' ' ILE . 27.1 mm -131.05 122.36 51.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.154 -0.313 . . . . 0.67 110.154 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 19.2 p90 -161.74 169.55 21.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.351 -0.611 . . . . 2.48 109.351 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 71' ' ' LEU . 1.2 p -94.29 133.85 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 118.608 0.64 . . . . 0.66 109.305 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -112.21 -6.7 14.08 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 124.743 1.277 . . . . 1.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.695 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 6.6 ptt180 -174.14 171.74 3.48 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.178 0.513 . . . . 3.02 111.006 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.041 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 71.7 t -145.63 139.63 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.825 -1.079 . . . . 0.72 109.934 -174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 3.9 m -67.17 98.61 0.61 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.113 -1.44 . . . . 1.77 107.113 162.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.13 155.29 32.46 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-O 122.614 1.197 . . . . 3.28 111.529 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.38 19.77 77.81 Favored Glycine 0 C--N 1.295 -1.714 0 CA-C-N 112.66 -2.064 . . . . 1.03 110.746 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.58 -145.78 6.88 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.082 -1.056 . . . . 1.27 112.931 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.841 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 2.9 Cg_exo -80.37 -32.69 1.2 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 124.692 3.595 . . . . 1.32 114.814 -169.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -68.16 -48.36 65.52 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.409 1.1 . . . . 0.37 108.218 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.64 -26.23 45.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 1.45 110.171 -166.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 65' ' ' PRO . 2.1 pp -80.07 -28.97 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 122.033 0.92 . . . . 0.89 108.74 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -64.1 -26.24 68.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.555 -1.657 . . . . 0.34 107.959 171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.86 54.18 0.53 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.371 -1.286 . . . . 0.49 111.07 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 57' ' ' VAL . 3.0 tm? -136.99 143.99 43.07 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.699 -1.223 . . . . 1.58 107.699 -175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.531 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.46 159.5 12.39 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.7 -1.136 . . . . 2.36 109.57 -167.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.4 mm -65.82 117.08 5.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.368 -0.833 . . . . 0.57 112.53 -163.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 107.58 51.49 0.75 Allowed Glycine 0 CA--C 1.498 -0.988 0 CA-C-N 114.242 -1.345 . . . . 0.6 110.663 171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.619 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.5 t0 -137.35 127.35 25.87 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.402 -0.519 . . . . 1.35 109.901 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 68.2 mttt -87.88 106.83 18.36 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.367 -0.533 . . . . 2.18 110.375 -168.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.23 97.23 2.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.049 -0.978 . . . . 0.64 109.664 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.404 ' C ' ' HG2' ' A' ' 79' ' ' GLN . 5.9 mmt -80.09 -32.02 39.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.984 -0.553 . . . . 0.48 110.656 -172.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.8 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -150.95 157.96 43.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.537 1.16 . . . . 2.26 112.861 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 85' ' ' MET . 0.6 OUTLIER -115.1 122.71 69.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 112.695 -2.048 . . . . 0.77 110.093 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.805 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 31.4 m-80 57.29 9.55 0.74 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.181 0.515 . . . . 1.9 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.01 1.2 26.96 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.64 -0.709 . . . . 1.1 112.939 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.543 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 2.5 m95 -99.4 88.93 4.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.343 -0.614 . . . . 2.75 109.343 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.763 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -28.52 104.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.338 1.024 . . . . 1.61 110.99 167.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.8 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 54.7 mtp -69.99 -13.21 62.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.042 -0.981 . . . . 1.72 112.053 -174.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.803 HG21 ' HG3' ' A' ' 53' ' ' LYS . 59.3 p -94.76 -5.5 45.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.91 0.386 . . . . 1.25 111.892 -170.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -102.04 -12.86 17.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.863 0.363 . . . . 3.22 110.942 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -98.01 -165.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.593 -0.891 . . . . 1.73 108.593 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.858 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.2 m -100.96 156.67 17.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.191 -1.411 . . . . 1.3 107.191 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 28.8 t60 -59.15 -36.01 74.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.689 0.28 . . . . 2.47 111.503 -173.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG22 ' A' ' 89' ' ' THR . 18.3 t70 -71.56 -37.1 71.11 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.056 0.455 . . . . 1.81 110.118 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.858 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 5.3 mm100 -61.82 -46.6 88.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.766 0.793 . . . . 2.66 109.781 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -70.68 -31.92 68.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.968 -1.015 . . . . 0.8 109.506 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.614 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 4.3 ptt180 -76.12 -25.71 55.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.881 -0.599 . . . . 3.95 110.414 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.4 pttp -81.37 -17.81 47.74 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 121.057 -0.257 . . . . 2.48 110.54 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 1.4 mmp_? -70.39 -27.12 64.06 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.231 0.539 . . . . 3.8 110.776 168.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 16.8 mt -75.63 -37.84 59.42 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.211 1.005 . . . . 1.26 109.628 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.5 p -124.15 57.04 1.23 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.781 -1.554 . . . . 1.53 111.751 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 55.8 pttt -76.25 -6.24 50.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.79 111.517 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 74.38 2.55 4.14 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.778 -1.101 . . . . 5.04 111.188 176.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.549 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 17.7 m -113.61 15.74 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.903 0.382 . . . . 2.31 110.89 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.715 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -135.89 155.35 50.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 2.11 107.977 178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -109.94 6.86 23.54 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.982 0.896 . . . . 3.94 109.183 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p -165.54 140.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 113.826 -1.534 . . . . 1.17 110.225 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 97' ' ' LEU . 2.0 t -100.17 124.17 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 CA-C-N 115.81 -0.632 . . . . 2.16 109.501 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.805 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -84.62 144.26 28.72 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.125 -0.694 . . . . 3.15 109.125 174.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 11.1 mp -134.23 156.66 47.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 1.35 111.754 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.0 mt -128.61 113.92 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.295 -1.321 . . . . 1.53 108.12 170.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 110' ' ' THR . 12.3 p -124.58 164.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 121.061 0.457 . . . . 1.14 109.785 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.662 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 18.8 p -126.59 113.37 16.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.384 -0.825 . . . . 0.58 111.863 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HB2' HE22 ' A' ' 14' ' ' GLN . 8.9 mmt85 -96.45 156.09 16.49 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.622 -1.172 . . . . 3.49 110.008 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.649 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -103.89 -30.76 10.14 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.713 1.244 . . . . 2.83 108.626 170.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 70.8 m 82.66 2.81 1.14 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 111.087 -2.779 . . . . 4.3 111.617 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.1 mm? -123.13 41.85 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.341 -1.3 . . . . 4.48 109.023 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.9 137.59 3.14 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.061 -2.336 . . . . 6.53 112.71 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -149.89 154.21 37.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.625 -0.716 . . . . 9.28 109.563 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -139.08 27.06 2.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.29 1.043 . . . . 11.58 108.824 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.1 t -123.06 84.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 113.634 -1.621 . . . . 12.38 109.709 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.18 107.33 8.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.463 -0.789 . . . . 14.96 110.637 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.52 -17.29 13.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 17.27 110.489 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.4 p -157.72 151.48 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.93 -0.577 . . . . 19.47 110.192 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.61 164.4 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.255 -0.429 . . . . 21.73 110.072 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.58 117.97 6.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.697 0.284 . . . . 23.08 110.723 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.123 -0.489 . . . . 23.96 110.442 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 29.9 mtmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.745 0.307 . . . . 8.27 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.53 145.12 45.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.206 0.527 . . . . 6.87 111.367 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -150.33 3.97 0.51 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.701 -0.681 . . . . 4.55 112.678 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.89 HD12 HE22 ' A' ' 39' ' ' GLN . 3.0 mt -96.16 138.44 33.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.464 -0.773 . . . . 2.71 111.846 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.6 pt-20 -139.61 172.26 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.226 -1.028 . . . . 4.92 108.226 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.4 m -149.97 120.97 7.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.893 -0.41 . . . . 1.22 109.893 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.707 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 65.1 mtp -100.47 106.75 18.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.505 -0.771 . . . . 3.19 109.842 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 11.5 m . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.515 -0.55 . . . . 1.54 109.515 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.24 -0.652 . . . . 18.34 109.24 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -132.95 143.22 49.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.985 0.422 . . . . 15.06 111.572 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -78.93 101.43 7.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.883 -0.598 . . . . 14.54 110.108 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -136.68 99.24 10.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.38 -0.827 . . . . 10.4 109.58 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.85 116.56 4.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.898 2.399 . . . . 10.74 111.287 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.97 -14.99 5.42 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.845 -0.693 . . . . 7.75 111.74 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -105.79 147.46 34.76 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 120.638 0.256 . . . . 6.84 110.345 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.57 155.72 56.81 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.292 2.661 . . . . 4.84 112.986 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 10' ' ' THR . 9.8 p -84.8 162.94 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.576 0.703 . . . . 3.26 110.316 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 9' ' ' VAL . 82.5 p -98.34 -60.04 1.63 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.785 -1.098 . . . . 2.17 109.977 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -171.67 121.7 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.124 -1.398 . . . . 0.98 110.475 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 79.2 t -71.22 109.14 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.72 -0.844 . . . . 1.35 108.72 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.37 104.97 15.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.83 -0.804 . . . . 1.84 108.83 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 109' ' ' VAL . 13.2 tt0 -134.15 137.14 44.28 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.039 -0.982 . . . . 2.31 110.345 -170.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.046 ' HD2' HD22 ' A' ' 108' ' ' LEU . 14.0 mmt180 -115.0 107.75 15.79 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.273 -0.876 . . . . 3.58 108.724 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.98 130.67 68.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.206 0.527 . . . . 0.86 110.506 -175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.9 pm0 -91.58 107.46 19.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.594 -0.73 . . . . 1.75 109.785 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.833 ' HB ' HG13 ' A' ' 105' ' ' VAL . 11.0 mm -85.9 159.5 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 108.202 -1.036 . . . . 0.93 108.202 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' HB2' HG23 ' A' ' 104' ' ' VAL . 11.5 t-80 -152.74 90.24 1.46 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.764 -0.653 . . . . 3.53 112.005 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HD2' ' HB ' ' B' ' 168' ' ' VAL . 7.6 ptmm? -61.5 152.56 29.8 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.849 -1.167 . . . . 5.69 107.849 167.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 28' ' ' ILE . 2.8 tt -124.32 121.55 35.3 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.383 -1.327 . . . . 4.5 113.346 -155.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -87.13 124.14 32.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.785 0.802 . . . . 5.24 110.143 167.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -130.77 63.63 1.58 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.597 -1.183 . . . . 4.48 110.145 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 77.8 -97.73 1.38 Allowed Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 114.182 -1.372 . . . . 3.78 112.26 169.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -77.93 -5.87 52.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.194 -1.039 . . . . 6.85 108.194 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.682 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 27.7 m-80 -111.61 131.81 55.0 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-O 123.507 1.622 . . . . 4.85 110.682 -175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.3 mm? -121.84 114.62 21.3 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 110.905 -2.861 . . . . 3.68 105.156 165.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 21' ' ' LEU . 33.3 mm -100.82 117.52 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 118.915 -1.114 . . . . 2.9 109.759 -173.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 7.9 tp -113.03 75.35 0.91 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 110.571 -3.013 . . . . 4.19 105.751 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.55 1.12 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 113.884 -1.507 . . . . 1.62 115.656 -162.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 21.5 p90 -77.38 174.27 11.0 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.273 0.537 . . . . 0.73 110.639 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -123.21 141.71 51.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.109 -0.637 . . . . 1.16 110.788 -166.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.672 HD11 ' HE1' ' A' ' 90' ' ' HIS . 2.0 pp -131.09 148.83 32.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.859 -0.793 . . . . 0.89 108.859 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.32 123.64 7.93 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.034 -1.079 . . . . 0.69 112.067 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' B' ' 164' ' ' LEU . . . -127.01 131.86 7.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 109.925 -1.27 . . . . 1.42 109.925 172.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.74 -26.37 0.94 Allowed Glycine 0 C--O 1.229 -0.208 0 C-N-CA 119.851 -1.166 . . . . 3.0 113.089 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -58.99 -36.84 64.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.557 0.577 . . . . 4.71 112.557 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' CG ' HG23 ' A' ' 89' ' ' THR . 29.3 t70 -105.16 13.79 30.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.49 -0.777 . . . . 7.49 110.637 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -98.26 -83.04 0.41 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.286 -0.566 . . . . 4.55 111.241 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 41' ' ' PRO . 26.2 t70 -156.29 125.31 3.04 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.051 -0.522 . . . . 5.14 110.07 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 74.1 Cg_endo -66.78 -13.04 38.35 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.912 3.075 . . . . 5.58 112.056 -175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.728 ' HB2' ' HG3' ' B' ' 161' ' ' LYS . 12.8 m -61.23 -45.05 96.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.14 -0.936 . . . . 6.54 110.141 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.682 ' OE1' ' HA ' ' B' ' 162' ' ' GLU . 7.0 pt20 -99.11 -36.78 9.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.001 0.429 . . . . 5.93 110.327 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.773 HD22 ' HA ' ' A' ' 48' ' ' GLU . 22.8 m120 -101.57 101.31 16.98 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.868 -0.606 . . . . 6.06 109.636 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.35 -14.45 38.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.039 2.493 . . . . 8.03 112.372 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -166.04 -40.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.194 -0.457 . . . . 8.87 110.75 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.692 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.4 p -149.13 -63.92 0.23 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.558 0.694 . . . . 5.13 109.87 -170.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.773 ' HA ' HD22 ' A' ' 44' ' ' ASN . 0.4 OUTLIER -171.97 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.009 -1.45 . . . . 7.43 108.554 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 7.1 t70 -142.7 -158.77 0.9 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.748 -1.114 . . . . 7.39 108.63 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 4.9 mtpm? -64.92 -66.25 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.121 0.486 . . . . 7.82 111.429 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -111.28 21.87 15.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.84 -0.618 . . . . 5.12 110.966 -175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 25.6 t70 -70.07 -41.23 74.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.34 0.867 . . . . 3.97 113.34 -174.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mptp? 90.25 -37.03 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.53 1.132 . . . . 6.09 110.525 -175.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 97.46 0.81 59.32 Favored Glycine 0 C--O 1.237 0.303 0 C-N-CA 120.668 -0.777 . . . . 1.05 112.838 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 85' ' ' MET . 39.4 mm -125.34 106.51 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.731 -0.84 . . . . 0.67 108.731 173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 1.7 p90 -160.92 167.4 26.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.028 -0.269 . . . . 2.48 111.003 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.58 139.43 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 108.9 -0.778 . . . . 0.66 108.9 170.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.534 HG21 ' HG2' ' B' ' 165' ' ' GLU . 14.6 t -117.9 -8.82 10.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.6 ttm180 -174.96 167.18 3.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.143 -0.935 . . . . 3.02 110.052 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 55.9 t -146.32 133.26 14.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.961 -1.018 . . . . 0.72 109.31 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -76.45 102.99 6.22 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.254 -1.387 . . . . 1.77 107.254 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -69.22 149.23 48.79 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.75 1.262 . . . . 3.28 112.02 -168.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 68.24 25.66 74.5 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 112.225 -2.261 . . . . 1.03 111.136 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.644 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -109.86 -125.32 4.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.101 -1.047 . . . . 1.27 112.566 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 68' ' ' ILE . 57.2 Cg_endo -98.73 -39.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.361 2.707 . . . . 1.32 115.356 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.79 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -74.61 -44.18 51.9 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.608 1.194 . . . . 0.37 108.657 -164.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.72 -22.74 34.35 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.482 -1.69 . . . . 1.45 108.07 -162.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -82.03 -27.25 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 CA-C-N 114.419 -1.264 . . . . 0.89 108.679 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.98 68.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.024 -1.898 . . . . 0.34 107.803 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.92 51.7 0.4 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.254 -1.339 . . . . 0.49 111.394 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -130.44 155.17 46.87 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.109 -1.812 . . . . 1.58 106.109 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.663 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -162.63 171.65 16.59 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 116.053 -0.522 . . . . 2.36 110.093 -172.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 59' ' ' ARG . 1.6 mm -73.36 113.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.194 -0.912 . . . . 0.57 112.404 -165.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.624 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.48 64.87 0.62 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.557 -1.017 . . . . 0.6 110.557 170.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' CG ' ' HB3' ' A' ' 111' ' ' ARG . 0.8 OUTLIER -142.69 121.08 12.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.411 . . . . 1.35 110.051 -170.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -97.18 110.11 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.338 -0.945 . . . . 2.18 111.158 -172.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 107' ' ' LEU . 41.6 mt -69.95 113.29 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.161 -1.381 . . . . 0.64 110.614 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' ' HE3' ' A' ' 53' ' ' LYS . 16.8 mmt -89.15 -38.54 14.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.284 0.564 . . . . 0.48 110.518 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.997 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.68 155.33 46.52 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 122.015 0.912 . . . . 2.26 111.517 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 85' ' ' MET . 3.4 p -115.78 124.47 72.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.366 -1.743 . . . . 0.77 109.24 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 19.0 m-80 61.13 4.59 0.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.009 0.374 . . . . 1.9 112.009 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.85 -3.19 11.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.053 -1.07 . . . . 1.1 114.317 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.662 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -126.92 117.86 23.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.343 1.072 . . . . 2.75 111.27 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.893 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.5 t70 -27.05 120.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.766 -1.561 . . . . 1.61 113.558 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -110.05 10.79 24.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 1.72 112.02 177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.6 p -85.08 -20.22 30.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.014 0.435 . . . . 1.25 111.1 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 41.2 mtt -78.36 -26.47 46.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.636 . . . . 3.22 110.167 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -82.31 -178.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.041 -0.981 . . . . 1.73 110.556 -173.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.672 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -102.88 161.77 13.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.672 ' HE1' HD11 ' A' ' 33' ' ' ILE . 80.4 t60 -62.07 -36.31 81.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.517 0.199 . . . . 2.47 110.496 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.19 -45.83 83.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.939 -0.573 . . . . 1.81 109.701 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 6.5 mm100 -56.18 -50.97 69.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.953 -1.022 . . . . 2.66 109.598 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -64.5 -40.0 94.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.362 -1.29 . . . . 0.8 109.405 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 13.2 mtp180 -63.89 -53.81 44.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.738 -0.664 . . . . 3.95 110.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -19.18 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.124 -0.489 . . . . 2.48 112.254 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.62 -38.02 17.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 119.625 -0.83 . . . . 3.8 110.974 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD12 HG23 ' A' ' 98' ' ' THR . 4.2 pp -70.95 -28.32 64.4 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.909 -0.494 . . . . 1.26 111.163 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.719 HG23 HD12 ' A' ' 97' ' ' LEU . 9.8 p -110.71 47.67 0.96 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 1.53 110.629 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.673 ' HE3' ' HB3' ' A' ' 101' ' ' SER . 36.3 pttt -78.66 -2.64 40.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.403 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? 74.51 -21.08 0.3 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.697 -1.138 . . . . 5.04 111.184 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.673 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 24.9 t -76.15 -16.61 59.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.912 -1.144 . . . . 2.31 107.912 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 99' ' ' LYS . 11.6 pt-20 -147.06 146.22 29.92 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.743 -1.577 . . . . 2.11 106.743 169.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 10.0 pt-20 -122.43 11.18 9.93 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 123.092 1.425 . . . . 3.94 107.369 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -97.17 166.44 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 112.005 -2.361 . . . . 1.17 107.713 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.833 HG13 ' HB ' ' A' ' 18' ' ' ILE . 7.5 p -148.66 108.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.62 -1.232 . . . . 2.16 110.462 169.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -83.74 139.66 32.59 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.015 -0.993 . . . . 3.15 109.283 176.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 77' ' ' ILE . 5.3 mt -125.36 129.01 49.07 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.127 -0.942 . . . . 1.35 109.963 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.046 HD22 ' HD2' ' A' ' 15' ' ' ARG . 7.9 mt -99.98 105.3 16.98 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.787 -1.931 . . . . 1.53 105.787 160.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 110' ' ' THR . 2.7 p -122.69 177.99 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.381 -0.827 . . . . 1.14 110.197 -160.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.758 ' OG1' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -146.8 109.91 4.74 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.03 -1.441 . . . . 0.58 111.422 -173.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.623 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 22.7 ptt180 -121.55 169.02 11.08 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 121.199 0.523 . . . . 3.49 111.196 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -88.64 -45.47 9.82 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.619 0.723 . . . . 2.83 110.324 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.543 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 9.1 t 91.17 -2.88 0.22 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.185 -2.28 . . . . 4.3 109.344 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 113' ' ' SER . 1.7 mm? -120.35 18.27 12.19 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.097 -1.865 . . . . 4.48 107.734 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HG3' ' H ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.27 140.28 40.02 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.324 -2.671 . . . . 6.53 111.367 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.646 ' HB3' HG22 ' A' ' 118' ' ' VAL . 38.8 mmtm -147.38 161.28 41.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.313 -0.858 . . . . 9.28 109.771 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.86 24.02 2.61 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.596 1.188 . . . . 11.58 108.645 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 116' ' ' LYS . 17.0 m -91.17 25.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 113.096 -1.865 . . . . 12.38 111.075 -174.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -105.34 141.54 36.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.912 -1.04 . . . . 14.96 110.09 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.73 171.93 10.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.36 0.6 . . . . 17.27 111.266 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.9 m -88.73 123.67 33.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 19.47 110.765 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.88 -14.42 54.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 21.73 109.727 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 123' ' ' LEU . 5.7 mp -86.09 129.98 34.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.475 -0.784 . . . . 23.08 110.185 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.107 -0.497 . . . . 23.96 109.768 174.378 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.728 ' HG3' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.513 0.673 . . . . 8.27 111.667 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.682 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.5 pt-20 -169.53 106.39 0.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 6.87 110.142 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -111.45 -100.12 0.41 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.544 -1.207 . . . . 4.55 110.716 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 75.6 mt 66.83 -81.94 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.148 0.905 . . . . 2.71 111.522 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.534 ' HG2' HG21 ' A' ' 58' ' ' THR . 34.0 mt-10 -56.87 118.16 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.008 0.908 . . . . 4.92 112.912 -171.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 26.7 m -130.8 114.16 14.98 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.285 -1.325 . . . . 1.22 107.69 167.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 51.7 mtt -77.06 142.53 39.79 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.912 -0.315 . . . . 3.19 110.357 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 31.1 m . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.173 -0.918 . . . . 1.54 109.988 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.566 0.222 . . . . 18.34 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' ILE . 11.5 p -100.33 20.78 14.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.332 -0.23 . . . . 15.06 111.347 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.9 -31.69 0.22 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.622 0.769 . . . . 14.54 112.32 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 2' ' ' SER . 49.7 mm 57.7 95.93 0.05 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 124.042 0.937 . . . . 10.4 112.111 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 135.01 67.43 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.936 2.424 . . . . 10.74 111.913 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.32 -38.72 2.4 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.588 -0.605 . . . . 7.75 111.588 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 28.2 mt-30 -91.71 147.57 35.4 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 6.84 109.99 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.2 Cg_exo -71.73 -175.79 1.77 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.107 2.538 . . . . 4.84 112.518 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.784 HG22 ' H ' ' A' ' 10' ' ' THR . 8.0 p -74.34 178.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 3.26 110.314 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 9' ' ' VAL . 44.5 p -135.47 113.68 11.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.816 0.817 . . . . 2.17 110.547 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -49.19 115.26 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.257 -1.792 . . . . 0.98 111.059 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 110' ' ' THR . 5.2 t -83.99 132.5 31.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 113.008 -1.905 . . . . 1.35 108.532 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -102.69 118.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.059 -0.973 . . . . 1.84 110.485 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.478 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -123.91 131.74 53.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.462 0.649 . . . . 2.31 109.765 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.656 ' HD3' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -105.17 104.03 13.69 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.291 -1.374 . . . . 3.58 107.291 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 18' ' ' ILE . 6.3 p -127.8 125.69 65.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.428 -1.26 . . . . 0.86 110.652 -168.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 52.2 mt-10 -100.35 107.8 19.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.079 -0.964 . . . . 1.75 108.826 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.879 HD12 HD22 ' A' ' 107' ' ' LEU . 78.5 mt -105.14 116.64 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.571 -1.195 . . . . 0.93 110.189 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 p80 -106.45 89.27 2.99 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 114.335 1.235 . . . . 3.53 114.335 -171.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.703 ' HE2' ' HG3' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -89.11 162.86 15.73 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.286 -1.325 . . . . 5.69 107.457 160.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.774 ' HB3' HE21 ' A' ' 23' ' ' GLN . 42.6 tp -150.73 138.84 20.14 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 116.834 -1.947 . . . . 4.5 115.091 -153.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' C ' ' HD2' ' A' ' 22' ' ' ARG . 1.6 tmm_? -81.38 112.49 18.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 5.24 108.276 162.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.774 HE21 ' HB3' ' A' ' 21' ' ' LEU . 2.4 mt-30 -112.32 65.84 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.045 0.926 . . . . 4.48 109.685 -173.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.66 -102.42 1.75 Allowed Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 113.954 -1.476 . . . . 3.78 111.772 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.6 3.04 46.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 6.85 109.908 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 36.5 m-80 -105.49 142.99 34.29 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 123.236 1.494 . . . . 4.85 109.689 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.1 mm? -130.22 111.73 12.69 Favored 'General case' 0 C--N 1.256 -3.478 0 CA-C-N 111.238 -2.71 . . . . 3.68 107.054 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 21' ' ' LEU . 7.6 mm -106.27 118.17 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 109.504 -0.554 . . . . 2.9 109.504 -176.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 1.7 tp -123.73 80.1 1.77 Allowed 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 127.365 2.916 . . . . 4.19 107.475 -173.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.66 -82.58 1.02 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 113.694 -1.594 . . . . 1.62 115.97 -166.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.975 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 18.2 p90 -81.44 165.75 20.98 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 117.266 0.533 . . . . 0.73 110.468 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 15.9 m -122.14 140.53 52.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.328 0.585 . . . . 1.16 111.047 -167.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 pt -126.48 139.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.753 -0.658 . . . . 0.89 109.338 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.12 13.07 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.583 -1.294 . . . . 0.69 112.438 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -131.4 91.27 0.29 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.729 -0.948 . . . . 1.42 110.729 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 39' ' ' GLN . . . 150.36 31.43 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.935 -1.126 . . . . 3.0 112.499 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.834 HG12 HE22 ' A' ' 39' ' ' GLN . 16.8 pt -52.58 -48.57 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.621 0.6 . . . . 4.71 112.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -125.67 -8.92 6.77 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.076 -0.713 . . . . 7.49 109.076 176.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.834 HE22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -139.69 -148.95 0.26 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.511 -1.222 . . . . 4.55 110.913 -168.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 9.6 t70 -161.68 137.64 5.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.578 -0.897 . . . . 5.14 108.578 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 71.6 Cg_endo -70.23 -18.57 34.72 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.324 2.683 . . . . 5.58 113.707 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 m -70.31 -40.89 73.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.221 0.534 . . . . 6.54 109.794 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 40' ' ' ASP . 30.2 mt-30 -88.15 -29.3 20.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.765 -0.652 . . . . 5.93 110.559 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.676 HD21 ' HA ' ' A' ' 47' ' ' SER . 29.4 t30 -122.05 89.62 48.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.26 -0.882 . . . . 6.06 110.533 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -86.49 33.61 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.212 2.608 . . . . 8.03 111.626 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -154.33 -71.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.821 -0.627 . . . . 8.87 111.557 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.676 ' HA ' HD21 ' A' ' 44' ' ' ASN . 3.6 m 150.25 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.413 -1.328 . . . . 5.13 107.413 -162.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.97 -16.7 31.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.108 -0.637 . . . . 7.43 110.409 -172.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.4 t70 -101.81 5.75 41.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.414 -0.812 . . . . 7.39 109.876 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 21.3 mmtt 70.78 -66.23 0.3 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.202 -0.908 . . . . 7.82 111.09 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -83.11 20.04 1.32 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.213 -0.903 . . . . 5.12 109.735 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' LYS . 4.6 t70 -39.55 -71.11 0.09 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 113.654 -1.612 . . . . 3.97 110.992 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG3' ' SD ' ' A' ' 78' ' ' MET . 5.1 mptp? 56.36 38.12 29.45 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.942 0.877 . . . . 6.09 108.783 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 37' ' ' ILE . . . -56.54 -3.96 0.77 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 113.494 -1.685 . . . . 1.05 115.014 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.0 mm -112.66 126.88 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 122.721 0.408 . . . . 0.67 110.902 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -158.21 170.86 21.32 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.321 -0.252 . . . . 2.48 110.321 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 71' ' ' LEU . 8.6 t -85.33 135.37 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.032 -0.729 . . . . 0.66 109.032 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -116.47 -8.91 11.52 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 125.136 1.522 . . . . 1.0 109.901 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -170.67 168.13 7.59 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.549 -0.75 . . . . 3.02 110.458 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.975 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 40.7 t -141.67 139.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.468 -1.242 . . . . 0.72 108.647 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -72.73 100.96 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.859 -1.163 . . . . 1.77 107.859 166.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.26 138.97 55.96 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.783 1.278 . . . . 3.28 111.965 -168.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 65.54 32.27 82.77 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.74 -2.482 . . . . 1.03 110.325 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.69 -122.25 3.97 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.441 -0.885 . . . . 1.27 112.936 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.703 ' HG3' ' HE2' ' A' ' 20' ' ' LYS . 92.9 Cg_endo -101.08 -40.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.477 2.785 . . . . 1.32 115.559 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -73.72 -44.12 57.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.919 0.866 . . . . 0.37 108.906 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -83.02 -22.8 33.5 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 113.988 -1.46 . . . . 1.45 108.266 -163.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -84.1 -27.71 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 114.51 -1.223 . . . . 0.89 108.749 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.98 -22.42 62.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 112.936 -1.938 . . . . 0.34 108.364 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.16 48.09 0.68 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.756 -1.111 . . . . 0.49 112.311 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.764 HD11 HG21 ' A' ' 57' ' ' VAL . 3.3 tm? -126.7 158.44 36.43 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.567 -1.272 . . . . 1.58 107.567 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.6 179.1 7.44 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.112 -0.494 . . . . 2.36 109.878 -175.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 60' ' ' VAL . 5.9 mm -80.53 115.67 23.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 122.286 1.041 . . . . 0.57 113.126 -169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.47 35.03 1.35 Allowed Glycine 0 CA--C 1.497 -1.056 0 CA-C-N 113.477 -1.692 . . . . 0.6 110.456 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 3.1 t0 -114.57 121.69 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.003 -0.679 . . . . 1.35 111.189 -167.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 11.7 mttp -86.78 107.75 18.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 2.18 110.938 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HG ' ' A' ' 107' ' ' LEU . 59.3 mt -77.11 113.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.237 -0.892 . . . . 0.64 110.416 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.623 ' SD ' ' HG3' ' A' ' 53' ' ' LYS . 18.4 mmt -99.07 -31.36 11.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.969 -0.752 . . . . 0.48 108.969 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -132.37 149.95 52.25 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.799 0.809 . . . . 2.26 111.246 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 85' ' ' MET . 14.0 p -134.62 137.37 51.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 113.336 -1.757 . . . . 0.77 109.618 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.622 ' CA ' ' HB2' ' A' ' 106' ' ' ARG . 14.9 m120 66.7 2.13 2.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.993 0.425 . . . . 1.9 110.87 174.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.57 -8.84 10.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.1 112.928 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -130.67 136.35 48.73 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.659 0.729 . . . . 2.75 112.08 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 78' ' ' MET . 12.6 t0 -35.69 121.47 0.62 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.002 -1.454 . . . . 1.61 111.633 167.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.805 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -104.14 7.42 36.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.656 -0.702 . . . . 1.72 112.553 -176.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -81.8 -25.78 34.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.758 -0.377 . . . . 1.25 111.786 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtt -77.47 -6.32 53.09 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.902 0.382 . . . . 3.22 111.616 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -105.74 -176.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.124 -0.489 . . . . 1.73 109.75 176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.919 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.2 m -93.88 159.22 15.28 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.418 -1.327 . . . . 1.3 107.418 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.664 ' O ' ' HB3' ' A' ' 94' ' ' ARG . 6.3 t60 -59.3 -37.03 76.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.215 -0.291 . . . . 2.47 110.215 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 23.2 t70 -66.13 -45.19 81.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.452 -0.573 . . . . 1.81 109.452 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.919 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.8 mm100 -58.89 -51.27 70.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.694 0.759 . . . . 2.66 110.59 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 85' ' ' MET . . . -68.12 -24.29 65.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.813 -1.085 . . . . 0.8 109.392 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.664 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 3.9 ptt180 -80.92 -34.01 33.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.582 -0.736 . . . . 3.95 109.524 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 22.1 mttp -62.87 -20.52 65.2 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.66 0.267 . . . . 2.48 111.063 170.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.2 mmm180 -75.07 -50.14 17.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.902 -0.777 . . . . 3.8 108.902 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 HG23 ' A' ' 98' ' ' THR . 2.6 pp -79.72 -25.98 40.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.731 HG23 HD12 ' A' ' 97' ' ' LEU . 33.6 p -107.12 42.24 1.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.458 -0.497 . . . . 1.53 111.06 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 23.0 pttm -84.29 -164.06 0.89 Allowed 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.213 -0.662 . . . . 1.79 109.213 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -116.27 20.19 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.977 0.418 . . . . 5.04 109.911 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 23.8 m -114.9 -9.49 12.45 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.364 0.876 . . . . 2.31 113.364 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 13.3 pt-20 -129.44 -176.72 3.98 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.822 0.82 . . . . 2.11 111.418 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 104' ' ' VAL . 14.5 pt-20 -128.57 2.2 5.56 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-N 113.743 -1.572 . . . . 3.94 107.092 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 15.0 p -165.24 141.0 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 113.2 -1.818 . . . . 1.17 112.565 -160.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 18' ' ' ILE . 34.4 m -104.49 125.45 59.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.939 -0.573 . . . . 2.16 110.0 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.622 ' HB2' ' CA ' ' A' ' 81' ' ' ASN . 3.5 mpt_? -85.83 115.1 23.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.834 -0.621 . . . . 3.15 110.252 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 18' ' ' ILE . 6.5 mp -114.67 140.39 48.88 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.101 0.953 . . . . 1.35 112.627 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 2.6 mp -119.36 106.49 12.33 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.551 -1.648 . . . . 1.53 106.551 166.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 110' ' ' THR . 3.6 p -122.43 166.29 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 114.588 -1.187 . . . . 1.14 109.573 -164.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.699 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.2 p -138.82 108.83 6.34 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.037 -1.438 . . . . 0.58 112.198 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.4 ptt180 -115.31 159.37 21.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.656 -0.702 . . . . 3.49 109.188 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.511 HE22 ' HA ' ' A' ' 11' ' ' ALA . 17.1 mm-40 -94.74 -17.6 22.04 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.95 0.881 . . . . 2.83 110.95 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.46 -5.35 0.62 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 111.728 -2.487 . . . . 4.3 109.9 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.9 mm? -99.64 55.45 0.96 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.366 -1.743 . . . . 4.48 109.3 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.36 142.62 55.41 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 112.231 -2.259 . . . . 6.53 111.272 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 119' ' ' GLN . 2.8 mmmm -117.53 108.97 16.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.696 -0.683 . . . . 9.28 109.912 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -116.84 15.77 15.27 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.747 1.261 . . . . 11.58 108.089 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.23 83.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.544 -2.116 . . . . 12.38 108.431 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 15.6 mm100 -120.76 165.37 15.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.477 -0.783 . . . . 14.96 111.114 -172.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -161.69 174.06 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.89 -0.782 . . . . 17.27 108.89 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.1 t 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.025 0.828 . . . . 19.47 111.131 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.4 mtt -140.98 111.44 6.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.968 -0.56 . . . . 21.73 109.519 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -118.91 141.1 48.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.407 . . . . 23.08 111.057 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 23.96 110.215 175.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 22.0 tptp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.668 -0.493 . . . . 8.27 109.668 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.77 104.56 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.286 0.565 . . . . 6.87 111.856 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.419 ' H ' ' HB2' ' A' ' 40' ' ' ASP . 57.2 t30 66.77 139.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.201 -1.363 . . . . 4.55 112.514 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.11 150.58 27.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.479 -0.563 . . . . 2.71 109.479 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.95 -179.73 3.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.98 0.419 . . . . 4.92 110.177 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -158.51 125.92 5.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.22 109.601 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.689 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.5 144.11 26.55 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.919 -1.141 . . . . 3.19 107.919 168.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 29.8 m . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.462 -0.78 . . . . 1.54 109.358 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.651 0.263 . . . . 18.34 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -84.83 -30.13 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.597 -0.274 . . . . 15.06 110.688 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 51.64 70.42 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.673 0.608 . . . . 14.54 112.227 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.5 92.13 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.918 -1.037 . . . . 10.4 111.266 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.32 95.34 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.5 2.133 . . . . 10.74 110.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 171.48 -33.86 0.15 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.827 -0.701 . . . . 7.75 112.198 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.1 pt20 -90.03 106.5 14.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 6.84 111.288 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 7.0 Cg_exo -73.36 141.44 31.88 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.853 2.368 . . . . 4.84 111.336 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 10' ' ' THR . 7.7 p -73.98 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.475 0.655 . . . . 3.26 109.793 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 9' ' ' VAL . 70.0 p -81.69 -56.38 4.04 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.808 -1.087 . . . . 2.17 110.888 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.709 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -170.46 131.53 0.93 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.427 -1.26 . . . . 0.98 109.51 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' THR . 98.6 t -86.42 109.23 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.504 -0.771 . . . . 1.35 109.008 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -91.48 104.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 1.84 107.949 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 5.2 tt0 -132.79 133.94 44.05 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 114.353 -1.294 . . . . 2.31 107.796 -171.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 4.0 ppt_? -127.18 114.66 17.97 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 121.443 0.639 . . . . 3.58 109.716 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 HD23 ' A' ' 107' ' ' LEU . 2.9 p -119.91 149.03 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.459 -1.311 . . . . 0.86 107.459 -171.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.851 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 28.4 mt-10 -110.08 107.79 17.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.91 0.386 . . . . 1.75 109.962 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.909 HG12 HD21 ' A' ' 107' ' ' LEU . 4.5 mm -100.38 130.25 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.648 -0.871 . . . . 0.93 108.648 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HB2' HG23 ' A' ' 104' ' ' VAL . 10.5 t-160 -121.08 96.66 5.19 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.701 -1.199 . . . . 3.53 112.234 176.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HZ1' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -108.59 117.9 35.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.166 -1.379 . . . . 5.69 109.516 174.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 22' ' ' ARG . 14.1 tp -153.76 158.6 41.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.401 -0.818 . . . . 4.5 109.973 -165.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 21' ' ' LEU . 3.9 tpp180 -62.45 108.32 1.1 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.446 -0.797 . . . . 5.24 109.695 161.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -122.72 60.3 1.03 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.205 1.002 . . . . 4.48 108.851 174.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.99 -100.42 1.36 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 113.563 -1.653 . . . . 3.78 111.73 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -72.1 -10.29 59.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.846 0.832 . . . . 6.85 109.486 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.629 ' HB3' HD11 ' A' ' 28' ' ' ILE . 26.7 m-80 -109.63 128.52 55.29 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 123.088 1.423 . . . . 4.85 110.041 -172.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 26' ' ' ASN . 3.2 mm? -123.63 109.34 13.62 Favored 'General case' 0 C--N 1.254 -3.568 0 CA-C-N 111.648 -2.523 . . . . 3.68 107.171 167.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -108.64 123.81 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 C-N-CA 119.691 -0.804 . . . . 2.9 109.122 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.066 HD23 ' HA ' ' B' ' 168' ' ' VAL . 1.2 mt -177.56 61.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.067 -2.197 . . . . 4.19 105.067 -166.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.63 -48.85 0.11 Allowed Glycine 0 C--N 1.314 -0.665 0 CA-C-N 113.709 -1.587 . . . . 1.62 115.135 -161.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.99 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 10.8 p90 -69.08 151.67 46.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.302 -0.999 . . . . 0.73 108.302 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 9.8 t -121.31 149.93 42.18 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.108 -1.037 . . . . 1.16 110.504 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 36.9 pt -133.75 136.77 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.742 -0.663 . . . . 0.89 110.247 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.99 132.6 11.37 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.288 -0.958 . . . . 0.69 112.063 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.744 ' HA3' ' HD2' ' A' ' 90' ' ' HIS . . . -138.2 140.19 10.94 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.709 -0.758 . . . . 1.42 112.091 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.6 63.98 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.786 -0.721 . . . . 3.0 112.309 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.734 HG12 ' H ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -112.52 -66.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.813 0.34 . . . . 4.71 111.181 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.734 ' H ' HG12 ' A' ' 37' ' ' ILE . 34.3 t70 -92.24 7.6 41.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.147 0.975 . . . . 7.49 109.224 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -82.62 -76.13 0.28 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.935 -1.029 . . . . 4.55 111.287 -171.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.706 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 8.5 t70 -138.76 119.63 9.93 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.716 -0.675 . . . . 5.14 110.491 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -91.8 -8.93 2.86 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 C-N-CA 123.571 2.847 . . . . 5.58 112.037 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 m -63.24 -27.91 69.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.754 -1.112 . . . . 6.54 112.517 -166.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -98.42 2.55 47.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.491 0.662 . . . . 5.93 111.016 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.757 HD21 ' HB2' ' A' ' 47' ' ' SER . 56.6 t30 -137.21 88.53 17.28 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 6.06 110.041 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.44 0.05 9.62 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.74 2.294 . . . . 8.03 111.274 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -94.17 -35.84 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.217 -0.901 . . . . 8.87 110.358 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.757 ' HB2' HD21 ' A' ' 44' ' ' ASN . 59.0 m -140.38 -168.25 2.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 120.85 -0.34 . . . . 5.13 110.112 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.1 ' HA ' ' HE3' ' B' ' 161' ' ' LYS . 12.5 pt-20 179.2 -33.21 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 7.43 108.966 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.06 -38.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.017 -0.992 . . . . 7.39 110.649 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.4 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.32 -0.854 . . . . 7.82 112.984 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 t -102.54 16.12 27.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.258 0.551 . . . . 5.12 109.772 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -75.28 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.297 -0.865 . . . . 3.97 111.534 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER 70.25 -48.1 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.629 -0.714 . . . . 6.09 110.379 -174.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 57.41 21.93 42.99 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 115.042 0.777 . . . . 1.05 115.042 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 77' ' ' ILE . 39.8 mm -129.89 120.42 49.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.403 0.602 . . . . 0.67 109.424 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 22.9 p90 -162.44 169.61 20.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.368 0.128 . . . . 2.48 111.339 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 73' ' ' ILE . 6.1 t -89.84 135.44 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.021 -0.733 . . . . 0.66 109.021 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 15.1 t -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.947 1.405 . . . . 1.0 109.432 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 6.6 mtm180 -157.32 167.36 30.52 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 122.089 0.947 . . . . 3.02 112.66 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.99 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 25.3 t -145.89 126.46 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.188 -1.823 . . . . 0.72 109.097 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 5.4 p -69.8 108.16 3.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.126 -0.694 . . . . 1.77 109.126 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.31 148.57 51.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 122.676 1.227 . . . . 3.28 111.392 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.26 26.72 59.36 Favored Glycine 0 C--N 1.293 -1.858 0 CA-C-N 112.161 -2.291 . . . . 1.03 111.791 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.07 -125.81 4.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.364 -0.922 . . . . 1.27 112.594 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HG3' HG21 ' A' ' 28' ' ' ILE . 58.6 Cg_endo -97.26 -38.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.825 3.017 . . . . 1.32 114.765 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.809 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -70.67 -44.77 66.35 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.99 0.9 . . . . 0.37 109.285 -164.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -86.01 -22.16 27.43 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.32 -1.309 . . . . 1.45 108.796 -165.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 64' ' ' GLY . 2.1 pp -81.53 -32.01 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 CA-C-N 114.815 -1.084 . . . . 0.89 108.65 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -69.23 -28.05 66.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.469 -1.696 . . . . 0.34 107.824 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.99 51.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.107 -1.406 . . . . 0.49 112.512 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.809 HD23 ' HB1' ' A' ' 66' ' ' ALA . 19.6 tp -119.32 156.72 29.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.752 -0.833 . . . . 1.58 108.752 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -163.74 174.09 12.05 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.681 -1.145 . . . . 2.36 110.124 -171.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 59' ' ' ARG . 6.5 mm -81.43 116.59 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 113.767 1.025 . . . . 0.57 113.767 -165.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.16 42.88 0.46 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-N 113.682 -1.599 . . . . 0.6 110.984 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -121.12 116.22 24.57 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.184 -0.606 . . . . 1.35 112.222 -164.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.662 ' C ' HG23 ' A' ' 109' ' ' VAL . 26.4 mttm -83.3 106.17 14.85 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.174 -0.306 . . . . 2.18 110.174 -172.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 55' ' ' ILE . 56.6 mt -79.57 114.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.031 -0.532 . . . . 0.64 110.637 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.402 ' O ' ' HG3' ' A' ' 85' ' ' MET . 22.1 mmt -93.31 -35.29 13.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.364 . . . . 0.48 110.115 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.051 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -141.01 155.06 46.26 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-O 122.113 0.959 . . . . 2.26 111.196 177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 5.7 p -123.53 134.56 66.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.814 -1.994 . . . . 0.77 108.735 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 80' ' ' VAL . 31.4 m120 63.25 -2.8 0.41 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.439 . . . . 1.9 111.044 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.06 -0.82 19.46 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.934 -0.65 . . . . 1.1 113.833 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.527 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -120.53 113.27 20.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 118.351 1.075 . . . . 2.75 111.871 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.88 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -27.3 116.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.337 -1.756 . . . . 1.61 113.811 171.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 55' ' ' ILE . 1.7 ptp -95.52 -83.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.603 -1.181 . . . . 1.72 109.644 168.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 p 60.93 -52.68 0.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.701 2.0 . . . . 1.25 114.186 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.8 mmt -112.32 -6.38 14.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.993 0.901 . . . . 3.22 109.428 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 92' ' ' GLN . 4.3 t -64.39 154.92 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 114.018 -1.446 . . . . 1.73 109.446 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 92' ' ' GLN . 12.2 t -87.96 146.84 25.32 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 118.491 -1.284 . . . . 1.3 110.356 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.744 ' HD2' ' HA3' ' A' ' 35' ' ' GLY . 2.9 t-80 -58.4 -30.31 66.74 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.781 -1.099 . . . . 2.47 110.087 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 18.7 t70 -66.79 -47.69 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.192 0.52 . . . . 1.81 110.638 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -82.95 -23.88 33.24 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-O 121.236 0.541 . . . . 2.66 110.001 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -72.28 -38.21 68.83 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.93 -1.137 . . . . 0.8 107.93 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 9.2 ptt180 -71.58 -31.24 66.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.1 -0.955 . . . . 3.95 109.721 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 92' ' ' GLN . 14.8 ptpt -80.04 -23.37 41.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.698 -0.401 . . . . 2.48 111.387 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -89.77 -35.39 15.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.491 -0.484 . . . . 3.8 111.764 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG11 ' A' ' 105' ' ' VAL . 4.6 pp -70.37 -29.7 66.44 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 122.062 -0.399 . . . . 1.26 111.136 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 p -117.4 59.09 0.78 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.651 0.739 . . . . 1.53 109.951 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 101' ' ' SER . 16.2 ptmt -77.31 -14.26 59.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.716 -1.129 . . . . 1.79 111.534 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 98' ' ' THR . 0.3 OUTLIER 70.57 13.59 7.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.11 -1.404 . . . . 5.04 110.086 175.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 28.6 m -134.22 20.72 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.013 -0.994 . . . . 2.31 110.089 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 170.29 8.07 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.214 1.007 . . . . 2.11 109.756 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.565 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 pt-20 -109.21 -6.76 15.44 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.732 -1.576 . . . . 3.94 109.065 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' HIS . 8.7 p 172.12 162.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.222 -1.354 . . . . 1.17 109.37 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 18' ' ' ILE . 6.8 m -124.83 121.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 119.314 -0.954 . . . . 2.16 109.955 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.851 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 57.4 mtt180 -87.21 131.02 34.33 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.506 -0.77 . . . . 3.15 110.589 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.909 HD21 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.15 108.07 15.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.742 -1.206 . . . . 1.35 107.742 175.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.051 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -88.96 106.29 18.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.465 -1.68 . . . . 1.53 106.465 169.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.662 HG23 ' C ' ' A' ' 76' ' ' LYS . 9.3 p -135.76 166.67 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 114.936 -1.029 . . . . 1.14 110.137 -156.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.4 p -134.31 121.92 21.93 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.101 -1.409 . . . . 0.58 110.849 -174.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.668 ' HE ' ' NE2' ' A' ' 14' ' ' GLN . 9.6 ptt180 -133.31 171.76 13.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.771 -0.649 . . . . 3.49 110.152 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.709 HE22 ' HA ' ' A' ' 11' ' ' ALA . 24.5 mm-40 -108.04 -58.91 1.92 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.489 0.661 . . . . 2.83 109.961 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.4 m 73.47 15.9 4.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.293 -1.776 . . . . 4.3 111.618 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 114' ' ' LEU . 1.1 mm? -123.69 36.99 4.51 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.913 1.34 . . . . 4.48 109.478 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -71.02 159.43 34.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 111.923 -2.399 . . . . 6.53 110.34 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.4 101.82 9.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 9.28 110.417 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.53 7.58 35.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.625 1.678 . . . . 11.58 106.705 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.3 t -109.17 -15.37 9.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.861 -2.881 . . . . 12.38 108.613 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 56.45 -166.51 0.12 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.468 -2.151 . . . . 14.96 112.271 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -160.98 132.59 5.67 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.755 -0.657 . . . . 17.27 109.359 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.6 p -108.88 -21.88 12.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.879 0.325 . . . . 19.47 111.879 -175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -121.34 147.14 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.813 0.34 . . . . 21.73 110.68 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.85 86.99 2.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 23.08 109.721 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 23.96 111.092 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 1.1 ' HE3' ' HA ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.561 -0.163 . . . . 8.27 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 10.0 tp10 75.04 145.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.463 0.705 . . . . 6.87 110.619 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.43 99.7 6.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 4.55 112.129 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' B' ' 164' ' ' LEU . 1.9 tp -114.84 104.29 11.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.26 -1.015 . . . . 2.71 108.26 168.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.3 pt-20 -102.96 156.28 17.77 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.209 -0.663 . . . . 4.92 109.209 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' SER . 14.5 m -145.73 126.49 14.36 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.233 -0.439 . . . . 1.22 109.952 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 17.2 ptp -73.85 122.8 23.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.321 -0.622 . . . . 3.19 109.321 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.066 ' HA ' HD23 ' A' ' 29' ' ' LEU . 7.0 m . . . . . 0 C--N 1.316 -0.884 0 CA-C-N 115.507 -0.77 . . . . 1.54 110.347 -172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.928 0.394 . . . . 18.34 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -101.82 121.01 41.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.165 0.507 . . . . 15.06 111.213 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.79 152.79 30.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.335 -0.848 . . . . 14.54 109.304 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.96 103.04 15.77 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.731 0.3 . . . . 10.4 110.472 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.25 9.99 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.279 2.652 . . . . 10.74 112.005 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.8 54.14 0.6 Allowed Glycine 0 C--N 1.312 -0.765 0 CA-C-N 114.838 -1.074 . . . . 7.75 111.471 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.43 152.87 95.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.665 0.269 . . . . 6.84 110.665 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -58.01 160.71 14.83 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.034 2.49 . . . . 4.84 113.106 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 m -59.86 176.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 115.391 -0.822 . . . . 3.26 112.274 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -113.42 100.09 8.27 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.08 1.419 . . . . 2.17 110.949 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -70.97 110.68 5.82 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 111.964 -2.38 . . . . 0.98 110.466 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' THR . 95.6 t -64.11 109.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.34 -1.3 . . . . 1.35 109.447 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.72 105.69 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.094 -1.076 . . . . 1.84 108.094 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 9.1 tt0 -115.65 136.28 53.22 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.18 -0.918 . . . . 2.31 109.946 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -105.29 119.52 39.27 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.177 -0.92 . . . . 3.58 108.806 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 107' ' ' LEU . 2.7 t -127.93 145.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.166 0.508 . . . . 0.86 109.769 -173.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 19.1 mt-10 -120.49 107.66 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.618 -1.253 . . . . 1.75 107.618 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.705 HG12 ' HA ' ' A' ' 66' ' ' ALA . 86.2 mt -107.03 115.36 48.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.685 0.755 . . . . 0.93 111.526 -171.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 104' ' ' VAL . 26.8 p80 -123.31 96.25 4.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.606 -0.724 . . . . 3.53 112.25 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.655 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 47.7 tptt -77.23 -104.66 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.144 -0.688 . . . . 5.69 109.144 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.787 ' HB3' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -151.2 116.52 5.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.772 -0.771 . . . . 4.5 112.199 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.521 ' HD3' ' H ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -81.05 108.92 15.13 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.089 -1.448 . . . . 5.24 107.089 160.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.787 HE21 ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.71 63.02 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.887 0.851 . . . . 4.48 108.794 -173.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.521 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 72.29 -98.53 0.82 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.016 -1.447 . . . . 3.78 111.971 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.09 -2.9 39.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.715 -0.742 . . . . 6.85 109.544 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.626 ' HB3' HD11 ' A' ' 28' ' ' ILE . 31.6 m-80 -110.39 138.84 46.24 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 123.109 1.433 . . . . 4.85 110.51 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD13 ' HG2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.25 108.76 12.05 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 111.46 -2.609 . . . . 3.68 106.854 170.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 26' ' ' ASN . 2.5 mm -121.82 131.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.66 -0.7 . . . . 2.9 110.497 -176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.882 HD21 HG11 ' A' ' 105' ' ' VAL . 7.1 tp -111.19 -29.35 7.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.218 -1.03 . . . . 4.19 108.218 167.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.28 -57.32 1.72 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.306 -0.861 . . . . 1.62 113.502 167.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 29.5 p90 -74.37 178.02 5.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.894 0.378 . . . . 0.73 110.981 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 167' ' ' MET . 15.6 m -125.31 138.55 54.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.882 -0.414 . . . . 1.16 109.882 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.888 HG13 ' HG3' ' B' ' 165' ' ' GLU . 46.7 pt -125.52 153.59 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.487 -0.56 . . . . 0.89 109.487 -175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 128.63 6.33 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 119.496 -1.335 . . . . 0.69 112.907 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.656 ' H ' ' HB2' ' B' ' 165' ' ' GLU . . . -117.97 85.74 0.39 Allowed Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 110.14 -1.184 . . . . 1.42 110.14 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' HE22 ' A' ' 39' ' ' GLN . . . 147.07 -4.86 1.02 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 119.672 -1.251 . . . . 3.0 111.567 -166.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.591 HG13 ' CD1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -68.69 -46.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.362 0.875 . . . . 4.71 113.362 -170.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 37' ' ' ILE . 4.1 t0 -109.63 -1.14 18.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.777 0.799 . . . . 7.49 110.35 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.707 ' CD ' ' HA2' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -158.25 -173.08 4.15 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.586 -0.734 . . . . 4.55 110.576 -173.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.967 ' OD1' ' HA ' ' B' ' 162' ' ' GLU . 0.2 OUTLIER 169.69 154.33 0.17 Allowed Pre-proline 0 C--N 1.316 -0.862 0 O-C-N 124.958 1.411 . . . . 5.14 108.291 -172.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' B' ' 162' ' ' GLU . 90.8 Cg_endo -81.84 -26.67 2.91 Favored 'Trans proline' 0 CA--C 1.502 -1.098 0 C-N-CA 122.196 1.93 . . . . 5.58 111.203 -167.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -95.34 -23.39 17.21 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.081 -1.418 . . . . 6.54 109.978 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.821 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -124.2 -4.21 7.93 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 120.021 -0.672 . . . . 5.93 111.309 -172.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -143.31 74.42 17.38 Favored Pre-proline 0 C--O 1.233 0.225 0 C-N-CA 120.893 -0.323 . . . . 6.06 110.803 166.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.47 7.59 5.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.23 1.954 . . . . 8.03 110.031 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -88.47 -29.06 20.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.176 . . . . 8.87 109.521 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 24.5 p -88.24 -159.64 0.56 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.067 -0.716 . . . . 5.13 109.067 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 40.8 tt0 65.45 0.97 1.52 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.28 0.562 . . . . 7.43 111.239 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -76.36 -55.45 5.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.33 -0.395 . . . . 7.39 111.949 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -86.64 -95.61 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.125 -0.489 . . . . 7.82 111.309 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -115.55 -4.03 12.3 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.222 -1.399 . . . . 5.12 107.222 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 35.2 t0 58.4 168.55 0.05 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.657 -1.61 . . . . 3.97 112.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.19 22.76 13.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.425 -1.261 . . . . 6.09 108.461 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.707 ' HA2' ' CD ' ' A' ' 39' ' ' GLN . . . -46.22 -53.69 9.11 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 113.94 -1.482 . . . . 1.05 114.797 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.634 HD13 ' HA2' ' A' ' 35' ' ' GLY . 31.4 mm -108.15 132.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.352 0.596 . . . . 0.67 110.969 -175.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.811 ' CE2' ' HA2' ' A' ' 74' ' ' GLY . 1.8 t80 -153.96 129.23 9.74 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.092 -0.958 . . . . 2.48 109.764 -173.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.82 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -69.41 127.07 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 109.033 -0.728 . . . . 0.66 109.033 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -102.32 -7.24 22.23 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.82 -1.082 . . . . 1.0 110.364 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HA ' HG23 ' A' ' 73' ' ' ILE . 2.5 ptm180 -174.18 172.72 3.24 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.453 0.645 . . . . 3.02 111.537 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.752 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 73.3 t -143.77 124.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.981 -1.463 . . . . 0.72 108.98 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 p -72.33 114.66 10.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.907 -1.146 . . . . 1.77 107.907 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.45 143.23 57.23 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 122.611 1.196 . . . . 3.28 109.744 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.48 37.24 94.49 Favored Glycine 0 C--N 1.28 -2.533 0 CA-C-N 112.356 -2.202 . . . . 1.03 109.587 -167.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.655 ' HA2' ' HD3' ' A' ' 20' ' ' LYS . . . -131.69 56.97 0.73 Allowed Glycine 0 CA--C 1.498 -0.985 0 CA-C-O 118.956 -0.913 . . . . 1.27 111.303 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -9.41 22.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 130.427 7.418 . . . . 1.32 121.269 -158.188 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -75.2 -40.47 59.28 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.406 -1.331 . . . . 0.37 107.406 168.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -37.8 52.18 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.381 -1.736 . . . . 1.45 109.85 -168.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 65' ' ' PRO . 5.5 pt -85.16 -24.17 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 CA-C-N 115.008 -0.996 . . . . 0.89 110.163 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -62.11 -27.53 68.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.083 -1.417 . . . . 0.34 107.918 167.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.25 1.18 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.164 -1.38 . . . . 0.49 112.477 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 16.8 tp -104.3 177.17 4.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.646 -0.872 . . . . 1.58 108.646 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.784 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -159.98 -179.02 7.43 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.66 -1.608 . . . . 2.36 106.66 -175.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mm -85.96 113.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.181 -0.918 . . . . 0.57 109.266 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.811 ' HA2' ' CE2' ' A' ' 56' ' ' TYR . . . 103.77 66.49 0.72 Allowed Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 119.058 -1.544 . . . . 0.6 111.299 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.82 ' H ' HG12 ' A' ' 57' ' ' VAL . 5.1 t0 -145.42 132.79 20.65 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.386 -0.598 . . . . 1.35 109.386 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.687 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 38.0 mttp -88.81 106.0 18.09 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.853 -0.739 . . . . 2.18 110.028 -170.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG12 ' A' ' 109' ' ' VAL . 43.9 mt -74.4 98.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.64 109.963 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mmt -81.52 -22.49 37.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.608 -0.724 . . . . 0.48 111.537 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.905 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -164.89 162.8 20.99 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 121.557 0.694 . . . . 2.26 111.586 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.598 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.76 133.01 54.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.616 -1.629 . . . . 0.77 109.916 178.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 30.6 m-80 55.84 14.93 1.48 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.349 0.66 . . . . 1.9 111.563 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.0 6.6 56.89 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.36 -0.837 . . . . 1.1 112.824 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.598 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.4 m95 -102.24 78.8 1.79 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.63 -0.507 . . . . 2.75 109.63 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -23.22 103.28 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.764 1.29 . . . . 1.61 111.75 167.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -103.74 35.69 2.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 1.72 112.209 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.0 p -74.01 -23.39 59.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.061 0.458 . . . . 1.25 111.705 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 18.1 ptm -133.24 27.13 4.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.451 1.12 . . . . 3.22 109.424 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.776 HG13 ' NE2' ' A' ' 92' ' ' GLN . 1.2 t -81.83 155.85 4.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 113.32 -1.764 . . . . 1.73 112.49 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.562 ' HB ' ' HG3' ' A' ' 92' ' ' GLN . 1.2 m -98.8 151.96 20.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.284 -0.636 . . . . 1.3 109.284 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 1.095 ' HB2' HD13 ' B' ' 164' ' ' LEU . 27.4 t-80 -51.65 -48.56 63.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.893 0.854 . . . . 2.47 111.633 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 8.2 t70 -63.75 -48.3 77.56 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.122 -1.399 . . . . 1.81 109.836 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.883 ' HA ' ' CD ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -81.08 -19.66 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.242 -0.89 . . . . 2.66 110.776 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.19 -43.03 68.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.075 -1.454 . . . . 0.8 107.075 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' B' ' 168' ' ' VAL . 5.3 mmm180 -55.09 -41.89 72.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.958 -1.474 . . . . 3.95 110.851 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.883 ' CD ' ' HA ' ' A' ' 92' ' ' GLN . 1.4 ptmt -78.85 -19.08 52.88 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.107 0.78 . . . . 2.48 113.107 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 1.8 mmp_? -80.03 -42.24 24.18 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.977 0.732 . . . . 3.8 112.977 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.0 pp -90.15 -24.58 21.02 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.44 0.533 . . . . 1.26 112.44 -170.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.664 HG22 HD12 ' A' ' 97' ' ' LEU . 11.0 t -144.44 66.64 1.27 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.363 1.078 . . . . 1.53 111.213 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 20.6 pttm -87.99 -177.37 5.74 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.388 -0.824 . . . . 1.79 109.311 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.05 14.19 26.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.254 0.549 . . . . 5.04 110.273 -175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.713 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 21.9 t -114.08 7.67 16.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.724 . . . . 2.31 110.201 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.05 143.07 21.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.252 -1.018 . . . . 2.11 108.252 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.9 23.8 10.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 123.15 1.452 . . . . 3.94 107.391 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.568 ' CB ' ' HB3' ' A' ' 19' ' ' HIS . 5.0 p -158.59 134.08 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 111.781 -2.463 . . . . 1.17 107.483 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.882 HG11 HD21 ' A' ' 29' ' ' LEU . 7.5 p -111.4 120.61 62.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.519 0.676 . . . . 2.16 110.606 -175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 16.0 ttt180 -84.87 141.81 30.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.656 -1.238 . . . . 3.15 107.656 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD1' ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -154.15 164.23 38.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 113.528 0.936 . . . . 1.35 113.528 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.813 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 1.4 tp -114.88 133.36 56.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.272 -1.785 . . . . 1.53 107.982 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 17.1 m -134.07 172.36 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.904 -0.406 . . . . 1.14 109.904 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.687 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.7 p -137.37 108.59 6.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.213 -0.903 . . . . 0.58 111.513 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 12' ' ' VAL . 12.9 ptt180 -117.49 168.75 10.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.478 -0.783 . . . . 3.49 109.592 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.616 HE22 ' HA ' ' A' ' 11' ' ' ALA . 28.6 mm-40 -104.8 -39.85 6.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.612 0.597 . . . . 2.83 112.612 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 72.0 m 75.66 13.43 2.92 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.676 1.235 . . . . 4.3 109.499 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 56.91 26.15 11.36 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.504 -1.68 . . . . 4.48 112.072 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -99.14 171.47 8.0 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.372 -1.74 . . . . 6.53 111.424 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -136.95 135.84 38.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.52 -0.764 . . . . 9.28 109.29 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HB2' HE22 ' A' ' 115' ' ' GLN . . . -142.43 19.85 2.05 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.228 1.013 . . . . 11.58 109.291 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.37 77.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.78 -1.555 . . . . 12.38 109.721 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -124.2 24.84 7.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.972 -1.467 . . . . 14.96 110.533 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -82.24 131.69 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.299 -0.864 . . . . 17.27 109.199 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.7 m -148.42 114.2 5.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.211 -0.195 . . . . 19.47 111.392 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.7 ptt? 46.36 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.449 1.1 . . . . 21.73 113.3 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 123' ' ' LEU . 6.9 mp -75.04 116.62 15.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.853 -0.612 . . . . 23.08 110.661 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.014 -0.539 . . . . 23.96 110.718 178.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 40' ' ' ASP . 7.4 tppt? . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.981 -0.748 . . . . 8.27 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.967 ' HA ' ' OD1' ' A' ' 40' ' ' ASP . 1.6 pm0 -64.38 154.55 35.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 6.87 110.397 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -47.38 105.95 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.343 0.497 . . . . 4.55 112.343 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 1.095 HD13 ' HB2' ' A' ' 90' ' ' HIS . 3.5 pp -152.28 -179.53 7.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.749 -0.205 . . . . 2.71 111.461 175.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.888 ' HG3' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 113.57 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.184 1.794 . . . . 4.92 112.161 172.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 1.3 m -154.81 178.57 10.0 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.081 1.141 . . . . 1.22 114.081 -154.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 ptp -92.99 144.61 25.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.6 -2.0 . . . . 3.19 105.6 147.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' A' ' 29' ' ' LEU . 6.6 m . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 118.508 -0.758 . . . . 1.54 111.134 -170.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.562 0.22 . . . . 18.34 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -99.79 169.9 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.844 0.354 . . . . 15.06 111.275 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.89 148.1 23.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.819 -0.808 . . . . 14.54 108.819 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -119.95 96.75 49.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.111 0.482 . . . . 10.4 110.468 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.91 112.47 2.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.242 2.628 . . . . 10.74 111.17 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 50.98 5.4 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.576 -0.821 . . . . 7.75 111.715 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 16.6 pt20 -69.21 127.87 92.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 6.84 110.753 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 24.1 Cg_exo -64.82 152.5 81.9 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 4.84 113.191 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.733 HG22 ' H ' ' A' ' 10' ' ' THR . 9.8 p -82.94 174.87 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.491 -0.777 . . . . 3.26 109.841 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.733 ' H ' HG22 ' A' ' 9' ' ' VAL . 34.2 p -128.88 110.1 11.83 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.8 1.286 . . . . 2.17 111.225 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.437 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -84.32 113.54 21.21 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 112.938 -1.937 . . . . 0.98 110.024 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.0 t -91.75 136.36 24.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 113.946 -1.479 . . . . 1.35 108.081 170.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.5 t -96.55 129.66 46.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.415 -0.811 . . . . 1.84 109.431 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 143.95 50.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.954 -0.566 . . . . 2.31 109.599 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 5.8 mpt_? -117.86 116.83 27.76 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.123 -1.066 . . . . 3.58 108.123 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 69' ' ' ALA . 7.6 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.039 -0.982 . . . . 0.86 108.353 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 45.1 mt-10 -118.31 109.98 16.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.903 0.383 . . . . 1.75 110.171 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 66' ' ' ALA . 4.2 mm -96.03 113.27 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 109.163 -0.68 . . . . 0.93 109.163 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 20.3 p80 -98.13 119.15 36.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.903 0.859 . . . . 3.53 112.242 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.667 ' HB3' ' C ' ' A' ' 27' ' ' LEU . 49.4 mtmt -54.77 163.66 0.92 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 112.746 -2.025 . . . . 5.69 111.37 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.634 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 59.8 tp -130.54 156.75 44.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 122.044 0.926 . . . . 4.5 110.786 -165.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -74.56 116.03 14.79 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.577 -1.192 . . . . 5.24 113.016 -168.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.484 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.78 70.4 1.38 Allowed 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.156 0.979 . . . . 4.48 109.584 167.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 -115.82 5.3 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 113.699 -1.591 . . . . 3.78 110.767 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -81.09 -1.66 45.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.585 0.707 . . . . 6.85 109.183 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -106.55 135.71 47.58 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-O 122.699 1.237 . . . . 4.85 109.495 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.667 ' C ' ' HB3' ' A' ' 20' ' ' LYS . 4.6 mm? -118.3 103.54 9.91 Favored 'General case' 0 C--N 1.263 -3.164 0 CA-C-N 112.397 -2.183 . . . . 3.68 107.792 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' OXT' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -161.72 171.0 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.78 1.232 . . . . 2.9 109.23 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CD2' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -129.2 -31.39 2.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.568 -0.853 . . . . 4.19 113.039 -175.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 105.19 18.62 11.79 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.999 -1.096 . . . . 1.62 114.02 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.028 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 12.6 p90 -87.72 152.98 21.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.028 -1.101 . . . . 0.73 108.028 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 23.8 t -125.61 141.93 51.77 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.785 -0.766 . . . . 1.16 111.078 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -123.61 166.79 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.813 -1.18 . . . . 0.89 107.813 175.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' B' ' 165' ' ' GLU . . . -139.39 151.96 22.17 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.465 -1.35 . . . . 0.69 113.761 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.76 -115.6 1.45 Allowed Glycine 0 C--O 1.245 0.824 0 C-N-CA 121.476 -0.392 . . . . 1.42 112.538 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . 150.84 -61.3 0.41 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.507 -1.037 . . . . 3.0 110.507 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -159.26 -58.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.346 -0.927 . . . . 4.71 110.249 -176.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -149.98 -48.49 0.13 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.198 -1.365 . . . . 7.49 109.044 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.485 ' NE2' ' HA3' ' A' ' 36' ' ' GLY . 40.0 mm-40 53.04 -71.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.198 -1.364 . . . . 4.55 114.287 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 9.8 t70 -143.25 134.48 12.67 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 114.659 -1.155 . . . . 5.14 110.523 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.889 ' HA ' ' HB3' ' A' ' 44' ' ' ASN . 74.5 Cg_endo -67.42 -3.97 11.03 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.282 3.322 . . . . 5.58 112.469 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.947 ' HB3' ' HG2' ' B' ' 161' ' ' LYS . 35.8 t -63.88 -45.29 90.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.357 -0.838 . . . . 6.54 109.694 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.66 HE21 ' HG3' ' B' ' 161' ' ' LYS . 6.9 pt20 -87.57 -28.97 21.62 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.448 -0.796 . . . . 5.93 109.6 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.889 ' HB3' ' HA ' ' A' ' 41' ' ' PRO . 12.8 t-20 -73.41 104.72 1.23 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.766 -1.106 . . . . 6.06 109.612 172.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.642 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -72.45 -30.38 12.5 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.969 2.446 . . . . 8.03 112.501 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.69 11.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 113.039 0.755 . . . . 8.87 113.039 -169.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 11.1 t -126.54 -137.19 0.26 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.81 -0.756 . . . . 5.13 109.325 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' SER . 13.1 pt-20 166.44 -29.95 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.081 0 O-C-N 124.302 1.001 . . . . 7.43 109.596 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 10.1 m-20 -146.69 155.32 42.33 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.637 -0.711 . . . . 7.39 109.313 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 51.5 tptt 68.81 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.312 0.856 . . . . 7.82 113.312 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -83.57 9.13 12.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.962 -0.563 . . . . 5.12 112.231 -168.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.589 ' OD1' ' HD2' ' A' ' 45' ' ' PRO . 7.1 t70 -87.3 -161.81 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.026 -0.67 . . . . 3.97 109.926 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.642 ' HD3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -109.99 22.9 15.05 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.021 -0.733 . . . . 6.09 109.021 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.12 -37.14 7.61 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 114.655 -1.157 . . . . 1.05 114.19 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 77' ' ' ILE . 35.5 mm -126.29 109.98 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.995 0.398 . . . . 0.67 110.054 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -152.39 147.32 26.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 2.48 111.562 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.984 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -75.44 138.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.329 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -119.54 -10.25 9.67 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 124.167 0.917 . . . . 1.0 109.962 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 47.7 mtt180 -145.09 170.25 16.56 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.931 0.872 . . . . 3.02 112.717 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.028 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 58.3 t -151.68 135.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.158 -1.837 . . . . 0.72 108.583 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -67.18 101.62 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.354 -0.98 . . . . 1.77 108.354 163.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.14 148.78 51.39 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.745 1.26 . . . . 3.28 111.911 -168.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.07 23.67 66.23 Favored Glycine 0 C--N 1.292 -1.907 0 CA-C-N 112.199 -2.273 . . . . 1.03 111.721 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -112.49 -133.65 6.03 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 120.037 -1.077 . . . . 1.27 112.733 -170.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.4 Cg_endo -90.99 -36.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.525 3.483 . . . . 1.32 114.567 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -67.04 -49.05 66.44 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.555 1.169 . . . . 0.37 108.889 -168.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -76.08 -27.18 57.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.566 -1.652 . . . . 1.45 110.459 -167.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 65' ' ' PRO . 1.9 pp -80.55 -27.64 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.264 1.03 . . . . 0.89 109.093 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.95 -27.74 69.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.135 -1.848 . . . . 0.34 107.748 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.56 46.38 0.62 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.373 -1.285 . . . . 0.49 111.477 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 2.5 tm? -124.68 158.29 33.53 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.264 -1.384 . . . . 1.58 107.264 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.658 HE22 ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -163.11 -174.76 3.99 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.853 -0.425 . . . . 2.36 109.853 -171.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mm -84.9 113.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 112.011 0.374 . . . . 0.57 112.011 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.96 71.03 0.72 Allowed Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.247 -0.977 . . . . 0.6 111.778 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' HE22 ' A' ' 72' ' ' GLN . 5.5 t0 -148.87 135.31 19.46 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.186 -0.606 . . . . 1.35 111.191 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.673 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 94.2 mttt -81.63 107.95 14.8 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.63 -0.428 . . . . 2.18 110.281 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.669 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 mt -72.98 97.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 109.544 -0.539 . . . . 0.64 109.544 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.609 ' CE ' ' HB3' ' A' ' 76' ' ' LYS . 13.1 mmt -92.16 -22.67 19.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.48 110.643 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.852 ' HG2' ' N ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -155.53 152.13 28.49 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.634 0.73 . . . . 2.26 109.415 -175.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.852 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.1 p -144.93 140.36 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.259 -1.337 . . . . 0.77 109.487 -172.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.745 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 32.7 m120 61.94 1.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.858 0.463 . . . . 1.9 111.89 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.94 13.5 27.21 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.141 -0.552 . . . . 1.1 113.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.671 ' C ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -131.27 115.37 16.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.302 1.051 . . . . 2.75 110.199 174.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -52.06 115.37 1.67 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.393 -1.276 . . . . 1.61 110.619 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.495 ' HG2' HG12 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -78.91 -101.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.141 -0.223 . . . . 1.72 110.825 177.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 50' ' ' LYS . 74.4 p 61.69 -42.58 0.14 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.123 1.769 . . . . 1.25 114.526 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 49' ' ' ASP . 95.2 mmm -106.74 26.79 9.58 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.115 0.483 . . . . 3.22 110.936 -174.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.561 ' HB ' ' CD ' ' A' ' 92' ' ' GLN . 3.8 m -115.49 -163.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.898 -0.592 . . . . 1.73 110.989 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 92' ' ' GLN . 9.0 t -118.97 156.72 29.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 167.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.475 ' HE1' HD11 ' A' ' 33' ' ' ILE . 81.3 t60 -62.81 -29.06 70.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.909 -0.587 . . . . 2.47 110.474 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 23.0 t70 -69.79 -38.63 76.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.688 -0.687 . . . . 1.81 110.849 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -84.98 -20.33 30.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.124 -1.065 . . . . 2.66 108.124 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.718 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.61 -37.96 77.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.731 -1.211 . . . . 0.8 107.731 172.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 18.1 mtm180 -55.88 -49.2 74.02 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.756 -1.111 . . . . 3.95 111.564 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 18.7 ptpt -66.66 -21.22 66.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 121.0 -0.28 . . . . 2.48 111.624 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 14.5 mmt180 -81.25 -54.02 5.85 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.405 -0.518 . . . . 3.8 111.823 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -72.7 -37.74 67.75 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.252 0.549 . . . . 1.26 112.398 -175.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 7.7 p -114.3 50.66 0.93 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.172 0.51 . . . . 1.53 111.523 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 19.3 ptmt -87.19 -165.3 1.26 Allowed 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -113.02 22.48 14.34 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.857 0.36 . . . . 5.04 110.753 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 99' ' ' LYS . 49.1 m -103.14 -17.0 15.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.179 -0.464 . . . . 2.31 111.493 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.47 175.1 9.88 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.746 0.784 . . . . 2.11 109.774 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -125.77 2.02 7.44 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.255 -1.339 . . . . 3.94 108.65 171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.839 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -136.82 139.1 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.555 -1.202 . . . . 1.17 110.686 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.1 t -107.9 134.6 49.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.327 -0.619 . . . . 2.16 109.327 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 77.5 mtt180 -87.38 136.01 33.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.749 -0.463 . . . . 3.15 109.749 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.729 ' CD2' HG12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -127.11 124.57 39.47 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.964 0.888 . . . . 1.35 110.016 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.4 mm? -109.79 106.55 16.21 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 113.59 -1.641 . . . . 1.53 107.547 169.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 77' ' ' ILE . 16.1 m -123.29 170.26 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.733 -0.667 . . . . 1.14 110.538 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 18.0 p -140.31 110.71 6.68 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.352 -0.84 . . . . 0.58 111.166 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.574 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -141.65 169.6 17.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.891 -0.595 . . . . 3.49 110.592 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.714 ' HB3' ' HG ' ' A' ' 114' ' ' LEU . 2.5 mp0 -83.5 -64.48 1.16 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.352 0.596 . . . . 2.83 111.879 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 73.7 m 80.97 17.39 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.398 -1.728 . . . . 4.3 111.281 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 2.6 pp -123.55 9.54 9.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.052 1.406 . . . . 4.48 111.216 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 114' ' ' LEU . 15.6 mm-40 -132.47 158.5 41.9 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.203 -2.271 . . . . 6.53 110.894 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 10.3 mtmp? -88.0 131.81 34.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.504 -0.554 . . . . 9.28 109.504 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.46 18.18 6.94 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.54 1.162 . . . . 11.58 108.473 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.22 80.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 113.124 -1.853 . . . . 12.38 109.472 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.52 20.38 7.95 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.457 -0.792 . . . . 14.96 109.307 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -90.61 133.25 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.252 -0.885 . . . . 17.27 111.391 -173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -132.86 103.6 6.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.691 -0.855 . . . . 19.47 108.691 171.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.4 mmm -96.83 161.98 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.293 0.568 . . . . 21.73 111.723 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -127.69 142.0 51.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 23.08 109.619 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.952 0.406 . . . . 23.96 110.408 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 16.8 tppt? . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.955 0.407 . . . . 8.27 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' B' ' 162' ' ' GLU . 1.4 pm0 -64.86 140.98 58.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.881 0.372 . . . . 6.87 110.419 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -102.53 -35.28 8.8 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.553 0.575 . . . . 4.55 112.553 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' B' ' 165' ' ' GLU . 1.9 pp -139.75 159.6 41.79 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.776 -0.453 . . . . 2.71 109.776 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.708 ' HB2' ' O ' ' B' ' 164' ' ' LEU . 0.3 OUTLIER 164.7 -151.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.45 1.094 . . . . 4.92 111.239 166.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 43.0 m -159.71 171.64 19.17 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.071 1.138 . . . . 1.22 114.071 -165.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 25.0 ptp -114.26 145.92 41.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.072 -1.422 . . . . 3.19 108.613 163.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.647 ' OXT' ' HB ' ' A' ' 28' ' ' ILE . 5.2 m . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 110.02 -0.363 . . . . 1.54 110.02 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HG2' ' H ' ' A' ' 2' ' ' SER . 9.4 ttt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.453 -0.573 . . . . 18.34 109.453 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.546 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.9 m -67.97 -38.99 83.42 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.105 0.409 . . . . 15.06 112.105 -176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 2' ' ' SER . 63.4 m-85 71.03 164.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.563 0.539 . . . . 14.54 111.056 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.3 mt -117.7 91.82 39.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 10.4 109.737 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.11 133.26 14.79 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.043 2.495 . . . . 10.74 111.855 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.8 -29.65 5.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.818 -0.706 . . . . 7.75 112.273 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -114.01 95.81 39.49 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.66 0.267 . . . . 6.84 110.73 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -94.88 -172.31 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.165 2.576 . . . . 4.84 112.432 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.38 161.08 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 3.26 110.057 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -89.56 -60.36 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 2.17 111.428 -172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.76 125.65 2.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.698 -1.137 . . . . 0.98 110.298 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 14.1 t -99.03 138.53 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.59 -1.186 . . . . 1.35 108.176 170.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.41 123.3 59.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.793 -0.64 . . . . 1.84 110.299 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.521 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -131.24 151.28 51.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.826 -0.624 . . . . 2.31 109.496 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HG3' HD22 ' A' ' 108' ' ' LEU . 3.0 mpt_? -123.05 106.2 10.61 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.372 -1.344 . . . . 3.58 107.372 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG13 HD23 ' A' ' 107' ' ' LEU . 7.2 p -124.03 148.64 28.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.67 -1.233 . . . . 0.86 107.67 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 44.2 mt-10 -115.49 108.55 16.61 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.712 -0.477 . . . . 1.75 109.712 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 HD21 ' A' ' 107' ' ' LEU . 3.1 mm -90.78 115.57 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 122.346 1.069 . . . . 0.93 109.787 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.643 ' HB2' HG23 ' A' ' 104' ' ' VAL . 8.4 t-160 -107.38 82.2 1.64 Allowed 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.199 -1.364 . . . . 3.53 110.505 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HE2' HG22 ' A' ' 98' ' ' THR . 18.3 pttp -57.11 173.52 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.266 -1.334 . . . . 5.69 109.771 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.639 HD12 ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -123.73 147.72 47.23 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 118.799 -1.16 . . . . 4.5 111.833 -166.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.73 110.25 15.71 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.768 -1.56 . . . . 5.24 108.275 169.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 3.3 mt-30 -113.2 63.4 0.64 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.464 -0.335 . . . . 4.48 111.513 -174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 20.34 66.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.781 0 O-C-N 125.36 1.662 . . . . 3.78 116.113 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 142.8 -26.22 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.1 -2.556 . . . . 6.85 104.1 -171.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.2 m-80 -126.11 149.62 48.8 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 112.4 -2.182 . . . . 4.85 110.681 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.2 mm? -128.81 125.99 38.95 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 110.408 -3.087 . . . . 3.68 104.734 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG1' ' HB3' ' A' ' 21' ' ' LEU . 32.7 mm -104.87 119.51 53.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.318 0.58 . . . . 2.9 109.778 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.753 ' HA ' ' O ' ' B' ' 168' ' ' VAL . 3.0 tp -124.35 73.66 1.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 127.656 3.097 . . . . 4.19 105.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.89 -87.78 0.67 Allowed Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.322 -1.308 . . . . 1.62 115.355 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.4 p90 -69.41 164.29 23.34 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.529 0.164 . . . . 0.73 110.756 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 8.4 t -119.79 145.3 46.73 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.666 -0.813 . . . . 1.16 110.296 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 HG22 HG22 ' A' ' 57' ' ' VAL . 37.4 pt -129.18 137.74 56.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.735 -0.666 . . . . 0.89 109.381 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.8 147.38 20.42 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.199 -1.001 . . . . 0.69 111.688 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -137.99 122.96 2.56 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 1.42 112.229 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.584 ' HA3' ' OE1' ' A' ' 48' ' ' GLU . . . -152.15 84.69 0.15 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.76 -0.733 . . . . 3.0 111.979 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.736 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -150.29 -65.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.218 0.532 . . . . 4.71 111.478 176.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' H ' HD12 ' A' ' 37' ' ' ILE . 37.7 t70 -107.58 19.61 19.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.873 1.321 . . . . 7.49 108.004 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.736 ' HG2' ' H ' ' A' ' 37' ' ' ILE . 4.1 mm100 -81.7 -74.54 0.33 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.861 -1.518 . . . . 4.55 111.34 -172.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.627 ' OD2' ' HB3' ' A' ' 42' ' ' SER . 38.7 t70 -149.35 125.17 5.06 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.321 -0.854 . . . . 5.14 110.474 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.08 -16.99 40.85 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.682 2.921 . . . . 5.58 112.512 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 22.9 t -68.6 -28.62 67.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.725 . . . . 6.54 109.989 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.706 ' HB3' ' HA ' ' B' ' 162' ' ' GLU . 5.5 mt-30 -90.05 -57.33 2.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.22 -0.9 . . . . 5.93 109.575 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 1.032 HD22 ' HA ' ' A' ' 48' ' ' GLU . 9.4 m120 -96.33 101.18 8.14 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-N 113.67 -1.605 . . . . 6.06 111.017 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 43' ' ' GLN . 50.1 Cg_endo -70.12 -30.76 20.1 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.822 2.348 . . . . 8.03 112.538 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.89 -47.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.394 -0.366 . . . . 8.87 111.358 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 3.2 m -159.38 -63.98 0.08 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.944 -1.502 . . . . 5.13 106.944 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.032 ' HA ' HD22 ' A' ' 44' ' ' ASN . 10.6 tp10 -139.93 -64.91 0.47 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.11 -1.859 . . . . 7.43 106.494 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.71 -94.78 0.49 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.017 -1.447 . . . . 7.39 107.929 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -127.51 -66.01 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.259 0.552 . . . . 7.82 110.519 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -92.65 5.04 52.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.498 -0.774 . . . . 5.12 111.814 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 2.9 t70 -83.78 172.61 12.03 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.752 0.787 . . . . 3.97 109.96 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -117.81 -7.13 11.0 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.111 -1.404 . . . . 6.09 109.589 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 86.5 -45.47 3.45 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.863 -0.608 . . . . 1.05 114.319 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.586 HD13 ' HA2' ' A' ' 35' ' ' GLY . 50.9 mm -92.31 128.52 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.173 -0.604 . . . . 0.67 110.552 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 44.2 p90 -166.89 170.28 12.37 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 123.174 0.297 . . . . 2.48 110.381 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.658 HG21 HD21 ' A' ' 71' ' ' LEU . 3.7 t -90.6 133.92 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.874 -0.788 . . . . 0.66 108.874 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 9.5 t -118.23 -7.72 10.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.75 1.281 . . . . 1.0 110.655 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.74 163.96 38.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.072 0.939 . . . . 3.02 112.924 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 54.9 t -149.2 122.27 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 112.382 -2.19 . . . . 0.72 108.622 174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -81.73 97.72 8.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.626 -0.879 . . . . 1.77 108.626 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.9 pt-20 -57.62 143.86 39.69 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.0 -1.455 . . . . 3.28 112.88 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.49 27.87 68.73 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.691 -2.504 . . . . 1.03 110.639 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -129.68 6.36 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.468 -0.872 . . . . 1.27 111.675 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 66' ' ' ALA . 57.8 Cg_endo -101.81 -35.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.77 2.98 . . . . 1.32 115.825 -177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.88 -45.81 19.86 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 122.55 1.167 . . . . 0.37 108.076 -162.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 2.5 pm0 -71.21 -29.26 64.94 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 112.69 -2.05 . . . . 1.45 109.182 -168.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' N ' ' HG2' ' A' ' 67' ' ' GLU . 25.0 pt -81.05 -26.01 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 122.462 1.125 . . . . 0.89 109.007 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.08 -22.48 62.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 112.919 -1.946 . . . . 0.34 108.18 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.13 45.44 1.09 Allowed Glycine 0 CA--C 1.507 -0.432 0 CA-C-N 114.553 -1.203 . . . . 0.49 111.071 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 72' ' ' GLN . 3.5 tm? -118.34 154.81 31.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.646 -1.242 . . . . 1.58 107.646 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.708 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -164.9 173.46 11.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.316 -0.856 . . . . 2.36 109.051 -172.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 60' ' ' VAL . 8.1 mm -78.44 115.78 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.842 0.829 . . . . 0.57 112.866 -168.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.1 40.77 0.73 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-N 113.798 -1.546 . . . . 0.6 110.613 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 4.1 t0 -113.42 109.89 19.43 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.372 -0.531 . . . . 1.35 111.122 -171.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 66.1 mttm -80.32 105.88 11.91 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.293 -0.563 . . . . 2.18 110.14 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HA ' HG12 ' A' ' 109' ' ' VAL . 47.6 mt -74.58 106.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.939 -0.573 . . . . 0.64 110.286 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.1 mmt -95.98 -19.86 19.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.538 -0.541 . . . . 0.48 109.538 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.045 ' HB2' ' HB2' ' A' ' 108' ' ' LEU . 22.2 mt-30 -151.5 135.79 16.8 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.937 -0.574 . . . . 2.26 110.079 -175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -122.6 123.2 67.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.266 -0.879 . . . . 0.77 111.212 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.904 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.4 m-80 57.34 24.4 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.84 0.828 . . . . 1.9 110.846 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.94 60.28 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.234 -1.348 . . . . 1.1 112.941 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 3.8 m0 -94.54 96.86 9.74 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 117.409 0.604 . . . . 2.75 109.634 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 1.033 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.7 t70 -46.27 104.66 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.52 -0.548 . . . . 1.61 109.52 167.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 80' ' ' VAL . 32.3 mtp -70.49 -95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 1.72 110.07 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 85' ' ' MET . 63.2 p 62.1 -47.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.107 1.763 . . . . 1.25 114.033 171.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -122.99 -8.39 8.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.317 0.58 . . . . 3.22 110.342 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.515 HG13 ' OE1' ' A' ' 92' ' ' GLN . 30.2 t -73.56 147.22 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.36 -0.836 . . . . 1.73 108.998 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.757 HG22 ' HG2' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -85.11 148.93 25.88 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.091 -1.044 . . . . 1.3 109.833 -176.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.599 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 19.3 t60 -64.61 -25.54 68.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.306 -1.315 . . . . 2.47 110.313 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 89' ' ' THR . 38.9 t70 -81.75 -34.85 30.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.724 -0.671 . . . . 1.81 110.544 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.757 ' HG2' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -83.88 -21.52 31.94 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.63 -0.507 . . . . 2.66 109.63 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -67.5 -43.57 80.57 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.823 -1.547 . . . . 0.8 106.823 170.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 28.8 mtm180 -58.05 -47.79 82.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.204 -1.362 . . . . 3.95 111.565 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 92' ' ' GLN . 19.4 ptmt -68.68 -27.51 66.03 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.624 -0.431 . . . . 2.48 111.927 -173.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.746 HH21 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -87.01 -27.25 23.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 120.052 -0.659 . . . . 3.8 110.589 -177.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD12 HG23 ' A' ' 98' ' ' THR . 4.1 pp -78.23 -25.49 46.96 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 120.615 -0.434 . . . . 1.26 111.718 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 97' ' ' LEU . 17.2 p -103.96 35.24 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.964 0.357 . . . . 1.53 111.964 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HG3' ' H ' ' A' ' 101' ' ' SER . 48.4 pttt -82.74 -5.68 59.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.176 0.513 . . . . 1.79 111.724 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 63.38 15.8 9.01 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.853 -1.067 . . . . 5.04 111.137 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.0 m -103.35 10.88 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.923 0.868 . . . . 2.31 109.101 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -127.48 156.49 42.06 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.275 -1.33 . . . . 2.11 108.36 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -108.27 7.43 27.31 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.769 -1.105 . . . . 3.94 109.442 177.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 19' ' ' HIS . 14.8 p 174.4 161.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.51 -1.223 . . . . 1.17 110.214 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 18' ' ' ILE . 18.2 m -118.55 130.05 73.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 118.938 -1.105 . . . . 2.16 111.072 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.904 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 4.1 mpt_? -85.1 132.63 34.28 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.333 -0.618 . . . . 3.15 109.333 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -123.59 113.6 18.91 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.225 -0.657 . . . . 1.35 109.225 177.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.045 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -91.44 106.73 18.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.305 -1.368 . . . . 1.53 107.305 167.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 77' ' ' ILE . 24.1 m -120.35 168.15 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-O 121.767 0.794 . . . . 1.14 111.431 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.682 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 19.8 p -128.7 110.11 11.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.965 -1.471 . . . . 0.58 110.043 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.555 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.1 ptp180 -128.47 164.11 23.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.751 -0.659 . . . . 3.49 109.724 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 mp0 -86.56 -47.28 9.36 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.434 -0.95 . . . . 2.83 108.434 169.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 t 95.77 17.15 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 112.301 -2.227 . . . . 4.3 109.806 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 115' ' ' GLN . 1.2 pp -150.44 -30.05 0.21 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.406 -1.724 . . . . 4.48 108.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HB2' ' HG2' ' A' ' 112' ' ' GLN . 41.2 mt-30 -97.31 120.97 38.64 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.976 -1.92 . . . . 6.53 109.584 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -99.15 169.73 9.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.212 -0.449 . . . . 9.28 110.318 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.08 26.39 4.9 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 122.134 0.968 . . . . 11.58 109.377 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.1 p -103.4 78.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.694 -1.594 . . . . 12.38 109.582 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -106.73 36.47 2.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.056 -1.429 . . . . 14.96 111.306 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -64.01 102.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.09 0.471 . . . . 17.27 110.096 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.6 m -88.67 -21.45 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 19.47 111.385 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.8 tpp -128.38 129.38 46.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 21.73 110.63 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -85.87 121.19 28.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 23.08 109.743 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 23.96 111.463 -177.079 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.686 ' HG3' ' HG2' ' A' ' 43' ' ' GLN . 10.1 tptp . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 119.452 -0.308 . . . . 8.27 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.706 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 176.68 166.09 0.49 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.357 0.411 . . . . 6.87 111.652 165.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 30.8 t30 57.32 99.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 124.537 1.148 . . . . 4.55 113.432 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -90.71 125.96 35.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.165 -1.05 . . . . 2.71 108.165 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 158.85 22.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.401 -0.592 . . . . 4.92 109.401 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 94' ' ' ARG . 68.7 m -152.85 105.48 2.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.309 -0.405 . . . . 1.22 110.216 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.75 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 10.9 ptp -76.98 138.6 39.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 3.19 110.049 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 m . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.44 -0.791 . . . . 1.54 109.839 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.431 0.634 . . . . 18.34 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -77.11 109.12 10.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.678 -0.692 . . . . 15.06 110.826 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.09 167.68 21.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 14.54 111.133 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.61 98.62 31.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.414 -0.587 . . . . 10.4 109.414 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.71 122.72 8.0 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.122 2.548 . . . . 10.74 112.787 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.68 -15.97 56.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.77 -0.729 . . . . 7.75 113.005 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.3 94.49 42.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.968 0.384 . . . . 6.84 111.149 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -98.67 -168.82 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.344 2.696 . . . . 4.84 113.159 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.812 HG22 ' H ' ' A' ' 10' ' ' THR . 4.6 p -130.94 -166.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.966 -1.016 . . . . 3.26 108.483 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.812 ' H ' HG22 ' A' ' 9' ' ' VAL . 70.6 p -104.07 -97.28 0.31 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.016 0.436 . . . . 2.17 111.437 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.13 135.23 0.98 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.358 -0.837 . . . . 0.98 111.02 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.7 t -101.97 141.14 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 113.969 -1.468 . . . . 1.35 107.909 170.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.22 119.7 61.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 120.821 0.343 . . . . 1.84 110.36 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.514 HE22 ' H ' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -147.27 171.66 15.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.622 -0.717 . . . . 2.31 109.571 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.752 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 43.7 mtm180 -122.29 138.65 54.43 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.034 -0.985 . . . . 3.58 110.823 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 69' ' ' ALA . 2.6 p -142.39 128.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.703 -1.135 . . . . 0.86 109.549 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 1.8 mm-40 -100.01 108.27 20.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.381 -0.97 . . . . 1.75 108.381 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.887 HD13 HD22 ' A' ' 107' ' ' LEU . 2.9 mp -94.94 103.99 15.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 122.577 1.18 . . . . 0.93 109.114 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.687 ' HA ' HG23 ' A' ' 104' ' ' VAL . 14.0 t-160 -87.48 93.28 9.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.291 -1.322 . . . . 3.53 110.52 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.81 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -75.35 161.23 29.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.113 -1.403 . . . . 5.69 110.38 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 tp -139.14 121.82 16.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.055 0.455 . . . . 4.5 111.589 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -76.49 132.29 39.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.64 0.733 . . . . 5.24 110.304 170.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.441 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.34 64.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.19 0.995 . . . . 4.48 110.172 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 78.75 -102.47 1.89 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.632 -1.622 . . . . 3.78 111.572 174.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.84 -2.05 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.428 -0.582 . . . . 6.85 109.428 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.633 ' HB3' HD11 ' A' ' 28' ' ' ILE . 32.7 m-80 -109.74 136.83 48.46 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 123.306 1.527 . . . . 4.85 110.573 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.5 mm? -125.66 108.85 11.95 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.186 -2.733 . . . . 3.68 106.567 170.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.81 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.0 mm -116.38 122.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 118.893 -0.575 . . . . 2.9 111.95 -173.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.71 ' HB2' HG23 ' B' ' 168' ' ' VAL . 6.7 mp -101.13 -24.81 14.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.479 -1.304 . . . . 4.19 107.479 159.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.89 36.49 21.97 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 113.686 -1.597 . . . . 1.62 114.451 161.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.5 p90 -162.76 177.57 9.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.497 0.648 . . . . 0.73 110.615 167.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.953 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 25.5 t -119.36 145.29 46.31 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.552 -0.459 . . . . 1.16 109.808 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.5 pt -132.4 146.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 116.083 -0.508 . . . . 0.89 109.813 -171.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.1 140.76 15.21 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.286 -0.959 . . . . 0.69 111.492 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.3 121.38 4.05 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.915 -0.659 . . . . 1.42 111.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' B' ' 162' ' ' GLU . . . -151.25 60.91 0.41 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.783 -0.722 . . . . 3.0 113.413 -175.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -119.78 -57.55 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.523 0.564 . . . . 4.71 112.523 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' H ' HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.99 20.33 3.47 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.136 -0.69 . . . . 7.49 109.136 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' HD12 ' B' ' 164' ' ' LEU . 36.5 mm-40 -58.39 -76.32 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.669 -1.15 . . . . 4.55 111.794 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' B' ' 161' ' ' LYS . 2.8 t0 -147.8 115.79 4.12 Favored Pre-proline 0 C--N 1.315 -0.903 0 C-N-CA 120.234 -0.586 . . . . 5.14 110.654 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.874 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 56.1 Cg_endo -61.74 -10.1 15.96 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.75 2.967 . . . . 5.58 111.193 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.445 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 22.6 t -47.44 -55.56 8.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.052 -1.885 . . . . 6.54 111.84 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.484 HE22 ' N ' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -97.32 -21.46 17.21 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.774 -0.648 . . . . 5.93 112.375 -161.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 7.3 t-20 -159.62 109.66 1.48 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.896 0.379 . . . . 6.06 110.832 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.4 -13.42 15.11 Favored 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.837 2.358 . . . . 8.03 113.649 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 11.4 t80 -141.0 -20.91 0.79 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.912 0.708 . . . . 8.87 112.912 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 89.5 p 57.35 -88.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.85 1.26 . . . . 5.13 110.519 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.668 ' HB2' ' HD2' ' A' ' 46' ' ' PHE . 41.0 tt0 62.06 15.39 7.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 7.43 111.046 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.3 72.31 0.93 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.565 0.698 . . . . 7.39 110.246 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 55.29 71.37 0.55 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.135 -1.393 . . . . 7.82 111.897 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.2 t 50.64 35.62 12.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.619 -1.173 . . . . 5.12 109.926 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -34.43 -58.21 0.49 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.684 -1.598 . . . . 3.97 113.047 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HG3' HG21 ' A' ' 86' ' ' THR . 52.1 tptt 77.8 -25.97 0.19 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.071 0.857 . . . . 6.09 110.553 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.675 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 97.87 -7.53 62.95 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.941 -0.572 . . . . 1.05 114.331 166.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mm -130.06 110.22 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.331 -0.618 . . . . 0.67 109.331 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 41.5 p90 -155.95 156.26 34.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.89 -0.324 . . . . 2.48 110.929 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.826 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -77.91 133.16 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 120.893 0.377 . . . . 0.66 110.038 174.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 59' ' ' ARG . 12.0 t -105.38 -16.94 14.6 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.13 -0.941 . . . . 1.0 110.069 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 14.1 ptt180 -174.93 174.5 2.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.675 0.75 . . . . 3.02 112.27 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 86.5 t -135.86 147.86 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.509 -1.223 . . . . 0.72 108.312 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -83.4 124.18 30.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.443 -1.317 . . . . 1.77 107.443 167.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.55 137.09 52.14 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.627 -1.624 . . . . 3.28 112.528 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.38 31.32 76.88 Favored Glycine 0 C--N 1.29 -1.975 0 CA-C-N 111.723 -2.49 . . . . 1.03 111.55 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -104.0 -128.59 6.33 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.218 -0.991 . . . . 1.27 111.678 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.6 Cg_endo -97.39 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.867 3.045 . . . . 1.32 114.944 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -76.39 -43.98 38.19 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.209 1.004 . . . . 0.37 109.229 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.91 -23.89 48.5 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.586 -1.188 . . . . 1.45 109.321 -167.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.21 -24.71 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-O 122.547 1.165 . . . . 0.89 108.796 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -66.16 -25.84 67.14 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.821 -1.991 . . . . 0.34 107.916 170.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.91 40.71 1.39 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.192 -1.367 . . . . 0.49 111.39 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 72' ' ' GLN . 2.9 tm? -120.45 156.18 31.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.365 -1.346 . . . . 1.58 107.365 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.596 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -163.0 -175.82 4.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.569 -0.741 . . . . 2.36 109.485 -171.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.3 mm -82.78 113.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 113.647 0.98 . . . . 0.57 113.647 -167.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.638 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 108.37 58.86 0.55 Allowed Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.76 -0.733 . . . . 0.6 114.089 161.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.826 ' H ' HG12 ' A' ' 57' ' ' VAL . 2.2 p30 -139.11 150.23 45.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.168 0.484 . . . . 1.35 110.683 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 8.6 mttm -94.16 108.48 20.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.585 0.707 . . . . 2.18 110.429 -172.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HG ' ' A' ' 107' ' ' LEU . 50.0 mt -77.01 106.37 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 114.607 -1.179 . . . . 0.64 109.781 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.526 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 11.7 mmt -85.59 -33.66 21.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.576 -0.283 . . . . 0.48 111.471 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.812 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -151.27 161.75 42.15 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 122.52 1.152 . . . . 2.26 112.663 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG12 ' HG2' ' A' ' 85' ' ' MET . 4.3 p -122.36 121.82 64.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 112.1 -2.318 . . . . 0.77 110.135 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 61.7 2.79 0.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.002 0.43 . . . . 1.9 111.573 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 125.49 -2.24 8.17 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.849 -0.691 . . . . 1.1 113.969 174.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.578 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -121.66 111.77 17.61 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 118.509 1.154 . . . . 2.75 111.713 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.812 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 9.8 t70 -24.89 116.85 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.606 -1.634 . . . . 1.61 112.96 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 24.6 mtp -85.71 -21.69 28.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.517 -0.765 . . . . 1.72 111.839 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 HG21 ' HG3' ' A' ' 53' ' ' LYS . 76.1 p -76.41 -21.7 55.66 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.397 0.517 . . . . 1.25 112.397 -169.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.1 mmm -87.32 3.87 45.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.314 0.578 . . . . 3.22 110.51 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -115.1 178.68 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.459 -0.791 . . . . 1.73 108.919 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.662 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -98.15 164.82 12.17 Favored 'General case' 0 C--O 1.225 -0.237 0 O-C-N 121.535 -0.728 . . . . 1.3 109.171 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.523 ' HB2' HE22 ' A' ' 39' ' ' GLN . 30.4 t60 -64.45 -34.47 78.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.045 0.45 . . . . 2.47 110.592 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.739 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 16.4 t70 -76.93 -29.63 55.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.28 -0.873 . . . . 1.81 109.981 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.662 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 7.5 mm100 -67.5 -46.72 72.1 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.6 0.714 . . . . 2.66 109.857 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -59.74 -37.39 78.83 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.588 -1.187 . . . . 0.8 108.425 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.739 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 69.1 mtt180 -51.76 -50.37 60.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.444 -1.253 . . . . 3.95 110.694 175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 87.0 mttt -66.57 -33.98 76.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.01 -0.995 . . . . 2.48 112.436 -173.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 8.7 ptp180 -87.03 -18.16 31.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.723 1.009 . . . . 3.8 113.723 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 98' ' ' THR . 3.9 pp -87.82 -22.51 24.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 1.26 110.882 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.706 HG23 HD12 ' A' ' 97' ' ' LEU . 16.5 p -118.44 51.5 1.09 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.719 -0.673 . . . . 1.53 110.456 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.757 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 52.4 pttt -82.91 -5.85 59.21 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.424 0.63 . . . . 1.79 110.403 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 65.27 11.69 7.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.274 -1.33 . . . . 5.04 111.621 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 22.8 t -109.31 12.37 24.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.622 -0.717 . . . . 2.31 109.841 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.757 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -133.91 156.8 47.47 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.684 0.754 . . . . 2.11 109.857 -178.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.15 -7.43 23.15 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.359 -1.291 . . . . 3.94 109.262 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 19' ' ' HIS . 13.4 p -166.18 152.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.497 -1.229 . . . . 1.17 110.253 -165.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 29' ' ' LEU . 9.9 p -114.89 109.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.876 0.846 . . . . 2.16 109.393 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.8 ttt180 -88.67 141.36 28.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.426 -0.806 . . . . 3.15 109.67 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.887 HD22 HD13 ' A' ' 18' ' ' ILE . 2.8 mp -124.44 144.69 49.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.828 0.677 . . . . 1.35 112.828 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 8.6 mt -110.25 109.26 19.65 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.219 -1.401 . . . . 1.53 107.219 165.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 110' ' ' THR . 12.5 p -123.9 165.16 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 121.352 0.596 . . . . 1.14 110.814 -167.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 4.8 p -124.65 112.98 17.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.84 -1.073 . . . . 0.58 111.294 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.607 ' HE ' ' HB3' ' A' ' 75' ' ' ASP . 2.9 mmp_? -92.14 157.87 16.49 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.221 -0.899 . . . . 3.49 111.748 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.656 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.8 mm-40 -96.12 -29.88 13.83 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.29 -1.323 . . . . 2.83 109.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.6 t 80.81 18.96 0.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.027 -1.897 . . . . 4.3 111.752 170.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 112' ' ' GLN . 1.3 pp -115.59 33.77 5.29 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.685 1.231 . . . . 4.48 110.424 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.59 73.52 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.278 -2.237 . . . . 6.53 112.911 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 73.44 146.87 0.08 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.938 0.895 . . . . 9.28 112.155 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.48 37.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.789 0.804 . . . . 11.58 109.175 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.21 84.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.668 -1.151 . . . . 12.38 109.809 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -130.81 133.26 45.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.8 -1.091 . . . . 14.96 110.439 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 54.15 81.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.877 0.736 . . . . 17.27 112.673 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 m -82.88 -7.62 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 19.47 111.151 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -89.98 -38.36 13.69 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.921 0.391 . . . . 21.73 111.101 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.09 104.69 14.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.011 -0.54 . . . . 23.08 110.346 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.546 . . . . 23.96 110.643 178.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.874 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 1.9 mptt . . . . . 0 C--O 1.225 -0.218 0 CA-C-O 119.409 -0.329 . . . . 8.27 110.451 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.631 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 16.5 tt0 -120.07 130.17 54.55 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 6.87 114.25 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -166.7 15.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.97 -1.013 . . . . 4.55 110.274 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.594 HD12 ' OE1' ' A' ' 39' ' ' GLN . 4.7 mt -110.68 133.17 53.56 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 113.302 0.853 . . . . 2.71 113.302 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.12 156.63 33.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.543 -1.208 . . . . 4.92 108.842 164.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 21.8 m -158.64 121.14 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.53 -0.305 . . . . 1.22 110.898 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.667 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 83.3 mtp -84.79 103.73 14.13 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.162 -1.051 . . . . 3.19 108.162 165.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 29' ' ' LEU . 3.8 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.204 -0.907 . . . . 1.54 108.584 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.0 mtm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.519 0.199 . . . . 18.34 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -84.33 -66.72 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.591 0.234 . . . . 15.06 110.606 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -111.98 -175.48 2.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.321 . . . . 14.54 110.536 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.05 98.75 26.41 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-N 116.232 -0.44 . . . . 10.4 110.141 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.58 141.4 22.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.836 2.357 . . . . 10.74 111.789 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.45 -36.13 3.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.268 -0.968 . . . . 7.75 112.624 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -116.87 85.12 16.9 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.384 0.512 . . . . 6.84 112.384 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -100.9 152.16 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.168 2.579 . . . . 4.84 111.707 168.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.89 152.2 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 3.26 109.693 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 117' ' ' ALA . 76.2 p -88.58 -54.47 4.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.914 -1.039 . . . . 2.17 110.9 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.51 145.79 3.26 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.863 -1.517 . . . . 0.98 109.036 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 110' ' ' THR . 2.8 t -103.15 116.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.208 -1.36 . . . . 1.35 110.386 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.28 104.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.295 -1.002 . . . . 1.84 108.295 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 111' ' ' ARG . 4.2 pt20 -133.13 156.58 47.18 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.624 0.726 . . . . 2.31 111.124 -175.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 mmm180 -117.06 121.64 41.91 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.073 -1.422 . . . . 3.58 108.933 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.6 p -137.92 133.66 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 C-N-CA 120.514 -0.474 . . . . 0.86 109.824 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 5.5 pt-20 -107.49 109.37 21.04 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.669 0.747 . . . . 1.75 110.409 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.841 HG21 ' CE1' ' A' ' 31' ' ' PHE . 11.7 mm -94.0 120.66 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.714 -1.13 . . . . 0.93 111.982 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 p80 -142.98 116.01 8.86 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.048 -0.978 . . . . 3.53 111.425 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.761 ' HA ' ' HB3' ' A' ' 65' ' ' PRO . 5.7 tmtm? -85.95 -81.18 0.21 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.034 -0.358 . . . . 5.69 110.034 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.3 tp -151.24 120.23 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.055 -0.52 . . . . 4.5 111.952 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.431 ' C ' ' HD2' ' A' ' 22' ' ' ARG . 1.3 tmm_? -77.59 112.7 14.66 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.931 -0.766 . . . . 5.24 108.931 166.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.945 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -123.04 68.31 0.98 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.225 1.012 . . . . 4.48 110.703 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 73.34 -99.54 0.99 Allowed Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.555 -1.657 . . . . 3.78 112.228 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.74 -8.13 56.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.757 -0.721 . . . . 6.85 109.509 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.945 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 33.1 m-80 -112.51 134.78 53.85 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.362 1.553 . . . . 4.85 110.69 -172.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' HD3' ' A' ' 100' ' ' ARG . 4.0 mm? -122.31 110.72 16.03 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 111.066 -2.788 . . . . 3.68 106.006 167.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.677 HG13 HE21 ' A' ' 23' ' ' GLN . 42.0 mm -107.65 132.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.048 -0.523 . . . . 2.9 111.555 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD21 HG11 ' A' ' 105' ' ' VAL . 5.7 mp -104.39 -31.87 9.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.584 -1.189 . . . . 4.19 108.511 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -56.26 4.99 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 114.185 -1.371 . . . . 1.62 114.574 172.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.874 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 5.1 p90 -72.42 -174.88 1.44 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.684 0.394 . . . . 0.73 111.479 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.649 ' HB3' ' HG3' ' B' ' 165' ' ' GLU . 15.7 m -138.71 151.03 46.8 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.964 -0.294 . . . . 1.16 111.381 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.961 HG22 HG23 ' A' ' 57' ' ' VAL . 2.1 pp -133.67 139.89 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.769 -0.456 . . . . 0.89 109.769 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.79 122.77 7.43 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.632 -0.794 . . . . 0.69 111.785 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . -163.89 125.67 1.42 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.475 -0.869 . . . . 1.42 111.265 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' B' ' 163' ' ' ASN . . . 144.35 -22.22 2.06 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.745 -1.217 . . . . 3.0 112.263 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.895 ' HA ' ' HB3' ' B' ' 163' ' ' ASN . 5.4 pt -46.95 -47.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.326 0.862 . . . . 4.71 113.326 -161.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -135.78 2.53 2.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.213 -1.032 . . . . 7.49 108.213 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.785 ' OE1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -107.29 -15.54 14.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.078 1.14 . . . . 4.55 114.078 -169.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 42' ' ' SER . 0.0 OUTLIER -54.04 128.6 56.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 121.203 0.525 . . . . 5.14 110.138 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 38.8 Cg_endo -61.61 -17.35 53.83 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 124.205 3.27 . . . . 5.58 111.929 -172.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 4.4 m -72.29 -40.3 67.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.41 -0.814 . . . . 6.54 110.019 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 40' ' ' ASP . 7.2 pt20 -100.75 -18.15 16.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.858 0.837 . . . . 5.93 110.636 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.0 t-20 -137.64 88.09 16.76 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.391 -1.277 . . . . 6.06 109.777 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 36.8 Cg_endo -65.68 -7.95 17.96 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.903 2.402 . . . . 8.03 111.804 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.599 ' O ' ' HB2' ' A' ' 47' ' ' SER . 88.2 m-85 -94.29 -66.73 0.9 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.667 -0.697 . . . . 8.87 109.994 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 6.2 t 161.57 -72.75 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.338 -0.986 . . . . 5.13 108.338 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' SER . 3.9 tm-20 174.08 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.648 -1.242 . . . . 7.43 107.648 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 7.5 t70 -118.17 -78.36 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.718 -1.128 . . . . 7.39 108.486 174.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD2' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -176.01 -38.1 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.393 -0.821 . . . . 7.82 109.149 170.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -96.63 6.23 49.13 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.895 -1.048 . . . . 5.12 108.857 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 38.6 t70 -76.2 -67.8 0.65 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.787 -0.642 . . . . 3.97 111.064 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER 77.22 -45.93 0.48 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.937 0.895 . . . . 6.09 108.813 -177.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.648 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 79.24 22.88 64.36 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.649 -1.16 . . . . 1.05 113.356 170.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' A' ' 35' ' ' GLY . 49.6 mm -126.04 110.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.487 -0.56 . . . . 0.67 109.487 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 33.9 p90 -151.5 156.73 41.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.637 -0.256 . . . . 2.48 110.885 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.961 HG23 HG22 ' A' ' 33' ' ' ILE . 2.4 p -73.33 134.73 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 109.754 -0.461 . . . . 0.66 109.754 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -101.82 -27.35 13.06 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.066 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HG23 ' A' ' 73' ' ' ILE . 5.9 ptt180 -160.92 173.18 15.68 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.665 -1.152 . . . . 3.02 112.382 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 69.2 t -144.2 138.2 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 113.751 -1.568 . . . . 0.72 107.318 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.59 98.78 3.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.662 -0.815 . . . . 1.77 109.192 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.787 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 5.0 mt-10 -62.71 144.85 55.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-O 123.121 1.439 . . . . 3.28 113.105 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.46 30.99 78.85 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 111.514 -2.584 . . . . 1.03 110.743 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -116.55 -123.34 3.48 Favored Glycine 0 N--CA 1.425 -2.087 0 C-N-CA 120.257 -0.973 . . . . 1.27 113.258 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HA ' ' A' ' 20' ' ' LYS . 98.3 Cg_endo -97.65 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.774 2.983 . . . . 1.32 115.372 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 18' ' ' ILE . . . -78.6 -37.64 41.9 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.669 0.747 . . . . 0.37 109.543 -163.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.787 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 1.5 pm0 -79.93 -27.17 39.87 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.296 -1.32 . . . . 1.45 109.763 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.68 -25.82 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 CA-C-O 122.303 1.049 . . . . 0.89 108.991 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -68.99 -26.85 65.23 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 112.958 -1.928 . . . . 0.34 107.861 168.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.44 42.34 0.82 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 114.654 -1.157 . . . . 0.49 112.889 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.852 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 14.4 tp -113.74 179.44 3.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.176 -0.675 . . . . 1.58 109.176 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.852 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 26.9 mt-30 -157.04 -179.4 8.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.241 -0.891 . . . . 2.36 108.879 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.589 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.0 mm -90.14 112.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 115.328 -0.851 . . . . 0.57 111.266 174.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.796 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.49 58.09 0.82 Allowed Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.445 -0.883 . . . . 0.6 113.19 167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.824 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.8 m-20 -140.1 142.76 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.798 -0.445 . . . . 1.35 109.798 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.705 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -90.1 108.94 20.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.064 0.459 . . . . 2.18 111.389 -167.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.3 mt -74.66 118.33 20.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.383 -0.826 . . . . 0.64 110.535 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.1 mmt -106.26 -19.08 13.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.386 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -148.55 160.39 43.15 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.407 0.622 . . . . 2.26 111.193 -177.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG12 ' HB3' ' A' ' 85' ' ' MET . 7.5 p -148.31 135.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.698 -1.137 . . . . 0.77 111.156 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.46 3.01 3.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.357 0.598 . . . . 1.9 109.829 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.22 7.69 14.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.026 -0.988 . . . . 1.1 113.048 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.656 ' HZ2' ' NE ' ' A' ' 96' ' ' ARG . 43.2 p-90 -135.81 132.03 36.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.847 0.832 . . . . 2.75 112.893 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.569 ' N ' ' HB2' ' A' ' 79' ' ' GLN . 18.4 t70 -45.18 111.74 0.36 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 113.138 -1.846 . . . . 1.61 111.636 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -105.12 27.02 8.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.313 -0.858 . . . . 1.72 112.372 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.7 p -64.7 -44.62 89.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.574 0.953 . . . . 1.25 113.574 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -96.26 16.7 17.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.979 0.895 . . . . 3.22 111.107 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.882 HG13 ' CG ' ' A' ' 92' ' ' GLN . 43.5 t -90.69 164.46 2.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.435 -1.257 . . . . 1.73 108.884 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.967 HG22 ' HB2' ' A' ' 92' ' ' GLN . 3.5 t -105.48 170.76 7.7 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 117.855 -1.538 . . . . 1.3 110.765 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.967 ' HB3' HD13 ' B' ' 164' ' ' LEU . 2.0 t-80 -70.82 -32.64 69.76 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.092 -0.504 . . . . 2.47 110.532 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 16.4 t70 -72.07 -48.46 44.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.273 -1.01 . . . . 1.81 108.273 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.967 ' HB2' HG22 ' A' ' 89' ' ' THR . 8.6 tp-100 -42.7 -58.67 2.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.927 -1.942 . . . . 2.66 110.95 170.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . . . -69.52 -35.2 75.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.416 -0.811 . . . . 0.8 110.957 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.668 ' HB3' ' O ' ' A' ' 90' ' ' HIS . 7.6 ptt180 -69.78 -41.24 75.38 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.243 0.544 . . . . 3.95 110.783 -171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 14.2 ptpt -77.17 -25.22 51.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.448 -0.501 . . . . 2.48 110.742 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.656 ' NE ' ' HZ2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -88.3 -22.77 23.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.197 -0.601 . . . . 3.8 110.969 -177.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 HG23 ' A' ' 98' ' ' THR . 4.5 pp -76.12 -25.27 55.23 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.108 0.48 . . . . 1.26 110.227 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.663 HG23 HD12 ' A' ' 97' ' ' LEU . 4.5 p -101.29 43.68 1.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 1.53 110.782 173.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.76 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 50.6 pttt -70.56 -7.05 40.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.967 0.413 . . . . 1.79 111.443 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' HD3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 65.6 15.11 9.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.898 -1.047 . . . . 5.04 110.974 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.562 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 75.3 m -117.99 11.89 13.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.553 -0.749 . . . . 2.31 111.289 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -122.1 -175.97 3.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.47 -0.937 . . . . 2.11 108.47 173.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -143.13 16.32 1.9 Allowed 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 106.158 -1.793 . . . . 3.94 106.158 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.1 p 179.6 145.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 111.93 -2.395 . . . . 1.17 110.997 -165.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.603 HG11 HD21 ' A' ' 29' ' ' LEU . 18.2 m -118.12 118.89 59.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 119.861 -0.735 . . . . 2.16 109.796 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 2.6 ttt180 -87.48 133.36 33.77 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.164 -0.614 . . . . 3.15 109.425 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 106' ' ' ARG . 11.4 mt -124.16 155.52 38.32 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.907 0.86 . . . . 1.35 111.55 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 11.2 tp -121.12 136.03 55.06 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.458 -2.423 . . . . 1.53 104.458 165.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 77' ' ' ILE . 27.3 m -144.05 -179.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-O 122.037 0.923 . . . . 1.14 109.787 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -135.99 113.45 10.79 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.033 -1.894 . . . . 0.58 107.29 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.699 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -87.28 145.31 26.41 Favored 'General case' 0 N--CA 1.397 -3.096 0 C-N-CA 120.105 -0.638 . . . . 3.49 110.69 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.643 ' HG3' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER 54.54 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 125.079 1.487 . . . . 2.83 109.298 -167.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ARG . 44.0 t 53.69 29.28 9.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.659 -2.519 . . . . 4.3 111.271 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 112' ' ' GLN . 2.7 pp -129.02 5.35 5.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 123.506 1.622 . . . . 4.48 109.419 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -88.83 -176.08 5.09 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 111.478 -2.601 . . . . 6.53 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 10' ' ' THR . 53.8 mtpt -65.51 125.99 26.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.603 -0.517 . . . . 9.28 109.603 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -133.92 25.26 3.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.332 1.063 . . . . 11.58 109.063 -173.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.97 80.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.684 -1.598 . . . . 12.38 109.806 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -111.7 28.0 9.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.948 -1.478 . . . . 14.96 110.403 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -78.06 65.93 3.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.47 0.652 . . . . 17.27 110.342 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -105.81 -36.62 6.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.561 -0.745 . . . . 19.47 109.762 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -131.32 113.76 14.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 21.73 110.048 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.4 pt? -104.26 101.39 11.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.237 -0.438 . . . . 23.08 109.857 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 23.96 110.258 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 42' ' ' SER . 27.7 mtmm . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.958 0.409 . . . . 8.27 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.518 ' H ' ' HB3' ' B' ' 161' ' ' LYS . 34.7 mt-10 73.04 -170.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.918 -1.037 . . . . 6.87 112.839 173.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.895 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 8.4 p30 -123.58 154.86 38.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.873 -1.058 . . . . 4.55 111.346 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.967 HD13 ' HB3' ' A' ' 90' ' ' HIS . 4.3 mp -139.88 162.73 34.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.938 0.399 . . . . 2.71 111.194 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.751 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.7 118.17 20.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.92 108.56 166.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -157.11 150.35 23.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.694 . . . . 1.22 111.193 -167.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.66 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mmt -161.27 -31.54 0.05 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.623 -0.88 . . . . 3.19 108.623 160.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' B' ' 167' ' ' MET . 74.9 t . . . . . 0 N--CA 1.44 -0.93 0 O-C-N 124.703 1.252 . . . . 1.54 111.019 160.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.543 -0.54 . . . . 18.34 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -115.75 -7.92 12.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.794 0.331 . . . . 15.06 110.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -120.44 136.83 54.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.323 -0.399 . . . . 14.54 110.224 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mt -113.38 96.28 39.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.954 0.407 . . . . 10.4 110.055 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.1 20.95 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.606 2.871 . . . . 10.74 112.832 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.84 -11.67 10.98 Favored Glycine 0 C--N 1.315 -0.629 0 C-N-CA 120.71 -0.757 . . . . 7.75 112.736 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.18 147.22 33.21 Favored Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 110.002 -0.369 . . . . 6.84 110.002 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.13 141.07 96.25 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.064 2.509 . . . . 4.84 112.826 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.95 -2.32 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 122.92 1.343 . . . . 3.26 108.936 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p 68.0 102.45 0.05 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.123 -2.762 . . . . 2.17 112.008 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.29 109.76 19.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.768 -2.015 . . . . 0.98 109.747 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.1 t -74.06 121.85 26.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 114.251 -1.341 . . . . 1.35 108.713 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.84 117.38 43.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.795 -0.639 . . . . 1.84 109.382 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.84 170.13 16.45 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.319 -0.623 . . . . 2.31 109.319 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG2' ' CD2' ' A' ' 108' ' ' LEU . 37.0 mtt180 -117.2 142.77 46.63 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-N 115.356 -0.838 . . . . 3.58 109.618 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -132.23 148.29 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 107.926 -1.138 . . . . 0.86 107.926 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.914 ' HB3' HG23 ' A' ' 105' ' ' VAL . 22.9 mt-10 -106.79 108.12 19.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.897 HD12 HD22 ' A' ' 107' ' ' LEU . 82.6 mt -148.43 112.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.912 -1.04 . . . . 0.93 110.605 -168.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -147.14 167.94 22.88 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.211 -0.904 . . . . 3.53 110.949 164.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' HD22 ' A' ' 29' ' ' LEU . 66.6 mttm -28.13 144.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 125.497 1.748 . . . . 5.69 114.358 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 57.8 tp -125.9 128.87 48.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.219 -0.9 . . . . 4.5 110.209 -168.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.945 ' HD3' ' HB3' ' A' ' 27' ' ' LEU . 2.9 tpp180 -60.86 120.77 10.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.864 -1.062 . . . . 5.24 113.366 -173.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.41 71.17 1.43 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.136 -1.393 . . . . 4.48 110.184 171.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.72 -107.81 2.37 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 113.469 -1.696 . . . . 3.78 112.119 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.99 -2.17 54.53 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.883 -0.784 . . . . 6.85 108.883 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 20.7 m-80 -115.67 153.27 31.62 Favored 'General case' 0 N--CA 1.405 -2.709 0 N-CA-C 108.186 -1.042 . . . . 4.85 108.186 -173.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.945 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.21 111.09 5.03 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 112.834 -1.985 . . . . 3.68 108.946 162.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' NE2' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -154.14 157.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 112.812 -1.994 . . . . 2.9 112.927 -170.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.867 ' HB3' ' HD1' ' A' ' 31' ' ' PHE . 3.5 mm? -75.68 -61.15 2.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.337 -0.847 . . . . 4.19 109.848 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.89 -5.74 72.83 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.337 -0.847 . . . . 1.62 112.449 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.979 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 14.1 p90 -94.14 167.33 11.63 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.208 0.504 . . . . 0.73 109.813 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 22.8 t -129.54 147.75 51.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.428 0.633 . . . . 1.16 111.13 -171.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 50.8 pt -128.18 149.51 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.513 -0.767 . . . . 0.89 109.543 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.89 133.93 11.91 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.159 -1.019 . . . . 0.69 111.18 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 39' ' ' GLN . . . -130.74 131.97 6.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.955 -0.64 . . . . 1.42 111.514 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' B' ' 162' ' ' GLU . . . -132.13 13.08 5.25 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.873 -0.68 . . . . 3.0 112.752 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.838 HG13 ' H ' ' A' ' 38' ' ' ASP . 5.3 pt -54.1 -72.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.374 0.669 . . . . 4.71 112.797 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' H ' HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -101.66 10.35 40.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.152 0.501 . . . . 7.49 109.836 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' B' ' 163' ' ' ASN . 28.4 mm-40 -78.57 -101.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.07 -0.968 . . . . 4.55 113.329 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' O ' ' HG3' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -125.5 102.43 29.66 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 120.48 -0.488 . . . . 5.14 111.674 -168.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.538 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 55.7 Cg_endo -63.19 -10.9 22.67 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 123.47 2.78 . . . . 5.58 109.468 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.8 m -52.74 -39.4 62.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.014 -1.903 . . . . 6.54 110.791 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.967 ' HB2' ' HA ' ' B' ' 161' ' ' LYS . 37.7 mt-30 -91.64 -12.77 33.24 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 120.495 -0.482 . . . . 5.93 111.275 -170.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HB2' ' HB2' ' B' ' 161' ' ' LYS . 7.8 t-20 -152.58 97.77 2.9 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.572 -0.74 . . . . 6.06 111.385 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.62 -12.07 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.703 2.269 . . . . 8.03 111.645 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -89.58 -44.72 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 8.87 111.301 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 p -135.29 -176.55 4.3 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.796 0.332 . . . . 5.13 110.778 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.6 -34.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 7.43 110.011 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 19.9 t70 -176.15 61.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.369 1.08 . . . . 7.39 109.207 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 49' ' ' ASP . 12.0 mptt -128.75 -52.09 1.24 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.672 -1.149 . . . . 7.82 108.306 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.2 p -116.42 8.37 14.08 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.732 -1.122 . . . . 5.12 110.268 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 12.9 t70 -124.57 -60.33 1.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.109 1.152 . . . . 3.97 114.109 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 4.5 mptp? 90.76 -16.52 0.2 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.444 1.09 . . . . 6.09 111.938 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.35 -4.0 82.83 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 114.882 0.713 . . . . 1.05 114.882 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.494 HG21 ' SD ' ' A' ' 85' ' ' MET . 34.8 mm -128.66 126.24 64.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.554 0.677 . . . . 0.67 110.294 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 10.0 p90 -164.35 156.75 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.56 -0.291 . . . . 2.48 110.506 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.1 p -73.69 139.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 110.305 -0.258 . . . . 0.66 110.305 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.621 HG23 ' HG2' ' A' ' 59' ' ' ARG . 14.8 t -109.44 -16.78 13.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.301 1.001 . . . . 1.0 110.216 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.621 ' HG2' HG23 ' A' ' 58' ' ' THR . 15.6 ptt180 -168.48 172.5 8.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.293 0.568 . . . . 3.02 111.307 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.979 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 92.7 t -140.59 143.05 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.259 -0.882 . . . . 0.72 110.182 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.1 p -71.88 108.13 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.036 -0.727 . . . . 1.77 109.036 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 36.8 mt-10 -66.85 135.44 53.89 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 123.177 1.465 . . . . 3.28 112.107 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 64.88 31.87 82.35 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 111.358 -2.656 . . . . 1.03 111.332 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -106.38 -128.45 6.06 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.256 -0.973 . . . . 1.27 111.319 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.48 ' HD3' ' HA3' ' A' ' 64' ' ' GLY . 44.0 Cg_endo -99.07 -38.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.355 2.703 . . . . 1.32 115.596 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -77.09 -41.37 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.288 -1.005 . . . . 0.37 108.288 -165.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -81.03 -23.86 38.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 114.69 -1.141 . . . . 1.45 109.06 -166.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 69' ' ' ALA . 30.8 pt -81.13 -27.27 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-O 122.609 1.195 . . . . 0.89 108.215 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.37 -27.32 68.48 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.583 -2.099 . . . . 0.34 108.091 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.56 42.67 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.49 111.767 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 18' ' ' ILE . 2.5 tm? -118.85 163.62 16.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.574 -2.01 . . . . 1.58 105.574 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.611 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -159.54 -176.16 5.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.73 -0.841 . . . . 2.36 108.73 -164.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 60' ' ' VAL . 3.5 mm -87.75 113.4 24.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 121.015 -0.274 . . . . 0.57 110.897 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.64 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 101.11 57.15 0.86 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.214 -1.154 . . . . 0.6 110.214 173.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.844 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -134.62 120.62 19.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.826 -0.805 . . . . 1.35 108.826 -167.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.733 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 45.8 mttm -84.27 107.16 16.41 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.195 0.521 . . . . 2.18 111.284 -166.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG23 ' HG ' ' A' ' 107' ' ' LEU . 48.9 mt -77.17 107.77 9.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.359 -0.837 . . . . 0.64 110.152 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.6 mmt -89.43 -26.79 20.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.108 -0.496 . . . . 0.48 109.962 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.974 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -165.27 159.22 17.12 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-O 122.152 0.977 . . . . 2.26 111.658 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.02 129.3 69.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 113.397 -1.728 . . . . 0.77 110.053 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER 59.45 6.89 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.797 0.686 . . . . 1.9 111.734 -178.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.36 -2.29 23.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.1 112.465 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 10.1 m95 -97.63 82.37 3.06 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.714 -0.476 . . . . 2.75 109.714 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.889 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.0 t70 -29.04 100.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.806 1.316 . . . . 1.61 110.717 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.727 ' HA ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -89.51 12.88 15.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 1.72 112.343 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.4 p -96.64 -19.94 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 1.25 110.682 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -89.64 -5.75 56.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.356 0.598 . . . . 3.22 110.417 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.727 HG23 ' HA ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.46 -173.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 1.73 110.583 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.1 m -103.96 165.16 11.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.941 -1.133 . . . . 1.3 107.941 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -64.58 -33.67 76.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.313 0.506 . . . . 2.47 111.228 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 33.3 t70 -77.26 -28.08 53.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.21 0.529 . . . . 1.81 110.533 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 3.2 mm100 -66.55 -47.43 72.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.898 0.856 . . . . 2.66 109.827 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -57.29 -35.89 70.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.262 -1.336 . . . . 0.8 108.382 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 47.9 mtt180 -54.0 -51.51 63.72 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.496 -1.229 . . . . 3.95 110.421 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 37.9 mtpt -61.58 -22.48 65.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.562 -175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 9.1 mmp_? -80.85 -45.47 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.42 0.526 . . . . 3.8 112.42 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.748 HD12 HG23 ' A' ' 98' ' ' THR . 2.9 pp -80.4 -23.33 40.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.153 0.798 . . . . 1.26 113.153 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.748 HG23 HD12 ' A' ' 97' ' ' LEU . 17.6 p -109.71 35.15 3.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.042 -0.263 . . . . 1.53 111.572 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -97.27 143.73 27.76 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 107.196 -1.409 . . . . 1.79 107.196 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 12.3 tpt180 -93.17 29.06 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.751 -1.204 . . . . 5.04 107.751 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 t -133.81 12.44 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.63 -1.623 . . . . 2.31 110.359 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -78.81 151.08 32.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.762 -0.829 . . . . 2.11 108.762 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -98.74 -2.22 38.64 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.604 -0.726 . . . . 3.94 110.312 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 105' ' ' VAL . 4.7 p -175.43 179.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.208 1.004 . . . . 1.17 113.147 -171.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG23 ' HB3' ' A' ' 17' ' ' GLU 0.299 29.9 m -94.32 107.19 19.02 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 C-N-CA 127.485 2.314 . . . . 2.16 106.736 174.604 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.812 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 1.1 tpt180 -139.39 137.27 35.55 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.005 -1.684 . . . . 3.15 112.794 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 18' ' ' ILE . 2.1 mp -138.98 154.62 48.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.974 0.796 . . . . 1.35 111.809 172.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.974 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.0 mt -114.98 130.9 57.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 157.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 7.7 p -142.78 159.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 CA-C-O 121.962 0.887 . . . . 1.14 110.454 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 1.7 p -134.53 114.36 12.74 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.776 -1.556 . . . . 0.58 111.32 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 10.8 ptt180 -125.18 169.98 11.69 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.571 -0.451 . . . . 3.49 109.802 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . 13.8 mm-40 -93.93 -46.02 7.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.67 0.747 . . . . 2.83 110.272 -175.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 38.9 m 79.18 9.38 1.72 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.453 -1.703 . . . . 4.3 110.953 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.566 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.32 5.76 1.47 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 124.008 1.861 . . . . 4.48 108.063 176.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 14.8 pt20 -63.6 166.01 7.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 110.206 -3.179 . . . . 6.53 112.43 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -105.86 134.64 48.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.066 -0.97 . . . . 9.28 109.228 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.11 19.96 7.61 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 122.357 1.075 . . . . 11.58 108.634 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.7 p -135.09 86.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 113.091 -1.868 . . . . 12.38 110.027 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.44 178.85 7.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.704 -0.68 . . . . 14.96 110.42 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.59 131.23 56.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.001 0.429 . . . . 17.27 110.709 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.9 p -145.28 103.76 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.823 -0.626 . . . . 19.47 110.425 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.78 132.06 34.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.163 -0.471 . . . . 21.73 110.229 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.76 157.34 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 23.08 110.563 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.94 -0.573 . . . . 23.96 110.214 178.323 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 42.0 tttm . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 122.043 0.925 . . . . 8.27 109.817 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.687 ' C ' HE22 ' A' ' 43' ' ' GLN . 8.6 pt-20 -98.82 133.12 43.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 115.097 1.517 . . . . 6.87 115.097 -168.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 39' ' ' GLN . 46.4 t-20 -111.21 -30.87 7.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.604 0.716 . . . . 4.55 109.198 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.78 123.09 42.79 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.875 -1.057 . . . . 2.71 113.097 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -112.27 159.41 18.65 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.608 -1.256 . . . . 4.92 107.608 169.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' SER . 28.6 m -152.74 122.47 6.9 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.171 -0.612 . . . . 1.22 112.023 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.5 ptp -92.71 125.95 37.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.574 -0.899 . . . . 3.19 108.574 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.506 ' CG1' HD13 ' A' ' 97' ' ' LEU . 28.1 m . . . . . 0 C--O 1.257 1.487 0 CA-C-O 118.975 -0.536 . . . . 1.54 111.585 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.391 -0.596 . . . . 18.34 109.391 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -119.76 143.17 47.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.365 -0.38 . . . . 15.06 111.409 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 71.14 143.42 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.038 0.837 . . . . 14.54 111.992 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mm -122.16 95.67 47.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 10.4 110.827 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.67 124.18 6.8 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.024 2.483 . . . . 10.74 111.734 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.69 42.81 38.18 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.897 -0.668 . . . . 7.75 111.984 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 pt20 -62.62 125.97 87.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 6.84 111.841 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 16.9 Cg_exo -67.57 167.81 19.88 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.011 2.474 . . . . 4.84 112.542 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -97.33 6.5 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.188 0.994 . . . . 3.26 110.485 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p 74.26 -54.66 0.67 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.482 -2.145 . . . . 2.17 112.178 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -163.23 120.69 1.9 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.784 -1.098 . . . . 0.98 111.042 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' THR . 19.3 t -84.08 134.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 107.422 -1.325 . . . . 1.35 107.422 166.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.41 118.51 50.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.834 -0.621 . . . . 1.84 110.343 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -130.5 144.19 51.25 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.603 0.716 . . . . 2.31 110.482 178.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.627 ' NE ' HD21 ' A' ' 108' ' ' LEU . 7.0 mtt180 -104.72 107.05 17.8 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.473 -1.24 . . . . 3.58 108.418 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.686 HG13 ' CD2' ' A' ' 107' ' ' LEU . 3.5 p -130.39 142.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.322 0.582 . . . . 0.86 109.583 -171.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 26.6 mt-10 -118.49 111.78 19.08 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.675 0.75 . . . . 1.75 109.782 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.943 HG23 ' HA ' ' A' ' 66' ' ' ALA . 23.9 mm -101.84 116.72 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.379 -1.282 . . . . 0.93 109.145 -172.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.587 ' HB3' HG23 ' A' ' 104' ' ' VAL . 7.4 p80 -94.42 82.22 4.03 Favored 'General case' 0 C--N 1.281 -2.395 0 C-N-CA 118.644 -1.222 . . . . 3.53 111.965 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.946 ' HD3' ' HG2' ' A' ' 65' ' ' PRO . 3.0 mmmp? -127.88 99.28 5.46 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 112.845 -1.98 . . . . 5.69 108.499 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 28' ' ' ILE . 55.3 tp -157.09 156.22 32.42 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.92 -0.582 . . . . 4.5 110.352 -162.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.924 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -80.67 109.89 15.63 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.879 0.847 . . . . 5.24 109.866 160.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.998 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 1.4 pt20 -138.12 69.83 1.39 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.228 -1.351 . . . . 4.48 111.492 -175.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.14 -100.46 0.86 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-N 114.07 -1.423 . . . . 3.78 112.861 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -76.13 -13.11 60.2 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.513 -0.921 . . . . 6.85 108.513 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.998 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 22.6 m-80 -108.01 120.85 43.48 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.791 1.281 . . . . 4.85 110.02 -171.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -117.24 107.12 14.04 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 112.488 -2.142 . . . . 3.68 107.565 169.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -127.23 121.08 56.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.833 -0.803 . . . . 2.9 108.833 174.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.047 HD12 ' HA ' ' B' ' 168' ' ' VAL . 34.7 tp -162.03 73.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 125.929 2.018 . . . . 4.19 107.256 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' H ' ' NZ ' ' A' ' 20' ' ' LYS . . . -131.7 -60.5 0.09 OUTLIER Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.968 1.147 . . . . 1.62 115.968 -166.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.987 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 17.8 p90 -69.67 156.86 38.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.471 1.135 . . . . 0.73 110.115 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.642 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 6.7 m -116.94 144.61 44.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.527 -0.869 . . . . 1.16 111.256 -168.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.682 HG22 HG23 ' A' ' 57' ' ' VAL . 36.8 pt -129.71 150.51 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.455 -0.793 . . . . 0.89 109.072 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.69 134.96 12.52 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.049 -1.072 . . . . 0.69 112.119 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 163' ' ' ASN . . . -136.06 131.16 5.59 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.13 -0.788 . . . . 1.42 111.13 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.578 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -148.33 57.12 0.48 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.605 -0.807 . . . . 3.0 112.88 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.512 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -126.34 -43.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.559 0.218 . . . . 4.71 111.218 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -98.23 7.46 46.22 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.119 -0.696 . . . . 7.49 109.119 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.578 ' HG2' ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -111.73 -67.3 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.011 -0.995 . . . . 4.55 111.838 -175.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 13.3 t70 -128.73 128.07 23.5 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.697 -0.483 . . . . 5.14 109.697 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.63 -16.02 11.95 Favored 'Trans proline' 0 CA--C 1.514 -0.509 0 C-N-CA 123.204 2.603 . . . . 5.58 111.902 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' B' ' 161' ' ' LYS . 17.8 t -84.34 -9.61 58.3 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.592 -0.731 . . . . 6.54 110.107 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' OE1' ' HB3' ' B' ' 163' ' ' ASN . 34.7 mm-40 -54.63 -30.91 56.31 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.871 0.843 . . . . 5.93 109.118 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -135.71 89.58 21.32 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.029 -1.442 . . . . 6.06 111.584 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.93 8.51 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.756 2.304 . . . . 8.03 111.733 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.42 -22.34 7.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 8.87 111.112 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.4 t -148.97 -153.66 0.51 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.184 -1.043 . . . . 5.13 108.184 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.39 -39.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.541 0.686 . . . . 7.43 110.101 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -173.04 -177.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.776 -1.194 . . . . 7.39 107.776 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mptt 68.56 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.198 0.599 . . . . 7.82 110.478 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -83.03 -7.92 59.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 5.12 110.006 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.587 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 2.4 t0 -120.76 170.86 9.05 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.609 -0.886 . . . . 3.97 108.609 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 3.3 mptp? -136.44 -21.74 1.33 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.66 -1.154 . . . . 6.09 108.899 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 58.22 22.24 49.49 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.005 -0.998 . . . . 1.05 115.477 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.498 HG21 ' SD ' ' A' ' 85' ' ' MET . 27.9 mm -129.83 125.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 117.786 0.793 . . . . 0.67 111.019 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 29.3 p90 -163.79 163.45 23.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.114 0.166 . . . . 2.48 111.068 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -88.08 141.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 109.868 -0.419 . . . . 0.66 109.868 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -117.19 -5.6 11.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.612 1.195 . . . . 1.0 110.915 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HG2' ' HB2' ' A' ' 32' ' ' SER . 1.4 ptp180 -174.62 172.24 3.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.134 0.492 . . . . 3.02 110.663 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.987 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 83.1 t -143.2 138.93 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.931 -1.031 . . . . 0.72 110.663 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 2.2 m -59.37 103.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.026 -1.101 . . . . 1.77 108.026 162.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.33 146.23 52.35 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-O 122.793 1.283 . . . . 3.28 112.534 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.93 70.22 Favored Glycine 0 C--N 1.294 -1.802 0 CA-C-N 112.044 -2.344 . . . . 1.03 111.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -113.95 -135.41 6.1 Favored Glycine 0 N--CA 1.426 -2.032 0 C-N-CA 120.182 -1.008 . . . . 1.27 112.355 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.946 ' HG2' ' HD3' ' A' ' 20' ' ' LYS . 1.7 Cg_endo -89.54 -36.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 124.331 3.354 . . . . 1.32 114.507 -172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.943 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -65.89 -48.98 69.69 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 122.35 1.072 . . . . 0.37 108.72 -170.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -80.71 -24.65 38.65 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.001 -1.454 . . . . 1.45 110.132 -164.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.55 -29.46 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 122.021 0.915 . . . . 0.89 108.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -65.44 -29.07 69.71 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.506 -1.679 . . . . 0.34 107.785 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.03 54.18 0.43 Allowed Glycine 0 C--O 1.227 -0.301 0 CA-C-N 114.802 -1.09 . . . . 0.49 111.324 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 3.2 tm? -137.41 141.52 41.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.281 -1.377 . . . . 1.58 107.281 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -167.45 162.08 14.33 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.328 -0.851 . . . . 2.36 110.03 -169.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -65.71 115.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.054 -0.976 . . . . 0.57 112.711 -161.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 106.87 48.52 0.95 Allowed Glycine 0 CA--C 1.492 -1.382 0 CA-C-N 114.215 -1.357 . . . . 0.6 110.226 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.7 t0 -127.62 127.16 43.35 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.943 -0.703 . . . . 1.35 110.036 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 42.6 mttt -87.66 106.48 18.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.175 0.512 . . . . 2.18 110.588 -168.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.532 HG23 ' HB3' ' A' ' 107' ' ' LEU . 71.2 mt -77.24 106.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.235 -0.893 . . . . 0.64 109.879 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.497 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 4.8 mmt -87.29 -30.66 20.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.305 -0.407 . . . . 0.48 110.492 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.934 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -158.3 153.96 26.35 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 122.242 1.02 . . . . 2.26 112.95 177.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.3 p -116.54 123.65 71.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 112.519 -2.128 . . . . 0.77 110.553 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.705 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 21.6 m120 59.67 5.99 0.77 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.854 0.359 . . . . 1.9 111.262 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.34 2.35 26.19 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.89 -0.596 . . . . 1.1 112.626 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.599 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 2.5 m95 -102.77 84.62 2.42 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.58 -0.526 . . . . 2.75 109.58 -176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.888 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 9.5 t70 -24.17 104.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.46 1.1 . . . . 1.61 111.745 167.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.2 ptp -105.44 63.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.904 -0.589 . . . . 1.72 111.025 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 p -106.22 -69.06 0.84 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 1.25 111.614 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -81.56 8.07 10.56 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.535 1.16 . . . . 3.22 109.553 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.573 HG13 ' NE2' ' A' ' 92' ' ' GLN . 28.4 t -89.69 148.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 113.308 -1.769 . . . . 1.73 108.703 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.677 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.8 m -86.45 137.42 32.56 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.555 -0.905 . . . . 1.3 108.555 -171.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' B' ' 166' ' ' SER . 26.6 t-80 -57.75 -37.85 74.34 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.878 -1.055 . . . . 2.47 110.542 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.32 -42.9 87.59 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.644 -1.162 . . . . 1.81 111.111 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.751 HE21 ' N ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -83.56 -20.8 33.16 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.341 1.067 . . . . 2.66 108.253 -175.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' N ' HE21 ' A' ' 92' ' ' GLN . . . -78.5 -34.41 47.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.919 -1.037 . . . . 0.8 109.251 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.693 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -78.11 -26.18 47.85 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.424 -0.91 . . . . 3.95 110.498 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 16.5 pttp -71.53 -30.9 66.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.194 -0.602 . . . . 2.48 110.507 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 83' ' ' TRP . 4.8 ptp180 -87.45 -24.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.756 -0.778 . . . . 3.8 112.327 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.778 ' HB2' HG21 ' A' ' 105' ' ' VAL . 4.1 pp -70.86 -24.94 62.61 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 120.456 -0.497 . . . . 1.26 111.349 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 HD12 ' A' ' 97' ' ' LEU . 9.1 p -114.32 46.58 1.34 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.866 0.365 . . . . 1.53 111.57 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 101' ' ' SER . 21.5 pttm -76.93 -9.26 58.57 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.189 0.811 . . . . 1.79 113.189 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.76 7.11 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 124.222 0.951 . . . . 5.04 110.838 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 21.0 t -98.86 -8.67 25.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.539 . . . . 2.31 111.234 -175.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' HG2' HD22 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -109.39 -174.41 2.5 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.942 0.877 . . . . 2.11 110.464 -177.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -119.73 0.35 10.9 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.556 -1.646 . . . . 3.94 106.556 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 19' ' ' HIS . 12.6 p 177.7 143.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 113.487 -1.688 . . . . 1.17 110.708 -164.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 97' ' ' LEU . 4.1 p -103.1 115.52 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.942 0.877 . . . . 2.16 109.057 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 13.6 ttt180 -87.26 138.91 31.08 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.647 -1.16 . . . . 3.15 108.911 -175.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -135.19 143.9 46.69 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.912 1.339 . . . . 1.35 111.585 169.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.934 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -95.42 109.41 21.6 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 111.89 -2.413 . . . . 1.53 107.533 168.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' A' ' 75' ' ' ASP . 1.4 p -122.52 165.82 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-O 121.807 0.813 . . . . 1.14 110.265 -164.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.745 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p -140.32 109.41 6.1 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.189 -1.369 . . . . 0.58 111.705 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 12' ' ' VAL . 16.4 ptt180 -122.38 170.02 10.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 3.49 110.451 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' SER . 18.0 mm-40 -100.01 -35.59 9.66 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.772 0.796 . . . . 2.83 109.684 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 37.7 m 104.13 22.97 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 110.975 -2.829 . . . . 4.3 109.589 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 54.72 71.8 0.51 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.512 -1.676 . . . . 4.48 112.301 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 115' ' ' GLN . 3.2 pt20 -68.68 115.78 8.44 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.957 -1.474 . . . . 6.53 109.408 172.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 68.89 125.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.227 -0.897 . . . . 9.28 109.778 -168.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.52 26.59 4.08 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.239 1.019 . . . . 11.58 109.324 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' VAL . 22.1 m -79.94 26.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.51 -1.677 . . . . 12.38 112.174 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -110.78 94.48 5.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.547 -0.751 . . . . 14.96 110.107 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -89.86 -97.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.601 -0.272 . . . . 17.27 110.735 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.6 m -161.53 136.45 7.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.077 0.151 . . . . 19.47 110.621 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.2 mtt 66.96 -82.44 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.463 0.705 . . . . 21.73 112.34 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 124' ' ' SER . 35.9 tp -135.52 166.62 22.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 23.08 109.865 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 123' ' ' LEU . 1.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.947 0.403 . . . . 23.96 110.514 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 40' ' ' ASP . 12.6 ttpp . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.324 0.583 . . . . 8.27 111.551 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.07 128.07 10.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 6.87 111.199 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.649 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 10.1 p30 -99.18 -166.38 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.539 -0.755 . . . . 4.55 110.55 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.464 HD21 ' ND1' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -128.02 136.51 51.35 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.415 -0.514 . . . . 2.71 110.249 175.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.1 157.5 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.571 -0.9 . . . . 4.92 108.571 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.601 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . 3.7 t -137.11 118.82 15.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.775 -0.454 . . . . 1.22 109.775 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 66.0 mtt -91.19 117.5 29.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.335 -0.617 . . . . 3.19 109.335 175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.047 ' HA ' HD12 ' A' ' 29' ' ' LEU . 28.7 m . . . . . 0 C--O 1.243 0.746 0 CA-C-O 119.098 -0.477 . . . . 1.54 110.633 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.026 -0.361 . . . . 18.34 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -72.32 78.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.288 0.477 . . . . 15.06 112.288 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -132.42 5.72 4.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.779 -0.646 . . . . 14.54 109.369 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.3 mt 57.5 81.36 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.796 -1.093 . . . . 10.4 111.488 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.57 105.62 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.687 2.258 . . . . 10.74 111.183 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 47.52 2.49 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.66 -0.781 . . . . 7.75 111.535 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.5 pt20 -63.58 126.68 90.14 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.9 0.381 . . . . 6.84 111.234 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 28.1 Cg_exo -63.27 135.67 51.57 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.854 2.369 . . . . 4.84 111.256 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -83.33 174.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.259 0.552 . . . . 3.26 110.318 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 9' ' ' VAL . 76.4 p -96.22 -113.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.024 -0.989 . . . . 2.17 111.602 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -171.99 143.63 1.6 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.681 -1.145 . . . . 0.98 110.985 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 110' ' ' THR . 20.2 t -96.53 139.8 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.891 -1.504 . . . . 1.35 107.957 169.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.3 t -102.72 125.7 57.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 116.11 -0.496 . . . . 1.84 110.089 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.499 HE22 ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -133.01 145.39 50.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.506 0.669 . . . . 2.31 110.412 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.93 119.66 40.09 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.641 -1.163 . . . . 3.58 108.089 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.859 HG13 HD12 ' A' ' 107' ' ' LEU . 2.3 p -139.01 129.78 33.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.91 -0.716 . . . . 0.86 110.976 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -103.41 109.14 20.67 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.539 0.685 . . . . 1.75 109.746 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.807 ' HB ' HG23 ' A' ' 105' ' ' VAL . 58.1 mt -91.12 148.62 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.343 -1.354 . . . . 0.93 107.343 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.713 ' HB2' HG23 ' A' ' 104' ' ' VAL . 19.7 t-160 -143.89 110.57 5.6 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.55 0.691 . . . . 3.53 112.339 -172.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 23.1 mmtp -129.52 -161.67 1.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.836 -1.542 . . . . 5.69 106.836 161.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 25.9 tp -150.51 135.75 17.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 119.685 1.129 . . . . 4.5 112.04 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.943 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.64 136.31 43.86 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.006 -0.739 . . . . 5.24 109.006 168.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 2.2 mt-30 -130.2 61.32 1.59 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.595 0.712 . . . . 4.48 109.514 -175.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.58 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 71.18 -94.01 0.53 Allowed Glycine 0 CA--C 1.502 -0.72 0 CA-C-N 114.337 -1.301 . . . . 3.78 112.216 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -71.42 -10.2 59.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.64 0.733 . . . . 6.85 109.656 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.7 m-80 -113.99 143.9 43.97 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-O 123.21 1.481 . . . . 4.85 110.39 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 22' ' ' ARG . 4.6 mm? -126.7 107.81 10.5 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 111.346 -2.661 . . . . 3.68 105.898 168.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 21' ' ' LEU . 13.5 mm -113.08 122.39 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 120.687 -0.405 . . . . 2.9 111.25 -174.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.75 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 50.0 tp -143.3 -52.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.266 -1.383 . . . . 4.19 107.266 165.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 102.51 -15.79 55.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 114.888 0.715 . . . . 1.62 114.888 159.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.05 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 31.1 p90 -96.26 162.92 13.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.522 1.161 . . . . 0.73 110.973 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' B' ' 166' ' ' SER . 6.9 t -114.11 132.27 56.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 1.16 110.513 -165.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.61 155.67 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 C-N-CA 120.571 -0.452 . . . . 0.89 109.809 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 165' ' ' GLU . . . -106.63 121.66 6.7 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 120.051 -1.071 . . . . 0.69 111.188 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' HD23 ' B' ' 164' ' ' LEU . . . -104.42 103.61 2.28 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.444 -1.062 . . . . 1.42 110.444 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' CA ' ' HG3' ' A' ' 41' ' ' PRO . . . -156.57 67.74 0.29 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.717 -1.23 . . . . 3.0 113.221 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG13 ' H ' ' A' ' 38' ' ' ASP . 1.6 pt -99.79 -76.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.411 0.624 . . . . 4.71 110.792 176.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' H ' HG13 ' A' ' 37' ' ' ILE . 28.0 t70 -115.67 14.46 16.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.277 1.037 . . . . 7.49 108.539 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 42.8 mm-40 -67.38 -72.1 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 113.952 -1.477 . . . . 4.55 111.303 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.922 ' H ' ' HD2' ' A' ' 41' ' ' PRO . 47.7 m-20 -144.54 -39.92 0.01 OUTLIER Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 113.898 -1.501 . . . . 5.14 109.522 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.922 ' HD2' ' H ' ' A' ' 40' ' ' ASP . 11.1 Cg_endo -47.71 -10.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.474 3.45 . . . . 5.58 111.582 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 40' ' ' ASP . 41.0 t -46.92 -24.84 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.15 -1.841 . . . . 6.54 110.673 163.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.74 ' OE1' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.9 -18.74 58.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.213 0.53 . . . . 5.93 111.255 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 2.4 t-20 -84.71 110.45 27.7 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.015 -0.993 . . . . 6.06 111.353 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 47.3 Cg_endo -71.21 -8.61 23.84 Favored 'Trans proline' 0 C--N 1.334 -0.231 0 C-N-CA 123.251 2.634 . . . . 8.03 111.526 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -84.28 -21.3 31.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.571 -0.74 . . . . 8.87 110.244 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 44' ' ' ASN . 13.4 p -98.78 -167.79 1.54 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.574 -0.898 . . . . 5.13 108.574 168.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 58.91 11.61 1.97 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.784 0.802 . . . . 7.43 110.298 -171.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -138.75 120.09 14.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.965 -1.016 . . . . 7.39 109.684 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm 52.49 90.2 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 124.484 1.115 . . . . 7.82 111.751 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' LYS . 31.8 p 75.33 -16.16 0.61 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.506 -1.225 . . . . 5.12 111.675 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.607 ' OD2' ' HA ' ' A' ' 37' ' ' ILE . 38.0 t70 69.45 -34.03 0.27 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.062 0.945 . . . . 3.97 112.419 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HD2' ' C ' ' A' ' 52' ' ' ASP . 5.2 mptt 67.76 13.73 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.793 0.837 . . . . 6.09 109.454 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 36' ' ' GLY . . . -62.6 -53.67 39.74 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.924 -1.035 . . . . 1.05 115.026 -173.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.55 HG22 ' HB ' ' A' ' 77' ' ' ILE . 50.7 mm -95.34 109.28 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.23 0.515 . . . . 0.67 110.168 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.4 p90 -155.23 157.9 38.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.34 . . . . 2.48 110.672 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -80.79 141.45 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 109.763 -0.458 . . . . 0.66 109.763 173.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -114.84 -7.94 12.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 73' ' ' ILE . 11.4 ttp180 -179.92 163.96 1.14 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.815 -1.084 . . . . 3.02 108.462 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.05 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -128.77 167.56 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 109.481 -0.563 . . . . 0.72 109.481 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.576 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -73.17 100.03 2.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.049 -1.093 . . . . 1.77 108.049 169.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -77.04 139.56 40.07 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.19 -1.368 . . . . 3.28 110.672 -169.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.24 30.08 76.8 Favored Glycine 0 C--N 1.29 -2.006 0 CA-C-N 112.186 -2.279 . . . . 1.03 110.146 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -123.21 -126.96 3.2 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.382 -0.913 . . . . 1.27 112.414 -172.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.536 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -96.0 -38.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.883 3.055 . . . . 1.32 114.738 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.64 -40.99 84.55 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.996 0.903 . . . . 0.37 109.682 -166.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.23 -23.84 24.6 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.439 -1.255 . . . . 1.45 109.299 -165.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 69' ' ' ALA . 39.3 pt -81.81 -27.8 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 CA-C-O 122.4 1.095 . . . . 0.89 109.006 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -67.34 -28.81 68.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.779 -2.009 . . . . 0.34 107.423 171.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.92 46.54 0.65 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 113.849 -1.523 . . . . 0.49 111.797 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 6.7 tp -123.24 165.68 16.52 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.043 -1.465 . . . . 1.58 107.043 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -163.53 -179.16 6.28 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.066 -0.716 . . . . 2.36 109.066 -177.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -78.89 112.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 120.85 0.357 . . . . 0.57 111.335 -169.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 109.31 69.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.577 -1.009 . . . . 0.6 110.577 174.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.727 ' OD1' ' HB3' ' A' ' 111' ' ' ARG . 0.4 OUTLIER -140.93 117.65 10.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.489 -0.356 . . . . 1.35 110.273 -168.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.748 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 71.1 mttt -82.14 108.14 15.38 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.439 -0.505 . . . . 2.18 110.135 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 55' ' ' ILE . 57.9 mt -74.48 115.15 15.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.828 -0.624 . . . . 0.64 110.378 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.402 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.6 mmt -105.2 -18.19 14.22 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.48 110.331 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -158.85 158.68 33.93 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 115.457 -0.792 . . . . 2.26 110.498 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.557 HG11 ' HD2' ' A' ' 96' ' ' ARG . 5.8 p -141.08 131.34 26.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.879 -1.509 . . . . 0.77 110.157 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.842 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 15.3 m-80 57.86 1.89 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.872 0.693 . . . . 1.9 112.872 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 116.29 8.38 13.04 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.83 -0.623 . . . . 1.1 111.85 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 80' ' ' VAL . 9.7 m95 -108.21 106.03 16.03 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.544 -0.539 . . . . 2.75 109.544 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 19.6 t70 -52.15 108.88 0.32 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.575 0.547 . . . . 1.61 109.833 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 mmt -62.32 -95.49 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.315 -0.857 . . . . 1.72 111.233 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.2 p 59.71 -43.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.184 1.794 . . . . 1.25 114.294 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptp -118.55 -1.16 11.23 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.474 0.654 . . . . 3.22 110.531 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.907 HG13 ' HG3' ' A' ' 92' ' ' GLN . 55.8 t -75.41 138.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.368 -0.833 . . . . 1.73 110.462 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -88.09 177.25 6.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 120.087 -0.645 . . . . 1.3 110.626 -175.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' N ' HG23 ' A' ' 89' ' ' THR . 20.2 t60 -67.19 -41.29 86.12 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.851 -0.34 . . . . 2.47 110.791 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . 3.5 m-20 -72.13 -50.1 30.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.361 1.077 . . . . 1.81 108.972 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.907 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.5 tp-100 -42.98 -50.99 5.8 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.874 -1.966 . . . . 2.66 111.561 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.03 -47.65 70.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.838 -0.801 . . . . 0.8 108.838 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 90' ' ' HIS . 8.6 mtp180 -50.04 -53.2 28.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.585 -1.189 . . . . 3.95 111.476 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 95' ' ' LYS . 17.6 ptmt -76.36 -26.86 56.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.601 0.593 . . . . 2.48 112.601 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HD2' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.94 -18.89 28.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.772 -0.771 . . . . 3.8 111.441 -174.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 4.3 pp -90.6 -32.36 16.3 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.431 0.53 . . . . 1.26 112.431 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' HD12 ' A' ' 27' ' ' LEU . 2.0 p -115.07 51.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.105 0.479 . . . . 1.53 111.421 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.712 ' HE2' ' HB2' ' A' ' 101' ' ' SER . 23.5 pttm -91.68 -152.56 0.3 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.084 -0.507 . . . . 1.79 110.425 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 100' ' ' ARG . 14.3 mmm180 -114.26 23.94 12.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.854 0.316 . . . . 5.04 111.854 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.712 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 23.8 m -104.41 -18.19 14.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.608 -0.269 . . . . 2.31 111.326 -177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 -176.5 3.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.936 0.874 . . . . 2.11 110.502 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -131.69 3.78 4.18 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.278 -1.749 . . . . 3.94 106.278 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG23 ' HB2' ' A' ' 19' ' ' HIS . 10.3 p -169.88 152.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.559 -1.655 . . . . 1.17 110.728 -156.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.807 HG23 ' HB ' ' A' ' 18' ' ' ILE . 15.6 m -111.44 110.85 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 118.583 -1.247 . . . . 2.16 110.454 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 37.7 ttt180 -86.41 145.61 26.78 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.316 -1.735 . . . . 3.15 106.316 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.859 HD12 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -155.94 165.69 35.72 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.71 1.243 . . . . 1.35 113.622 176.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 7.6 tp -118.45 139.38 51.51 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.259 -2.246 . . . . 1.53 105.724 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 5.4 p -151.89 156.02 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 CA-C-O 122.043 0.925 . . . . 1.14 110.327 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 13.0 p -129.9 112.71 13.81 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.545 -1.661 . . . . 0.58 111.098 -176.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.727 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . 6.6 ptp180 -124.34 169.32 11.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.727 -0.67 . . . . 3.49 110.497 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 113' ' ' SER . 1.7 mp0 -85.66 -44.11 12.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.794 0.807 . . . . 2.83 109.363 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 63.6 m 86.75 12.88 0.13 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.254 -2.248 . . . . 4.3 109.956 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.49 32.79 5.84 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.622 -1.626 . . . . 4.48 108.361 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 13.9 mm-40 -79.12 -177.5 5.67 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 111.781 -2.463 . . . . 6.53 111.127 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 116' ' ' LYS . 3.3 ptpp? -113.5 129.85 56.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.091 0.472 . . . . 9.28 111.415 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.13 23.28 3.02 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.607 1.194 . . . . 11.58 107.904 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.28 84.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 113.333 -1.758 . . . . 12.38 109.564 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -118.6 158.76 24.83 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.06 -1.427 . . . . 14.96 110.138 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -86.34 80.63 8.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.554 -0.535 . . . . 17.27 109.554 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.1 p -76.09 102.03 5.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 19.47 110.028 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -77.76 46.0 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.679 -0.691 . . . . 21.73 111.213 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -172.1 -51.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.809 -0.811 . . . . 23.08 108.809 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 115.381 -0.827 . . . . 23.96 110.682 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.845 ' HE3' ' HA ' ' A' ' 40' ' ' ASP . 23.2 tptt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.333 -0.617 . . . . 8.27 109.333 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.481 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 39.9 tt0 -166.03 156.66 12.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.849 0.357 . . . . 6.87 110.998 174.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.02 158.71 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.637 -0.711 . . . . 4.55 112.73 -174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.602 ' H ' HD23 ' B' ' 164' ' ' LEU . 2.2 pt? -113.18 125.83 54.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.531 -0.759 . . . . 2.71 111.046 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.417 ' HG3' ' HA2' ' A' ' 34' ' ' GLY . 3.0 mp0 -104.65 161.56 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.642 -0.708 . . . . 4.92 110.843 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' SER . 21.1 m -159.32 162.39 35.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.702 -0.681 . . . . 1.22 109.804 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 15.3 ptp -109.13 110.08 21.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.174 -0.676 . . . . 3.19 109.174 164.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.656 ' OXT' ' HB3' ' A' ' 29' ' ' LEU . 9.0 m . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 108.084 -1.08 . . . . 1.54 108.084 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.72 0.295 . . . . 18.34 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -108.04 98.81 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.766 0.317 . . . . 15.06 110.647 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.05 142.86 30.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.097 0.475 . . . . 14.54 110.867 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.4 mt -137.27 97.33 10.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.242 -0.651 . . . . 10.4 109.242 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.38 104.95 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.618 2.212 . . . . 10.74 112.161 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.36 -47.14 0.81 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.792 -0.718 . . . . 7.75 112.017 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -128.81 83.33 66.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.717 0.294 . . . . 6.84 111.008 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.38 128.28 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.181 2.588 . . . . 4.84 111.724 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.88 126.47 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.694 0.759 . . . . 3.26 111.434 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 63.6 p -91.56 -46.17 8.1 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.487 -1.233 . . . . 2.17 111.083 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 1.007 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -157.68 130.62 7.52 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.302 -1.317 . . . . 0.98 111.248 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 110' ' ' THR . 40.4 t -99.54 120.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -1.308 . . . . 1.35 110.165 177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.2 t -72.25 113.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.313 -0.625 . . . . 1.84 109.313 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -135.04 148.73 49.99 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.536 -0.756 . . . . 2.31 110.441 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HD3' HD21 ' A' ' 108' ' ' LEU . 6.1 mtm180 -112.45 114.3 26.92 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 124.081 0.952 . . . . 3.58 109.537 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.91 142.57 35.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.935 -0.765 . . . . 0.86 108.935 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.847 ' HB3' ' HG3' ' A' ' 106' ' ' ARG . 1.6 pt-20 -114.4 110.93 20.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.216 1.008 . . . . 1.75 110.107 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.898 HG21 ' HE2' ' A' ' 31' ' ' PHE . 27.9 mm -92.61 98.99 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.855 -1.52 . . . . 0.93 111.062 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.892 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 30.3 p80 -94.07 96.36 9.61 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.815 0.817 . . . . 3.53 112.401 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -61.25 177.52 0.35 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.345 -1.298 . . . . 5.69 111.122 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.753 HD13 ' HG2' ' A' ' 23' ' ' GLN . 0.7 OUTLIER -148.9 118.89 7.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.215 -0.594 . . . . 4.5 111.087 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.2 ttt180 -69.85 145.57 51.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.255 -0.884 . . . . 5.24 110.472 167.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.933 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 9.2 mt-30 -139.09 61.71 1.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.519 -0.764 . . . . 4.48 109.627 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.93 -97.32 0.25 Allowed Glycine 0 CA--C 1.495 -1.209 0 CA-C-N 113.91 -1.495 . . . . 3.78 112.146 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -79.95 1.75 26.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.569 -0.816 . . . . 6.85 109.871 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.933 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 47.6 m-80 -117.26 147.73 42.29 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-O 122.664 1.221 . . . . 4.85 109.869 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 26' ' ' ASN . 4.0 mm? -133.49 109.92 9.61 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 111.8 -2.454 . . . . 3.68 106.691 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.796 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.9 mm -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.612 -0.884 . . . . 2.9 108.612 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.628 ' HB2' ' C ' ' B' ' 168' ' ' VAL . 1.0 OUTLIER -95.85 -33.57 12.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.479 -0.934 . . . . 4.19 108.479 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.7 -63.95 0.35 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.023 -1.084 . . . . 1.62 115.786 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.898 ' HE2' HG21 ' A' ' 18' ' ' ILE . 28.2 p90 -160.16 -177.35 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.38 0.59 . . . . 0.73 111.577 -162.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 27.9 t -110.02 138.72 46.0 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.716 -0.475 . . . . 1.16 109.716 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG22 HG23 ' A' ' 57' ' ' VAL . 42.1 pt -126.56 145.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.415 -0.587 . . . . 0.89 109.415 -173.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.19 127.78 8.22 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.521 -0.847 . . . . 0.69 112.156 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . -108.75 134.84 12.48 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.37 -0.692 . . . . 1.42 111.37 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -143.24 60.61 0.52 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.313 -1.115 . . . . 3.0 110.313 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -124.02 -37.3 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.449 0.642 . . . . 4.71 110.746 -172.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 37' ' ' ILE . 1.2 p30 -119.89 25.07 10.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.298 -0.864 . . . . 7.49 109.755 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.528 ' CG ' ' HA2' ' A' ' 36' ' ' GLY . 68.1 mm-40 -91.23 -83.61 0.27 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.727 0.775 . . . . 4.55 112.45 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' B' ' 161' ' ' LYS . 0.2 OUTLIER -150.17 144.57 17.68 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 114.639 -1.164 . . . . 5.14 111.097 -165.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.81 -12.15 13.62 Favored 'Trans proline' 0 C--N 1.336 -0.127 0 C-N-CA 123.389 2.726 . . . . 5.58 112.079 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 4.5 t -73.04 -21.0 60.87 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.572 -0.74 . . . . 6.54 111.022 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -82.9 -8.88 59.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.526 0.679 . . . . 5.93 110.059 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -177.3 108.54 0.23 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 114.545 -1.207 . . . . 6.06 109.611 176.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 44' ' ' ASN . 9.8 Cg_endo -53.91 -17.01 9.82 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.063 2.509 . . . . 8.03 112.571 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -166.16 -46.14 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.07 -0.514 . . . . 8.87 111.018 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 117' ' ' ALA . 26.7 t 159.19 147.85 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 109.185 -0.672 . . . . 5.13 109.185 -157.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -138.32 4.69 2.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.887 -0.597 . . . . 7.43 110.62 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -153.17 23.29 0.55 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.75 0.786 . . . . 7.39 109.786 173.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.4 mmtm 74.94 -88.1 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.209 1.189 . . . . 7.82 114.209 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.0 p -99.69 36.84 1.71 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.669 -0.696 . . . . 5.12 111.574 -165.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.899 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 43.0 t0 -74.32 155.38 38.26 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.538 1.161 . . . . 3.97 110.125 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 32.0 mmtp -94.89 -37.0 11.39 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.899 -1.955 . . . . 6.09 108.86 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 32.05 20.17 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 114.789 -1.096 . . . . 1.05 114.446 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.7 mm -115.8 131.32 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.618 0.367 . . . . 0.67 110.13 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 37.0 p90 -163.74 161.99 23.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.344 0.498 . . . . 2.48 112.344 177.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.768 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -78.94 142.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 116.18 -0.464 . . . . 0.66 110.157 175.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 t -116.86 -8.71 11.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.951 0.782 . . . . 1.0 109.879 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -166.97 172.66 10.01 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.88 0.848 . . . . 3.02 111.335 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 97.8 t -144.44 140.79 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 106.618 -1.623 . . . . 0.72 106.618 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 m -79.39 105.79 10.95 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.145 -1.428 . . . . 1.77 107.145 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.83 136.95 54.92 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 122.605 1.193 . . . . 3.28 109.979 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.18 48.13 Favored Glycine 0 C--N 1.287 -2.157 0 CA-C-N 112.614 -2.085 . . . . 1.03 108.779 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -133.47 117.9 1.99 Allowed Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.688 -1.365 . . . . 1.27 109.688 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.796 ' HA ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -19.04 -13.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.559 1 C-N-CA 130.315 7.344 . . . . 1.32 120.029 -178.366 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.916 ' HB1' ' HG ' ' A' ' 71' ' ' LEU . . . -72.87 -39.17 66.69 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HA ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -81.38 -28.74 34.27 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.165 -0.925 . . . . 1.45 109.913 -171.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 65' ' ' PRO . 23.0 pt -82.15 -23.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-O 122.095 0.95 . . . . 0.89 109.889 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.16 -29.8 67.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.354 -1.748 . . . . 0.34 106.913 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.91 48.17 0.85 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.143 -1.39 . . . . 0.49 112.873 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.916 ' HG ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -109.11 -178.47 3.58 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.136 -1.431 . . . . 1.58 107.136 175.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.47 ' N ' HD13 ' A' ' 71' ' ' LEU . 2.2 pp0? -167.39 175.94 6.94 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.996 -0.742 . . . . 2.36 108.996 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.4 mm -82.54 112.77 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.684 0.278 . . . . 0.57 110.295 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 107.09 63.58 0.59 Allowed Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 109.453 -1.459 . . . . 0.6 109.453 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.768 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -135.88 115.41 12.76 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.138 -0.531 . . . . 1.35 109.729 -167.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HE2' ' HG3' ' A' ' 115' ' ' GLN . 4.4 mttp -82.45 106.75 14.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.012 -0.54 . . . . 2.18 112.292 -169.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.21 107.69 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 116.248 -0.433 . . . . 0.64 110.312 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 mmt -88.88 -43.3 11.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.297 0.57 . . . . 0.48 110.003 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HB3' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -145.61 158.22 43.87 Favored 'General case' 0 CA--C 1.479 -1.761 0 CA-C-O 122.039 0.923 . . . . 2.26 111.715 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 85' ' ' MET . 4.2 p -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 113.372 -1.74 . . . . 0.77 109.537 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.67 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 18.2 m-80 55.61 22.41 5.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.242 0.544 . . . . 1.9 110.995 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.57 61.6 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.448 -0.796 . . . . 1.1 114.442 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.584 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 3.1 p90 -122.09 114.9 21.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 118.492 1.146 . . . . 2.75 110.879 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.798 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 10.6 t70 -27.31 116.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.365 -1.289 . . . . 1.61 112.022 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.706 ' HB3' HG12 ' A' ' 80' ' ' VAL . 2.6 ppp? -106.54 8.42 31.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.103 -0.953 . . . . 1.72 110.76 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LYS . 40.5 p -98.48 -22.13 16.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 1.25 112.139 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.2 ptp -78.31 -7.47 57.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.494 0.664 . . . . 3.22 110.473 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -97.68 -175.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.4 -0.818 . . . . 1.73 109.379 178.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.781 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 1.1 m -99.08 162.55 13.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.676 -1.231 . . . . 1.3 107.676 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.695 ' HB2' HD21 ' B' ' 164' ' ' LEU . 38.6 t-80 -57.77 -41.24 81.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.889 0.376 . . . . 2.47 111.025 -175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 32.9 t70 -67.16 -33.25 75.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.788 -0.642 . . . . 1.81 110.91 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.781 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 4.4 mm100 -71.7 -44.48 64.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.714 0.769 . . . . 2.66 109.285 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -64.73 -29.77 70.77 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.903 -1.044 . . . . 0.8 108.909 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.602 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 5.0 mtp180 -56.34 -56.62 18.8 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.021 -0.99 . . . . 3.95 110.335 177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -69.24 -19.13 63.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.545 . . . . 2.48 111.403 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -76.42 -31.58 57.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.046 0.451 . . . . 3.8 110.364 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 94' ' ' ARG . 4.5 pp -91.07 -32.64 15.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 1.26 110.864 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 29' ' ' LEU . 8.8 t -125.51 67.58 1.15 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.924 0.869 . . . . 1.53 111.097 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 101' ' ' SER . 57.0 pttt -75.5 -5.74 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 1.79 110.686 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.6 tpp180 66.25 12.1 8.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.336 -1.302 . . . . 5.04 110.568 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.554 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 14.5 m -112.0 17.19 19.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.29 -0.868 . . . . 2.31 109.727 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 1.6 pm0 -133.5 155.55 49.37 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.656 -0.702 . . . . 2.11 109.41 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.72 -3.62 24.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.819 -1.082 . . . . 3.94 108.833 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.9 p -159.08 141.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.63 -1.168 . . . . 1.17 110.691 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.1 t -103.08 109.75 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.058 -1.09 . . . . 2.16 108.058 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HG3' ' HB3' ' A' ' 17' ' ' GLU . 6.1 ttt180 -84.65 144.56 28.5 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.786 -1.561 . . . . 3.15 106.786 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -155.02 164.12 39.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.622 1.201 . . . . 1.35 113.178 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 9.7 mt -117.35 109.9 17.39 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 112.223 -2.262 . . . . 1.53 108.164 177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 9.4 p -120.95 169.43 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 CA-C-N 114.926 -1.033 . . . . 1.14 109.59 -166.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.007 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -139.12 110.49 6.98 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.165 -1.38 . . . . 0.58 108.768 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -88.9 173.84 8.28 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.697 -0.683 . . . . 3.49 109.222 -170.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER 70.13 -62.53 0.43 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 122.247 1.022 . . . . 2.83 109.185 -157.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.486 ' OG ' ' HG3' ' A' ' 76' ' ' LYS . 33.2 t 68.73 19.56 8.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.27 -2.241 . . . . 4.3 111.391 170.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -88.76 26.42 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.533 -1.212 . . . . 4.48 112.268 -167.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.718 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 6.7 pt20 -112.2 144.72 41.13 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.025 -1.898 . . . . 6.53 109.721 171.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 52' ' ' ASP . 26.4 mtpp -141.5 160.91 39.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.458 0.171 . . . . 9.28 111.451 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . . . 168.1 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.179 0.992 . . . . 11.58 108.726 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 118' ' ' VAL . 12.2 p -77.06 33.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.563 1.173 . . . . 12.38 110.278 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 117' ' ' ALA . 16.2 mm100 -109.12 91.11 3.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.228 -0.896 . . . . 14.96 112.206 -172.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -118.15 166.05 13.04 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.04 -0.527 . . . . 17.27 110.12 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -85.14 142.24 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.053 -0.351 . . . . 19.47 110.053 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.2 tpt -97.78 118.68 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.235 -0.438 . . . . 21.73 110.66 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 123' ' ' LEU . 3.5 pp -90.82 167.66 12.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.092 -0.504 . . . . 23.08 110.273 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.096 0.474 . . . . 23.96 110.752 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 43' ' ' GLN . 14.1 mptt . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.604 -0.236 . . . . 8.27 110.582 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.36 112.07 12.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.859 -0.737 . . . . 6.87 111.04 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.47 27.26 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.938 -1.028 . . . . 4.55 113.047 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 90' ' ' HIS . 2.8 tp -100.31 86.07 3.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 121.584 -0.697 . . . . 2.71 109.459 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 25.7 mt-10 -109.27 162.75 14.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.447 0.641 . . . . 4.92 111.759 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.511 ' OG ' ' HE1' ' A' ' 90' ' ' HIS . 39.6 m -156.93 125.78 5.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.785 -1.098 . . . . 1.22 109.818 171.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 167' ' ' MET . 17.6 ptp -80.43 90.29 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.903 0.859 . . . . 3.19 109.386 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.628 ' C ' ' HB2' ' A' ' 29' ' ' LEU . 10.1 m . . . . . 0 C--O 1.252 1.208 0 CA-C-N 114.854 -1.067 . . . . 1.54 109.242 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.074 -0.343 . . . . 18.34 110.074 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 72.03 176.09 0.28 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.801 0.688 . . . . 15.06 111.727 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -123.45 141.64 51.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.997 -0.742 . . . . 14.54 108.997 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.84 94.03 45.27 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.399 . . . . 10.4 110.509 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.94 96.73 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.887 2.392 . . . . 10.74 111.571 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.01 -41.15 0.29 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.028 -0.987 . . . . 7.75 110.722 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -93.38 127.36 46.83 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 115.403 -0.398 . . . . 6.84 110.266 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 3.0 Cg_exo -76.05 144.39 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.761 2.307 . . . . 4.84 111.887 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -80.31 177.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.32 -0.622 . . . . 3.26 109.32 175.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.593 ' H ' HG22 ' A' ' 9' ' ' VAL . 78.4 p -92.76 -119.05 0.09 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.249 -0.887 . . . . 2.17 110.397 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.878 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -171.74 125.36 0.58 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.828 -1.078 . . . . 0.98 110.559 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 111' ' ' ARG . 6.6 p -99.9 117.38 44.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 122.236 1.017 . . . . 1.35 111.359 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 25.5 t -79.85 117.31 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.267 -1.333 . . . . 1.84 109.544 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -134.32 168.2 19.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.03 -0.73 . . . . 2.31 109.03 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.723 ' HE ' HD21 ' A' ' 108' ' ' LEU . 4.2 mtt180 -118.16 124.9 49.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 116.016 -0.538 . . . . 3.58 110.328 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 107' ' ' LEU . 1.5 p -134.0 129.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.283 0.564 . . . . 0.86 109.625 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.939 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 36.9 mt-10 -104.59 109.01 20.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.374 -0.83 . . . . 1.75 109.533 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 104' ' ' VAL . 75.1 mt -100.04 160.52 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 106.091 -1.818 . . . . 0.93 106.091 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG22 ' A' ' 18' ' ' ILE . 11.3 t-160 -131.95 123.49 27.48 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.829 0.823 . . . . 3.53 112.668 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.915 ' HD3' HG13 ' A' ' 105' ' ' VAL . 11.7 mmmm -46.01 160.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.523 -1.672 . . . . 5.69 110.989 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' H ' ' N ' ' A' ' 28' ' ' ILE . 42.3 tp -126.12 136.81 53.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.947 0.879 . . . . 4.5 111.665 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.574 HH11 HD21 ' A' ' 27' ' ' LEU . 3.7 tpt180 -59.41 118.6 6.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.801 -1.545 . . . . 5.24 113.332 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.675 HE22 ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -139.69 69.79 1.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.361 -1.291 . . . . 4.48 110.393 167.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 46.81 78.42 0.09 OUTLIER Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 114.319 -1.31 . . . . 3.78 113.915 173.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.5 mm-40 89.21 -3.85 0.41 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.122 1.369 . . . . 6.85 107.743 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' C ' HD22 ' A' ' 27' ' ' LEU . 16.8 m-80 -117.35 140.89 48.99 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 114.952 -1.022 . . . . 4.85 109.473 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 4.6 mm? -123.32 102.87 8.16 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.118 -1.855 . . . . 3.68 107.655 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.692 ' HB ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 pt -163.56 177.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 115.348 1.61 . . . . 2.9 115.348 -174.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.692 ' HG ' ' HB ' ' A' ' 28' ' ' ILE . 69.9 mt 74.48 77.6 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 112.119 -2.31 . . . . 4.19 112.481 156.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.32 -50.48 0.66 Allowed Glycine 0 C--N 1.298 -1.538 0 CA-C-N 111.093 -2.776 . . . . 1.62 113.102 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.784 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 36.0 p90 -158.42 -179.13 7.81 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.856 -0.791 . . . . 0.73 111.825 -169.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.495 ' HB2' ' HG2' ' B' ' 167' ' ' MET . 23.4 t -119.15 145.59 45.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.04 -0.356 . . . . 1.16 110.04 -174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 2.4 pp -132.16 151.42 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.403 -0.592 . . . . 0.89 109.403 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.35 132.39 8.0 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.014 -1.089 . . . . 0.69 112.24 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -151.17 120.21 1.08 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.623 -0.799 . . . . 1.42 112.021 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.589 ' HA2' HE22 ' A' ' 39' ' ' GLN . . . 146.05 -4.31 1.16 Allowed Glycine 0 C--O 1.224 -0.511 0 C-N-CA 119.498 -1.334 . . . . 3.0 112.544 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.626 HG13 ' H ' ' A' ' 38' ' ' ASP . 11.1 pt -41.03 -65.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 115.759 1.763 . . . . 4.71 115.759 -164.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' H ' HG13 ' A' ' 37' ' ' ILE . 23.5 t70 -131.8 -8.38 3.56 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.686 0.755 . . . . 7.49 109.958 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.589 HE22 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -117.96 -16.21 9.9 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.211 1.189 . . . . 4.55 114.211 -163.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 13.3 t70 -53.94 137.87 55.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.505 -0.771 . . . . 5.14 110.647 -175.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 40' ' ' ASP . 58.8 Cg_endo -59.48 -16.31 35.0 Favored 'Trans proline' 0 N--CA 1.475 0.406 0 C-N-CA 124.345 3.363 . . . . 5.58 113.014 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -75.23 -34.7 61.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.078 -0.712 . . . . 6.54 109.078 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -106.33 -48.36 3.59 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.722 0.772 . . . . 5.93 110.636 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' H ' ' HG2' ' A' ' 43' ' ' GLN . 9.2 t-20 -122.46 81.55 46.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.182 -1.372 . . . . 6.06 111.758 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.59 -3.78 14.11 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.049 1.833 . . . . 8.03 111.464 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -83.74 -22.88 31.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.915 -0.772 . . . . 8.87 108.915 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' ASP . 74.6 m -96.51 -161.37 0.86 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.668 -0.696 . . . . 5.13 109.145 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 47' ' ' SER . 44.3 tt0 69.52 -20.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.176 0.513 . . . . 7.43 110.856 -175.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . 16.1 t70 -64.95 -28.94 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 7.39 110.446 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' CD ' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.82 0.67 17.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.033 -0.985 . . . . 7.82 110.318 179.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 p 62.45 27.58 16.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.335 1.022 . . . . 5.12 108.34 -164.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -51.5 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.043 -1.435 . . . . 3.97 111.33 -178.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 13.0 tptt 69.39 -23.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.783 1.233 . . . . 6.09 112.468 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.699 ' O ' ' HA2' ' A' ' 35' ' ' GLY . . . 58.38 50.23 68.72 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 1.05 112.335 170.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.697 HD13 ' HA3' ' A' ' 35' ' ' GLY . 31.5 mm -104.86 123.18 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.978 0.458 . . . . 0.67 110.255 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.1 p90 -155.04 154.09 31.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.288 -0.264 . . . . 2.48 110.288 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -73.37 134.76 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 110.001 -0.37 . . . . 0.66 110.001 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.1 p -105.08 -17.44 14.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.897 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.8 ptm180 -167.18 173.64 8.89 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.195 -0.911 . . . . 3.02 112.292 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 96.6 t -146.3 107.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 113.215 -1.812 . . . . 0.72 106.897 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -103.78 81.17 1.85 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 117.454 -1.699 . . . . 1.77 108.251 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.689 ' OE1' ' HD2' ' A' ' 65' ' ' PRO . 4.6 mm-40 -109.08 162.65 14.05 Favored 'General case' 0 N--CA 1.382 -3.852 0 CA-C-N 111.819 -2.446 . . . . 3.28 116.589 -170.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 -23.51 1.67 Allowed Glycine 0 C--N 1.277 -2.722 0 CA-C-N 108.779 -3.828 . . . . 1.03 108.532 158.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.755 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -147.85 -89.46 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 121.789 0.661 . . . . 1.27 113.58 -170.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.689 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 63.6 Cg_exo -47.84 -49.41 13.77 Favored 'Trans proline' 0 CA--C 1.517 -0.346 1 C-N-CA 125.788 4.326 . . . . 1.32 116.093 -158.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' A' ' 71' ' ' LEU . . . -71.34 -43.61 66.67 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.122 0.963 . . . . 0.37 108.743 -170.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -85.07 -25.75 27.4 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.557 -1.202 . . . . 1.45 110.054 -171.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 65' ' ' PRO . 2.1 pp -77.44 -29.3 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 122.011 0.91 . . . . 0.89 109.135 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 66' ' ' ALA . . . -62.76 -29.32 70.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.637 -1.62 . . . . 0.34 107.204 170.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.69 35.43 2.42 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.648 -1.615 . . . . 0.49 111.643 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 26.0 tp -96.35 174.68 6.75 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.563 -0.903 . . . . 1.58 108.563 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.772 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 5.4 mt-30 -161.06 175.03 12.88 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 114.914 -1.039 . . . . 2.36 109.698 -166.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.1 mm -88.35 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.282 -0.872 . . . . 0.57 110.475 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.723 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.24 63.57 0.8 Allowed Glycine 0 CA--C 1.502 -0.742 0 C-N-CA 119.664 -1.255 . . . . 0.6 111.581 167.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.796 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -145.94 130.38 17.75 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.394 -0.965 . . . . 1.35 108.394 -172.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.96 105.87 17.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.17 -1.012 . . . . 2.18 110.192 -162.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -75.89 112.2 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 114.924 -1.034 . . . . 0.64 109.427 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.463 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 2.3 mmt -94.7 -24.29 17.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.17 -0.468 . . . . 0.48 110.331 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.077 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.7 OUTLIER -160.17 158.65 30.51 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.429 1.109 . . . . 2.26 112.37 177.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 97' ' ' LEU . 1.5 p -123.88 123.63 67.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 112.46 -2.154 . . . . 0.77 110.815 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.749 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 82.1 m-20 62.06 -0.78 0.43 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.368 0.604 . . . . 1.9 111.299 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 117.58 6.76 12.73 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.142 -0.935 . . . . 1.1 112.302 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.691 ' HB3' HH11 ' A' ' 96' ' ' ARG . 2.1 m95 -100.73 88.82 3.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.31 -0.626 . . . . 2.75 109.31 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.932 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -30.91 104.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 124.307 1.004 . . . . 1.61 111.404 167.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.077 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 10.4 mtp -82.45 22.47 0.85 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.745 -0.661 . . . . 1.72 111.313 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.5 p -85.01 -25.56 27.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.116 1.154 . . . . 1.25 114.116 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.4 mtp -124.48 -13.93 6.99 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.149 0.426 . . . . 3.22 112.149 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 92' ' ' GLN . 2.2 t -84.5 166.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.508 -0.553 . . . . 1.73 109.508 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.827 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -88.21 164.91 15.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.952 -0.758 . . . . 1.3 108.952 -170.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 43.8 t60 -62.36 -39.02 91.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.586 0.231 . . . . 2.47 110.566 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 19.4 t70 -72.32 -32.77 66.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.064 -0.516 . . . . 1.81 110.217 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.827 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 5.8 mm100 -65.85 -39.84 91.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.451 1.119 . . . . 2.66 108.948 174.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . . . -62.63 -40.45 97.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.234 -1.348 . . . . 0.8 108.198 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.517 HH22 HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -59.37 -46.75 87.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.514 -1.221 . . . . 3.95 110.266 175.006 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -53.16 -38.5 62.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.045 0.757 . . . . 2.48 113.045 -177.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.881 ' HE ' ' HA ' ' A' ' 93' ' ' ALA . 5.8 ptt180 -85.74 -31.45 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.98 0.733 . . . . 3.8 112.98 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.823 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.2 pp -89.21 -21.26 23.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.879 0.696 . . . . 1.26 112.879 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.4 p -124.48 51.23 1.62 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.879 0.371 . . . . 1.53 111.437 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 101' ' ' SER . 47.5 pttt -93.97 -151.04 0.3 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.165 -0.47 . . . . 1.79 109.883 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 5.6 tpt180 -129.91 20.77 5.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.873 0.844 . . . . 5.04 109.63 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.505 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 37.1 t -107.07 -4.14 19.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.136 -0.938 . . . . 2.31 110.553 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 1.6 pm0 -118.03 -177.91 3.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.634 0.73 . . . . 2.11 109.613 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -123.32 -9.58 8.06 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.859 -1.534 . . . . 3.94 106.859 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -152.19 169.65 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.181 -1.827 . . . . 1.17 111.153 -149.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.915 HG13 ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -125.59 105.45 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.303 -0.959 . . . . 2.16 109.58 169.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.939 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 20.0 ttp180 -86.97 144.93 26.72 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.625 -1.25 . . . . 3.15 107.625 171.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.27 155.98 44.08 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.591 1.186 . . . . 1.35 111.751 171.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.891 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 2.4 mt -110.04 111.07 22.22 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 112.254 -2.248 . . . . 1.53 108.27 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 110' ' ' THR . 8.3 p -113.87 -178.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 108.176 -1.046 . . . . 1.14 108.176 -170.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.878 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 2.1 p -137.38 109.53 7.27 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.168 -0.923 . . . . 0.58 110.247 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.86 140.93 29.2 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.587 -0.733 . . . . 3.49 110.447 -173.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.62 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -92.99 -45.73 7.8 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.072 -1.084 . . . . 2.83 108.072 171.028 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 56.7 m 69.08 6.25 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.817 -1.992 . . . . 4.3 110.428 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 114' ' ' LEU . 1.7 mm? -133.73 29.8 3.81 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.699 -2.046 . . . . 4.48 107.396 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -53.27 114.79 1.6 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 111.197 -2.729 . . . . 6.53 110.347 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -87.11 132.06 33.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 9.28 112.143 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.41 24.03 0.24 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.509 -1.223 . . . . 11.58 109.238 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.41 81.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.152 -1.385 . . . . 12.38 110.209 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -103.66 97.8 7.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.435 -1.257 . . . . 14.96 109.208 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -104.64 -0.76 27.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.861 0.319 . . . . 17.27 111.861 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.2 m 57.97 41.02 25.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.3 0.571 . . . . 19.47 111.223 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 62.9 mtm -76.51 92.23 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 21.73 110.67 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -62.28 -45.01 95.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.685 -0.688 . . . . 23.08 111.129 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.533 0.322 0 O-C-N 123.803 0.689 . . . . 23.96 111.341 -179.455 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.852 ' HE2' ' HA ' ' B' ' 161' ' ' LYS . 10.3 mmpt? . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 110.198 -0.297 . . . . 8.27 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.456 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 32.3 tt0 -173.96 -116.35 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 112.11 0.411 . . . . 6.87 112.11 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -176.47 157.91 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 4.55 109.412 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.34 123.38 48.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.917 0.389 . . . . 2.71 111.552 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 22.7 mt-10 -113.29 148.5 35.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 4.92 109.992 172.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.416 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.9 m -159.78 141.97 13.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.088 -0.505 . . . . 1.22 110.945 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 81.3 mtp -100.89 133.51 45.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.446 -0.576 . . . . 3.19 109.446 171.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 97' ' ' LEU . 16.0 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.56 -0.733 . . . . 1.54 109.862 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.301 . . . . 18.34 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -101.45 117.05 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 15.06 110.066 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 4' ' ' ILE . 36.8 p90 -116.5 30.43 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 14.54 109.439 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 80.1 mt 73.36 88.92 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.083 -1.417 . . . . 10.4 110.149 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.77 95.47 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.672 2.248 . . . . 10.74 112.247 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.75 -46.2 0.45 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.046 -0.979 . . . . 7.75 110.666 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.5 mt-30 -135.57 99.0 11.92 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.804 -0.443 . . . . 6.84 109.804 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' GLN . 16.7 Cg_endo -57.84 130.19 37.19 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.053 2.502 . . . . 4.84 113.184 -176.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 10' ' ' THR . 4.2 p -147.23 178.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.691 -0.686 . . . . 3.26 109.411 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.708 ' H ' HG22 ' A' ' 9' ' ' VAL . 48.2 p -131.77 103.86 6.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.224 1.012 . . . . 2.17 110.558 -172.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.17 99.22 8.43 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.101 -1.863 . . . . 0.98 110.39 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 21.5 t -75.99 116.64 19.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.903 -1.499 . . . . 1.35 109.706 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.51 113.16 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.664 -0.698 . . . . 1.84 109.783 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -142.54 150.05 39.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.364 -0.835 . . . . 2.31 108.986 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -122.72 137.56 54.88 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.483 -0.562 . . . . 3.58 109.483 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.786 HG13 HD23 ' A' ' 107' ' ' LEU . 2.7 p -140.31 149.54 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.922 -1.14 . . . . 0.86 107.922 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 31.2 mt-10 -119.32 108.91 15.18 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 122.075 -0.39 . . . . 1.75 109.989 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.051 HG13 ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -93.58 116.27 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.407 -0.59 . . . . 0.93 109.407 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.727 ' HB2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -121.69 112.69 18.73 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.206 -0.598 . . . . 3.53 111.254 174.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.978 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 1.8 tmtt? -91.77 -99.01 0.12 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.505 -0.77 . . . . 5.69 109.44 173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 24.5 tp -153.89 123.65 6.75 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.192 0.812 . . . . 4.5 113.192 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.987 ' HB2' ' HB3' ' A' ' 103' ' ' GLU . 5.7 tmm_? -79.27 107.16 11.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.549 -0.908 . . . . 5.24 108.549 164.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' NE2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -112.82 65.87 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.208 1.004 . . . . 4.48 109.868 -176.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' H ' ' HD2' ' A' ' 22' ' ' ARG . . . 80.33 -104.22 2.24 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.584 -1.644 . . . . 3.78 111.481 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.69 -7.19 56.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.864 -0.791 . . . . 6.85 108.864 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' C ' HD22 ' A' ' 27' ' ' LEU . 34.3 m-80 -101.72 134.82 44.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.179 1.466 . . . . 4.85 110.365 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD22 ' C ' ' A' ' 26' ' ' ASN . 4.3 mm? -122.88 109.89 14.73 Favored 'General case' 0 C--N 1.256 -3.467 0 CA-C-N 111.256 -2.702 . . . . 3.68 105.767 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 ' NE2' ' A' ' 23' ' ' GLN . 35.6 mm -109.17 124.13 65.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.996 -0.547 . . . . 2.9 110.95 -172.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD12 HG11 ' A' ' 105' ' ' VAL . 1.2 tt -100.51 -28.05 13.1 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 124.607 1.192 . . . . 4.19 109.369 172.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -57.17 4.03 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.989 -0.624 . . . . 1.62 114.426 169.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 55.7 p90 -81.72 177.98 8.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 117.423 0.612 . . . . 0.73 110.947 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 27.1 t -124.48 150.28 45.92 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.579 -0.526 . . . . 1.16 109.579 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' B' ' 165' ' ' GLU . 47.0 pt -128.34 141.59 46.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.89 109.788 -173.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.74 135.07 12.19 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.086 -1.054 . . . . 0.69 113.105 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' B' ' 164' ' ' LEU . . . -83.53 100.61 2.28 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 109.164 -1.574 . . . . 1.42 109.164 169.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.634 ' HA3' ' HE1' ' A' ' 56' ' ' TYR . . . -121.81 38.07 2.72 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.993 -0.843 . . . . 3.0 110.993 -167.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.8 ' HB ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -55.89 -47.94 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 CA-C-N 114.652 -0.774 . . . . 4.71 111.092 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 30.4 t70 163.55 -23.75 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.916 -1.493 . . . . 7.49 107.448 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.607 ' HA ' ' NE2' ' A' ' 43' ' ' GLN . 2.2 mp0 69.48 160.23 0.19 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 113.769 -1.559 . . . . 4.55 112.751 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.609 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 22.2 t70 74.76 162.37 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.062 -1.881 . . . . 5.14 108.802 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.909 ' HA ' ' HG2' ' B' ' 161' ' ' LYS . 1.0 OUTLIER -42.76 -24.23 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 123.917 3.078 . . . . 5.58 111.938 175.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 39' ' ' GLN . 40.5 t -44.98 -38.91 5.08 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.006 -2.361 . . . . 6.54 112.328 172.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.8 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 5.6 pt20 -80.13 -20.9 43.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.887 -0.597 . . . . 5.93 110.526 -167.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 46' ' ' PHE . 3.7 t-20 52.72 92.16 0.06 OUTLIER Pre-proline 0 C--O 1.216 -0.668 0 O-C-N 124.642 1.213 . . . . 6.06 113.423 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.573 ' CG ' ' HD2' ' B' ' 161' ' ' LYS . 71.9 Cg_endo -76.13 11.96 1.63 Allowed 'Trans proline' 0 CA--C 1.521 -0.162 0 C-N-CA 122.534 2.156 . . . . 8.03 110.708 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' HB2' HD21 ' A' ' 44' ' ' ASN . 86.2 m-85 -98.6 -15.47 19.46 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.846 -1.07 . . . . 8.87 109.151 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -84.28 -91.82 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.029 -0.668 . . . . 5.13 109.216 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 89' ' ' THR . 47.2 mt-10 47.1 34.18 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.771 0.796 . . . . 7.43 109.355 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -98.01 -30.95 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.728 -1.124 . . . . 7.39 113.31 -166.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER 175.15 -64.15 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.568 0.699 . . . . 7.82 112.24 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 m -68.43 -15.08 63.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.425 -1.261 . . . . 5.12 110.464 -170.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.28 -61.62 2.18 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.366 -1.288 . . . . 3.97 110.636 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tptm 59.86 22.67 11.64 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.541 -0.754 . . . . 6.09 109.635 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 37' ' ' ILE . . . -89.59 30.04 5.92 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.821 -1.081 . . . . 1.05 114.323 -169.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.0 mm -122.38 118.09 54.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 117.753 0.776 . . . . 0.67 110.639 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 53.6 p90 -154.73 156.69 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 2.48 110.935 176.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -74.63 135.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 116.203 -0.453 . . . . 0.66 110.295 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 t -117.44 -8.54 11.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.347 1.029 . . . . 1.0 110.102 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.736 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 1.1 mmp_? -145.73 171.58 14.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.02 0.914 . . . . 3.02 112.102 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 6.4 t -152.5 133.61 4.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 112.836 -1.984 . . . . 0.72 108.424 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.13 100.92 0.64 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.614 -0.884 . . . . 1.77 108.614 166.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -74.31 143.97 44.73 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 122.796 1.284 . . . . 3.28 111.379 -169.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 30.42 76.71 Favored Glycine 0 C--N 1.293 -1.822 0 CA-C-N 112.23 -2.259 . . . . 1.03 110.689 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -123.8 -125.19 2.97 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.606 -0.807 . . . . 1.27 113.003 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.978 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 61.3 Cg_endo -95.19 -40.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.742 2.961 . . . . 1.32 114.426 -175.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.051 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -66.97 -41.73 86.36 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.553 0.692 . . . . 0.37 110.096 -165.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.97 -24.03 26.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.752 -1.113 . . . . 1.45 108.77 -165.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.9 pp -85.09 -27.54 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 CA-C-O 122.46 1.124 . . . . 0.89 109.007 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 18' ' ' ILE . . . -65.14 -29.16 69.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.06 -1.882 . . . . 0.34 107.363 168.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.15 43.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.488 -1.233 . . . . 0.49 112.274 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HB1' ' A' ' 66' ' ' ALA . 16.4 tp -122.11 164.0 18.51 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.03 -1.1 . . . . 1.58 108.03 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -164.01 179.27 7.08 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.232 -1.025 . . . . 2.36 108.232 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 60' ' ' VAL . 5.9 mm -80.72 114.0 21.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.113 0.482 . . . . 0.57 111.572 -171.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 108.89 63.06 0.54 Allowed Glycine 0 CA--C 1.504 -0.613 0 C-N-CA 120.501 -0.857 . . . . 0.6 111.043 173.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.775 ' H ' HG12 ' A' ' 57' ' ' VAL . 3.2 t0 -139.98 120.17 13.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.208 -0.664 . . . . 1.35 109.208 -171.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.802 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 0.0 OUTLIER -85.29 106.49 16.73 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.667 -0.813 . . . . 2.18 109.904 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.7 mt -78.63 126.93 38.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.64 109.63 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.483 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 mmt -111.57 -16.42 13.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.016 -0.735 . . . . 0.48 109.016 -169.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.729 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -162.61 157.9 22.6 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.084 -0.962 . . . . 2.26 109.788 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -136.65 124.63 33.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 CA-C-N 113.902 -1.499 . . . . 0.77 110.428 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 91.1 m-20 60.63 11.75 3.26 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.764 0.792 . . . . 1.9 111.428 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.29 36.16 Favored Glycine 0 C--N 1.307 -1.053 0 CA-C-N 114.3 -1.318 . . . . 1.1 112.498 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.542 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.2 m95 -104.69 93.64 4.86 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.296 -1.001 . . . . 2.75 108.296 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -48.19 109.56 0.25 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 124.031 0.832 . . . . 1.61 110.954 176.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.729 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 28.6 mtp -77.37 -2.62 35.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.475 -0.784 . . . . 1.72 112.124 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.445 ' OG1' ' HE2' ' A' ' 50' ' ' LYS . 82.3 p -82.21 -17.1 47.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 1.25 110.745 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 68.1 mmm -103.34 19.03 20.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.627 -0.879 . . . . 3.22 108.627 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 HH22 ' A' ' 96' ' ' ARG . 4.3 t -136.99 155.78 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.146 -0.934 . . . . 1.73 112.079 -164.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 92' ' ' GLN . 2.4 m -88.22 140.03 29.89 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.749 ' HD1' HD13 ' B' ' 164' ' ' LEU . 34.5 t-80 -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.667 -0.697 . . . . 2.47 111.499 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.765 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 16.7 t70 -74.56 -37.98 62.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.023 -0.99 . . . . 1.81 110.576 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.732 ' NE2' HG13 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -84.24 -21.86 31.02 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.188 -1.412 . . . . 2.66 107.188 -175.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . . . -76.07 -34.55 59.57 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.935 -1.029 . . . . 0.8 109.167 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 2.9 ptm180 -66.16 -39.59 89.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.249 -0.887 . . . . 3.95 109.523 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -80.33 -24.23 40.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 2.48 112.099 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.743 HH22 HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -88.28 -16.7 32.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.587 . . . . 3.8 111.105 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.673 HD11 HG21 ' B' ' 168' ' ' VAL . 4.6 pp -80.01 -32.51 39.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.679 -0.489 . . . . 1.26 109.679 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 1.1 p -86.62 48.62 1.66 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.368 0.604 . . . . 1.53 109.802 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 96' ' ' ARG . 2.3 ptmm? -83.76 169.67 14.98 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -98.59 16.09 23.02 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.509 -0.769 . . . . 5.04 110.401 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . 27.4 t -92.53 -25.99 18.12 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.361 -0.535 . . . . 2.31 110.444 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -160.89 167.53 26.46 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.936 -0.764 . . . . 2.11 108.936 177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.987 ' HB3' ' HB2' ' A' ' 22' ' ' ARG . 16.2 pt-20 -112.25 7.86 19.57 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.433 1.111 . . . . 3.94 108.729 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 19' ' ' HIS . 92.4 t -102.09 130.17 52.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 113.46 -1.7 . . . . 1.17 108.78 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.643 HG11 HD12 ' A' ' 29' ' ' LEU . 12.7 p -110.47 113.27 43.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.522 -0.918 . . . . 2.16 108.522 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 1.8 ttt180 -84.72 137.36 33.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.378 -0.828 . . . . 3.15 108.843 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.786 HD23 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -125.73 136.28 53.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.599 0.714 . . . . 1.35 110.091 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -98.49 132.32 44.02 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.068 -2.197 . . . . 1.53 105.068 159.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 110' ' ' THR . 2.3 p -143.22 173.26 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 CA-C-O 121.652 0.739 . . . . 1.14 109.628 -171.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.802 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 2.6 p -134.9 114.56 12.67 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 113.912 -1.494 . . . . 0.58 111.693 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 26.2 mmt85 -91.51 159.48 15.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.38 -0.827 . . . . 3.49 109.373 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 14.2 mm-40 -101.84 -34.35 9.44 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.318 1.056 . . . . 2.83 108.405 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 12' ' ' VAL . 28.9 m 67.42 19.3 10.08 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.417 -2.174 . . . . 4.3 112.22 175.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.03 3.16 1.04 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.75 1.262 . . . . 4.48 108.536 177.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 112' ' ' GLN . 9.4 mm100 4.43 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.082 -3.235 . . . . 6.53 114.17 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -106.8 149.83 26.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.006 -0.543 . . . . 9.28 109.802 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.07 19.0 1.77 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.185 -1.042 . . . . 11.58 108.185 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 11.6 p 31.85 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 112.049 -2.341 . . . . 12.38 114.337 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -113.54 33.64 5.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.736 -1.12 . . . . 14.96 109.874 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.99 140.61 52.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.228 -0.896 . . . . 17.27 109.252 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t 62.58 79.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.842 0.714 . . . . 19.47 109.235 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.4 mmt 67.14 -166.31 0.21 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.105 -0.952 . . . . 21.73 109.301 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.24 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.407 0.622 . . . . 23.08 111.818 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.524 . . . . 23.96 110.704 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.909 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.996 0.369 . . . . 8.27 111.996 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.454 ' HA ' ' H ' ' A' ' 40' ' ' ASP . 11.0 pt-20 -173.7 -176.92 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 6.87 110.961 172.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -55.42 125.9 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 4.55 110.491 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.749 HD13 ' HD1' ' A' ' 90' ' ' HIS . 7.9 mt -113.48 148.9 35.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.25 0.548 . . . . 2.71 112.321 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 15.0 mt-10 -144.56 155.04 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.151 -0.931 . . . . 4.92 109.855 169.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -158.35 101.09 1.7 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.997 -0.547 . . . . 1.22 110.787 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.9 ptp -86.4 133.18 33.8 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.233 -1.395 . . . . 3.19 107.233 162.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 CA-C-O 118.487 -0.768 . . . . 1.54 111.132 -173.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.148 -0.316 . . . . 18.34 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 67.02 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.729 0.643 . . . . 15.06 110.935 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -133.5 141.49 47.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 14.54 109.603 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm 49.82 85.48 0.18 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.87 0.731 . . . . 10.4 112.105 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.9 109.17 0.39 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.841 2.361 . . . . 10.74 112.11 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.18 -28.11 3.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.022 -0.609 . . . . 7.75 112.167 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -121.9 102.03 41.56 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-O 120.939 0.4 . . . . 6.84 111.624 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -91.91 -167.53 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.089 2.526 . . . . 4.84 112.619 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 10' ' ' THR . 2.9 p -128.68 -176.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.259 -0.645 . . . . 3.26 109.259 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.741 ' H ' HG22 ' A' ' 9' ' ' VAL . 57.1 p -111.17 -88.56 0.51 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.107 0.479 . . . . 2.17 111.424 -175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -170.8 142.04 1.87 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.055 0.931 . . . . 0.98 111.759 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.5 t -121.24 138.73 50.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 113.419 -1.719 . . . . 1.35 108.483 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.34 125.06 63.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 120.967 0.413 . . . . 1.84 110.85 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.01 167.03 21.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.366 0.603 . . . . 2.31 109.82 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HD22 ' A' ' 108' ' ' LEU . 17.0 mtm180 -120.59 121.05 37.54 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 115.062 -0.972 . . . . 3.58 109.333 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 18' ' ' ILE . 7.7 p -138.46 128.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.451 0.643 . . . . 0.86 109.985 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 44.6 mt-10 -106.81 109.17 21.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.484 0.659 . . . . 1.75 110.296 -175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 7.3 mm -94.21 124.28 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.12 -0.946 . . . . 0.93 111.429 -174.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.2 p80 -146.67 119.01 8.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.096 -0.956 . . . . 3.53 111.484 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.935 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 27.5 tptp -95.22 -80.06 0.42 Allowed 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 121.997 -0.439 . . . . 5.69 110.504 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.478 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 22.6 tp -149.9 117.26 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.148 0.499 . . . . 4.5 111.618 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.587 ' HD3' ' H ' ' A' ' 24' ' ' GLY . 2.3 tmt_? -79.71 112.03 16.58 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.772 -0.825 . . . . 5.24 108.772 167.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.94 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.6 64.84 0.84 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.858 0.837 . . . . 4.48 110.232 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' H ' ' HD3' ' A' ' 22' ' ' ARG . . . 75.9 -98.24 1.18 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 113.799 -1.546 . . . . 3.78 112.114 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.12 0.92 38.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.802 -0.699 . . . . 6.85 109.569 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.94 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 24.3 m-80 -115.47 132.98 56.45 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-O 123.076 1.417 . . . . 4.85 110.515 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 101' ' ' SER . 3.8 mm? -120.58 110.94 17.04 Favored 'General case' 0 C--N 1.261 -3.254 0 CA-C-N 111.524 -2.58 . . . . 3.68 105.881 166.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG13 ' NE2' ' A' ' 23' ' ' GLN . 51.9 mm -107.25 128.32 62.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.7 -0.682 . . . . 2.9 112.087 -169.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' HG23 ' B' ' 168' ' ' VAL . 2.9 mm? -114.76 -49.53 2.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.793 -1.094 . . . . 4.19 108.511 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 168' ' ' VAL . . . 91.11 -40.33 2.99 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.599 -0.728 . . . . 1.62 113.366 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.897 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 25.2 p90 -70.05 167.9 16.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.717 -0.475 . . . . 0.73 109.717 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -131.38 148.07 52.63 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.636 -0.426 . . . . 1.16 110.814 -173.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.523 HD11 ' HG2' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -129.15 153.75 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 119.762 -0.775 . . . . 0.89 109.338 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.39 126.07 3.53 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.806 -1.088 . . . . 0.69 112.821 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' H ' ' H ' ' B' ' 164' ' ' LEU . . . 140.61 170.85 12.23 Favored Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.692 -1.363 . . . . 1.42 109.692 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.821 ' HA3' HD23 ' B' ' 164' ' ' LEU . . . 149.4 -124.38 1.79 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.313 -1.422 . . . . 3.0 113.973 169.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HD22 ' B' ' 164' ' ' LEU . 0.4 OUTLIER 17.44 -77.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 127.353 2.261 . . . . 4.71 115.837 -178.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' H ' HG13 ' A' ' 37' ' ' ILE . 12.1 t70 166.4 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.969 -1.123 . . . . 7.49 107.969 -170.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 1.08 ' HG2' ' HB3' ' B' ' 162' ' ' GLU . 0.0 OUTLIER -2.5 -104.23 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 N-CA-C 116.032 1.864 . . . . 4.55 116.032 -168.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 161' ' ' LYS . 1.3 t70 -138.67 132.98 16.52 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 112.492 0.553 . . . . 5.14 112.492 -169.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' B' ' 161' ' ' LYS . 56.7 Cg_endo -80.5 -12.8 12.44 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 124.034 3.156 . . . . 5.58 112.639 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 36.2 t -44.84 -43.09 8.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.016 0.926 . . . . 6.54 112.694 -172.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.715 HE22 ' HB2' ' B' ' 162' ' ' GLU . 6.7 pt20 -90.08 -0.03 57.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.755 -0.657 . . . . 5.93 112.304 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.628 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -33.8 109.61 0.35 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 114.33 1.233 . . . . 6.06 114.33 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.4 -8.86 12.65 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.883 2.389 . . . . 8.03 111.446 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 48' ' ' GLU . 19.9 t80 -155.74 -54.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.754 -0.657 . . . . 8.87 110.587 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.815 ' HA ' ' HE2' ' B' ' 161' ' ' LYS . 3.8 t 69.09 11.43 8.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.465 0.706 . . . . 5.13 110.651 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.806 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 7.2 mm-40 70.32 -59.64 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.955 0.785 . . . . 7.43 112.023 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t70 161.77 -38.82 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.64 -1.615 . . . . 7.39 106.64 -169.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.806 ' HE3' ' HB3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -98.27 -97.75 0.21 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.131 -1.85 . . . . 7.82 110.061 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -137.18 12.89 3.06 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.894 -1.15 . . . . 5.12 107.894 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.754 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 20.9 t0 66.26 165.82 0.2 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.114 -1.403 . . . . 3.97 110.912 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HG2' ' SD ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -81.06 -23.33 38.61 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.909 -1.042 . . . . 6.09 110.491 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.27 10.05 86.4 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 115.712 1.045 . . . . 1.05 115.712 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 mm -125.25 116.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 117.981 0.891 . . . . 0.67 110.594 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -127.05 169.05 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 2.48 110.251 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.0 p -101.29 132.33 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.514 0 N-CA-C 106.987 -1.486 . . . . 0.66 106.987 169.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -118.34 -1.67 11.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.69 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.3 mmm180 -150.26 135.59 18.02 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.013 -0.994 . . . . 3.02 112.284 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.897 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 38.8 t -132.11 126.9 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 114.642 -1.163 . . . . 0.72 108.057 169.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -69.55 100.82 1.49 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 119.754 -0.779 . . . . 1.77 109.042 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.49 150.98 38.07 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 114.715 -1.13 . . . . 3.28 109.093 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.76 27.12 71.61 Favored Glycine 0 C--N 1.287 -2.17 0 CA-C-N 113.233 -1.803 . . . . 1.03 110.084 -167.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.35 -132.35 4.05 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 111.267 -0.733 . . . . 1.27 111.267 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.935 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 96.6 Cg_endo -98.15 -37.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.917 2.411 . . . . 1.32 114.951 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -70.6 -40.94 72.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.153 -0.93 . . . . 0.37 109.271 -162.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -77.2 -30.62 54.81 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.124 -1.398 . . . . 1.45 110.369 -169.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 pt -82.44 -28.72 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 CA-C-O 122.244 1.021 . . . . 0.89 109.556 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -67.92 -29.67 68.81 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.442 -1.708 . . . . 0.34 107.359 170.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.45 50.39 0.37 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.15 -1.386 . . . . 0.49 112.691 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.767 HD23 ' HB1' ' A' ' 66' ' ' ALA . 21.2 tp -128.47 160.05 33.52 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.674 -0.862 . . . . 1.58 108.674 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.4 176.27 9.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.139 -1.06 . . . . 2.36 108.139 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.507 ' CD1' ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -81.03 115.84 24.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.25 0.547 . . . . 0.57 111.672 -169.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 57' ' ' VAL . . . 113.0 48.43 0.62 Allowed Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.108 -1.197 . . . . 0.6 110.108 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.795 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.9 t0 -125.8 132.54 52.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.749 -0.725 . . . . 1.35 109.181 -169.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 110' ' ' THR . 20.0 mttm -82.88 105.0 13.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.26 -0.576 . . . . 2.18 109.506 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.01 109.25 17.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.26 0.553 . . . . 0.64 110.656 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.591 ' SD ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mmt -87.83 -39.41 14.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.934 -0.575 . . . . 0.48 110.296 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.798 ' HG3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.13 153.56 35.24 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.334 1.064 . . . . 2.26 113.026 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.717 HG21 HD23 ' A' ' 97' ' ' LEU . 7.1 p -117.25 141.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 112.283 -2.235 . . . . 0.77 109.16 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.4 m-80 54.0 14.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.093 0.405 . . . . 1.9 112.093 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.63 51.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.024 0.769 . . . . 1.1 115.024 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' C ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -119.4 113.78 21.31 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.011 1.405 . . . . 2.75 111.367 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.791 ' N ' ' HB3' ' A' ' 79' ' ' GLN . 7.9 t70 -30.61 118.77 0.18 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.843 -1.526 . . . . 1.61 112.041 172.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 18.2 ptm -118.64 35.67 4.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.937 -1.029 . . . . 1.72 111.676 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -80.81 -32.68 35.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.25 111.643 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -102.89 20.51 17.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 122.851 1.31 . . . . 3.22 108.855 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.772 HG22 HE22 ' A' ' 92' ' ' GLN . 0.9 OUTLIER -82.12 157.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 112.993 -1.912 . . . . 1.73 113.209 -170.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.573 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 1.3 m -111.33 152.72 26.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.711 -0.848 . . . . 1.3 108.711 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.95 ' HB2' HD11 ' B' ' 164' ' ' LEU . 1.9 t-160 -47.73 -51.59 21.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.808 0.814 . . . . 2.47 111.444 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 5.3 t70 -59.08 -48.54 81.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.85 -1.068 . . . . 1.81 110.959 -175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.782 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -83.64 -19.83 34.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 120.147 -0.621 . . . . 2.66 111.372 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.785 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.38 -40.86 77.15 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.288 -1.375 . . . . 0.8 107.288 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -57.05 -42.54 80.74 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.319 -1.309 . . . . 3.95 110.363 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.715 ' CG ' ' HA ' ' A' ' 92' ' ' GLN . 7.8 ptpt -72.86 -19.7 61.25 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.264 0.839 . . . . 2.48 113.264 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -85.26 -24.47 27.76 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.732 -0.605 . . . . 3.8 110.887 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 43.1 mt -87.24 -33.32 19.34 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.377 -0.829 . . . . 1.26 110.31 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.2 p -127.84 73.58 1.47 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.141 -1.39 . . . . 1.53 110.64 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 102' ' ' GLU . 17.4 ptmt -79.72 -136.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 1.79 112.149 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.566 ' NH1' ' HB3' ' A' ' 101' ' ' SER . 6.4 tmm_? -48.62 -36.55 16.02 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.999 -1.0 . . . . 5.04 111.077 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.655 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 37.7 t 150.61 -22.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.085 -1.45 . . . . 2.31 107.085 -171.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 101' ' ' SER . 0.9 OUTLIER 49.71 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 116.834 2.161 . . . . 2.11 116.834 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' SER . 40.4 mm-40 85.74 -20.99 0.24 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 126.06 1.744 . . . . 3.94 108.131 -171.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 17' ' ' GLU . 8.2 p 174.06 147.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 115.053 -0.976 . . . . 1.17 110.893 -171.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 18' ' ' ILE . 32.8 m -101.32 122.92 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 119.226 -0.99 . . . . 2.16 110.487 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 5.7 mpt_? -84.79 105.27 15.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.595 0.712 . . . . 3.15 111.857 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.559 HD22 ' CG1' ' A' ' 18' ' ' ILE . 5.5 mp -102.36 119.91 39.62 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.397 -0.819 . . . . 1.35 110.606 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.5 mt -95.41 107.05 19.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.88 -1.526 . . . . 1.53 106.88 170.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 6.4 p -121.74 161.34 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-O 122.022 0.915 . . . . 1.14 109.693 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -125.16 109.54 13.01 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.577 -1.647 . . . . 0.58 111.017 -172.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -92.75 164.78 13.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.851 -1.068 . . . . 3.49 111.441 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -99.24 9.73 42.83 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.998 0.904 . . . . 2.83 111.3 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 t 80.2 26.06 0.33 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.692 -2.049 . . . . 4.3 110.157 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 114' ' ' LEU . 2.7 mm? 60.63 57.84 2.61 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.195 -1.366 . . . . 4.48 110.495 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 9' ' ' VAL . 53.5 mm-40 -39.7 105.76 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.528 -2.123 . . . . 6.53 114.043 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.69 142.85 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.508 -1.224 . . . . 9.28 108.165 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.23 20.29 7.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.428 1.109 . . . . 11.58 108.872 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.68 82.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 113.299 -1.773 . . . . 12.38 108.578 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -115.12 177.77 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.694 -1.139 . . . . 14.96 110.543 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -106.58 130.2 54.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.632 -0.713 . . . . 17.27 109.217 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -84.48 170.1 13.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.514 -0.312 . . . . 19.47 110.181 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 5.2 mpp? 72.27 105.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.932 0.77 . . . . 21.73 111.401 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.7 -171.55 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.077 -0.965 . . . . 23.08 111.369 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.607 -0.724 . . . . 23.96 110.445 -178.231 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 47' ' ' SER . 11.8 mmtp . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.525 0.202 . . . . 8.27 110.985 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 1.08 ' HB3' ' HG2' ' A' ' 39' ' ' GLN . 27.7 tt0 -79.8 156.23 27.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.179 0.514 . . . . 6.87 110.013 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.414 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 7.3 p30 -87.7 128.48 35.3 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.134 -0.939 . . . . 4.55 113.17 -168.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -120.69 163.65 17.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.511 -1.292 . . . . 2.71 107.511 168.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.653 ' OE1' ' HA ' ' A' ' 90' ' ' HIS . 4.9 tp10 89.49 -145.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.107 0.963 . . . . 4.92 112.132 172.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.477 ' H ' ' HG3' ' B' ' 165' ' ' GLU . 63.7 m -173.35 -169.03 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.626 0.727 . . . . 1.22 112.615 -148.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 24.5 ptp -101.15 165.86 11.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.385 -1.279 . . . . 3.19 108.727 164.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 109.477 -0.564 . . . . 1.54 109.477 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.307 0.099 . . . . 18.34 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t 67.91 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.39 0.614 . . . . 15.06 111.093 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -137.46 103.82 5.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.941 -0.572 . . . . 14.54 110.073 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.58 103.43 6.46 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.691 . . . . 10.4 110.754 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.82 -154.03 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.249 2.632 . . . . 10.74 111.417 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.0 50.12 1.87 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.032 -0.604 . . . . 7.75 112.37 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 20.92 86.81 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.49 1.516 . . . . 6.84 114.998 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -91.29 -169.05 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.479 2.786 . . . . 4.84 112.312 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 p -85.68 -10.37 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 122.567 1.175 . . . . 3.26 109.412 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p 69.08 109.55 0.05 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 111.693 -2.503 . . . . 2.17 112.439 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -55.92 137.22 50.96 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 113.008 -1.906 . . . . 0.98 110.814 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 110' ' ' THR . 3.0 t -84.39 147.44 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 112.927 -1.942 . . . . 1.35 107.841 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 t -120.31 116.87 51.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.007 0.432 . . . . 1.84 110.089 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' ARG . 0.6 OUTLIER -140.04 171.46 14.15 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.721 0.772 . . . . 2.31 111.083 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -124.82 118.68 26.92 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.308 -1.315 . . . . 3.58 110.047 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.5 p -130.23 140.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.209 -0.663 . . . . 0.86 109.209 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -117.39 112.15 20.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.452 0.644 . . . . 1.75 110.183 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.785 HG12 ' HA ' ' A' ' 66' ' ' ALA . 21.6 mt -107.5 126.58 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 C-N-CA 123.894 0.878 . . . . 0.93 111.545 -171.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 104' ' ' VAL . 15.8 p80 -130.29 104.63 7.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.193 -0.912 . . . . 3.53 111.667 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.742 ' HG2' ' HG3' ' A' ' 65' ' ' PRO . 5.4 tmtt? -79.64 -100.77 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.561 -0.533 . . . . 5.69 109.561 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 21.9 tp -154.47 134.07 12.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.533 -0.467 . . . . 4.5 111.524 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -76.62 132.78 39.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.109 -0.7 . . . . 5.24 109.109 167.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.9 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 14.8 mt-30 -128.92 62.4 1.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.014 0.911 . . . . 4.48 109.91 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.69 -99.6 0.85 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 113.581 -1.645 . . . . 3.78 111.91 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.64 -5.06 43.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.777 0.799 . . . . 6.85 109.697 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.9 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 39.6 m-80 -109.57 146.42 34.71 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 123.228 1.49 . . . . 4.85 110.308 -175.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 26' ' ' ASN . 3.9 mm? -135.43 110.24 8.71 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 110.815 -2.902 . . . . 3.68 104.98 172.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.881 HG13 HE21 ' A' ' 23' ' ' GLN . 43.1 mm -107.49 129.51 61.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.359 0.6 . . . . 2.9 111.815 -168.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 105' ' ' VAL . 7.6 tp -93.47 -41.05 10.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.413 -1.721 . . . . 4.19 108.849 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.52 -48.73 1.36 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.618 -0.801 . . . . 1.62 114.036 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 41.6 p90 -88.03 173.81 8.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.6 0.7 . . . . 0.73 111.322 -173.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.782 ' HB2' ' HB3' ' B' ' 167' ' ' MET . 37.4 t -127.6 140.48 52.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.0 -0.545 . . . . 1.16 110.122 -174.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.944 HD11 ' HG3' ' B' ' 165' ' ' GLU . 0.2 OUTLIER -126.93 168.58 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 119.92 -0.712 . . . . 0.89 109.181 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.81 138.1 10.63 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.001 -1.095 . . . . 0.69 111.76 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -134.01 155.5 21.86 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.935 -0.65 . . . . 1.42 111.753 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.88 60.64 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.292 -0.48 . . . . 3.0 112.492 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.793 HG23 ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -124.21 -58.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 4.71 111.272 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 37' ' ' ILE . 19.9 t70 -109.26 16.63 22.28 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.434 -0.95 . . . . 7.49 108.434 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.673 ' HB3' HD21 ' B' ' 164' ' ' LEU . 33.3 mm-40 -85.14 -75.26 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.485 -1.234 . . . . 4.55 111.222 -174.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 1.5 t70 -130.78 127.17 22.13 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.809 -1.087 . . . . 5.14 109.557 -176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.53 -17.99 26.16 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 123.197 2.598 . . . . 5.58 111.747 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.452 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 3.6 m -67.16 -37.32 83.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.109 -0.951 . . . . 6.54 110.77 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' B' ' 162' ' ' GLU . 0.6 OUTLIER -86.66 -33.93 19.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.428 0.632 . . . . 5.93 110.543 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.976 HD21 ' HA ' ' A' ' 48' ' ' GLU . 2.3 t-20 -162.66 97.95 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 114.867 -1.061 . . . . 6.06 111.098 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.97 6.87 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.707 2.271 . . . . 8.03 111.326 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -119.51 -73.14 0.66 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.565 -0.743 . . . . 8.87 110.66 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HG22 ' A' ' 37' ' ' ILE . 1.6 m 171.33 -47.95 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.309 -0.997 . . . . 5.13 108.309 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.976 ' HA ' HD21 ' A' ' 44' ' ' ASN . 0.0 OUTLIER 170.61 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.069 -1.878 . . . . 7.43 108.53 178.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -111.37 37.31 2.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.401 -0.963 . . . . 7.39 108.401 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tptm 72.3 -65.58 0.34 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 114.36 -1.291 . . . . 7.82 111.219 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 10.16 8.0 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.719 -1.128 . . . . 5.12 112.199 -172.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.27 -174.31 4.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.69 -0.856 . . . . 3.97 108.69 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HD2' ' HB ' ' A' ' 86' ' ' THR . 69.9 mmtt -127.33 -16.17 4.99 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.282 -0.872 . . . . 6.09 110.088 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.793 ' HA3' HG23 ' A' ' 37' ' ' ILE . . . 70.92 -5.29 8.08 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.795 -1.093 . . . . 1.05 115.734 171.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.1 mm -104.88 132.56 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 118.439 1.119 . . . . 0.67 110.254 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 21.8 p90 -159.94 151.23 19.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.246 -0.649 . . . . 2.48 109.246 175.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.897 HG23 HG22 ' A' ' 33' ' ' ILE . 1.3 p -76.38 137.79 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 122.305 -0.247 . . . . 0.66 110.743 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -113.54 -8.38 13.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 124.208 0.943 . . . . 1.0 110.26 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 1.4 ptm180 -166.12 171.77 12.02 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.661 0.743 . . . . 3.02 110.421 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 6.1 t -138.3 140.77 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 114.384 -1.28 . . . . 0.72 109.838 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 31' ' ' PHE . 1.2 p -64.38 97.76 0.21 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.1 -1.074 . . . . 1.77 108.1 165.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -78.57 149.04 33.1 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.203 -1.362 . . . . 3.28 110.957 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.55 29.56 61.06 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 112.657 -2.065 . . . . 1.03 110.505 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 65' ' ' PRO . . . -125.61 -125.83 2.93 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 120.438 -0.887 . . . . 1.27 112.748 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.742 ' HG3' ' HG2' ' A' ' 20' ' ' LYS . 74.4 Cg_endo -95.92 -39.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.576 2.851 . . . . 1.32 114.711 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.785 ' HA ' HG12 ' A' ' 18' ' ' ILE . . . -67.14 -40.88 86.8 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 121.591 0.71 . . . . 0.37 109.523 -166.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.86 -23.72 26.98 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.822 -1.081 . . . . 1.45 109.752 -167.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 69' ' ' ALA . 28.9 pt -84.16 -30.49 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-O 122.21 1.005 . . . . 0.89 108.897 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -65.57 -27.69 68.61 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.472 -1.695 . . . . 0.34 107.729 171.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.72 48.04 0.51 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.424 -1.262 . . . . 0.49 112.605 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 13.6 tp -128.38 164.57 22.39 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.517 -0.92 . . . . 1.58 108.517 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -164.92 -176.32 4.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.147 -1.057 . . . . 2.36 108.147 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 59' ' ' ARG . 2.8 mm -81.92 113.75 21.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 111.997 0.369 . . . . 0.57 111.997 -170.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.731 ' O ' ' HB3' ' A' ' 114' ' ' LEU . . . 112.73 59.86 0.43 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 110.876 -0.89 . . . . 0.6 110.876 172.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.771 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -136.87 116.24 12.7 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.615 -0.434 . . . . 1.35 110.29 -167.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 19.7 mtpp -79.8 106.0 11.5 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.937 -0.705 . . . . 2.18 109.533 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 33' ' ' ILE . 76.6 mt -81.0 115.7 24.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.906 -1.043 . . . . 0.64 109.948 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.518 ' SD ' ' HG3' ' A' ' 53' ' ' LYS . 4.6 mmt -98.72 -18.65 17.91 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.062 -0.517 . . . . 0.48 110.333 -173.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.104 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 20.3 mt-30 -155.31 157.83 37.81 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.991 -0.55 . . . . 2.26 110.095 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.666 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -136.05 124.6 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.019 -0.991 . . . . 0.77 110.156 173.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 78.7 m-20 59.1 10.18 1.55 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.615 0.766 . . . . 1.9 111.711 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.73 -2.86 21.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.634 -1.167 . . . . 1.1 112.218 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.666 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 7.1 m95 -98.57 102.5 14.26 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.373 -0.603 . . . . 2.75 109.373 -175.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 1.104 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 9.3 t70 -46.08 107.17 0.09 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.177 -0.92 . . . . 1.61 110.926 170.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.547 ' HA ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -101.33 34.71 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.496 -0.774 . . . . 1.72 111.892 178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.712 ' HB ' ' HD2' ' A' ' 53' ' ' LYS . 54.8 p -90.87 -23.95 20.39 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.533 -0.467 . . . . 1.25 111.936 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.8 mtt -118.26 20.94 12.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.176 0.513 . . . . 3.22 110.347 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.906 HG12 ' HG2' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -116.87 179.74 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-N 115.417 -0.811 . . . . 1.73 110.059 -172.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.918 HG22 ' H ' ' A' ' 90' ' ' HIS . 3.3 m -93.44 -153.14 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.378 0.536 . . . . 1.3 111.175 -170.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.918 ' H ' HG22 ' A' ' 89' ' ' THR . 18.0 t-160 -82.44 -60.2 2.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.275 1.036 . . . . 2.47 111.895 167.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.634 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 35.2 t70 -55.58 -63.28 1.22 Allowed 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.372 -1.285 . . . . 1.81 114.064 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.906 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -45.93 -40.0 9.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.085 0.772 . . . . 2.66 113.085 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.874 ' H ' ' NE2' ' A' ' 92' ' ' GLN . . . -71.16 -37.44 72.2 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.456 -0.942 . . . . 0.8 108.456 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 33.1 mtm180 -56.87 -37.1 70.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.486 -1.234 . . . . 3.95 109.651 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 1.8 mmmm -73.54 -20.66 60.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 2.48 110.62 -178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.608 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 2.8 mmp_? -80.99 -46.69 14.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.524 0.565 . . . . 3.8 112.524 175.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 HG21 ' B' ' 168' ' ' VAL . 3.6 pp -68.58 -27.53 66.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.244 -0.435 . . . . 1.26 112.13 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.529 ' N ' HD12 ' A' ' 97' ' ' LEU . 3.3 t -126.08 58.75 1.34 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.008 0.908 . . . . 1.53 109.69 170.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.713 ' HG2' ' OE2' ' A' ' 102' ' ' GLU . 17.1 pttp -71.4 -8.86 56.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.79 111.309 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 6.0 mmm180 73.46 8.78 5.11 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.58 -1.191 . . . . 5.04 111.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.3 t -120.65 20.9 11.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.261 0.553 . . . . 2.31 109.92 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.713 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -121.87 178.53 4.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.873 0.844 . . . . 2.11 109.631 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -138.25 13.01 2.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 105.407 -2.071 . . . . 3.94 105.407 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 19' ' ' HIS . 13.8 p 178.22 142.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 112.361 -2.2 . . . . 1.17 110.016 -162.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG21 HD13 ' A' ' 29' ' ' LEU . 2.1 t -107.42 109.64 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.554 -0.906 . . . . 2.16 108.554 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' C ' HD13 ' A' ' 107' ' ' LEU . 17.8 ttt180 -87.2 145.04 26.56 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.323 -0.991 . . . . 3.15 108.323 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.64 158.71 43.82 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.6 1.19 . . . . 1.35 112.81 171.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.817 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.4 mt -100.79 138.99 37.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 112.419 -2.173 . . . . 1.53 106.685 168.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 110' ' ' THR . 7.3 p -146.41 162.54 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-O 121.374 0.607 . . . . 1.14 109.569 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.82 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.0 p -118.51 110.51 17.47 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.151 -1.386 . . . . 0.58 111.019 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.0 mmt85 -100.44 169.94 8.74 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.47 -0.786 . . . . 3.49 112.742 -171.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 0.0 OUTLIER 61.64 11.51 3.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.17 1.938 . . . . 2.83 109.692 -173.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 111' ' ' ARG . 8.5 t -102.17 14.31 32.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 111.388 -2.642 . . . . 4.3 109.137 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.731 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -110.69 17.73 20.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.708 -1.587 . . . . 4.48 110.386 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -73.9 90.22 1.91 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 112.804 -1.998 . . . . 6.53 111.814 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -112.13 128.49 56.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.566 -0.743 . . . . 9.28 109.604 172.34 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.22 22.57 3.77 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.447 1.118 . . . . 11.58 108.893 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 118' ' ' VAL . 5.7 p -128.51 90.15 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 113.311 -1.768 . . . . 12.38 110.049 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -116.55 125.25 51.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.017 -0.992 . . . . 14.96 109.257 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -88.36 99.35 12.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 17.27 110.275 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 52.6 m 71.62 134.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.054 0.846 . . . . 19.47 111.258 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 84.3 mtp -104.27 119.48 39.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 21.73 111.672 -173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.4 mt 56.73 42.71 26.41 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.977 -0.556 . . . . 23.08 111.777 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.466 0.374 0 O-C-N 123.725 0.64 . . . . 23.96 110.946 -179.324 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 14.0 tppt? . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.324 -0.991 . . . . 8.27 108.324 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.533 ' HA ' ' NE2' ' A' ' 43' ' ' GLN . 2.3 pt-20 -84.47 111.96 19.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.409 -1.268 . . . . 6.87 111.67 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 175.78 89.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.448 -0.796 . . . . 4.55 110.928 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -163.93 138.42 5.82 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.796 -0.446 . . . . 2.71 109.796 164.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.944 ' HG3' HD11 ' A' ' 33' ' ' ILE . 6.8 tp10 167.52 -37.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.618 1.198 . . . . 4.92 108.039 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . . . . . . . . . 14.6 m 80.05 -175.34 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.436 0.902 . . . . 1.22 113.436 159.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.782 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 21.4 ptm -105.89 161.72 14.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.132 -0.94 . . . . 3.19 109.559 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.648 HG23 ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.313 -1.013 0 CA-C-O 118.694 -0.67 . . . . 1.54 110.502 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.68 0.276 . . . . 18.34 110.603 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -133.38 -70.35 0.53 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.086 -0.709 . . . . 15.06 109.086 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 61.47 122.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.106 0.879 . . . . 14.54 111.941 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.0 mt 64.94 103.86 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.181 -0.918 . . . . 10.4 110.563 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.94 -135.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.863 2.375 . . . . 10.74 111.589 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.728 -0.749 . . . . 7.75 111.335 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -16.46 100.86 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 125.141 1.377 . . . . 6.84 113.738 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -92.03 -171.92 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.161 2.574 . . . . 4.84 112.328 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -93.84 179.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.468 -0.567 . . . . 3.26 109.468 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.621 ' H ' HG22 ' A' ' 9' ' ' VAL . 75.1 p -90.26 -113.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.6 0.714 . . . . 2.17 111.561 -174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -170.88 130.44 0.8 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.719 -1.128 . . . . 0.98 110.956 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 110' ' ' THR . 4.6 t -99.2 137.9 25.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.31 -1.314 . . . . 1.35 108.129 170.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.88 123.68 60.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.899 0.381 . . . . 1.84 111.041 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.574 ' NE2' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -137.29 164.38 28.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.979 -0.555 . . . . 2.31 110.223 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HE ' HD21 ' A' ' 108' ' ' LEU . 8.1 mtt180 -120.89 125.05 46.48 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.985 -1.007 . . . . 3.58 109.319 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.28 138.97 36.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.144 -0.48 . . . . 0.86 109.904 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.761 ' HG3' ' HG3' ' A' ' 106' ' ' ARG . 3.9 mp0 -101.68 109.45 21.24 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.572 -0.529 . . . . 1.75 109.572 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 66' ' ' ALA . 32.1 mm -98.5 122.08 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-O 121.63 0.729 . . . . 0.93 109.652 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.64 ' HB3' HG23 ' A' ' 104' ' ' VAL . 25.2 p80 -104.88 72.36 1.01 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.973 0.892 . . . . 3.53 112.402 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.914 ' HG3' ' HD2' ' A' ' 31' ' ' PHE . 17.2 mmtt -106.68 95.83 6.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 113.913 -1.494 . . . . 5.69 109.219 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.0 tp -158.4 146.58 18.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.235 -0.893 . . . . 4.5 111.308 -161.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.647 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.34 116.7 6.93 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.729 0.776 . . . . 5.24 108.915 159.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.115 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 2.0 pt20 -143.61 60.65 1.38 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.697 0.761 . . . . 4.48 110.487 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.46 -91.66 0.21 Allowed Glycine 0 CA--C 1.497 -1.042 0 CA-C-N 113.733 -1.576 . . . . 3.78 113.291 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -71.15 -12.73 61.65 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.49 -0.93 . . . . 6.85 108.49 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.115 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 13.1 m-80 -125.84 136.4 53.05 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.331 -1.304 . . . . 4.85 108.215 -174.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.509 HD22 ' O ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -135.03 108.37 7.8 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 113.493 -1.685 . . . . 3.68 108.174 167.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.844 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -117.69 119.86 62.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.119 -1.4 . . . . 2.9 107.445 176.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' B' ' 168' ' ' VAL . 56.5 tp -162.15 75.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 125.782 1.926 . . . . 4.19 109.081 -169.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' B' ' 167' ' ' MET . . . 177.08 31.22 0.05 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 118.705 -1.712 . . . . 1.62 116.576 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.914 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -109.65 139.63 44.45 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.586 -1.264 . . . . 0.73 107.586 168.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 32.2 t -109.72 131.97 54.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.822 -0.751 . . . . 1.16 111.864 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.796 HG23 HH22 ' A' ' 94' ' ' ARG . 0.0 OUTLIER -156.82 145.25 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 108.01 -1.108 . . . . 0.89 108.01 -176.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' B' ' 165' ' ' GLU . . . -170.93 178.04 43.61 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 118.836 -1.649 . . . . 0.69 113.947 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.923 ' HA2' HD13 ' A' ' 55' ' ' ILE . . . -71.5 133.47 21.57 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 107.299 -2.32 . . . . 1.42 107.299 162.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.45 -25.3 71.32 Favored Glycine 0 CA--C 1.489 -1.582 0 O-C-N 124.992 1.054 . . . . 3.0 112.12 -157.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -141.35 -137.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 121.793 0.806 . . . . 4.71 112.255 -172.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 37' ' ' ILE . 12.0 p-10 -131.46 21.52 4.74 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.257 -1.338 . . . . 7.49 108.111 -170.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.862 HE22 ' HB2' ' B' ' 163' ' ' ASN . 0.0 OUTLIER -60.37 -138.16 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.23 -2.259 . . . . 4.55 111.319 171.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' B' ' 161' ' ' LYS . 33.0 t70 163.15 -67.58 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.852 -0.613 . . . . 5.14 111.869 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 93.8 Cg_endo -71.2 -6.83 20.05 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.088 1.859 . . . . 5.58 109.096 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 t -69.58 -39.73 77.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.125 -2.307 . . . . 6.54 110.927 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.734 ' NE2' ' HB3' ' B' ' 161' ' ' LYS . 5.8 pt20 -82.5 3.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.322 -0.854 . . . . 5.93 111.146 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 9.1 t-20 -23.41 138.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 125.571 1.548 . . . . 6.06 114.151 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.674 ' HA ' ' OG1' ' A' ' 86' ' ' THR . 11.9 Cg_endo -60.1 -19.69 57.6 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 124.209 3.273 . . . . 8.03 112.8 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -92.86 -22.68 19.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.798 -0.816 . . . . 8.87 108.798 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t 74.37 142.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.335 -1.302 . . . . 5.13 110.717 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -54.82 -35.08 63.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.213 -0.903 . . . . 7.43 111.587 -176.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.41 41.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.094 -0.706 . . . . 7.39 109.094 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.69 -80.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.808 -1.087 . . . . 7.82 110.414 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.637 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 13.4 t -91.97 40.32 1.04 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.837 0.827 . . . . 5.12 109.236 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.477 ' CG ' ' HB3' ' A' ' 48' ' ' GLU . 14.4 t70 -77.15 7.92 4.54 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.061 0.934 . . . . 3.97 111.898 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HD3' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 70.4 10.5 7.24 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.253 -1.339 . . . . 6.09 111.014 172.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -42.42 -49.19 5.74 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 124.096 0.872 . . . . 1.05 113.916 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.923 HD13 ' HA2' ' A' ' 35' ' ' GLY . 39.3 mm -128.93 134.22 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.056 -0.35 . . . . 0.67 110.056 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.7 p90 -165.33 162.09 19.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 2.48 111.157 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.872 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.6 p -83.53 138.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 109.357 -0.608 . . . . 0.66 109.357 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.693 HG21 ' HG2' ' B' ' 165' ' ' GLU . 0.5 OUTLIER -113.33 -13.18 12.93 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.545 1.153 . . . . 1.0 111.425 -173.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.583 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -172.16 172.37 4.61 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.389 0.614 . . . . 3.02 111.202 176.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 74.2 t -144.25 138.85 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.543 -1.208 . . . . 0.72 110.486 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -67.47 107.05 2.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.924 -1.139 . . . . 1.77 107.924 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -63.02 140.28 58.86 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.778 1.275 . . . . 3.28 112.034 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.74 83.35 Favored Glycine 0 C--N 1.288 -2.12 0 CA-C-N 111.776 -2.466 . . . . 1.03 111.423 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.25 -131.82 6.36 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.044 -1.074 . . . . 1.27 111.311 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.901 ' HG2' ' HG2' ' A' ' 20' ' ' LYS . 18.0 Cg_endo -95.13 -36.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.922 3.081 . . . . 1.32 114.981 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.825 ' HA ' HG23 ' A' ' 18' ' ' ILE . . . -71.36 -43.73 66.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.122 0.963 . . . . 0.37 109.242 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -84.49 -23.35 29.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.328 -1.305 . . . . 1.45 108.607 -163.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' ALA . 19.9 pt -80.75 -28.88 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 CA-C-N 114.819 -1.082 . . . . 0.89 108.697 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' ILE . . . -66.42 -24.23 66.43 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.828 -1.987 . . . . 0.34 107.966 172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.43 41.21 0.97 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.661 -1.154 . . . . 0.49 111.581 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.662 HD22 HH12 ' A' ' 111' ' ' ARG . 2.7 tm? -116.98 162.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.247 -1.39 . . . . 1.58 107.247 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -159.2 -174.0 4.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.426 -1.324 . . . . 2.36 107.426 -173.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 59' ' ' ARG . 2.3 mm -86.29 114.84 26.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.861 -1.063 . . . . 0.57 112.283 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.744 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 104.64 53.04 0.83 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.117 -1.039 . . . . 0.6 113.139 163.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.872 ' H ' HG12 ' A' ' 57' ' ' VAL . 28.7 m-20 -135.7 145.99 47.27 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.862 -0.335 . . . . 1.35 110.198 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 5.7 mttp -90.65 108.68 19.97 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.507 0.67 . . . . 2.18 111.108 -166.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.686 HG13 HG13 ' A' ' 33' ' ' ILE . 32.2 mm -73.43 110.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.307 -1.315 . . . . 0.64 109.656 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.7 mmt -96.07 -38.75 10.06 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.702 -0.399 . . . . 0.48 110.237 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.0 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 9.9 mt-30 -146.75 149.38 33.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.927 0.87 . . . . 2.26 112.674 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.737 HG12 ' SD ' ' A' ' 85' ' ' MET . 1.0 OUTLIER -111.48 122.32 65.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 113.931 -1.486 . . . . 0.77 111.232 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' A' ' 106' ' ' ARG . 38.7 m-80 53.44 12.33 0.35 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.222 0.609 . . . . 1.9 112.446 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.65 27.24 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.1 112.582 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.595 ' HB2' HG13 ' A' ' 80' ' ' VAL . 6.4 m95 -102.16 101.11 11.4 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 1.0 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 66.1 t0 -47.78 107.46 0.12 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.778 -1.101 . . . . 1.61 110.915 173.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.737 ' SD ' HG12 ' A' ' 80' ' ' VAL . 43.9 mmm -59.71 -27.02 66.09 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.924 -1.034 . . . . 1.72 111.923 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 45' ' ' PRO . 63.2 p -72.4 -21.85 61.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.605 0.594 . . . . 1.25 112.605 -167.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' PRO . 22.2 ptp -96.95 -8.54 30.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.71 -0.396 . . . . 3.22 111.564 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -105.58 -178.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.113 -0.329 . . . . 1.73 110.113 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.069 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 21.7 m -96.59 154.49 17.25 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.094 -1.447 . . . . 1.3 107.094 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.446 ' HD1' ' HG2' ' A' ' 94' ' ' ARG . 3.2 t-80 -56.59 -39.14 73.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.889 0.313 . . . . 2.47 110.47 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 11.3 t70 -57.7 -47.87 81.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.441 . . . . 1.81 110.626 172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 1.069 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -61.57 -43.11 99.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.644 0.735 . . . . 2.66 109.486 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.681 ' HB1' ' CE ' ' A' ' 85' ' ' MET . . . -62.86 -36.33 82.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.441 -1.254 . . . . 0.8 109.113 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.796 HH22 HG23 ' A' ' 33' ' ' ILE . 21.0 mmt180 -68.02 -29.41 68.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.985 -1.007 . . . . 3.95 110.987 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 30.0 mmtp -77.79 -19.55 54.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.112 -0.494 . . . . 2.48 111.433 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.532 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 1.3 mmp_? -82.36 -41.03 20.55 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.819 0.674 . . . . 3.8 112.819 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -71.12 -39.21 72.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.696 0.628 . . . . 1.26 112.696 -178.221 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.774 HG22 HD12 ' A' ' 97' ' ' LEU . 5.5 t -125.45 60.57 1.24 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.521 0.677 . . . . 1.53 111.094 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 47.8 pttt -82.54 -7.71 59.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 1.79 111.402 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' HA ' ' HE ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 64.29 18.13 11.12 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.875 -1.057 . . . . 5.04 109.858 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.529 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 33.3 t -107.65 7.69 28.69 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.402 -1.272 . . . . 2.31 108.604 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.601 ' OE2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -128.22 -176.5 3.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.866 -1.061 . . . . 2.11 109.002 -178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 31.6 mt-10 -124.96 4.28 8.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.905 -1.517 . . . . 3.94 106.905 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 19' ' ' HIS . 11.5 p 175.34 143.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.052 -1.886 . . . . 1.17 109.963 -168.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 80' ' ' VAL . 2.6 p -106.89 125.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 119.839 -0.745 . . . . 2.16 109.279 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.815 ' HB3' ' HA ' ' A' ' 81' ' ' ASN . 32.5 ttt180 -83.72 146.05 28.41 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.029 -0.73 . . . . 3.15 109.029 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 106' ' ' ARG . 6.8 mp -129.23 155.23 45.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.861 0.839 . . . . 1.35 111.967 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD21 ' HE ' ' A' ' 15' ' ' ARG . 6.7 mt -133.86 110.3 9.66 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.714 -1.585 . . . . 1.53 107.569 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 110' ' ' THR . 7.8 p -137.18 165.78 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 115.158 -0.928 . . . . 1.14 108.508 -164.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.3 p -124.42 124.05 41.48 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.555 -1.202 . . . . 0.58 111.042 -175.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.67 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 28.5 mmt180 -92.98 167.93 11.48 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.327 -0.99 . . . . 3.49 108.327 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.667 HE21 ' CA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -90.44 -37.33 14.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.04 0.924 . . . . 2.83 109.566 173.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -171.82 19.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.557 -1.656 . . . . 4.3 110.731 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' H ' ' HB3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -96.6 42.13 1.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.413 1.101 . . . . 4.48 109.81 -174.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.592 ' HB3' HG11 ' A' ' 12' ' ' VAL . 29.3 pt20 -84.27 161.51 20.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.362 -1.745 . . . . 6.53 111.141 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -115.93 138.89 50.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.985 -0.552 . . . . 9.28 110.56 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -142.33 27.41 1.74 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.327 1.061 . . . . 11.58 108.499 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.2 t -131.61 90.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.49 -1.687 . . . . 12.38 109.161 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -100.97 130.16 46.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.519 -0.764 . . . . 14.96 110.617 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.01 -11.4 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.938 -0.574 . . . . 17.27 109.69 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 p 51.1 70.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.002 -0.999 . . . . 19.47 112.159 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.4 mmt -104.63 161.58 14.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.32 -0.855 . . . . 21.73 109.242 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.57 12.54 1.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.615 -0.266 . . . . 23.08 111.645 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.196 0.522 . . . . 23.96 110.311 175.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.734 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 110.25 -0.278 . . . . 8.27 110.25 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . 0.452 ' N ' HE22 ' A' ' 43' ' ' GLN . 31.4 mm-40 63.84 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.091 1.145 . . . . 6.87 114.091 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.862 ' HB2' HE22 ' A' ' 39' ' ' GLN . 29.9 m-20 -147.33 -178.39 6.2 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.933 0.716 . . . . 4.55 112.933 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' B' ' 163' ' ' ASN . 1.7 pt? 160.74 162.66 0.01 OUTLIER 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.225 -1.028 . . . . 2.71 108.225 -165.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 58' ' ' THR . 22.1 mt-10 -87.51 157.21 19.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.296 -0.561 . . . . 4.92 109.958 170.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.777 ' HB2' HH21 ' A' ' 94' ' ' ARG . 2.8 m -153.75 155.21 35.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.931 -0.766 . . . . 1.22 108.931 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.472 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 12.4 ptm -123.43 121.65 36.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.13 0.491 . . . . 3.19 110.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.01 ' HA ' HD12 ' A' ' 29' ' ' LEU . 32.7 m . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.513 -0.767 . . . . 1.54 109.143 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.665 0.269 . . . . 18.34 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -164.64 143.25 6.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 15.06 110.091 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.57 141.58 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.821 -0.437 . . . . 14.54 109.821 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -116.15 99.48 52.7 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 10.4 109.83 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.73 111.95 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.041 2.494 . . . . 10.74 111.453 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.46 32.56 2.71 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 7.75 112.078 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.3 pt20 -81.7 120.49 77.95 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.365 . . . . 6.84 110.377 173.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 81.2 Cg_endo -91.48 -167.84 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.777 2.318 . . . . 4.84 113.291 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 112' ' ' GLN . 1.0 OUTLIER -149.47 -179.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.306 -0.861 . . . . 3.26 108.995 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.587 ' H ' HG22 ' A' ' 9' ' ' VAL . 59.3 p -92.84 -123.84 0.09 Allowed 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.27 -0.877 . . . . 2.17 110.119 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' ARG . . . -171.89 119.75 0.44 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.299 -0.864 . . . . 0.98 111.583 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 t -137.92 108.21 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-N 114.592 -1.185 . . . . 1.35 110.812 174.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.995 ' HB ' ' H ' ' A' ' 111' ' ' ARG 0.328 1.0 OUTLIER -159.7 168.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.334 1.064 . . . . 1.84 111.186 160.59 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.692 ' H ' HG13 ' A' ' 13' ' ' VAL . 1.5 mp0 -100.61 178.31 4.76 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 112.358 -2.201 . . . . 2.31 110.568 -161.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.501 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 6.3 mtt180 -94.33 137.59 33.31 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.187 -1.042 . . . . 3.58 108.187 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG13 ' CD2' ' A' ' 107' ' ' LEU . 1.3 p -138.69 145.1 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.945 -0.702 . . . . 0.86 110.177 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.58 111.24 21.91 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.06 0.934 . . . . 1.75 110.276 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 105' ' ' VAL . 88.2 mt -95.98 97.73 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.136 -1.393 . . . . 0.93 109.96 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.463 ' HB2' HG23 ' A' ' 104' ' ' VAL . 48.3 t-80 -78.4 83.26 4.63 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.614 -1.176 . . . . 3.53 110.678 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.908 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 20.4 pttm -58.7 160.46 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.698 -1.137 . . . . 5.69 110.958 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.4 tp -133.14 124.08 26.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.108 -0.637 . . . . 4.5 112.312 -165.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.878 ' HD2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -73.66 138.22 44.63 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.585 -0.734 . . . . 5.24 111.006 169.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.63 ' HG3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -134.39 63.76 1.62 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.671 -1.15 . . . . 4.48 111.097 174.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . 16.64 69.15 0.01 OUTLIER Glycine 0 N--CA 1.469 0.877 0 O-C-N 125.393 1.683 . . . . 3.78 116.202 174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 30.4 tt0 142.26 -25.04 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 104.218 -2.512 . . . . 6.85 104.218 -169.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.656 ' HB3' HD11 ' A' ' 28' ' ' ILE . 8.0 m-80 -128.63 133.33 48.24 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 112.758 -2.019 . . . . 4.85 110.961 -172.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.878 HD13 ' HD2' ' A' ' 22' ' ' ARG . 2.4 mm? -115.64 109.12 17.29 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 111.69 -2.504 . . . . 3.68 105.24 165.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.908 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 10.3 mm -110.16 132.36 58.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.479 -0.489 . . . . 2.9 110.83 -174.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.789 ' HB3' ' HB ' ' B' ' 168' ' ' VAL . 10.7 tp -86.23 -46.51 10.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.3 -1.37 . . . . 4.19 107.3 164.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' HG2' ' A' ' 65' ' ' PRO . . . 109.01 14.11 16.04 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.57 -1.195 . . . . 1.62 115.165 166.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 25.6 p90 -166.85 -178.42 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.466 1.133 . . . . 0.73 112.038 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.895 ' HB2' ' HG3' ' B' ' 167' ' ' MET . 44.8 t -126.06 139.42 53.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.527 -0.545 . . . . 1.16 109.527 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' B' ' 165' ' ' GLU . 20.3 pt -125.47 163.21 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.064 -0.654 . . . . 0.89 109.42 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' B' ' 165' ' ' GLU . . . -146.39 120.29 1.28 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.077 -1.059 . . . . 0.69 111.197 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.978 ' HA3' HD13 ' A' ' 55' ' ' ILE . . . -150.62 109.62 0.43 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.287 -1.435 . . . . 1.42 114.244 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.939 ' HA3' ' HB2' ' B' ' 163' ' ' ASN . . . 142.82 -23.24 2.31 Favored Glycine 0 CA--C 1.493 -1.31 0 C-N-CA 120.262 -0.97 . . . . 3.0 111.434 175.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.1 pt -56.99 -56.14 16.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.129 -1.536 . . . . 4.71 113.952 -164.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' H ' HG13 ' A' ' 37' ' ' ILE . 22.3 t70 -119.02 13.97 13.09 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.066 0.936 . . . . 7.49 109.204 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.778 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.37 -16.44 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.622 -1.172 . . . . 4.55 112.469 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.57 123.18 82.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.177 -0.675 . . . . 5.14 109.177 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 30.8 Cg_endo -59.31 -23.53 70.36 Favored 'Trans proline' 0 C--N 1.327 -0.568 0 C-N-CA 124.32 3.347 . . . . 5.58 113.142 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.456 ' H ' ' HG2' ' B' ' 161' ' ' LYS . 19.1 t -77.1 -33.05 57.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.146 -0.479 . . . . 6.54 110.801 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -99.43 -8.74 24.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.484 0.659 . . . . 5.93 109.422 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 23.0 t-20 -150.68 88.65 4.54 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.666 -1.152 . . . . 6.06 110.639 173.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.07 -1.06 11.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.789 2.326 . . . . 8.03 111.412 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.92 -22.95 17.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 8.87 111.008 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.5 m -122.78 156.9 33.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 120.888 0.375 . . . . 5.13 110.144 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 47' ' ' SER . 10.3 pt-20 163.47 -23.6 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.349 -1.296 . . . . 7.43 108.758 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -140.03 121.03 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.997 -1.001 . . . . 7.39 109.752 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.8 mptt 68.13 -55.24 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.609 0.764 . . . . 7.82 111.072 -173.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 p -77.21 -6.41 52.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.082 0.468 . . . . 5.12 110.399 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -50.77 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.691 -1.141 . . . . 3.97 112.035 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm 60.69 29.13 18.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.819 -0.808 . . . . 6.09 108.819 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.778 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -40.62 -67.48 0.71 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.392 -1.276 . . . . 1.05 115.235 -168.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.978 HD13 ' HA3' ' A' ' 35' ' ' GLY . 44.1 mm -114.61 125.02 71.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.892 -0.41 . . . . 0.67 109.892 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 p90 -155.82 162.47 40.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.071 0.462 . . . . 2.48 111.035 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -78.54 137.17 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 116.022 -0.535 . . . . 0.66 110.071 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 t -109.83 -10.99 14.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.129 0.893 . . . . 1.0 110.412 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 0.3 OUTLIER -166.68 172.24 10.78 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.549 0.69 . . . . 3.02 111.378 175.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.66 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 43.7 t -143.21 131.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.122 -1.399 . . . . 0.72 108.349 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -77.5 105.91 8.94 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.307 -0.957 . . . . 1.77 108.468 173.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.93 146.88 54.19 Favored 'General case' 0 N--CA 1.405 -2.703 0 CA-C-N 114.21 -1.359 . . . . 3.28 112.018 -171.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . 67.69 27.04 73.63 Favored Glycine 0 C--N 1.297 -1.613 0 CA-C-N 112.473 -2.149 . . . . 1.03 110.845 -175.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.624 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -115.43 -135.01 5.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.439 -0.886 . . . . 1.27 112.116 -175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 68' ' ' ILE . 7.1 Cg_endo -93.87 -35.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.997 3.131 . . . . 1.32 114.428 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -73.39 -41.08 63.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.893 0.854 . . . . 0.37 110.415 -163.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.17 -23.86 26.36 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.421 -1.263 . . . . 1.45 108.871 -167.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 64' ' ' GLY . 1.8 pp -83.27 -26.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 CA-C-O 122.662 1.22 . . . . 0.89 108.658 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . . . -67.45 -29.41 68.87 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.517 -2.129 . . . . 0.34 107.077 171.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.92 41.5 0.84 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.777 -1.556 . . . . 0.49 112.537 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 72' ' ' GLN . 13.1 tp -115.85 171.26 7.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.657 -1.238 . . . . 1.58 107.657 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.681 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 4.0 pp0? -165.52 -179.92 5.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.403 -0.962 . . . . 2.36 108.403 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.2 mm -82.85 112.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.03 0.443 . . . . 0.57 112.027 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 102.53 71.38 0.89 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 111.059 -0.816 . . . . 0.6 111.059 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 1.5 t0 -150.36 129.48 12.7 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.661 -0.496 . . . . 1.35 109.661 -171.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' HB2' ' OG1' ' A' ' 110' ' ' THR . 12.8 mtpp -83.12 107.7 15.87 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 122.109 -0.369 . . . . 2.18 111.093 -167.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 33' ' ' ILE . 65.8 mt -80.78 106.64 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.412 0.625 . . . . 0.64 110.031 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mmt -87.1 -31.6 20.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.685 -0.689 . . . . 0.48 111.061 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 1.028 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 1.3 pt20 -161.39 156.79 24.26 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 121.417 0.627 . . . . 2.26 111.263 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -128.11 134.15 65.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 113.972 -1.467 . . . . 0.77 110.531 -177.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 17.4 m-80 54.66 22.72 4.23 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.735 0.647 . . . . 1.9 111.152 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.34 10.01 66.37 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.047 -0.979 . . . . 1.1 114.282 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 6.9 m95 -107.61 86.55 2.32 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 118.201 1.0 . . . . 2.75 109.66 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 1.028 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 8.1 t70 -25.6 106.94 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 O-C-N 124.472 1.107 . . . . 1.61 111.52 166.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.022 ' HG3' ' HA ' ' A' ' 79' ' ' GLN . 33.8 mtp -76.4 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.097 -0.956 . . . . 1.72 110.143 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 85' ' ' MET . 60.6 p 64.31 -45.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.06 1.744 . . . . 1.25 114.316 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.4 mtt -125.61 17.51 8.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.712 0.292 . . . . 3.22 111.747 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG12 ' CB ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -83.14 173.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.857 0.837 . . . . 1.73 112.749 -175.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.755 ' HB ' ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -108.1 165.77 11.23 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.151 -1.386 . . . . 1.3 108.265 176.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.813 ' HB2' HD11 ' B' ' 164' ' ' LEU . 59.1 t-80 -50.73 -49.53 57.56 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.507 0.504 . . . . 2.47 110.853 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 14.1 t70 -64.18 -41.3 97.17 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.075 -0.966 . . . . 1.81 110.488 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.755 ' HG2' ' HB ' ' A' ' 89' ' ' THR . 5.7 mm100 -61.34 -46.79 88.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 2.66 109.476 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.13 -37.15 86.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.218 -1.03 . . . . 0.8 108.218 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.797 ' NH2' ' HB3' ' B' ' 166' ' ' SER . 7.0 mmt-85 -69.91 -26.12 64.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.112 -0.949 . . . . 3.95 111.38 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 41.8 mttm -70.44 -31.51 68.71 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.656 -0.417 . . . . 2.48 110.763 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -86.94 -43.93 12.02 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.855 0.687 . . . . 3.8 112.855 -178.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 37.1 mt -65.55 -46.76 78.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.011 0.91 . . . . 1.26 111.023 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -123.31 57.36 1.15 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.895 -1.502 . . . . 1.53 110.972 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.774 ' HE2' ' HB3' ' A' ' 102' ' ' GLU . 49.1 pttt -74.47 -12.56 60.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.79 112.147 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 65.66 14.08 9.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.174 -0.921 . . . . 5.04 111.371 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.522 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 32.9 t -119.72 7.34 11.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.544 -0.753 . . . . 2.31 109.882 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.774 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -111.92 177.46 4.64 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.907 0.861 . . . . 2.11 109.731 -177.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -116.81 -4.64 11.58 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.029 -1.441 . . . . 3.94 107.234 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 19' ' ' HIS . 13.3 p -178.24 147.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.938 -1.483 . . . . 1.17 109.996 -164.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 18' ' ' ILE . 3.6 t -98.05 110.82 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.262 -0.975 . . . . 2.16 109.867 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -83.94 132.61 34.75 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.383 -0.599 . . . . 3.15 109.383 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.651 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -144.03 147.95 34.55 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.53 1.157 . . . . 1.35 112.165 166.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.682 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 7.1 mt -99.49 109.07 21.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 112.887 -1.96 . . . . 1.53 107.729 173.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.856 HG13 ' CG1' ' A' ' 13' ' ' VAL . 13.0 p -121.05 167.56 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.915 -0.402 . . . . 1.14 109.915 -168.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.701 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 7.3 p -153.14 126.75 8.77 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.656 0.984 . . . . 0.58 113.656 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.995 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -92.59 173.41 7.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.402 0.681 . . . . 3.49 109.567 177.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.867 ' HB3' HG11 ' A' ' 9' ' ' VAL . 8.5 mm-40 -77.71 -58.65 3.15 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.109 0.48 . . . . 2.83 109.905 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 112' ' ' GLN . 6.4 t 167.19 -30.66 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.253 -1.34 . . . . 4.3 108.897 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.93 77.86 2.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.738 -1.574 . . . . 4.48 109.954 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.15 -165.72 1.41 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 112.714 -2.039 . . . . 6.53 111.023 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -120.64 176.33 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 9.28 110.569 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.61 22.13 1.47 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.007 0.908 . . . . 11.58 109.196 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.77 91.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.08 -1.418 . . . . 12.38 110.34 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.23 89.82 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.483 -0.78 . . . . 14.96 109.449 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -83.88 -4.42 58.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.163 -0.471 . . . . 17.27 110.558 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.7 m -65.38 -79.6 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 19.47 111.584 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.8 -13.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.101 0.408 . . . . 21.73 112.101 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.8 mt 65.05 -166.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.494 0.496 . . . . 23.08 110.353 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.803 0.335 . . . . 23.96 110.787 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 42' ' ' SER . 11.5 mptt . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.061 0.393 . . . . 8.27 112.061 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.33 82.85 0.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.912 0.863 . . . . 6.87 110.86 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . 0.939 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 94.6 m-20 -91.03 -163.99 1.11 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.036 -0.983 . . . . 4.55 109.905 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 90' ' ' HIS . 0.7 OUTLIER -178.42 -158.33 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.924 -0.398 . . . . 2.71 109.924 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . 0.681 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER 175.67 -156.72 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.256 0.973 . . . . 4.92 112.099 168.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' SER . . . . . 0.797 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 8.3 t -158.69 177.25 11.4 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 113.617 0.969 . . . . 1.22 113.617 -161.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.895 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 37.0 ttm -128.81 124.35 35.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.529 -1.214 . . . . 3.19 109.083 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.789 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.979 -0.555 . . . . 1.54 110.829 -170.547 . . . . . . . . 2 2 . 1 stop_ save_